data_1m9w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m9w _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 13.51 96.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 130.969 3.708 . . . . 0.0 114.943 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 167.4 9.9 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 123.293 1.521 . . . . 0.0 112.161 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 m -146.37 155.75 42.83 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.051 2.941 . . . . 0.0 103.967 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.74 153.64 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.639 0.733 . . . . 0.0 109.588 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HZ3' ' CG ' ' A' ' 10' ' ' ASP . 17.8 mtpt -112.78 120.42 41.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.728 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.6 mtm -80.25 119.94 23.68 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.47 2.708 . . . . 0.0 106.109 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.34 97.74 1.06 Allowed Glycine 0 N--CA 1.47 0.929 0 N-CA-C 106.347 -2.701 . . . . 0.0 106.347 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -59.51 155.89 14.3 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.42 ' CG ' ' HZ3' ' A' ' 6' ' ' LYS . 94.2 m-20 -57.52 -17.89 16.16 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -84.97 -3.74 58.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.591 1.556 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.18 14.6 68.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.241 0.924 . . . . 0.0 112.955 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.34 136.36 33.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.341 0.656 . . . . 0.0 109.798 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.23 65.28 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.8 2.04 . . . . 0.0 111.653 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -145.82 148.53 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.979 0.912 . . . . 0.0 108.563 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.93 135.98 33.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.779 1.232 . . . . 0.0 110.656 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -117.87 111.02 39.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.943 1.297 . . . . 0.0 112.216 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.25 142.91 71.35 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 115.501 1.308 . . . . 0.0 115.501 -2.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -3.86 58.92 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 112.36 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m -151.96 129.28 11.27 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 129.732 3.213 . . . . 0.0 107.521 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.3 164.82 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.98 113.17 10.53 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.244 1.021 . . . . 0.0 111.703 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 141.35 52.03 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.174 1.806 . . . . 0.0 112.374 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -11.59 99.67 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 130.779 3.632 . . . . 0.0 115.747 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.31 -12.95 28.43 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.778 1.18 . . . . 0.0 112.679 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.43 173.06 12.38 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.549 1.166 . . . . 0.0 109.718 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 175.96 6.91 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.72 108.67 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 129.902 3.281 . . . . 0.0 106.64 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -104.77 52.51 0.74 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -49.54 142.83 7.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 120.739 3.607 . . . . 0.0 120.739 177.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.57 152.82 34.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 130.92 3.688 . . . . 0.0 112.65 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.441 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 10.4 t-20 -80.12 122.48 26.86 Favored 'General case' 0 CA--C 1.543 0.678 1 C-N-CA 132.479 4.312 . . . . 0.0 109.868 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -136.31 -29.88 0.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.974 -1.489 . . . . 0.0 114.112 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.65 157.44 38.16 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp 38.22 51.33 1.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 131.379 3.871 . . . . 0.0 112.534 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.86 151.39 2.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 130.16 3.384 . . . . 0.0 112.579 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.6 176.46 41.64 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-O 122.371 0.905 . . . . 0.0 113.135 -2.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.58 157.0 43.37 Favored 'General case' 0 N--CA 1.462 0.174 1 C-N-CA 132.541 4.336 . . . . 0.0 113.82 177.911 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -147.29 161.8 40.24 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.328 1.451 . . . . 0.0 109.974 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mm -138.1 98.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.193 0.997 . . . . 0.0 111.996 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.53 122.15 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 120.796 -1.19 . . . . 0.0 112.624 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -82.04 162.01 22.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.355 0.598 . . . . 0.0 110.952 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.25 -14.07 34.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.67 39.75 0.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.91 1.686 . . . . 0.0 111.96 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 122.376 1.084 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -63.4 1.49 0.52 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.491 2.717 . . . . 0.0 114.279 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.5 4.21 5.1 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.889 2.876 . . . . 0.0 110.936 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.08 10.02 4.15 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.295 2.238 . . . . 0.0 113.054 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -132.73 162.9 30.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 129.396 3.078 . . . . 0.0 110.532 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -68.67 0.37 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.004 2.122 . . . . 0.0 110.904 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' LYS . 13.3 t 150.74 154.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.229 3.412 . . . . 0.0 107.764 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -69.77 15.05 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.811 1.645 . . . . 0.0 112.448 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' SER . 1.3 tpmp? -145.03 -18.04 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.69 3.196 . . . . 0.0 111.582 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.7 37.79 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 122.138 2.244 . . . . 0.0 110.555 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 tp -150.71 143.31 24.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' CB ' HD21 ' A' ' 33' ' ' ASN . . . -114.15 108.74 17.38 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -112.9 -26.18 8.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.28 49.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.586 1.154 . . . . 0.0 111.365 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.74 113.95 1.38 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.878 1.271 . . . . 0.0 111.64 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.37 -11.61 28.5 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.903 -1.499 . . . . 0.0 112.794 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -62.17 162.94 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.174 1.987 . . . . 0.0 109.606 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.4 t -161.25 162.55 31.13 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 119.755 -1.841 . . . . 0.0 114.998 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CE1' ' CD1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -142.3 146.25 34.86 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 100.35 -3.944 . . . . 0.0 100.35 176.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -118.85 149.7 41.1 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 119.43 -2.044 . . . . 0.0 111.64 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.9 p -134.08 141.99 47.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.503 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -139.79 124.51 18.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.547 2.339 . . . . 0.0 107.908 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.75 146.29 33.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 118.837 2.903 . . . . 0.0 118.837 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 t -131.69 15.28 4.88 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.28 108.95 39.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.818 2.553 . . . . 0.0 106.463 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -52.47 119.26 5.62 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.71 1.606 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.59 -178.95 24.86 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 128.956 3.169 . . . . 0.0 108.867 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -112.17 131.48 55.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.719 -1.24 . . . . 0.0 111.851 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.25 0.1 OUTLIER -121.94 137.25 54.86 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 124.328 2.013 . . . . 0.0 116.045 177.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -84.25 148.34 26.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 109.959 -3.291 . . . . 0.0 112.951 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -155.53 168.58 26.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.373 1.869 . . . . 0.0 110.06 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -167.61 172.74 9.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.72 1.208 . . . . 0.0 111.628 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.92 114.71 29.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -41.36 -61.45 1.37 Allowed Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.37 -0.78 8.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.828 3.018 . . . . 0.0 114.973 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -129.53 -3.69 4.81 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -39.37 -59.51 1.06 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.83 2.452 . . . . 0.0 112.083 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.36 -13.13 59.92 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.621 1.581 . . . . 0.0 116.42 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.48 -6.07 28.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.839 2.456 . . . . 0.0 111.603 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.41 5.89 33.97 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 117.744 -1.587 . . . . 0.0 116.459 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.3 ttt -81.27 62.53 5.23 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.202 2.001 . . . . 0.0 110.497 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.57 149.26 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 130.292 3.437 . . . . 0.0 108.828 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.46 -178.39 34.41 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -144.72 124.29 13.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.77 153.7 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 129.558 3.143 . . . . 0.0 109.197 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.48 134.58 62.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 117.999 -1.001 . . . . 0.0 108.489 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.89 65.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 119.137 3.014 . . . . 0.0 119.137 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 129.578 3.151 . . . . 0.0 115.002 177.782 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 50.4 77.85 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.695 1.598 . . . . 0.0 111.255 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.94 165.0 23.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 123.81 1.767 . . . . 0.0 115.133 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -150.28 142.77 24.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.805 3.242 . . . . 0.0 105.491 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.75 153.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 122.802 1.287 . . . . 0.0 111.19 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HZ3' ' CG ' ' A' ' 10' ' ' ASP . 11.8 mtpt -117.57 120.97 39.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.488 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.4 mmm -83.09 121.98 27.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.264 2.226 . . . . 0.0 106.04 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.51 98.07 0.89 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -61.72 155.25 23.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.671 -0.265 . . . . 0.0 111.474 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CG ' ' HZ3' ' A' ' 6' ' ' LYS . 84.3 m-20 -55.35 -20.43 11.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.392 1.077 . . . . 0.0 113.639 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -84.92 -3.05 58.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.928 1.291 . . . . 0.0 113.216 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.41 12.31 76.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.131 0.872 . . . . 0.0 111.863 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.72 128.66 34.21 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.42 64.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.969 2.108 . . . . 0.0 110.898 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.48 155.23 22.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.751 1.221 . . . . 0.0 109.374 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' CE1' ' CE1' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -101.42 136.9 40.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.04 0.924 . . . . 0.0 110.964 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.92 109.05 34.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 125.787 1.635 . . . . 0.0 112.464 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.2 141.32 65.1 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 N-CA-C 116.639 1.746 . . . . 0.0 116.639 -2.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -15.71 59.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.752 2.421 . . . . 0.0 113.917 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -153.12 133.35 13.48 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.431 2.692 . . . . 0.0 106.165 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.64 167.15 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.626 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -136.87 114.02 10.68 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.041 0.838 . . . . 0.0 111.164 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.84 -172.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.965 1.706 . . . . 0.0 109.754 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 171.51 9.94 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.66 84.2 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.295 2.238 . . . . 0.0 111.353 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 18.45 3.61 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.002 2.239 . . . . 0.0 113.571 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -106.64 177.39 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.342 1.457 . . . . 0.0 112.037 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -120.61 161.88 20.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -148.85 103.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.431 2.292 . . . . 0.0 107.184 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 104.13 13.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.363 1.065 . . . . 0.0 113.46 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -102.66 119.52 38.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.42 151.31 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 108.944 -3.753 . . . . 0.0 112.751 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.469 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 18.3 t-20 -79.7 113.88 18.19 Favored 'General case' 0 C--N 1.324 -0.511 1 C-N-CA 132.877 4.471 . . . . 0.0 108.553 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -127.61 -27.34 2.87 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 116.445 -1.74 . . . . 0.0 114.015 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.77 159.12 43.1 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.22 -66.32 0.31 Allowed 'General case' 0 CA--C 1.518 -0.258 1 C-N-CA 132.185 4.194 . . . . 0.0 111.75 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m 66.22 147.88 0.11 Allowed Pre-proline 0 C--N 1.292 -1.905 2 C-N-CA 132.966 4.506 . . . . 0.0 111.556 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.44 179.07 31.3 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-O 122.418 0.924 . . . . 0.0 112.318 -2.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.61 160.19 42.03 Favored 'General case' 0 CA--C 1.534 0.35 1 C-N-CA 135.149 5.38 . . . . 0.0 113.603 177.768 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.49 154.65 39.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.646 1.579 . . . . 0.0 111.668 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' CG2' ' CE1' ' A' ' 69' ' ' PHE . 4.2 mp -124.72 95.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 110.492 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -120.21 116.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 119.962 -1.711 . . . . 0.0 114.342 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -78.94 134.24 36.86 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.963 0.905 . . . . 0.0 109.906 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.44 58.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.67 70.82 0.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.801 1.64 . . . . 0.0 109.551 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 124.217 1.007 . . . . 0.0 109.998 177.706 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -63.79 -5.81 4.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.781 2.032 . . . . 0.0 114.245 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.55 -3.27 8.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.254 1.422 . . . . 0.0 110.482 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.12 3.01 9.87 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -136.59 161.31 36.26 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.272 1.397 . . . . 0.0 112.07 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.83 -24.22 64.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 112.813 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 59' ' ' LYS . 3.9 t 66.32 99.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 24.82 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 1 C-N-CA 140.867 7.667 . . . . 0.0 118.563 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.72 -12.4 0.12 Allowed 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 131.52 3.928 . . . . 0.0 110.291 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.96 148.7 50.04 Favored Glycine 0 N--CA 1.493 2.446 0 CA-C-N 123.867 3.03 . . . . 0.0 106.285 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tp -140.55 156.92 46.16 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.42 100.98 7.47 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 101.084 -3.673 . . . . 0.0 101.084 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.8 -19.44 12.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.48 134.23 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.467 1.03 . . . . 0.0 111.719 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.62 113.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.208 1.403 . . . . 0.0 112.295 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.84 26.8 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.818 -1.546 . . . . 0.0 112.484 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -68.03 164.77 19.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 120.541 2.17 . . . . 0.0 108.851 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -168.08 166.02 13.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 118.928 -2.357 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.401 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.41 136.22 32.86 Favored 'General case' 0 CA--C 1.55 0.959 1 N-CA-C 98.612 -4.588 . . . . 0.0 98.612 176.655 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -106.8 144.47 33.4 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 118.654 -2.529 . . . . 0.0 109.278 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -117.41 142.51 47.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.037 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.3 m -151.38 89.11 1.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 152.65 21.73 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 127.008 2.123 . . . . 0.0 114.539 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -129.16 2.47 5.2 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -90.82 102.8 5.78 Favored Pre-proline 0 N--CA 1.438 -1.063 0 C-N-CA 126.954 2.102 . . . . 0.0 108.787 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -56.54 123.78 14.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.003 3.135 . . . . 0.0 108.461 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.46 170.91 27.94 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.425 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.7 t -111.39 126.12 54.6 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 131.25 47.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.967 1.365 . . . . 0.0 113.989 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 148.49 25.87 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.718 2.007 . . . . 0.0 112.593 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -153.12 163.5 39.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.96 0.886 . . . . 0.0 109.489 177.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -159.01 178.21 10.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.525 1.53 . . . . 0.0 112.48 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.2 t -113.16 109.05 18.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.36 1.464 . . . . 0.0 107.212 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -38.12 -61.25 0.85 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.75 -10.64 27.41 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.154 1.903 . . . . 0.0 115.927 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -128.95 -2.78 5.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -44.92 34.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.079 1.752 . . . . 0.0 113.103 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.43 -14.78 67.3 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.226 1.393 . . . . 0.0 115.12 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.51 -3.34 26.99 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.094 2.958 . . . . 0.0 110.998 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.15 32.55 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 117.589 -1.673 . . . . 0.0 116.282 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.0 ttt -81.45 64.94 6.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.489 2.144 . . . . 0.0 109.258 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.96 158.41 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 131.178 3.791 . . . . 0.0 109.827 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.22 -168.61 35.31 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 114.056 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -131.92 173.21 11.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.285 1.034 . . . . 0.0 110.008 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 t -149.95 140.76 16.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 129.585 3.154 . . . . 0.0 107.026 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.7 t -127.31 129.23 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.75 141.71 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.428 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.25 1.087 1 C-N-CA 136.377 5.871 . . . . 0.0 111.779 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.409 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.19 -1.386 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.9 m120 4.16 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 129.444 3.098 . . . . 0.0 115.605 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.43 -178.38 6.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 118.267 2.691 . . . . 0.0 118.267 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 m -159.46 120.11 3.14 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.9 159.76 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 123.625 1.679 . . . . 0.0 109.829 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -111.53 112.1 23.59 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.311 1.444 . . . . 0.0 109.084 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.2 mtt -74.39 115.52 14.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.7 95.33 1.75 Allowed Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.1 t -54.17 148.71 10.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.912 0.856 . . . . 0.0 111.991 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -22.7 21.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 p -75.05 -12.74 60.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.783 2.033 . . . . 0.0 111.343 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.02 66.44 1.62 Allowed Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.79 134.86 30.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.19 70.28 0.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.41 1.884 . . . . 0.0 111.912 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.49 133.52 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.11 145.53 31.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -137.07 103.18 8.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.279 1.032 . . . . 0.0 112.431 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . 0.374 8.1 Cg_exo -70.44 126.58 10.25 Favored 'Cis proline' 0 CA--C 1.559 1.774 1 N-CA-C 128.411 6.273 . . . . 0.0 128.411 -2.102 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -80.51 -11.99 59.6 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.703 3.201 . . . . 0.0 112.667 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -150.33 120.42 7.22 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 130.356 3.462 . . . . 0.0 105.215 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -136.83 157.08 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.05 0.386 . . . . 0.0 111.769 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -131.68 107.38 8.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.125 0.964 . . . . 0.0 110.652 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.35 -175.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.707 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -134.0 172.2 13.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 177.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 111.97 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.418 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.39 -13.92 59.69 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.732 1.634 . . . . 0.0 114.506 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 98.3 mt-10 -79.67 162.64 25.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.715 1.245 . . . . 0.0 110.701 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 177.57 4.95 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.327 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.95 101.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 66.64 3.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.109 0.964 . . . . 0.0 112.437 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.45 138.38 43.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.469 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 39.2 t -118.28 151.58 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 1 C-N-CA 132.432 4.293 . . . . 0.0 116.485 -176.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -72.56 114.79 11.07 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -109.72 -41.55 4.51 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 114.108 -2.853 . . . . 0.0 113.336 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -169.65 152.64 4.7 Favored 'General case' 0 N--CA 1.483 1.191 1 N-CA-C 122.949 4.426 . . . . 0.0 122.949 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 tp 63.11 56.84 1.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.828 2.051 . . . . 0.0 108.521 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.44 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 3.2 m -60.75 154.11 59.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.083 2.153 . . . . 0.0 111.478 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.36 171.51 63.96 Favored 'Cis proline' 0 CA--C 1.545 1.045 0 N-CA-C 114.677 0.991 . . . . 0.0 114.677 -1.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 37' ' ' SER 0.292 0.8 OUTLIER -157.59 163.12 38.65 Favored 'General case' 0 C--O 1.21 -0.988 1 C-N-CA 136.504 5.921 . . . . 0.0 119.29 177.846 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.08 169.3 23.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.949 1.3 . . . . 0.0 113.425 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mm -131.02 83.48 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 125.548 1.539 . . . . 0.0 111.459 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.43 110.71 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.148 0.975 . . . . 0.0 111.15 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 39.5 m-85 -69.09 166.93 17.12 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.65 -20.23 17.77 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 79.93 70.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.38 2.272 . . . . 0.0 106.477 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.55 0.973 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -177.358 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -60.1 -7.15 1.68 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.361 1.865 . . . . 0.0 113.248 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.48 1.39 14.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.65 1.58 . . . . 0.0 111.842 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.73 3.56 2.07 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -118.15 163.7 16.25 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.023 2.129 . . . . 0.0 113.877 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.52 165.49 25.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.361 1.464 . . . . 0.0 110.588 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -64.42 150.52 46.27 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.099 -1.626 . . . . 0.0 110.166 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -65.36 -20.42 66.38 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.607 -1.308 . . . . 0.0 110.847 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.92 -14.98 13.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.995 0.518 . . . . 0.0 111.306 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.66 153.4 33.08 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 104.822 -3.311 . . . . 0.0 104.822 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.07 177.34 10.81 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.78 96.35 6.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -103.57 -3.54 25.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . -146.43 129.77 16.72 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 120.411 1.459 . . . . 0.0 112.151 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.88 123.2 4.94 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.494 -1.379 . . . . 0.0 114.636 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.65 0.67 32.49 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 127.413 2.435 . . . . 0.0 114.697 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 64' ' ' ALA . 9.0 mt-10 -67.89 -67.04 0.49 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.688 2.744 . . . . 0.0 118.201 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.469 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 2.5 p 70.27 172.08 0.31 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 71' ' ' SER . 0.1 OUTLIER -163.62 150.85 12.43 Favored 'General case' 0 CA--C 1.549 0.917 1 N-CA-C 99.906 -4.109 . . . . 0.0 99.906 176.074 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -108.84 138.54 45.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 118.392 -2.693 . . . . 0.0 109.087 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 62.5 p -117.19 160.09 21.61 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 m -157.75 138.75 13.3 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.277 0.2 OUTLIER -156.19 155.1 31.86 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 120.174 3.398 . . . . 0.0 120.174 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.2 t -139.82 23.5 2.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.458 2.303 . . . . 0.0 116.746 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -102.79 86.88 1.06 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.772 1.629 . . . . 0.0 112.121 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.26 114.07 0.9 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.726 2.284 . . . . 0.0 110.317 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.09 -132.78 3.06 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.186 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.72 128.55 2.46 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.439 -0.881 . . . . 0.0 110.488 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -124.61 141.56 52.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 124.297 1.999 . . . . 0.0 112.53 176.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 m -77.73 144.64 37.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 110.297 -3.138 . . . . 0.0 110.315 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 34.3 p90 -147.21 164.85 31.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.731 1.613 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -170.26 175.17 5.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.068 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.9 t -107.97 112.38 24.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.764 -2.016 . . . . 0.0 106.622 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.86 -65.52 0.29 Allowed Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.883 1.22 . . . . 0.0 113.869 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.98 -2.53 5.69 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.81 3.007 . . . . 0.0 116.499 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -132.37 11.31 4.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -13.83 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.46 -7.51 32.12 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.602 2.049 . . . . 0.0 113.158 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.63 -8.33 23.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.083 2.553 . . . . 0.0 110.759 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.83 2.15 32.17 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 117.78 -1.567 . . . . 0.0 115.868 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.2 ttt -83.26 66.41 8.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.526 2.163 . . . . 0.0 110.65 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.26 148.47 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 129.205 3.002 . . . . 0.0 108.816 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.65 -178.29 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -140.79 113.0 7.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.87 1.668 . . . . 0.0 114.041 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.95 140.98 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 125.01 1.324 . . . . 0.0 107.638 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -118.38 129.36 74.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.67 131.75 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 O-C-N 124.227 0.954 . . . . 0.0 112.692 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.2 pt-20 . . . . . 0 C--O 1.255 1.363 1 C-N-CA 136.294 5.837 . . . . 0.0 116.204 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 34.47 78.24 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.334 2.653 . . . . 0.0 112.675 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.88 166.81 15.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.8 m -144.22 142.27 30.39 Favored 'General case' 0 C--N 1.329 -0.32 1 C-N-CA 132.489 4.316 . . . . 0.0 103.37 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.36 151.89 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 122.183 0.992 . . . . 0.0 109.436 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -112.99 126.82 55.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.459 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.9 mtm -90.71 125.88 35.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.866 2.066 . . . . 0.0 107.401 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.87 93.78 0.9 Allowed Glycine 0 N--CA 1.465 0.605 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -52.38 154.14 2.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.642 0.721 . . . . 0.0 112.526 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -16.19 34.44 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.993 -1.067 . . . . 0.0 113.112 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -82.94 -3.01 56.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.462 1.905 . . . . 0.0 111.451 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.47 6.13 84.01 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.894 1.712 . . . . 0.0 114.127 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.83 38.51 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.619 0.768 . . . . 0.0 110.048 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.06 71.56 0.83 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.857 1.663 . . . . 0.0 110.924 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.61 158.84 4.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.66 1.184 . . . . 0.0 108.268 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.16 137.41 42.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.627 1.571 . . . . 0.0 111.943 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.15 107.06 40.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.276 1.43 . . . . 0.0 110.92 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.68 140.6 51.73 Favored 'Cis proline' 0 CA--C 1.549 1.235 0 N-CA-C 117.271 1.989 . . . . 0.0 117.271 -2.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.12 -9.7 59.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 129.147 2.979 . . . . 0.0 113.691 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -149.45 129.66 13.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 129.238 3.015 . . . . 0.0 106.956 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.66 167.56 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.577 1.08 . . . . 0.0 112.055 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -138.68 116.1 11.22 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.48 173.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.62 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.63 146.68 52.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -7.83 87.5 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 129.839 3.256 . . . . 0.0 116.826 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -8.24 29.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.693 1.616 . . . . 0.0 115.316 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.19 -172.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.422 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -136.44 161.05 36.92 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -143.04 100.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.237 2.615 . . . . 0.0 106.627 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HE3' ' OE2' ' A' ' 28' ' ' GLU . 6.6 ptpp? -101.49 84.8 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.6 142.27 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 118.602 2.816 . . . . 0.0 118.602 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.37 156.51 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 129.795 3.238 . . . . 0.0 112.88 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 62' ' ' ALA . 9.1 m-20 -75.64 140.31 42.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.036 2.534 . . . . 0.0 109.873 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.19 -30.95 0.33 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 116.178 -1.867 . . . . 0.0 114.234 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -158.16 157.76 33.33 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 tp 37.79 52.79 1.46 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 130.497 3.519 . . . . 0.0 113.331 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.21 152.9 7.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 130.698 3.599 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.9 171.23 59.66 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-O 122.881 1.117 . . . . 0.0 112.527 -2.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 157.49 44.45 Favored 'General case' 0 CA--C 1.537 0.453 1 C-N-CA 131.795 4.038 . . . . 0.0 114.651 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.7 156.82 44.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 113.441 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.79 87.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.997 1.719 . . . . 0.0 111.394 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.11 118.99 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 121.143 1.792 . . . . 0.0 113.047 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -84.55 141.96 30.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.548 1.139 . . . . 0.0 111.209 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.35 156.7 35.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 71.36 4.16 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.363 -1.46 . . . . 0.0 108.422 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 125.437 1.495 . . . . 0.0 114.063 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.636 0.255 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -68.38 -1.86 7.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.52 1.928 . . . . 0.0 115.58 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -134.79 -14.66 2.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.1 1.76 . . . . 0.0 112.39 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.33 15.45 29.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.11 1.764 . . . . 0.0 110.971 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -148.26 166.14 28.85 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 113.2 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.8 80.6 8.89 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.36 2.264 . . . . 0.0 113.372 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.572 ' C ' ' H ' ' A' ' 59' ' ' LYS . 1.5 m -1.11 49.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 1 N-CA-C 124.84 5.126 . . . . 0.0 124.84 -177.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 50.33 1.84 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.278 2.631 . . . . 0.0 115.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -152.78 -11.11 0.17 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 128.78 2.832 . . . . 0.0 110.648 177.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.97 144.58 46.76 Favored Glycine 0 C--N 1.364 2.122 0 C-N-CA 116.343 -2.837 . . . . 0.0 106.759 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 165.42 32.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.604 2.202 . . . . 0.0 115.555 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' C ' HD22 ' A' ' 33' ' ' ASN 0.274 . . -119.82 101.12 7.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -83.56 -23.03 32.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.89 140.99 43.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.47 1.032 . . . . 0.0 113.265 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 121.44 11.77 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.725 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.54 -13.14 39.32 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.98 -1.456 . . . . 0.0 112.563 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -67.08 166.64 13.44 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.206 2.003 . . . . 0.0 109.028 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 t -168.84 160.29 10.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 119.668 -1.895 . . . . 0.0 115.807 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 147.72 38.14 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 100.927 -3.731 . . . . 0.0 100.927 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -113.33 151.08 31.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 118.517 -2.614 . . . . 0.0 109.584 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.6 p -132.17 133.35 44.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.752 1.221 . . . . 0.0 110.075 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 136.06 36.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.81 2.844 . . . . 0.0 106.787 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.3 168.55 26.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -151.16 52.16 0.85 Allowed 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.02 101.84 38.31 Favored Pre-proline 0 CA--C 1.562 1.427 0 O-C-N 120.435 -1.415 . . . . 0.0 107.576 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . 0.278 19.2 Cg_endo -48.47 110.24 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.847 3.698 . . . . 0.0 118.996 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.44 -130.85 2.64 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.169 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.1 t -153.88 134.03 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.731 0.812 . . . . 0.0 112.723 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.85 131.71 51.14 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 124.101 1.905 . . . . 0.0 115.524 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.34 153.52 29.75 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 128.477 2.711 . . . . 0.0 112.581 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.84 163.81 37.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.135 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -164.23 165.9 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.355 1.062 . . . . 0.0 111.049 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -103.3 105.55 15.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 87' ' ' ARG . 6.7 mm-40 -38.72 -60.87 1.0 Allowed Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -60.76 -14.44 31.88 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.102 1.868 . . . . 0.0 114.114 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -121.39 12.26 10.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.059 1.3 . . . . 0.0 113.827 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 84' ' ' GLU . 6.8 ttp85 -50.61 -47.22 58.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.787 1.235 . . . . 0.0 112.867 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.94 -7.82 88.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.405 1.479 . . . . 0.0 115.811 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.7 30.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.161 2.185 . . . . 0.0 111.705 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.52 6.16 41.57 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.934 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.9 ttt -80.91 66.02 6.27 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.844 1.822 . . . . 0.0 109.261 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 149.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 129.996 3.318 . . . . 0.0 110.596 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.98 -177.09 31.74 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.72 1.153 . . . . 0.0 114.821 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -144.8 121.24 10.99 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.064 1.346 . . . . 0.0 114.128 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.6 t -91.26 148.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 127.395 2.278 . . . . 0.0 108.039 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.9 128.04 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.83 140.05 49.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 125.173 1.545 . . . . 0.0 112.113 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 1 C-N-CA 135.101 5.361 . . . . 0.0 107.864 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.027 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 26.66 86.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.149 2.98 . . . . 0.0 114.743 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 168.7 17.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.187 1.47 . . . . 0.0 113.877 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 m -152.16 124.22 8.09 Favored 'General case' 0 N--CA 1.464 0.228 1 C-N-CA 131.714 4.005 . . . . 0.0 102.783 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.08 153.61 36.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.216 1.406 . . . . 0.0 111.791 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -120.54 113.32 20.1 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.948 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 78.2 mtm -74.35 121.91 22.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.25 88.64 1.5 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.58 1.082 . . . . 0.0 110.485 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -57.35 145.47 32.31 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.862 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -21.42 28.28 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -74.91 -9.18 58.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.836 0.744 . . . . 0.0 110.388 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.45 66.89 1.33 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 126.532 2.015 . . . . 0.0 109.224 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.12 140.0 27.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.035 0.534 . . . . 0.0 109.611 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.54 69.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.808 1.243 . . . . 0.0 111.984 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -149.93 137.81 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.44 143.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 112.535 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -128.21 105.83 19.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.948 1.299 . . . . 0.0 112.793 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.75 139.16 52.89 Favored 'Cis proline' 0 C--N 1.352 0.763 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 -2.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -76.34 -4.48 42.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.725 3.21 . . . . 0.0 116.007 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 m -135.04 -75.99 0.45 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.909 1.231 . . . . 0.0 109.7 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.29 160.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 130.264 3.425 . . . . 0.0 115.89 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -132.37 110.78 10.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 112.883 -1.962 . . . . 0.0 109.203 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.55 -178.26 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.89 0.876 . . . . 0.0 110.253 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.33 175.17 5.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.91 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.872 2.069 . . . . 0.0 110.256 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.33 -0.78 53.84 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.201 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 9.2 tt0 -79.91 -178.3 6.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 120.4 2.1 . . . . 0.0 114.038 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.84 154.69 37.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.636 -1.29 . . . . 0.0 112.595 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -146.22 105.08 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 127.389 2.275 . . . . 0.0 106.117 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -106.87 112.78 25.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.408 ' CZ3' ' CE2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -113.6 117.11 30.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 119.382 3.105 . . . . 0.0 119.382 178.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.42 149.55 9.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 109.859 -3.337 . . . . 0.0 115.725 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.562 ' ND2' ' HG ' ' A' ' 37' ' ' SER . 2.5 t30 -77.56 106.06 9.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.563 2.345 . . . . 0.0 109.931 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -111.58 -37.91 5.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.681 -1.628 . . . . 0.0 114.801 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -164.2 122.06 1.77 Allowed 'General case' 0 N--CA 1.479 1.02 1 N-CA-C 123.482 4.623 . . . . 0.0 123.482 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp 85.48 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.978 3.711 . . . . 0.0 110.348 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.562 ' HG ' ' ND2' ' A' ' 33' ' ' ASN . 15.5 m -54.81 155.07 8.48 Favored Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 129.177 2.991 . . . . 0.0 112.636 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.82 168.17 67.77 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 N-CA-C 114.574 0.952 . . . . 0.0 114.574 0.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' CD2' ' OD1' ' A' ' 33' ' ' ASN 0.344 0.8 OUTLIER -160.39 125.91 3.97 Favored 'General case' 0 C--O 1.219 -0.518 1 C-N-CA 131.944 4.098 . . . . 0.0 121.079 177.495 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -114.06 164.51 13.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 129.03 2.932 . . . . 0.0 115.985 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.9 mm -124.44 109.02 21.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 126.271 1.828 . . . . 0.0 110.72 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.35 118.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.495 1.043 . . . . 0.0 113.621 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -82.03 131.28 35.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.333 1.453 . . . . 0.0 110.021 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -2.87 0.31 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.61 56.93 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.976 2.11 . . . . 0.0 108.607 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 127.527 2.331 . . . . 0.0 116.539 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 122.014 0.911 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -62.55 -4.1 1.79 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.42 -19.17 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.052 1.741 . . . . 0.0 112.182 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.22 -1.02 57.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.857 2.063 . . . . 0.0 111.793 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -137.3 155.09 49.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.117 0.967 . . . . 0.0 112.273 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.61 154.05 39.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.074 0.95 . . . . 0.0 109.171 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 59' ' ' LYS . 2.3 p -58.11 42.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 133.632 4.773 . . . . 0.0 119.272 -177.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 41.57 -37.01 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 138.426 6.69 . . . . 0.0 115.313 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -110.9 -13.28 14.15 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.962 1.705 . . . . 0.0 106.951 177.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.2 138.02 19.27 Favored Glycine 0 C--N 1.355 1.605 1 N-CA-C 103.01 -4.036 . . . . 0.0 103.01 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.48 170.47 16.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.98 105.98 16.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -95.38 -24.88 16.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.81 159.11 15.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.326 1.05 . . . . 0.0 109.415 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.59 120.79 22.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.589 -1.319 . . . . 0.0 108.516 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.36 35.86 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.691 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.37 146.03 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.558 1.679 . . . . 0.0 108.083 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 p -158.02 174.06 15.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 119.505 -1.997 . . . . 0.0 114.649 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.71 144.14 30.18 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 101.096 -3.668 . . . . 0.0 101.096 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 t -114.59 139.81 49.31 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.186 -2.196 . . . . 0.0 108.576 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 p -120.95 140.74 51.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.715 1.606 . . . . 0.0 111.734 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -143.71 125.93 15.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.07 172.21 13.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -152.31 44.38 0.71 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 120.767 3.617 . . . . 0.0 120.767 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -113.19 95.72 36.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 120.5 -1.375 . . . . 0.0 109.959 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.32 105.35 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.14 3.227 . . . . 0.0 115.147 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.81 -129.51 2.16 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.614 2.054 . . . . 0.0 110.674 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.1 t -149.46 135.07 18.55 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.553 -0.969 . . . . 0.0 112.848 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -133.28 100.69 4.92 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 124.598 2.142 . . . . 0.0 114.665 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.22 143.15 18.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 131.222 3.809 . . . . 0.0 110.621 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 3.1 p90 -155.24 167.64 29.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.196 0.998 . . . . 0.0 110.485 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -165.92 -178.16 4.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.87 1.268 . . . . 0.0 110.838 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.0 t -110.9 108.61 18.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -38.24 -50.62 3.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 119.186 3.032 . . . . 0.0 119.186 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 -12.86 25.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.904 1.736 . . . . 0.0 115.174 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -121.68 17.17 11.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.46 -28.92 67.42 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.08 -8.82 58.71 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 125.364 1.459 . . . . 0.0 114.732 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 -8.19 37.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.659 1.984 . . . . 0.0 111.459 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.84 3.22 34.39 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 118.021 -1.433 . . . . 0.0 115.809 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.8 ttt -82.25 62.73 6.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 120.056 1.928 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 147.38 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 129.036 2.934 . . . . 0.0 110.033 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.49 -169.43 15.35 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.714 1.626 . . . . 0.0 112.951 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.02 -62.98 1.38 Allowed 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t 75.56 127.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 131.607 3.963 . . . . 0.0 110.896 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -121.67 128.86 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.97 143.59 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.378 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.258 1.538 1 C-N-CA 137.496 6.318 . . . . 0.0 113.457 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.412 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 117.497 -1.24 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 20.65 99.03 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 129.73 3.212 . . . . 0.0 117.219 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.42 165.14 11.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.9 m -144.67 144.51 31.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.309 2.643 . . . . 0.0 106.006 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.3 152.18 11.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 122.583 1.182 . . . . 0.0 111.864 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -114.37 118.38 33.71 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.2 mtm -79.97 119.98 23.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.11 96.18 1.58 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 t -57.51 150.72 18.25 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 117.104 0.452 . . . . 0.0 111.363 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.6 -21.1 9.42 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -80.75 -6.37 58.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.193 1.397 . . . . 0.0 112.707 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.0 45.7 5.01 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.128 1.347 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.11 0.564 . . . . 0.0 110.214 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 62.9 0.06 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.495 1.918 . . . . 0.0 114.176 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.56 146.86 18.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 O-C-N 120.787 -1.195 . . . . 0.0 107.992 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.86 137.36 32.42 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.415 1.486 . . . . 0.0 112.035 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -119.97 106.77 40.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.141 1.376 . . . . 0.0 111.711 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.88 151.9 94.63 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 -2.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.28 -7.83 46.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.781 2.832 . . . . 0.0 113.518 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.2 m -149.58 124.65 10.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.267 3.027 . . . . 0.0 105.231 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.8 155.49 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.675 0.671 . . . . 0.0 112.494 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -130.97 100.47 5.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.57 1.176 . . . . 0.0 112.069 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.04 -177.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HA ' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.69 135.33 52.95 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.636 1.107 . . . . 0.0 111.643 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -31.16 103.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.933 2.093 . . . . 0.0 112.966 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 -4.64 14.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.688 1.613 . . . . 0.0 112.968 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 64.7 mt-10 -91.94 169.61 10.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.34 1.57 . . . . 0.0 114.747 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.64 163.9 12.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.4 t -148.0 104.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 127.844 2.458 . . . . 0.0 106.715 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.68 111.28 23.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.682 0.793 . . . . 0.0 110.926 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.14 114.06 26.26 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.486 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 14.2 t -96.9 136.98 25.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 131.094 3.757 . . . . 0.0 114.161 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.468 ' CG ' ' CE1' ' A' ' 39' ' ' HIS 0.263 3.7 t-20 -69.9 120.16 15.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 129.955 3.302 . . . . 0.0 107.3 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -132.8 -30.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 116.968 -1.492 . . . . 0.0 113.482 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -158.99 163.96 35.98 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 tp 43.15 48.45 5.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.433 3.093 . . . . 0.0 111.478 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -56.41 144.88 61.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.493 2.317 . . . . 0.0 111.747 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.09 175.22 49.07 Favored 'Cis proline' 0 CA--C 1.548 1.214 0 CA-C-O 123.108 1.212 . . . . 0.0 114.166 0.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -146.46 152.11 38.49 Favored 'General case' 0 CA--C 1.528 0.123 1 C-N-CA 132.815 4.446 . . . . 0.0 113.956 177.886 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -142.46 162.03 36.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.279 1.832 . . . . 0.0 110.006 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 mm -135.62 94.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.312 1.445 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.5 118.45 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 O-C-N 120.839 -1.163 . . . . 0.0 112.056 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 132.83 39.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -0.71 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 73.24 33.03 1.19 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.101 2.56 . . . . 0.0 111.602 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 CA--C 1.548 0.877 0 CA-C-O 115.644 -2.122 . . . . 0.0 116.061 -177.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.53 -10.38 11.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.395 1.878 . . . . 0.0 115.531 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.48 -10.19 7.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.411 2.284 . . . . 0.0 110.316 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 8.56 25.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.885 1.674 . . . . 0.0 112.563 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -142.61 156.96 45.15 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.272 0.942 . . . . 0.0 109.393 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -76.37 60.71 1.59 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.044 2.538 . . . . 0.0 105.338 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 59' ' ' LYS . 44.7 m -21.0 86.11 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 121.106 3.743 . . . . 0.0 121.106 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 34.38 12.21 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 1 C-N-CA 135.087 5.355 . . . . 0.0 115.803 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -156.38 -13.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.375 3.07 . . . . 0.0 110.01 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.53 148.85 50.51 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 116.296 -2.859 . . . . 0.0 106.531 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.06 147.43 32.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.451 ' CB ' HD21 ' A' ' 33' ' ' ASN . . . -117.29 110.43 18.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 102.505 -3.146 . . . . 0.0 102.505 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -116.9 -31.08 5.54 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.1 136.2 41.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.394 1.477 . . . . 0.0 110.752 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.62 118.54 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.683 1.193 . . . . 0.0 112.423 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.79 4.04 52.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.297 1.904 . . . . 0.0 113.793 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.29 -60.8 3.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.486 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 1.2 p 64.03 171.38 0.18 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.82 135.99 13.95 Favored 'General case' 0 CA--C 1.559 1.318 1 N-CA-C 98.35 -4.685 . . . . 0.0 98.35 176.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.26 146.9 30.89 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 118.88 -2.387 . . . . 0.0 108.357 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 p -126.52 151.98 47.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.8 m -153.0 118.68 5.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.95 158.47 44.02 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -136.81 23.71 3.09 Favored 'General case' 0 CA--C 1.546 0.807 1 N-CA-C 123.439 4.607 . . . . 0.0 123.439 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 2.8 pt-20 -89.6 108.83 27.68 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.45 103.0 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.497 1.464 . . . . 0.0 110.446 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.11 -162.98 36.77 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 127.899 2.666 . . . . 0.0 110.969 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -124.01 128.67 49.72 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.107 0.956 . . . . 0.0 113.054 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.406 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -120.27 127.11 52.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 124.203 1.954 . . . . 0.0 114.25 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -80.53 144.5 32.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.617 -2.538 . . . . 0.0 108.406 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.5 166.06 33.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.848 0.832 . . . . 0.0 109.709 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -163.77 175.23 10.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.701 0.8 . . . . 0.0 111.502 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.6 t -109.32 116.17 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -42.35 -63.47 0.9 Allowed Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.89 -4.24 8.41 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.427 2.751 . . . . 0.0 116.02 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -130.77 12.18 5.26 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.908 1.231 . . . . 0.0 113.128 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.79 -28.42 22.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.851 2.06 . . . . 0.0 115.161 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.59 -5.77 41.85 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 126.68 2.086 . . . . 0.0 114.813 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.2 -5.74 32.74 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.019 2.528 . . . . 0.0 110.932 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.25 34.22 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.789 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 ttt -82.99 63.47 7.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.285 2.042 . . . . 0.0 110.656 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.11 144.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 129.879 3.272 . . . . 0.0 109.345 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.4 -175.94 27.0 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.567 1.079 . . . . 0.0 113.927 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -143.35 115.71 8.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.368 1.467 . . . . 0.0 114.074 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.6 147.38 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 127.569 2.348 . . . . 0.0 107.594 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.78 120.5 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.58 113.68 37.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 123.83 0.852 . . . . 0.0 110.481 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.418 ' N ' ' HA ' ' A' ' 24' ' ' LYS . 17.2 pt-20 . . . . . 0 C--O 1.256 1.43 1 C-N-CA 133.961 4.904 . . . . 0.0 114.89 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 48.41 72.86 0.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 109.699 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.12 163.62 27.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 123.941 1.829 . . . . 0.0 112.638 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -143.8 148.55 35.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 129.579 3.152 . . . . 0.0 103.377 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.36 156.0 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.283 1.04 . . . . 0.0 109.532 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -120.58 105.66 11.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.5 mtm -65.26 119.34 10.72 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.78 99.61 1.09 Allowed Glycine 0 N--CA 1.47 0.961 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.3 t -59.41 152.01 22.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.65 -18.36 53.14 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.907 -1.121 . . . . 0.0 111.16 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -81.49 -7.84 59.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.619 1.968 . . . . 0.0 112.412 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.87 9.19 64.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.84 2.162 . . . . 0.0 115.292 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.56 138.65 34.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.356 0.663 . . . . 0.0 110.154 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.05 73.94 0.91 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.066 1.746 . . . . 0.0 108.646 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.43 134.66 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.02 132.41 37.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -117.45 113.34 38.75 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.466 -0.772 . . . . 0.0 112.568 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.67 138.82 51.56 Favored 'Cis proline' 0 C--N 1.354 0.865 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 -2.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -78.1 -10.94 59.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.62 1.968 . . . . 0.0 112.588 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -142.82 128.47 19.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 129.676 3.191 . . . . 0.0 108.561 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 p -148.14 165.51 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.19 0.904 . . . . 0.0 113.426 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -131.13 106.32 8.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.943 1.297 . . . . 0.0 110.855 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 2.6 pp -123.24 175.21 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 0.0 109.291 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -130.79 174.09 10.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.91 100.77 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.889 1.275 . . . . 0.0 113.519 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.88 -2.59 25.82 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.01 1.767 . . . . 0.0 114.245 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.47 173.31 9.71 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.729 1.252 . . . . 0.0 114.356 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.697 ' HB2' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -130.71 171.77 12.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 123.426 1.584 . . . . 0.0 111.361 -178.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.84 94.85 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.443 2.297 . . . . 0.0 106.332 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -84.44 51.92 2.23 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 133.67 55.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.86 149.9 21.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 1 C-N-CA 133.564 4.746 . . . . 0.0 114.277 -176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.443 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 2.9 t-20 -78.71 117.72 20.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.57 3.148 . . . . 0.0 107.047 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -129.53 -20.12 3.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 115.748 -2.072 . . . . 0.0 113.939 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.06 153.73 16.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.6 tp 45.98 50.46 11.43 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 131.466 3.907 . . . . 0.0 112.08 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 151.18 4.08 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 129.616 3.166 . . . . 0.0 112.33 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.95 174.25 45.48 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 O-C-N 122.13 0.542 . . . . 0.0 112.507 -2.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.95 163.33 37.17 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 130.097 3.359 . . . . 0.0 113.624 177.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -149.28 163.09 38.67 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.82 1.248 . . . . 0.0 113.089 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.14 79.68 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.781 2.032 . . . . 0.0 110.109 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.86 118.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 119.89 -1.756 . . . . 0.0 111.663 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -79.54 141.38 36.7 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 121.699 -0.626 . . . . 0.0 110.371 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.64 -16.17 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 69.4 68.51 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.584 1.954 . . . . 0.0 108.181 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.513 0.725 . . . . 0.0 112.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -60.6 -5.83 1.4 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.679 2.392 . . . . 0.0 115.466 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.34 -3.32 6.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 111.114 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.77 -5.72 14.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.913 2.085 . . . . 0.0 114.642 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -130.32 167.61 18.24 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.05 1.74 . . . . 0.0 114.904 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.97 -69.16 0.35 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.93 2.092 . . . . 0.0 110.534 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t 153.06 150.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.737 2.815 . . . . 0.0 110.014 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -70.8 5.16 2.07 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.212 2.205 . . . . 0.0 111.481 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 -25.92 0.82 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.887 2.475 . . . . 0.0 111.266 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.85 136.97 18.0 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 120.342 1.428 . . . . 0.0 110.352 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.45 165.56 29.04 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 105.55 15.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -99.07 -24.92 14.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.22 56.26 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.73 112.35 0.45 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.102 1.761 . . . . 0.0 112.288 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.93 -12.61 29.42 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.407 1.48 . . . . 0.0 112.712 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -68.92 87.04 0.36 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.207 1.503 . . . . 0.0 113.811 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -83.71 157.26 22.23 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.799 -1.188 . . . . 0.0 109.863 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -26.02 6.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.387 -2.125 . . . . 0.0 108.526 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t 47.49 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 131.529 3.932 . . . . 0.0 116.868 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -135.27 152.79 51.85 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.679 -1.263 . . . . 0.0 111.777 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.697 ' HG1' ' HB2' ' A' ' 28' ' ' GLU . 24.9 m -143.93 112.05 6.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.753 2.021 . . . . 0.0 109.503 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 154.6 51.24 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.792 2.037 . . . . 0.0 115.44 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -136.52 16.87 3.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 pm0 -92.85 96.05 1.26 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 75' ' ' GLU . 8.5 Cg_endo -41.84 118.22 0.86 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 124.433 3.422 . . . . 0.0 112.893 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.51 -152.05 22.7 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 123.243 1.468 . . . . 0.0 112.983 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -145.63 117.57 8.25 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.692 1.197 . . . . 0.0 108.968 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.82 133.43 54.44 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 124.076 1.893 . . . . 0.0 112.346 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 151.15 24.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.927 3.291 . . . . 0.0 115.021 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -154.78 162.32 41.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.987 1.315 . . . . 0.0 110.108 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -159.64 164.15 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 110.164 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.9 t -99.69 104.59 16.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -35.8 -60.62 0.63 Allowed Pre-proline 0 N--CA 1.48 1.055 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.75 -8.11 20.28 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.504 2.136 . . . . 0.0 114.048 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.8 1.84 7.42 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.859 1.209 . . . . 0.0 112.64 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -43.15 -59.69 1.96 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.29 2.636 . . . . 0.0 111.353 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.13 71.04 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.127 1.346 . . . . 0.0 116.056 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -11.25 33.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.274 1.429 . . . . 0.0 111.803 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.03 -0.2 17.1 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-O 118.3 -1.278 . . . . 0.0 115.733 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttt -81.67 73.84 8.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.092 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.53 147.65 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 129.351 3.061 . . . . 0.0 108.251 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.63 179.73 34.09 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.039 0.828 . . . . 0.0 114.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -147.48 131.71 17.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.31 155.99 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 127.367 2.267 . . . . 0.0 108.161 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.71 125.47 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -123.96 142.17 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 124.489 1.118 . . . . 0.0 112.997 177.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 6.0 pt-20 . . . . . 0 C--O 1.253 1.261 1 C-N-CA 134.396 5.078 . . . . 0.0 116.254 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.416 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 26.2 t-20 18.93 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 128.976 2.91 . . . . 0.0 115.189 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.73 156.8 24.82 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.951 -1.093 . . . . 0.0 113.855 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.0 m -136.88 125.08 23.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 103.433 -2.803 . . . . 0.0 103.433 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.06 149.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 122.79 1.281 . . . . 0.0 112.486 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HZ3' ' CG ' ' A' ' 10' ' ' ASP . 21.5 mtpt -117.02 116.83 28.12 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.946 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp -76.97 120.81 22.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.68 94.43 1.54 Allowed Glycine 0 N--CA 1.47 0.962 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -58.01 152.41 16.52 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.726 0.411 . . . . 0.0 111.836 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.413 ' CG ' ' HZ3' ' A' ' 6' ' ' LYS . 74.5 m-20 -57.46 -17.63 14.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -80.54 -7.53 59.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.255 1.022 . . . . 0.0 112.183 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.97 25.86 30.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.529 1.538 . . . . 0.0 113.984 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.73 140.61 32.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.529 0.732 . . . . 0.0 109.863 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.14 63.41 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.132 1.773 . . . . 0.0 112.093 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.85 145.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.609 -1.307 . . . . 0.0 107.637 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.46 144.54 28.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.666 1.186 . . . . 0.0 111.367 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -123.86 108.07 30.72 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.544 1.538 . . . . 0.0 110.928 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.41 147.26 81.8 Favored 'Cis proline' 0 CA--C 1.542 0.911 0 N-CA-C 116.042 1.516 . . . . 0.0 116.042 -2.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -0.77 57.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.819 2.048 . . . . 0.0 113.351 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -151.48 127.11 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 128.671 2.788 . . . . 0.0 104.929 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.6 158.21 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -138.49 107.17 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.272 1.034 . . . . 0.0 111.078 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.76 173.34 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.239 1.416 . . . . 0.0 108.088 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 152.01 48.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.68 1.582 . . . . 0.0 110.87 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -24.34 115.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.506 2.722 . . . . 0.0 114.713 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.13 -19.92 39.31 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.827 1.679 . . . . 0.0 113.364 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 mt-10 -79.54 167.63 20.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 122.455 1.121 . . . . 0.0 111.097 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -122.02 -178.89 3.97 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 122.667 1.222 . . . . 0.0 109.937 -177.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.54 101.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -88.5 123.11 32.7 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -127.88 122.22 31.99 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 177.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.32 148.9 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 128.872 2.869 . . . . 0.0 115.315 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' OD1' ' CE1' ' A' ' 39' ' ' HIS . 14.0 t-20 -76.88 116.19 17.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 131.182 3.793 . . . . 0.0 109.879 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -131.33 -27.44 1.99 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 116.995 -1.479 . . . . 0.0 114.09 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.35 159.96 37.98 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tp 47.8 49.57 16.52 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 127.92 2.488 . . . . 0.0 111.503 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.43 ' HG ' ' C ' ' A' ' 63' ' ' PHE . 1.3 t -55.42 140.48 64.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.919 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 165.53 84.79 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 CA-C-O 125.068 2.028 . . . . 0.0 115.79 2.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -144.04 169.63 17.47 Favored 'General case' 0 CA--C 1.515 -0.395 1 C-N-CA 131.915 4.086 . . . . 0.0 111.833 177.723 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -167.63 175.04 7.28 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.372 1.869 . . . . 0.0 109.282 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mm -146.67 93.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.402 1.481 . . . . 0.0 109.404 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.03 111.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.209 1.404 . . . . 0.0 112.362 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -72.49 131.8 43.01 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 120.813 -1.179 . . . . 0.0 108.259 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.55 -3.41 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.642 1.977 . . . . 0.0 115.856 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.44 52.62 8.36 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.282 1.033 . . . . 0.0 109.783 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 126.898 2.079 . . . . 0.0 110.865 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -56.95 -9.0 0.71 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 129.713 3.205 . . . . 0.0 115.677 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.39 -4.28 6.08 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.792 2.037 . . . . 0.0 111.003 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.23 -10.52 14.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.68 2.392 . . . . 0.0 113.935 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -130.5 166.9 19.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.045 1.738 . . . . 0.0 114.368 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.17 -72.51 0.21 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.721 1.608 . . . . 0.0 111.99 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t 158.15 149.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.619 2.367 . . . . 0.0 108.664 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -69.43 -10.26 57.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.123 0.969 . . . . 0.0 111.482 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -19.47 8.6 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.244 1.418 . . . . 0.0 110.444 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.46 111.32 4.21 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 120.228 1.377 . . . . 0.0 110.938 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.52 173.08 7.63 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.5 101.47 10.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 126.911 2.084 . . . . 0.0 105.95 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' C ' ' HG ' ' A' ' 37' ' ' SER . 1.6 p90 -103.82 -14.09 16.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.842 1.657 . . . . 0.0 114.24 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.47 51.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.552 1.524 . . . . 0.0 113.312 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.11 116.25 1.92 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.127 1.371 . . . . 0.0 112.312 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.35 -13.29 33.45 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.262 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -65.54 157.47 29.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.294 2.047 . . . . 0.0 109.35 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 p -163.29 174.04 12.55 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 118.893 -2.379 . . . . 0.0 113.361 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.534 ' CE1' ' CD1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -152.03 151.03 30.62 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -113.22 139.27 48.93 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 120.168 -1.583 . . . . 0.0 108.718 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 54.0 p -119.53 152.21 37.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -153.74 125.6 7.76 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.263 0.3 OUTLIER -143.15 150.91 40.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.6 t -137.21 14.71 3.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 111.573 -2.558 . . . . 0.0 114.93 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -103.97 99.58 17.14 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.364 1.865 . . . . 0.0 109.409 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.55 125.92 15.03 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.778 2.986 . . . . 0.0 111.395 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.43 -174.72 43.18 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 123.7 1.722 . . . . 0.0 113.157 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -134.11 106.31 7.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.253 0.2 OUTLIER -115.08 137.76 51.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 123.918 1.818 . . . . 0.0 113.646 -177.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 147.36 28.76 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 111.737 -2.483 . . . . 0.0 113.176 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -147.65 155.97 42.31 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.26 0.624 . . . . 0.0 109.591 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -156.19 170.7 21.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.512 0.673 . . . . 0.0 109.696 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER -105.5 119.65 39.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.274 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.81 -57.7 11.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.18 -18.88 64.54 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.879 2.064 . . . . 0.0 114.314 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -119.43 14.46 12.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.402 1.455 . . . . 0.0 113.923 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -48.91 -40.75 31.19 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.43 -10.43 59.33 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.819 1.676 . . . . 0.0 114.175 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.86 -7.23 52.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.88 2.072 . . . . 0.0 111.58 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.21 3.96 29.29 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 118.169 -1.351 . . . . 0.0 115.123 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.8 ttt -83.75 76.78 9.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 124.001 1.857 . . . . 0.0 108.413 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.09 146.4 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 129.101 2.96 . . . . 0.0 109.071 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -179.69 32.15 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 124.721 1.153 . . . . 0.0 114.692 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -138.92 120.17 14.74 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.473 1.509 . . . . 0.0 114.851 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.68 153.35 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.722 2.009 . . . . 0.0 108.591 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.77 122.24 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.66 126.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 123.347 0.659 . . . . 0.0 109.844 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.252 1.204 1 C-N-CA 135.391 5.477 . . . . 0.0 113.94 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 31.06 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 130.26 3.424 . . . . 0.0 111.944 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.34 172.78 7.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 m -151.42 147.37 26.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 130.757 3.623 . . . . 0.0 104.87 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.81 151.99 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 122.872 1.32 . . . . 0.0 109.647 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -111.86 123.84 51.1 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 mtp -87.46 125.17 34.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.97 92.77 1.2 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -58.58 147.0 33.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.257 0.621 . . . . 0.0 109.573 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.35 -15.94 30.41 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -76.73 -8.88 58.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.317 0.647 . . . . 0.0 111.107 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.92 58.1 2.29 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.627 2.06 . . . . 0.0 108.769 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.08 133.25 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 67.02 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.335 1.454 . . . . 0.0 113.062 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.08 147.72 16.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.8 140.58 31.16 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.504 1.921 . . . . 0.0 112.782 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -124.3 103.48 32.57 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.46 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.78 140.26 45.33 Favored 'Cis proline' 0 CA--C 1.551 1.357 0 N-CA-C 118.397 2.422 . . . . 0.0 118.397 -2.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -16.59 62.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.676 3.591 . . . . 0.0 114.495 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 20.8 m -157.16 141.09 16.13 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 128.513 2.725 . . . . 0.0 105.38 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.97 149.63 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.973 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -112.19 102.41 10.59 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 125.22 1.575 . . . . 0.0 109.113 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pt -126.32 -178.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 112.274 -2.239 . . . . 0.0 109.134 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.72 172.29 7.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.06 65.4 0.14 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.326 2.25 . . . . 0.0 111.932 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.05 40.35 0.09 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 129.653 3.501 . . . . 0.0 111.904 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -122.13 166.47 14.52 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 1.3 pt-20 -109.39 161.6 15.14 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.926 1.346 . . . . 0.0 114.39 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -145.69 103.47 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 129.442 3.097 . . . . 0.0 106.793 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -105.97 88.28 2.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -177.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.3 138.81 31.55 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.3 145.57 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 130.55 3.54 . . . . 0.0 115.363 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.417 ' OD1' ' CE1' ' A' ' 39' ' ' HIS . 11.1 t-20 -74.61 124.15 26.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.871 2.469 . . . . 0.0 107.285 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.24 -29.21 1.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.841 -1.552 . . . . 0.0 114.779 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.73 158.84 11.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.9 tp 48.51 57.21 6.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.685 . . . . 0.0 111.367 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.56 156.37 32.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.01 160.54 86.36 Favored 'Cis proline' 0 CA--C 1.544 0.982 0 CA-C-O 123.808 1.503 . . . . 0.0 113.857 -1.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 143.03 42.51 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 128.149 2.58 . . . . 0.0 113.599 177.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . 0.305 20.1 t-20 -141.56 150.64 42.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.13 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.86 94.74 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.62 114.61 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 123.908 0.883 . . . . 0.0 110.935 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.491 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 36.4 m-85 -74.4 167.96 20.63 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.725 0.81 . . . . 0.0 109.077 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.43 -6.05 23.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.961 2.949 . . . . 0.0 118.961 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 64.83 51.17 1.85 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.407 1.458 . . . . 0.0 110.328 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 127.008 2.123 . . . . 0.0 112.641 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -60.71 -7.27 2.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.093 1.757 . . . . 0.0 113.863 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.71 -0.01 11.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.36 1.864 . . . . 0.0 111.337 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.88 16.72 3.88 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -137.51 160.36 39.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.386 0.993 . . . . 0.0 111.8 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.36 1.464 . . . . 0.0 111.469 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -71.82 43.8 0.1 Allowed 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 128.935 2.894 . . . . 0.0 116.62 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.92 -56.17 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.098 1 C-N-CA 136.622 5.969 . . . . 0.0 112.115 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 -16.85 22.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.264 1.603 . . . . 0.0 108.23 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.59 139.51 23.9 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 103.193 -3.963 . . . . 0.0 103.193 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.1 176.74 12.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.94 95.35 8.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -88.45 -27.02 21.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.31 -130.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.176 0.99 . . . . 0.0 109.255 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.9 120.89 10.03 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.618 1.967 . . . . 0.0 109.895 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.27 -13.16 23.69 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 117.601 -1.666 . . . . 0.0 113.454 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.84 161.82 25.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.871 2.335 . . . . 0.0 109.329 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 p -161.37 162.76 30.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.242 -1.536 . . . . 0.0 112.655 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.75 139.73 28.06 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 101.608 -3.478 . . . . 0.0 101.608 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 118.968 -2.333 . . . . 0.0 109.519 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.0 p -121.68 126.02 47.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.543 1.137 . . . . 0.0 108.766 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.2 m -127.62 101.3 6.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.08 2.152 . . . . 0.0 107.796 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -116.62 138.84 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 118.754 2.872 . . . . 0.0 118.754 178.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -118.2 6.53 11.99 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.152 2.981 . . . . 0.0 118.114 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -106.31 94.83 10.31 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.345 1.058 . . . . 0.0 112.553 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -56.26 120.35 8.15 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.284 2.656 . . . . 0.0 108.453 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.34 -3.17 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t 53.79 94.85 0.02 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 130.619 3.568 . . . . 0.0 110.868 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -101.8 149.61 24.0 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 117.112 -1.835 . . . . 0.0 113.421 -177.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -92.21 154.42 18.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 110.851 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.78 171.62 19.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.55 1.54 . . . . 0.0 112.036 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.16 -171.41 2.19 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.746 2.019 . . . . 0.0 109.832 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -122.58 113.05 18.75 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.59 1.556 . . . . 0.0 111.185 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -41.38 -50.16 8.91 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -0.3 10.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.299 2.666 . . . . 0.0 116.799 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -137.54 10.13 2.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -43.71 -50.45 7.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.08 -8.88 85.96 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 126.152 1.834 . . . . 0.0 115.01 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.09 -8.94 35.12 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.43 1.892 . . . . 0.0 111.169 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 7.47 30.22 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.377 -1.235 . . . . 0.0 115.996 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.3 ttt -83.15 63.52 7.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.911 1.855 . . . . 0.0 110.623 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.57 145.78 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 129.312 3.045 . . . . 0.0 111.507 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.26 -176.74 31.65 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 125.406 1.479 . . . . 0.0 115.026 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.0 ttmm -136.11 171.45 14.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.36 1.464 . . . . 0.0 110.304 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -141.25 150.73 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 119.257 -2.152 . . . . 0.0 108.362 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.44 110.49 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 100.898 -3.741 . . . . 0.0 100.898 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.94 53.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 124.377 2.037 . . . . 0.0 110.98 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 131.379 3.871 . . . . 0.0 113.388 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.502 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 42.41 73.15 0.14 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.14 1.776 . . . . 0.0 110.453 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.02 157.32 35.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.856 1.789 . . . . 0.0 112.854 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 m -139.45 143.47 37.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 150.59 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 119.19 0.905 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -120.1 116.56 25.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtm -76.33 122.28 24.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.597 1.959 . . . . 0.0 106.917 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.04 1.19 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.041 -2.023 . . . . 0.0 108.041 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 t -58.2 148.18 27.84 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.148 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.23 -14.21 16.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.2 m -79.42 -10.83 59.89 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.75 0.704 . . . . 0.0 111.126 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.32 15.0 45.88 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.927 1.727 . . . . 0.0 113.461 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.76 128.31 35.32 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.821 1.311 . . . . 0.0 109.188 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.69 66.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.433 1.893 . . . . 0.0 111.667 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.03 151.01 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.52 130.4 46.59 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.757 1.223 . . . . 0.0 108.009 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -100.87 131.55 23.28 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.414 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . 0.301 7.4 Cg_exo -77.58 -13.23 30.16 Favored 'Cis proline' 0 C--N 1.355 0.882 1 N-CA-C 125.071 4.989 . . . . 0.0 125.071 2.757 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t 93.12 -15.98 0.13 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 131.242 3.817 . . . . 0.0 109.929 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 m -153.82 129.78 10.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.959 1.704 . . . . 0.0 108.083 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.86 168.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 113.307 -1.77 . . . . 0.0 113.726 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -132.63 115.08 14.96 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.518 -1.673 . . . . 0.0 110.936 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.8 -179.27 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.361 1.464 . . . . 0.0 110.267 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 176.65 5.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -60.44 115.18 3.38 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.181 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.77 67.61 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.878 1.704 . . . . 0.0 112.383 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 18.3 tt0 -82.92 161.58 21.8 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.162 0.985 . . . . 0.0 112.498 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.453 ' CD ' ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt-20 -108.09 166.7 10.54 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.977 1.37 . . . . 0.0 113.762 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.32 97.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.177 2.591 . . . . 0.0 105.456 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HE3' ' CD ' ' A' ' 28' ' ' GLU . 5.0 ptpp? -98.95 106.59 18.87 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.636 1.208 . . . . 0.0 112.756 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -106.57 122.22 45.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.08 153.02 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 109.092 -3.685 . . . . 0.0 113.435 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' CG ' ' CE1' ' A' ' 39' ' ' HIS 0.261 3.8 t-20 -86.81 107.84 18.47 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 131.612 3.965 . . . . 0.0 106.883 177.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.0 -32.54 4.18 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.96 34.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 tp 41.32 57.91 2.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.058 2.943 . . . . 0.0 112.952 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.41 151.53 59.34 Favored Pre-proline 0 CA--C 1.537 0.452 1 C-N-CA 132.256 4.222 . . . . 0.0 111.692 177.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.52 174.99 45.92 Favored 'Cis proline' 0 CA--C 1.543 0.96 0 CA-C-O 122.57 0.987 . . . . 0.0 112.314 -2.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.0 161.23 42.73 Favored 'General case' 0 C--O 1.224 -0.287 1 C-N-CA 132.99 4.516 . . . . 0.0 114.449 177.912 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.13 159.11 42.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.92 0.888 . . . . 0.0 112.602 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.87 109.14 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.262 0.625 . . . . 0.0 110.576 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.05 113.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.244 1.018 . . . . 0.0 113.722 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -80.85 134.6 35.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.177 1.391 . . . . 0.0 110.383 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.32 43.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.801 1.24 . . . . 0.0 113.616 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 87.92 -23.33 0.12 Allowed 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 129.742 3.217 . . . . 0.0 115.387 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.557 1.239 0 C-N-CA 129.076 2.95 . . . . 0.0 113.952 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -71.78 0.1 9.77 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.46 -19.55 3.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.269 1.427 . . . . 0.0 112.532 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.21 0.15 39.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.753 1.221 . . . . 0.0 112.806 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -133.9 168.72 18.24 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 119.871 1.214 . . . . 0.0 113.86 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.45 163.32 28.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.999 1.319 . . . . 0.0 112.035 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -66.5 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 129.112 2.965 . . . . 0.0 118.487 -177.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 51.45 -47.9 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 1 C-N-CA 136.801 6.04 . . . . 0.0 111.518 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -88.18 -22.09 24.22 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 126.932 2.093 . . . . 0.0 106.958 177.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.37 150.98 41.11 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 177.13 11.22 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.449 2.124 . . . . 0.0 116.56 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.5 104.45 13.51 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -102.69 -24.06 13.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.17 131.69 55.77 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.35 116.06 1.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.357 1.463 . . . . 0.0 112.186 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.91 -9.96 34.35 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.712 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -68.36 163.39 23.22 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.286 2.043 . . . . 0.0 109.214 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -167.49 165.38 14.76 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 119.312 -2.117 . . . . 0.0 111.706 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.71 140.62 34.92 Favored 'General case' 0 CA--C 1.551 0.986 1 N-CA-C 99.626 -4.213 . . . . 0.0 99.626 176.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -110.6 143.85 40.38 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 109.504 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.9 p -124.53 135.03 52.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.858 1.263 . . . . 0.0 110.012 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.7 m -135.4 137.24 42.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.912 2.085 . . . . 0.0 107.651 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.324 0.2 OUTLIER -148.31 156.61 42.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 119.67 3.211 . . . . 0.0 119.67 -177.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -140.12 23.45 2.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.272 2.693 . . . . 0.0 118.272 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -101.04 92.51 2.48 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.82 1.648 . . . . 0.0 111.197 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.48 108.9 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.443 2.095 . . . . 0.0 112.037 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.13 -128.2 1.72 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.879 1.704 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 t -167.02 146.37 5.3 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.773 -1.427 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.06 140.55 46.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.669 1.223 . . . . 0.0 112.424 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.51 141.51 28.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.833 2.853 . . . . 0.0 112.233 -177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' CZ3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.52 169.63 18.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.082 0.944 . . . . 0.0 112.424 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -162.76 -178.31 6.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.26 2.224 . . . . 0.0 113.183 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.1 t -114.26 111.82 22.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.64 1.976 . . . . 0.0 109.059 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -38.04 -64.23 0.47 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -64.93 -10.3 24.8 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.931 2.421 . . . . 0.0 115.422 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -124.26 9.78 8.6 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -44.16 -62.33 1.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.87 1.668 . . . . 0.0 111.457 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.17 -13.85 60.63 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 126.025 1.774 . . . . 0.0 116.046 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.89 -7.2 40.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.383 2.273 . . . . 0.0 111.147 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.28 10.43 36.36 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.326 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.7 ttt -81.03 64.42 5.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.348 2.074 . . . . 0.0 109.635 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.07 154.86 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 131.494 3.918 . . . . 0.0 110.897 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.38 -169.61 32.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.687 1.613 . . . . 0.0 114.002 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -140.12 174.19 10.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.311 1.044 . . . . 0.0 110.208 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -150.72 133.83 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 128.18 2.592 . . . . 0.0 108.795 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.29 131.1 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.25 132.72 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 125.029 1.456 . . . . 0.0 112.911 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.482 1.167 1 C-N-CA 137.992 6.517 . . . . 0.0 114.526 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 13.51 96.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 130.969 3.708 . . . . 0.0 114.943 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 167.4 9.9 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 123.293 1.521 . . . . 0.0 112.161 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 m -146.37 155.75 42.83 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.051 2.941 . . . . 0.0 103.967 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.74 153.64 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.639 0.733 . . . . 0.0 109.588 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HZ3' ' CG ' ' A' ' 10' ' ' ASP . 17.8 mtpt -112.78 120.42 41.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.728 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.6 mtm -80.25 119.94 23.68 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.47 2.708 . . . . 0.0 106.109 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.34 97.74 1.06 Allowed Glycine 0 N--CA 1.47 0.929 0 N-CA-C 106.347 -2.701 . . . . 0.0 106.347 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -59.51 155.89 14.3 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.42 ' CG ' ' HZ3' ' A' ' 6' ' ' LYS . 94.2 m-20 -57.52 -17.89 16.16 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -84.97 -3.74 58.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.591 1.556 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.18 14.6 68.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.241 0.924 . . . . 0.0 112.955 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.34 136.36 33.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.341 0.656 . . . . 0.0 109.798 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.23 65.28 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.8 2.04 . . . . 0.0 111.653 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -145.82 148.53 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.979 0.912 . . . . 0.0 108.563 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.93 135.98 33.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.779 1.232 . . . . 0.0 110.656 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -117.87 111.02 39.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.943 1.297 . . . . 0.0 112.216 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.25 142.91 71.35 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 115.501 1.308 . . . . 0.0 115.501 -2.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -3.86 58.92 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 112.36 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m -151.96 129.28 11.27 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 129.732 3.213 . . . . 0.0 107.521 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.3 164.82 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.98 113.17 10.53 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.244 1.021 . . . . 0.0 111.703 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 141.35 52.03 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.174 1.806 . . . . 0.0 112.374 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -11.59 99.67 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 130.779 3.632 . . . . 0.0 115.747 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.31 -12.95 28.43 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.778 1.18 . . . . 0.0 112.679 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.43 173.06 12.38 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.549 1.166 . . . . 0.0 109.718 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 175.96 6.91 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.72 108.67 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 129.902 3.281 . . . . 0.0 106.64 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -104.77 52.51 0.74 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -49.54 142.83 7.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 120.739 3.607 . . . . 0.0 120.739 177.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.57 152.82 34.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 130.92 3.688 . . . . 0.0 112.65 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 10.4 t-20 -80.12 122.48 26.86 Favored 'General case' 0 CA--C 1.543 0.678 1 C-N-CA 132.479 4.312 . . . . 0.0 109.868 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -136.31 -29.88 0.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.974 -1.489 . . . . 0.0 114.112 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.65 157.44 38.16 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp 38.22 51.33 1.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 131.379 3.871 . . . . 0.0 112.534 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.86 151.39 2.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 130.16 3.384 . . . . 0.0 112.579 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.6 176.46 41.64 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-O 122.371 0.905 . . . . 0.0 113.135 -2.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.58 157.0 43.37 Favored 'General case' 0 N--CA 1.462 0.174 1 C-N-CA 132.541 4.336 . . . . 0.0 113.82 177.911 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -147.29 161.8 40.24 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.328 1.451 . . . . 0.0 109.974 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.1 mm -138.1 98.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.193 0.997 . . . . 0.0 111.996 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.53 122.15 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 120.796 -1.19 . . . . 0.0 112.624 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -82.04 162.01 22.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.355 0.598 . . . . 0.0 110.952 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.25 -14.07 34.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.67 39.75 0.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.91 1.686 . . . . 0.0 111.96 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.28 -24.33 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.98 -100.43 0.32 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 121.552 1.978 . . . . 0.0 116.206 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.74 -9.78 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.194 0.598 . . . . 0.0 112.426 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.29 152.13 44.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 123.24 1.495 . . . . 0.0 110.149 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.47 76.39 4.98 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.52 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.99 -29.26 28.06 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.376 1.084 . . . . 0.0 109.937 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -63.4 1.49 0.52 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.491 2.717 . . . . 0.0 114.279 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.5 4.21 5.1 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.889 2.876 . . . . 0.0 110.936 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.08 10.02 4.15 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.295 2.238 . . . . 0.0 113.054 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -132.73 162.9 30.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 129.396 3.078 . . . . 0.0 110.532 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -68.67 0.37 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.004 2.122 . . . . 0.0 110.904 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' LYS . 13.3 t 150.74 154.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.229 3.412 . . . . 0.0 107.764 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -69.77 15.05 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.811 1.645 . . . . 0.0 112.448 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' SER . 1.3 tpmp? -145.03 -18.04 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.69 3.196 . . . . 0.0 111.582 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.7 37.79 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 122.138 2.244 . . . . 0.0 110.555 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 tp -150.71 143.31 24.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' CB ' HD21 ' A' ' 33' ' ' ASN . . . -114.15 108.74 17.38 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -112.9 -26.18 8.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.28 49.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.586 1.154 . . . . 0.0 111.365 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.74 113.95 1.38 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.878 1.271 . . . . 0.0 111.64 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.37 -11.61 28.5 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.903 -1.499 . . . . 0.0 112.794 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -62.17 162.94 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.174 1.987 . . . . 0.0 109.606 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.4 t -161.25 162.55 31.13 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 119.755 -1.841 . . . . 0.0 114.998 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CE1' ' CD1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -142.3 146.25 34.86 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 100.35 -3.944 . . . . 0.0 100.35 176.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -118.85 149.7 41.1 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 119.43 -2.044 . . . . 0.0 111.64 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.9 p -134.08 141.99 47.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.503 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -139.79 124.51 18.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.547 2.339 . . . . 0.0 107.908 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.75 146.29 33.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 118.837 2.903 . . . . 0.0 118.837 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 t -131.69 15.28 4.88 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.28 108.95 39.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.818 2.553 . . . . 0.0 106.463 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -52.47 119.26 5.62 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.71 1.606 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.59 -178.95 24.86 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 128.956 3.169 . . . . 0.0 108.867 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -112.17 131.48 55.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.719 -1.24 . . . . 0.0 111.851 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.25 0.1 OUTLIER -121.94 137.25 54.86 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 124.328 2.013 . . . . 0.0 116.045 177.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -84.25 148.34 26.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 109.959 -3.291 . . . . 0.0 112.951 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -155.53 168.58 26.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.373 1.869 . . . . 0.0 110.06 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -167.61 172.74 9.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.72 1.208 . . . . 0.0 111.628 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.92 114.71 29.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -41.36 -61.45 1.37 Allowed Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.37 -0.78 8.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.828 3.018 . . . . 0.0 114.973 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -129.53 -3.69 4.81 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -39.37 -59.51 1.06 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.83 2.452 . . . . 0.0 112.083 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.36 -13.13 59.92 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.621 1.581 . . . . 0.0 116.42 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.48 -6.07 28.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.839 2.456 . . . . 0.0 111.603 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.41 5.89 33.97 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 117.744 -1.587 . . . . 0.0 116.459 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.3 ttt -81.27 62.53 5.23 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.202 2.001 . . . . 0.0 110.497 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.57 149.26 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 130.292 3.437 . . . . 0.0 108.828 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.46 -178.39 34.41 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -144.72 124.29 13.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.77 153.7 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 129.558 3.143 . . . . 0.0 109.197 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.48 134.58 62.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 117.999 -1.001 . . . . 0.0 108.489 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.89 65.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 119.137 3.014 . . . . 0.0 119.137 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 129.578 3.151 . . . . 0.0 115.002 177.782 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 50.4 77.85 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.695 1.598 . . . . 0.0 111.255 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.94 165.0 23.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 123.81 1.767 . . . . 0.0 115.133 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -150.28 142.77 24.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.805 3.242 . . . . 0.0 105.491 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.75 153.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 122.802 1.287 . . . . 0.0 111.19 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HZ3' ' CG ' ' A' ' 10' ' ' ASP . 11.8 mtpt -117.57 120.97 39.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.488 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.4 mmm -83.09 121.98 27.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.264 2.226 . . . . 0.0 106.04 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.51 98.07 0.89 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -61.72 155.25 23.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.671 -0.265 . . . . 0.0 111.474 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CG ' ' HZ3' ' A' ' 6' ' ' LYS . 84.3 m-20 -55.35 -20.43 11.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.392 1.077 . . . . 0.0 113.639 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -84.92 -3.05 58.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.928 1.291 . . . . 0.0 113.216 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.41 12.31 76.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.131 0.872 . . . . 0.0 111.863 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.72 128.66 34.21 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.42 64.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.969 2.108 . . . . 0.0 110.898 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.48 155.23 22.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.751 1.221 . . . . 0.0 109.374 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' CE1' ' CE1' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -101.42 136.9 40.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.04 0.924 . . . . 0.0 110.964 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.92 109.05 34.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 125.787 1.635 . . . . 0.0 112.464 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.2 141.32 65.1 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 N-CA-C 116.639 1.746 . . . . 0.0 116.639 -2.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -15.71 59.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.752 2.421 . . . . 0.0 113.917 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -153.12 133.35 13.48 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.431 2.692 . . . . 0.0 106.165 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.64 167.15 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.626 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -136.87 114.02 10.68 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.041 0.838 . . . . 0.0 111.164 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.84 -172.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.965 1.706 . . . . 0.0 109.754 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 171.51 9.94 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.66 84.2 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.295 2.238 . . . . 0.0 111.353 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 18.45 3.61 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.002 2.239 . . . . 0.0 113.571 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -106.64 177.39 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.342 1.457 . . . . 0.0 112.037 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -120.61 161.88 20.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -148.85 103.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.431 2.292 . . . . 0.0 107.184 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 104.13 13.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.363 1.065 . . . . 0.0 113.46 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -102.66 119.52 38.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.42 151.31 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 108.944 -3.753 . . . . 0.0 112.751 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.469 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 18.3 t-20 -79.7 113.88 18.19 Favored 'General case' 0 C--N 1.324 -0.511 1 C-N-CA 132.877 4.471 . . . . 0.0 108.553 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -127.61 -27.34 2.87 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 116.445 -1.74 . . . . 0.0 114.015 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.77 159.12 43.1 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.22 -66.32 0.31 Allowed 'General case' 0 CA--C 1.518 -0.258 1 C-N-CA 132.185 4.194 . . . . 0.0 111.75 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m 66.22 147.88 0.11 Allowed Pre-proline 0 C--N 1.292 -1.905 2 C-N-CA 132.966 4.506 . . . . 0.0 111.556 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.44 179.07 31.3 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-O 122.418 0.924 . . . . 0.0 112.318 -2.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.61 160.19 42.03 Favored 'General case' 0 CA--C 1.534 0.35 1 C-N-CA 135.149 5.38 . . . . 0.0 113.603 177.768 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.49 154.65 39.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.646 1.579 . . . . 0.0 111.668 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' CG2' ' CE1' ' A' ' 69' ' ' PHE . 4.2 mp -124.72 95.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 110.492 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -120.21 116.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 119.962 -1.711 . . . . 0.0 114.342 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -78.94 134.24 36.86 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.963 0.905 . . . . 0.0 109.906 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.44 58.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.67 70.82 0.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.801 1.64 . . . . 0.0 109.551 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.8 -8.36 21.13 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.217 1.007 . . . . 0.0 109.998 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.2 -9.17 69.9 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 127.587 2.517 . . . . 0.0 114.413 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 m -97.42 -12.86 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.346 1.458 . . . . 0.0 112.556 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 79' ' ' TYR . 15.3 p-10 -115.14 145.13 42.67 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 130.144 3.378 . . . . 0.0 116.332 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.59 68.15 9.48 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.236 1.414 . . . . 0.0 107.528 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -44.67 -54.37 6.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.315 1.446 . . . . 0.0 113.907 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -63.79 -5.81 4.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.781 2.032 . . . . 0.0 114.245 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.55 -3.27 8.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.254 1.422 . . . . 0.0 110.482 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.12 3.01 9.87 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -136.59 161.31 36.26 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.272 1.397 . . . . 0.0 112.07 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.83 -24.22 64.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 112.813 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 59' ' ' LYS . 3.9 t 66.32 99.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 24.82 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 1 C-N-CA 140.867 7.667 . . . . 0.0 118.563 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.72 -12.4 0.12 Allowed 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 131.52 3.928 . . . . 0.0 110.291 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.96 148.7 50.04 Favored Glycine 0 N--CA 1.493 2.446 0 CA-C-N 123.867 3.03 . . . . 0.0 106.285 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tp -140.55 156.92 46.16 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.42 100.98 7.47 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 101.084 -3.673 . . . . 0.0 101.084 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.8 -19.44 12.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.48 134.23 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.467 1.03 . . . . 0.0 111.719 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.62 113.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.208 1.403 . . . . 0.0 112.295 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.84 26.8 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.818 -1.546 . . . . 0.0 112.484 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -68.03 164.77 19.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 120.541 2.17 . . . . 0.0 108.851 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -168.08 166.02 13.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 118.928 -2.357 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.401 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.41 136.22 32.86 Favored 'General case' 0 CA--C 1.55 0.959 1 N-CA-C 98.612 -4.588 . . . . 0.0 98.612 176.655 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -106.8 144.47 33.4 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 118.654 -2.529 . . . . 0.0 109.278 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -117.41 142.51 47.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.037 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.3 m -151.38 89.11 1.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 152.65 21.73 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 127.008 2.123 . . . . 0.0 114.539 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -129.16 2.47 5.2 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -90.82 102.8 5.78 Favored Pre-proline 0 N--CA 1.438 -1.063 0 C-N-CA 126.954 2.102 . . . . 0.0 108.787 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -56.54 123.78 14.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.003 3.135 . . . . 0.0 108.461 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.46 170.91 27.94 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.425 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.7 t -111.39 126.12 54.6 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -128.86 131.25 47.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.967 1.365 . . . . 0.0 113.989 -177.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 148.49 25.87 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.718 2.007 . . . . 0.0 112.593 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -153.12 163.5 39.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.96 0.886 . . . . 0.0 109.489 177.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -159.01 178.21 10.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.525 1.53 . . . . 0.0 112.48 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.2 t -113.16 109.05 18.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.36 1.464 . . . . 0.0 107.212 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -38.12 -61.25 0.85 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.75 -10.64 27.41 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.154 1.903 . . . . 0.0 115.927 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -128.95 -2.78 5.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -44.92 34.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.079 1.752 . . . . 0.0 113.103 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.43 -14.78 67.3 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.226 1.393 . . . . 0.0 115.12 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.51 -3.34 26.99 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.094 2.958 . . . . 0.0 110.998 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.15 32.55 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 117.589 -1.673 . . . . 0.0 116.282 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.0 ttt -81.45 64.94 6.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.489 2.144 . . . . 0.0 109.258 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.96 158.41 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 131.178 3.791 . . . . 0.0 109.827 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.22 -168.61 35.31 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 114.056 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -131.92 173.21 11.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.285 1.034 . . . . 0.0 110.008 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 t -149.95 140.76 16.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 129.585 3.154 . . . . 0.0 107.026 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.7 t -127.31 129.23 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.75 141.71 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.428 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--O 1.25 1.087 1 C-N-CA 136.377 5.871 . . . . 0.0 111.779 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.19 -1.386 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.9 m120 4.16 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 129.444 3.098 . . . . 0.0 115.605 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.43 -178.38 6.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 118.267 2.691 . . . . 0.0 118.267 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 m -159.46 120.11 3.14 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.9 159.76 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 123.625 1.679 . . . . 0.0 109.829 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -111.53 112.1 23.59 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.311 1.444 . . . . 0.0 109.084 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.2 mtt -74.39 115.52 14.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.7 95.33 1.75 Allowed Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.1 t -54.17 148.71 10.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.912 0.856 . . . . 0.0 111.991 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -22.7 21.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 p -75.05 -12.74 60.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.783 2.033 . . . . 0.0 111.343 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.02 66.44 1.62 Allowed Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.79 134.86 30.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.19 70.28 0.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.41 1.884 . . . . 0.0 111.912 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.49 133.52 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.11 145.53 31.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -137.07 103.18 8.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.279 1.032 . . . . 0.0 112.431 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . 0.374 8.1 Cg_exo -70.44 126.58 10.25 Favored 'Cis proline' 0 CA--C 1.559 1.774 1 N-CA-C 128.411 6.273 . . . . 0.0 128.411 -2.102 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -80.51 -11.99 59.6 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.703 3.201 . . . . 0.0 112.667 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -150.33 120.42 7.22 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 130.356 3.462 . . . . 0.0 105.215 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -136.83 157.08 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.05 0.386 . . . . 0.0 111.769 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -131.68 107.38 8.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.125 0.964 . . . . 0.0 110.652 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.35 -175.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.707 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -134.0 172.2 13.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 177.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 111.97 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.418 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.39 -13.92 59.69 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.732 1.634 . . . . 0.0 114.506 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 98.3 mt-10 -79.67 162.64 25.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.715 1.245 . . . . 0.0 110.701 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 177.57 4.95 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.327 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.95 101.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 66.64 3.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.109 0.964 . . . . 0.0 112.437 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.45 138.38 43.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 39.2 t -118.28 151.58 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 1 C-N-CA 132.432 4.293 . . . . 0.0 116.485 -176.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -72.56 114.79 11.07 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -109.72 -41.55 4.51 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 114.108 -2.853 . . . . 0.0 113.336 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -169.65 152.64 4.7 Favored 'General case' 0 N--CA 1.483 1.191 1 N-CA-C 122.949 4.426 . . . . 0.0 122.949 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 tp 63.11 56.84 1.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.828 2.051 . . . . 0.0 108.521 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.44 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 3.2 m -60.75 154.11 59.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.083 2.153 . . . . 0.0 111.478 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.36 171.51 63.96 Favored 'Cis proline' 0 CA--C 1.545 1.045 0 N-CA-C 114.677 0.991 . . . . 0.0 114.677 -1.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 37' ' ' SER 0.292 0.8 OUTLIER -157.59 163.12 38.65 Favored 'General case' 0 C--O 1.21 -0.988 1 C-N-CA 136.504 5.921 . . . . 0.0 119.29 177.846 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.08 169.3 23.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.949 1.3 . . . . 0.0 113.425 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mm -131.02 83.48 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 125.548 1.539 . . . . 0.0 111.459 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.43 110.71 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.148 0.975 . . . . 0.0 111.15 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 39.5 m-85 -69.09 166.93 17.12 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.65 -20.23 17.77 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 79.93 70.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.38 2.272 . . . . 0.0 106.477 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.6 -16.48 56.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.13 -5.35 27.03 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 119.229 2.451 . . . . 0.0 119.229 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.45 -12.78 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.992 1.377 . . . . 0.0 113.502 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -92.43 -179.47 5.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.801 3.24 . . . . 0.0 113.987 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.21 66.97 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.51 1.524 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -51.68 -54.35 29.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.875 1.27 . . . . 0.0 113.214 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -60.1 -7.15 1.68 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.361 1.865 . . . . 0.0 113.248 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.48 1.39 14.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.65 1.58 . . . . 0.0 111.842 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.73 3.56 2.07 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -118.15 163.7 16.25 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.023 2.129 . . . . 0.0 113.877 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.52 165.49 25.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.361 1.464 . . . . 0.0 110.588 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -64.42 150.52 46.27 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.099 -1.626 . . . . 0.0 110.166 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -65.36 -20.42 66.38 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.607 -1.308 . . . . 0.0 110.847 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.92 -14.98 13.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.995 0.518 . . . . 0.0 111.306 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.66 153.4 33.08 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 104.822 -3.311 . . . . 0.0 104.822 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.07 177.34 10.81 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.78 96.35 6.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -103.57 -3.54 25.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . -146.43 129.77 16.72 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 120.411 1.459 . . . . 0.0 112.151 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.88 123.2 4.94 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.494 -1.379 . . . . 0.0 114.636 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.65 0.67 32.49 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 127.413 2.435 . . . . 0.0 114.697 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 64' ' ' ALA . 9.0 mt-10 -67.89 -67.04 0.49 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.688 2.744 . . . . 0.0 118.201 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.469 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 2.5 p 70.27 172.08 0.31 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 71' ' ' SER . 0.1 OUTLIER -163.62 150.85 12.43 Favored 'General case' 0 CA--C 1.549 0.917 1 N-CA-C 99.906 -4.109 . . . . 0.0 99.906 176.074 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -108.84 138.54 45.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 118.392 -2.693 . . . . 0.0 109.087 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 62.5 p -117.19 160.09 21.61 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 m -157.75 138.75 13.3 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.277 0.2 OUTLIER -156.19 155.1 31.86 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 120.174 3.398 . . . . 0.0 120.174 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.2 t -139.82 23.5 2.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.458 2.303 . . . . 0.0 116.746 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -102.79 86.88 1.06 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.772 1.629 . . . . 0.0 112.121 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.26 114.07 0.9 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.726 2.284 . . . . 0.0 110.317 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.09 -132.78 3.06 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.186 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.72 128.55 2.46 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.439 -0.881 . . . . 0.0 110.488 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -124.61 141.56 52.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 124.297 1.999 . . . . 0.0 112.53 176.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 m -77.73 144.64 37.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 110.297 -3.138 . . . . 0.0 110.315 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 34.3 p90 -147.21 164.85 31.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.731 1.613 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -170.26 175.17 5.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.068 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.9 t -107.97 112.38 24.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.764 -2.016 . . . . 0.0 106.622 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.86 -65.52 0.29 Allowed Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.883 1.22 . . . . 0.0 113.869 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.98 -2.53 5.69 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.81 3.007 . . . . 0.0 116.499 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -132.37 11.31 4.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -13.83 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.46 -7.51 32.12 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.602 2.049 . . . . 0.0 113.158 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.63 -8.33 23.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.083 2.553 . . . . 0.0 110.759 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.83 2.15 32.17 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 117.78 -1.567 . . . . 0.0 115.868 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.2 ttt -83.26 66.41 8.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.526 2.163 . . . . 0.0 110.65 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.26 148.47 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 129.205 3.002 . . . . 0.0 108.816 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.65 -178.29 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -140.79 113.0 7.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.87 1.668 . . . . 0.0 114.041 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.95 140.98 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 125.01 1.324 . . . . 0.0 107.638 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -118.38 129.36 74.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.67 131.75 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 O-C-N 124.227 0.954 . . . . 0.0 112.692 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.2 pt-20 . . . . . 0 C--O 1.255 1.363 1 C-N-CA 136.294 5.837 . . . . 0.0 116.204 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 34.47 78.24 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.334 2.653 . . . . 0.0 112.675 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.88 166.81 15.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.8 m -144.22 142.27 30.39 Favored 'General case' 0 C--N 1.329 -0.32 1 C-N-CA 132.489 4.316 . . . . 0.0 103.37 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.36 151.89 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 122.183 0.992 . . . . 0.0 109.436 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -112.99 126.82 55.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.459 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.9 mtm -90.71 125.88 35.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.866 2.066 . . . . 0.0 107.401 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.87 93.78 0.9 Allowed Glycine 0 N--CA 1.465 0.605 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -52.38 154.14 2.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.642 0.721 . . . . 0.0 112.526 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -16.19 34.44 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.993 -1.067 . . . . 0.0 113.112 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -82.94 -3.01 56.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.462 1.905 . . . . 0.0 111.451 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.47 6.13 84.01 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.894 1.712 . . . . 0.0 114.127 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.83 38.51 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.619 0.768 . . . . 0.0 110.048 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.06 71.56 0.83 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.857 1.663 . . . . 0.0 110.924 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.61 158.84 4.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.66 1.184 . . . . 0.0 108.268 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.16 137.41 42.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.627 1.571 . . . . 0.0 111.943 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.15 107.06 40.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.276 1.43 . . . . 0.0 110.92 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.68 140.6 51.73 Favored 'Cis proline' 0 CA--C 1.549 1.235 0 N-CA-C 117.271 1.989 . . . . 0.0 117.271 -2.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.12 -9.7 59.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 129.147 2.979 . . . . 0.0 113.691 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -149.45 129.66 13.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 129.238 3.015 . . . . 0.0 106.956 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.66 167.56 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.577 1.08 . . . . 0.0 112.055 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -138.68 116.1 11.22 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.48 173.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.62 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.63 146.68 52.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -7.83 87.5 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 129.839 3.256 . . . . 0.0 116.826 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -8.24 29.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.693 1.616 . . . . 0.0 115.316 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.19 -172.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.422 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -136.44 161.05 36.92 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -143.04 100.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.237 2.615 . . . . 0.0 106.627 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HE3' ' OE2' ' A' ' 28' ' ' GLU . 6.6 ptpp? -101.49 84.8 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.6 142.27 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 118.602 2.816 . . . . 0.0 118.602 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.37 156.51 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 129.795 3.238 . . . . 0.0 112.88 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 62' ' ' ALA . 9.1 m-20 -75.64 140.31 42.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.036 2.534 . . . . 0.0 109.873 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.19 -30.95 0.33 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 116.178 -1.867 . . . . 0.0 114.234 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -158.16 157.76 33.33 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 tp 37.79 52.79 1.46 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 130.497 3.519 . . . . 0.0 113.331 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.21 152.9 7.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 130.698 3.599 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.9 171.23 59.66 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-O 122.881 1.117 . . . . 0.0 112.527 -2.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 157.49 44.45 Favored 'General case' 0 CA--C 1.537 0.453 1 C-N-CA 131.795 4.038 . . . . 0.0 114.651 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.7 156.82 44.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 113.441 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.79 87.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.997 1.719 . . . . 0.0 111.394 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.11 118.99 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 121.143 1.792 . . . . 0.0 113.047 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -84.55 141.96 30.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.548 1.139 . . . . 0.0 111.209 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.35 156.7 35.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 71.36 4.16 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.363 -1.46 . . . . 0.0 108.422 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.44 -15.51 61.82 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.437 1.495 . . . . 0.0 114.063 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.63 -141.17 3.12 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 120.686 1.584 . . . . 0.0 114.782 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.01 -0.22 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.276 -0.868 . . . . 0.0 112.381 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -68.61 159.53 31.81 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.61 73.18 6.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.8 -36.48 62.49 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.599 -0.688 . . . . 0.0 111.278 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -68.38 -1.86 7.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.52 1.928 . . . . 0.0 115.58 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -134.79 -14.66 2.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.1 1.76 . . . . 0.0 112.39 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.33 15.45 29.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.11 1.764 . . . . 0.0 110.971 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -148.26 166.14 28.85 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 113.2 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.8 80.6 8.89 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.36 2.264 . . . . 0.0 113.372 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.572 ' C ' ' H ' ' A' ' 59' ' ' LYS . 1.5 m -1.11 49.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 1 N-CA-C 124.84 5.126 . . . . 0.0 124.84 -177.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 50.33 1.84 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.278 2.631 . . . . 0.0 115.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -152.78 -11.11 0.17 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 128.78 2.832 . . . . 0.0 110.648 177.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.97 144.58 46.76 Favored Glycine 0 C--N 1.364 2.122 0 C-N-CA 116.343 -2.837 . . . . 0.0 106.759 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 165.42 32.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.604 2.202 . . . . 0.0 115.555 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' C ' HD22 ' A' ' 33' ' ' ASN 0.274 . . -119.82 101.12 7.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -83.56 -23.03 32.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.89 140.99 43.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.47 1.032 . . . . 0.0 113.265 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 121.44 11.77 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.725 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.54 -13.14 39.32 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.98 -1.456 . . . . 0.0 112.563 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -67.08 166.64 13.44 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.206 2.003 . . . . 0.0 109.028 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 t -168.84 160.29 10.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 119.668 -1.895 . . . . 0.0 115.807 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 147.72 38.14 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 100.927 -3.731 . . . . 0.0 100.927 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -113.33 151.08 31.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 118.517 -2.614 . . . . 0.0 109.584 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.6 p -132.17 133.35 44.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.752 1.221 . . . . 0.0 110.075 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 136.06 36.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.81 2.844 . . . . 0.0 106.787 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.3 168.55 26.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -151.16 52.16 0.85 Allowed 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.02 101.84 38.31 Favored Pre-proline 0 CA--C 1.562 1.427 0 O-C-N 120.435 -1.415 . . . . 0.0 107.576 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . 0.278 19.2 Cg_endo -48.47 110.24 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.847 3.698 . . . . 0.0 118.996 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.44 -130.85 2.64 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.169 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.1 t -153.88 134.03 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.731 0.812 . . . . 0.0 112.723 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.85 131.71 51.14 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 124.101 1.905 . . . . 0.0 115.524 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.34 153.52 29.75 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 128.477 2.711 . . . . 0.0 112.581 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -157.84 163.81 37.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.135 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -164.23 165.9 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.355 1.062 . . . . 0.0 111.049 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -103.3 105.55 15.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 87' ' ' ARG . 6.7 mm-40 -38.72 -60.87 1.0 Allowed Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -60.76 -14.44 31.88 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.102 1.868 . . . . 0.0 114.114 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -121.39 12.26 10.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.059 1.3 . . . . 0.0 113.827 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 84' ' ' GLU . 6.8 ttp85 -50.61 -47.22 58.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.787 1.235 . . . . 0.0 112.867 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.94 -7.82 88.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.405 1.479 . . . . 0.0 115.811 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.7 30.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.161 2.185 . . . . 0.0 111.705 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.52 6.16 41.57 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.934 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.9 ttt -80.91 66.02 6.27 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.844 1.822 . . . . 0.0 109.261 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 149.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 129.996 3.318 . . . . 0.0 110.596 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.98 -177.09 31.74 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.72 1.153 . . . . 0.0 114.821 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -144.8 121.24 10.99 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.064 1.346 . . . . 0.0 114.128 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.6 t -91.26 148.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 127.395 2.278 . . . . 0.0 108.039 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.9 128.04 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.83 140.05 49.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 125.173 1.545 . . . . 0.0 112.113 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 1 C-N-CA 135.101 5.361 . . . . 0.0 107.864 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.027 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 26.66 86.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.149 2.98 . . . . 0.0 114.743 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 168.7 17.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.187 1.47 . . . . 0.0 113.877 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 m -152.16 124.22 8.09 Favored 'General case' 0 N--CA 1.464 0.228 1 C-N-CA 131.714 4.005 . . . . 0.0 102.783 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.08 153.61 36.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.216 1.406 . . . . 0.0 111.791 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -120.54 113.32 20.1 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.948 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 78.2 mtm -74.35 121.91 22.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.25 88.64 1.5 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.58 1.082 . . . . 0.0 110.485 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -57.35 145.47 32.31 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.862 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -21.42 28.28 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -74.91 -9.18 58.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.836 0.744 . . . . 0.0 110.388 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.45 66.89 1.33 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 126.532 2.015 . . . . 0.0 109.224 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.12 140.0 27.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.035 0.534 . . . . 0.0 109.611 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.54 69.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.808 1.243 . . . . 0.0 111.984 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -149.93 137.81 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.44 143.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 112.535 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -128.21 105.83 19.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.948 1.299 . . . . 0.0 112.793 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.75 139.16 52.89 Favored 'Cis proline' 0 C--N 1.352 0.763 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 -2.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -76.34 -4.48 42.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.725 3.21 . . . . 0.0 116.007 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 m -135.04 -75.99 0.45 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.909 1.231 . . . . 0.0 109.7 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.29 160.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 130.264 3.425 . . . . 0.0 115.89 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -132.37 110.78 10.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 112.883 -1.962 . . . . 0.0 109.203 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.55 -178.26 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.89 0.876 . . . . 0.0 110.253 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.33 175.17 5.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.91 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.872 2.069 . . . . 0.0 110.256 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.33 -0.78 53.84 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.201 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 9.2 tt0 -79.91 -178.3 6.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 120.4 2.1 . . . . 0.0 114.038 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.84 154.69 37.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.636 -1.29 . . . . 0.0 112.595 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -146.22 105.08 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 127.389 2.275 . . . . 0.0 106.117 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -106.87 112.78 25.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.408 ' CZ3' ' CE2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -113.6 117.11 30.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 119.382 3.105 . . . . 0.0 119.382 178.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.42 149.55 9.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 109.859 -3.337 . . . . 0.0 115.725 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.562 ' ND2' ' HG ' ' A' ' 37' ' ' SER . 2.5 t30 -77.56 106.06 9.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.563 2.345 . . . . 0.0 109.931 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -111.58 -37.91 5.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.681 -1.628 . . . . 0.0 114.801 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -164.2 122.06 1.77 Allowed 'General case' 0 N--CA 1.479 1.02 1 N-CA-C 123.482 4.623 . . . . 0.0 123.482 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp 85.48 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.978 3.711 . . . . 0.0 110.348 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.562 ' HG ' ' ND2' ' A' ' 33' ' ' ASN . 15.5 m -54.81 155.07 8.48 Favored Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 129.177 2.991 . . . . 0.0 112.636 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.82 168.17 67.77 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 N-CA-C 114.574 0.952 . . . . 0.0 114.574 0.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' CD2' ' OD1' ' A' ' 33' ' ' ASN 0.344 0.8 OUTLIER -160.39 125.91 3.97 Favored 'General case' 0 C--O 1.219 -0.518 1 C-N-CA 131.944 4.098 . . . . 0.0 121.079 177.495 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -114.06 164.51 13.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 129.03 2.932 . . . . 0.0 115.985 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.9 mm -124.44 109.02 21.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 126.271 1.828 . . . . 0.0 110.72 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.35 118.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.495 1.043 . . . . 0.0 113.621 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -82.03 131.28 35.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.333 1.453 . . . . 0.0 110.021 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -2.87 0.31 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.61 56.93 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.976 2.11 . . . . 0.0 108.607 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -20.34 62.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.527 2.331 . . . . 0.0 116.539 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.45 -103.92 0.18 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 121.507 1.958 . . . . 0.0 117.928 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.94 -8.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -70.55 164.69 24.3 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.97 78.81 5.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -50.29 -42.43 52.4 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.549 1.068 . . . . 0.0 110.854 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -62.55 -4.1 1.79 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.42 -19.17 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.052 1.741 . . . . 0.0 112.182 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.22 -1.02 57.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.857 2.063 . . . . 0.0 111.793 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -137.3 155.09 49.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.117 0.967 . . . . 0.0 112.273 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.61 154.05 39.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.074 0.95 . . . . 0.0 109.171 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 59' ' ' LYS . 2.3 p -58.11 42.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 133.632 4.773 . . . . 0.0 119.272 -177.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 41.57 -37.01 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 138.426 6.69 . . . . 0.0 115.313 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -110.9 -13.28 14.15 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.962 1.705 . . . . 0.0 106.951 177.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.2 138.02 19.27 Favored Glycine 0 C--N 1.355 1.605 1 N-CA-C 103.01 -4.036 . . . . 0.0 103.01 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.48 170.47 16.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.98 105.98 16.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -95.38 -24.88 16.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.81 159.11 15.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.326 1.05 . . . . 0.0 109.415 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.59 120.79 22.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.589 -1.319 . . . . 0.0 108.516 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.36 35.86 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.691 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.37 146.03 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.558 1.679 . . . . 0.0 108.083 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 p -158.02 174.06 15.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 119.505 -1.997 . . . . 0.0 114.649 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.71 144.14 30.18 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 101.096 -3.668 . . . . 0.0 101.096 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 t -114.59 139.81 49.31 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.186 -2.196 . . . . 0.0 108.576 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 p -120.95 140.74 51.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.715 1.606 . . . . 0.0 111.734 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -143.71 125.93 15.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.07 172.21 13.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -152.31 44.38 0.71 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 120.767 3.617 . . . . 0.0 120.767 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -113.19 95.72 36.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 120.5 -1.375 . . . . 0.0 109.959 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.32 105.35 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.14 3.227 . . . . 0.0 115.147 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.81 -129.51 2.16 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.614 2.054 . . . . 0.0 110.674 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.1 t -149.46 135.07 18.55 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.553 -0.969 . . . . 0.0 112.848 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -133.28 100.69 4.92 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 124.598 2.142 . . . . 0.0 114.665 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.22 143.15 18.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 131.222 3.809 . . . . 0.0 110.621 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 3.1 p90 -155.24 167.64 29.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.196 0.998 . . . . 0.0 110.485 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -165.92 -178.16 4.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.87 1.268 . . . . 0.0 110.838 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.0 t -110.9 108.61 18.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -38.24 -50.62 3.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 119.186 3.032 . . . . 0.0 119.186 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 -12.86 25.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.904 1.736 . . . . 0.0 115.174 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -121.68 17.17 11.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.46 -28.92 67.42 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.08 -8.82 58.71 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 125.364 1.459 . . . . 0.0 114.732 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 -8.19 37.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.659 1.984 . . . . 0.0 111.459 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.84 3.22 34.39 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 118.021 -1.433 . . . . 0.0 115.809 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.8 ttt -82.25 62.73 6.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 120.056 1.928 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 147.38 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 129.036 2.934 . . . . 0.0 110.033 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.49 -169.43 15.35 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.714 1.626 . . . . 0.0 112.951 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.02 -62.98 1.38 Allowed 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t 75.56 127.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 131.607 3.963 . . . . 0.0 110.896 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -121.67 128.86 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.97 143.59 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.378 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.258 1.538 1 C-N-CA 137.496 6.318 . . . . 0.0 113.457 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 117.497 -1.24 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 20.65 99.03 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 129.73 3.212 . . . . 0.0 117.219 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.42 165.14 11.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.9 m -144.67 144.51 31.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.309 2.643 . . . . 0.0 106.006 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.3 152.18 11.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 122.583 1.182 . . . . 0.0 111.864 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -114.37 118.38 33.71 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.2 mtm -79.97 119.98 23.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.11 96.18 1.58 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 t -57.51 150.72 18.25 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 117.104 0.452 . . . . 0.0 111.363 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.6 -21.1 9.42 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -80.75 -6.37 58.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.193 1.397 . . . . 0.0 112.707 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.0 45.7 5.01 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.128 1.347 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.11 0.564 . . . . 0.0 110.214 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 62.9 0.06 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.495 1.918 . . . . 0.0 114.176 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.56 146.86 18.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 O-C-N 120.787 -1.195 . . . . 0.0 107.992 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.86 137.36 32.42 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.415 1.486 . . . . 0.0 112.035 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -119.97 106.77 40.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.141 1.376 . . . . 0.0 111.711 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.88 151.9 94.63 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 -2.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.28 -7.83 46.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.781 2.832 . . . . 0.0 113.518 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.2 m -149.58 124.65 10.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.267 3.027 . . . . 0.0 105.231 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.8 155.49 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.675 0.671 . . . . 0.0 112.494 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -130.97 100.47 5.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.57 1.176 . . . . 0.0 112.069 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.04 -177.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HA ' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.69 135.33 52.95 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.636 1.107 . . . . 0.0 111.643 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -31.16 103.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.933 2.093 . . . . 0.0 112.966 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 -4.64 14.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.688 1.613 . . . . 0.0 112.968 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 64.7 mt-10 -91.94 169.61 10.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.34 1.57 . . . . 0.0 114.747 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.64 163.9 12.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.4 t -148.0 104.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 127.844 2.458 . . . . 0.0 106.715 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.68 111.28 23.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.682 0.793 . . . . 0.0 110.926 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.14 114.06 26.26 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.486 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 14.2 t -96.9 136.98 25.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 131.094 3.757 . . . . 0.0 114.161 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.468 ' CG ' ' CE1' ' A' ' 39' ' ' HIS 0.263 3.7 t-20 -69.9 120.16 15.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 129.955 3.302 . . . . 0.0 107.3 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -132.8 -30.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 116.968 -1.492 . . . . 0.0 113.482 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -158.99 163.96 35.98 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 tp 43.15 48.45 5.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.433 3.093 . . . . 0.0 111.478 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -56.41 144.88 61.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.493 2.317 . . . . 0.0 111.747 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.09 175.22 49.07 Favored 'Cis proline' 0 CA--C 1.548 1.214 0 CA-C-O 123.108 1.212 . . . . 0.0 114.166 0.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -146.46 152.11 38.49 Favored 'General case' 0 CA--C 1.528 0.123 1 C-N-CA 132.815 4.446 . . . . 0.0 113.956 177.886 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -142.46 162.03 36.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.279 1.832 . . . . 0.0 110.006 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 mm -135.62 94.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.312 1.445 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.5 118.45 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 O-C-N 120.839 -1.163 . . . . 0.0 112.056 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 132.83 39.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -0.71 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 73.24 33.03 1.19 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.101 2.56 . . . . 0.0 111.602 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.88 -16.63 0.44 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 115.644 -2.122 . . . . 0.0 116.061 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.41 -140.94 3.03 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 123.334 2.788 . . . . 0.0 118.748 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.54 -7.11 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.147 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -64.75 153.35 40.08 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.132 1.373 . . . . 0.0 109.447 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.21 66.05 9.11 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.293 -0.879 . . . . 0.0 112.442 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.59 -38.39 20.61 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.53 -10.38 11.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.395 1.878 . . . . 0.0 115.531 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.48 -10.19 7.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.411 2.284 . . . . 0.0 110.316 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 8.56 25.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.885 1.674 . . . . 0.0 112.563 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -142.61 156.96 45.15 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.272 0.942 . . . . 0.0 109.393 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -76.37 60.71 1.59 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.044 2.538 . . . . 0.0 105.338 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 59' ' ' LYS . 44.7 m -21.0 86.11 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 121.106 3.743 . . . . 0.0 121.106 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 34.38 12.21 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 1 C-N-CA 135.087 5.355 . . . . 0.0 115.803 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -156.38 -13.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.375 3.07 . . . . 0.0 110.01 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.53 148.85 50.51 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 116.296 -2.859 . . . . 0.0 106.531 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.06 147.43 32.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.451 ' CB ' HD21 ' A' ' 33' ' ' ASN . . . -117.29 110.43 18.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 102.505 -3.146 . . . . 0.0 102.505 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -116.9 -31.08 5.54 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.1 136.2 41.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.394 1.477 . . . . 0.0 110.752 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.62 118.54 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.683 1.193 . . . . 0.0 112.423 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.79 4.04 52.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.297 1.904 . . . . 0.0 113.793 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.29 -60.8 3.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.486 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 1.2 p 64.03 171.38 0.18 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.82 135.99 13.95 Favored 'General case' 0 CA--C 1.559 1.318 1 N-CA-C 98.35 -4.685 . . . . 0.0 98.35 176.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.26 146.9 30.89 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 118.88 -2.387 . . . . 0.0 108.357 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 p -126.52 151.98 47.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.8 m -153.0 118.68 5.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.95 158.47 44.02 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -136.81 23.71 3.09 Favored 'General case' 0 CA--C 1.546 0.807 1 N-CA-C 123.439 4.607 . . . . 0.0 123.439 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 2.8 pt-20 -89.6 108.83 27.68 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.45 103.0 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.497 1.464 . . . . 0.0 110.446 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.11 -162.98 36.77 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 127.899 2.666 . . . . 0.0 110.969 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -124.01 128.67 49.72 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.107 0.956 . . . . 0.0 113.054 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.406 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -120.27 127.11 52.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 124.203 1.954 . . . . 0.0 114.25 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -80.53 144.5 32.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.617 -2.538 . . . . 0.0 108.406 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.5 166.06 33.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.848 0.832 . . . . 0.0 109.709 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -163.77 175.23 10.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.701 0.8 . . . . 0.0 111.502 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.6 t -109.32 116.17 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -42.35 -63.47 0.9 Allowed Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.89 -4.24 8.41 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.427 2.751 . . . . 0.0 116.02 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -130.77 12.18 5.26 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.908 1.231 . . . . 0.0 113.128 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.79 -28.42 22.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.851 2.06 . . . . 0.0 115.161 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.59 -5.77 41.85 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 126.68 2.086 . . . . 0.0 114.813 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.2 -5.74 32.74 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.019 2.528 . . . . 0.0 110.932 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.25 34.22 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.789 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 ttt -82.99 63.47 7.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.285 2.042 . . . . 0.0 110.656 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.11 144.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 129.879 3.272 . . . . 0.0 109.345 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.4 -175.94 27.0 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.567 1.079 . . . . 0.0 113.927 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -143.35 115.71 8.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.368 1.467 . . . . 0.0 114.074 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.6 147.38 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 127.569 2.348 . . . . 0.0 107.594 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.78 120.5 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.58 113.68 37.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 123.83 0.852 . . . . 0.0 110.481 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.418 ' N ' ' HA ' ' A' ' 24' ' ' LYS . 17.2 pt-20 . . . . . 0 C--O 1.256 1.43 1 C-N-CA 133.961 4.904 . . . . 0.0 114.89 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 48.41 72.86 0.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 109.699 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.12 163.62 27.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 123.941 1.829 . . . . 0.0 112.638 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -143.8 148.55 35.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 129.579 3.152 . . . . 0.0 103.377 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.36 156.0 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.283 1.04 . . . . 0.0 109.532 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -120.58 105.66 11.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.5 mtm -65.26 119.34 10.72 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.78 99.61 1.09 Allowed Glycine 0 N--CA 1.47 0.961 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.3 t -59.41 152.01 22.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.65 -18.36 53.14 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.907 -1.121 . . . . 0.0 111.16 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -81.49 -7.84 59.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.619 1.968 . . . . 0.0 112.412 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.87 9.19 64.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.84 2.162 . . . . 0.0 115.292 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.56 138.65 34.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.356 0.663 . . . . 0.0 110.154 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.05 73.94 0.91 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.066 1.746 . . . . 0.0 108.646 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.43 134.66 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.02 132.41 37.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -117.45 113.34 38.75 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.466 -0.772 . . . . 0.0 112.568 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.67 138.82 51.56 Favored 'Cis proline' 0 C--N 1.354 0.865 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 -2.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -78.1 -10.94 59.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.62 1.968 . . . . 0.0 112.588 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -142.82 128.47 19.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 129.676 3.191 . . . . 0.0 108.561 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 p -148.14 165.51 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.19 0.904 . . . . 0.0 113.426 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -131.13 106.32 8.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.943 1.297 . . . . 0.0 110.855 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 2.6 pp -123.24 175.21 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 0.0 109.291 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -130.79 174.09 10.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.91 100.77 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.889 1.275 . . . . 0.0 113.519 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.88 -2.59 25.82 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.01 1.767 . . . . 0.0 114.245 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.47 173.31 9.71 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.729 1.252 . . . . 0.0 114.356 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.697 ' HB2' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -130.71 171.77 12.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 123.426 1.584 . . . . 0.0 111.361 -178.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.84 94.85 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.443 2.297 . . . . 0.0 106.332 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -84.44 51.92 2.23 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 133.67 55.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.86 149.9 21.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 1 C-N-CA 133.564 4.746 . . . . 0.0 114.277 -176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.443 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 2.9 t-20 -78.71 117.72 20.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.57 3.148 . . . . 0.0 107.047 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -129.53 -20.12 3.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 115.748 -2.072 . . . . 0.0 113.939 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.06 153.73 16.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.6 tp 45.98 50.46 11.43 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 131.466 3.907 . . . . 0.0 112.08 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 151.18 4.08 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 129.616 3.166 . . . . 0.0 112.33 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.95 174.25 45.48 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 O-C-N 122.13 0.542 . . . . 0.0 112.507 -2.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.95 163.33 37.17 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 130.097 3.359 . . . . 0.0 113.624 177.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -149.28 163.09 38.67 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.82 1.248 . . . . 0.0 113.089 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.14 79.68 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.781 2.032 . . . . 0.0 110.109 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.86 118.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 119.89 -1.756 . . . . 0.0 111.663 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -79.54 141.38 36.7 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 121.699 -0.626 . . . . 0.0 110.371 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.64 -16.17 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 69.4 68.51 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.584 1.954 . . . . 0.0 108.181 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -17.44 12.81 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.513 0.725 . . . . 0.0 112.616 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.07 -25.72 6.99 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 117.781 1.872 . . . . 0.0 117.781 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 -9.33 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.906 0.86 . . . . 0.0 111.598 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -93.07 137.78 32.12 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.852 2.461 . . . . 0.0 114.675 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.04 65.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.241 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -43.56 -50.1 7.31 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.175 1.39 . . . . 0.0 112.635 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -60.6 -5.83 1.4 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.679 2.392 . . . . 0.0 115.466 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.34 -3.32 6.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 111.114 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.77 -5.72 14.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.913 2.085 . . . . 0.0 114.642 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -130.32 167.61 18.24 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.05 1.74 . . . . 0.0 114.904 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.97 -69.16 0.35 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.93 2.092 . . . . 0.0 110.534 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t 153.06 150.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.737 2.815 . . . . 0.0 110.014 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -70.8 5.16 2.07 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.212 2.205 . . . . 0.0 111.481 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 -25.92 0.82 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.887 2.475 . . . . 0.0 111.266 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.85 136.97 18.0 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 120.342 1.428 . . . . 0.0 110.352 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.45 165.56 29.04 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 105.55 15.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -99.07 -24.92 14.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.22 56.26 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.73 112.35 0.45 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.102 1.761 . . . . 0.0 112.288 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.93 -12.61 29.42 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.407 1.48 . . . . 0.0 112.712 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -68.92 87.04 0.36 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.207 1.503 . . . . 0.0 113.811 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -83.71 157.26 22.23 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.799 -1.188 . . . . 0.0 109.863 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -26.02 6.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.387 -2.125 . . . . 0.0 108.526 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t 47.49 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 131.529 3.932 . . . . 0.0 116.868 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -135.27 152.79 51.85 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.679 -1.263 . . . . 0.0 111.777 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.697 ' HG1' ' HB2' ' A' ' 28' ' ' GLU . 24.9 m -143.93 112.05 6.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.753 2.021 . . . . 0.0 109.503 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 154.6 51.24 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.792 2.037 . . . . 0.0 115.44 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -136.52 16.87 3.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 pm0 -92.85 96.05 1.26 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 75' ' ' GLU . 8.5 Cg_endo -41.84 118.22 0.86 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 124.433 3.422 . . . . 0.0 112.893 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.51 -152.05 22.7 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 123.243 1.468 . . . . 0.0 112.983 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -145.63 117.57 8.25 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.692 1.197 . . . . 0.0 108.968 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.82 133.43 54.44 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 124.076 1.893 . . . . 0.0 112.346 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 151.15 24.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.927 3.291 . . . . 0.0 115.021 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -154.78 162.32 41.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.987 1.315 . . . . 0.0 110.108 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -159.64 164.15 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 110.164 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.9 t -99.69 104.59 16.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -35.8 -60.62 0.63 Allowed Pre-proline 0 N--CA 1.48 1.055 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.75 -8.11 20.28 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.504 2.136 . . . . 0.0 114.048 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.8 1.84 7.42 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.859 1.209 . . . . 0.0 112.64 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -43.15 -59.69 1.96 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.29 2.636 . . . . 0.0 111.353 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.13 71.04 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.127 1.346 . . . . 0.0 116.056 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -11.25 33.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.274 1.429 . . . . 0.0 111.803 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.03 -0.2 17.1 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-O 118.3 -1.278 . . . . 0.0 115.733 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttt -81.67 73.84 8.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.092 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.53 147.65 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 129.351 3.061 . . . . 0.0 108.251 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.63 179.73 34.09 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.039 0.828 . . . . 0.0 114.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -147.48 131.71 17.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -97.31 155.99 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 127.367 2.267 . . . . 0.0 108.161 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.71 125.47 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -123.96 142.17 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 124.489 1.118 . . . . 0.0 112.997 177.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 6.0 pt-20 . . . . . 0 C--O 1.253 1.261 1 C-N-CA 134.396 5.078 . . . . 0.0 116.254 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 26.2 t-20 18.93 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 128.976 2.91 . . . . 0.0 115.189 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.73 156.8 24.82 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.951 -1.093 . . . . 0.0 113.855 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.0 m -136.88 125.08 23.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 103.433 -2.803 . . . . 0.0 103.433 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.06 149.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 122.79 1.281 . . . . 0.0 112.486 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HZ3' ' CG ' ' A' ' 10' ' ' ASP . 21.5 mtpt -117.02 116.83 28.12 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.946 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp -76.97 120.81 22.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.68 94.43 1.54 Allowed Glycine 0 N--CA 1.47 0.962 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -58.01 152.41 16.52 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.726 0.411 . . . . 0.0 111.836 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.413 ' CG ' ' HZ3' ' A' ' 6' ' ' LYS . 74.5 m-20 -57.46 -17.63 14.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -80.54 -7.53 59.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.255 1.022 . . . . 0.0 112.183 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.97 25.86 30.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.529 1.538 . . . . 0.0 113.984 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.73 140.61 32.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.529 0.732 . . . . 0.0 109.863 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.14 63.41 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.132 1.773 . . . . 0.0 112.093 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.85 145.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.609 -1.307 . . . . 0.0 107.637 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.46 144.54 28.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.666 1.186 . . . . 0.0 111.367 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -123.86 108.07 30.72 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.544 1.538 . . . . 0.0 110.928 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.41 147.26 81.8 Favored 'Cis proline' 0 CA--C 1.542 0.911 0 N-CA-C 116.042 1.516 . . . . 0.0 116.042 -2.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -0.77 57.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.819 2.048 . . . . 0.0 113.351 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -151.48 127.11 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 128.671 2.788 . . . . 0.0 104.929 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.6 158.21 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -138.49 107.17 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.272 1.034 . . . . 0.0 111.078 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.76 173.34 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.239 1.416 . . . . 0.0 108.088 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 152.01 48.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.68 1.582 . . . . 0.0 110.87 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -24.34 115.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.506 2.722 . . . . 0.0 114.713 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.13 -19.92 39.31 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.827 1.679 . . . . 0.0 113.364 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 mt-10 -79.54 167.63 20.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 122.455 1.121 . . . . 0.0 111.097 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -122.02 -178.89 3.97 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 122.667 1.222 . . . . 0.0 109.937 -177.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.54 101.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -88.5 123.11 32.7 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -127.88 122.22 31.99 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 177.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.32 148.9 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 128.872 2.869 . . . . 0.0 115.315 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' OD1' ' CE1' ' A' ' 39' ' ' HIS . 14.0 t-20 -76.88 116.19 17.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 131.182 3.793 . . . . 0.0 109.879 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -131.33 -27.44 1.99 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 116.995 -1.479 . . . . 0.0 114.09 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.35 159.96 37.98 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tp 47.8 49.57 16.52 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 127.92 2.488 . . . . 0.0 111.503 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.43 ' HG ' ' C ' ' A' ' 63' ' ' PHE . 1.3 t -55.42 140.48 64.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.919 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 165.53 84.79 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 CA-C-O 125.068 2.028 . . . . 0.0 115.79 2.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -144.04 169.63 17.47 Favored 'General case' 0 CA--C 1.515 -0.395 1 C-N-CA 131.915 4.086 . . . . 0.0 111.833 177.723 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -167.63 175.04 7.28 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.372 1.869 . . . . 0.0 109.282 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mm -146.67 93.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.402 1.481 . . . . 0.0 109.404 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.03 111.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.209 1.404 . . . . 0.0 112.362 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -72.49 131.8 43.01 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 120.813 -1.179 . . . . 0.0 108.259 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.55 -3.41 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.642 1.977 . . . . 0.0 115.856 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.44 52.62 8.36 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.282 1.033 . . . . 0.0 109.783 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.64 -36.02 2.0 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.898 2.079 . . . . 0.0 110.865 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.68 -21.53 3.77 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 118.033 1.973 . . . . 0.0 118.033 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.94 -23.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 117.334 0.567 . . . . 0.0 111.584 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.03 134.45 41.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.257 3.023 . . . . 0.0 113.752 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 64.44 8.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -38.6 -50.85 1.62 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.206 2.203 . . . . 0.0 112.733 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -56.95 -9.0 0.71 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 129.713 3.205 . . . . 0.0 115.677 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.39 -4.28 6.08 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.792 2.037 . . . . 0.0 111.003 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.23 -10.52 14.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.68 2.392 . . . . 0.0 113.935 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -130.5 166.9 19.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.045 1.738 . . . . 0.0 114.368 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.17 -72.51 0.21 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.721 1.608 . . . . 0.0 111.99 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t 158.15 149.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.619 2.367 . . . . 0.0 108.664 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -69.43 -10.26 57.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.123 0.969 . . . . 0.0 111.482 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -19.47 8.6 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.244 1.418 . . . . 0.0 110.444 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.46 111.32 4.21 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 120.228 1.377 . . . . 0.0 110.938 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.52 173.08 7.63 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.5 101.47 10.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 126.911 2.084 . . . . 0.0 105.95 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' C ' ' HG ' ' A' ' 37' ' ' SER . 1.6 p90 -103.82 -14.09 16.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.842 1.657 . . . . 0.0 114.24 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.47 51.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.552 1.524 . . . . 0.0 113.312 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.11 116.25 1.92 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.127 1.371 . . . . 0.0 112.312 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.35 -13.29 33.45 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.262 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -65.54 157.47 29.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.294 2.047 . . . . 0.0 109.35 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 p -163.29 174.04 12.55 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 118.893 -2.379 . . . . 0.0 113.361 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.534 ' CE1' ' CD1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -152.03 151.03 30.62 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -113.22 139.27 48.93 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 120.168 -1.583 . . . . 0.0 108.718 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 54.0 p -119.53 152.21 37.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -153.74 125.6 7.76 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.263 0.3 OUTLIER -143.15 150.91 40.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.6 t -137.21 14.71 3.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 111.573 -2.558 . . . . 0.0 114.93 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -103.97 99.58 17.14 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.364 1.865 . . . . 0.0 109.409 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.55 125.92 15.03 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.778 2.986 . . . . 0.0 111.395 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.43 -174.72 43.18 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 123.7 1.722 . . . . 0.0 113.157 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -134.11 106.31 7.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.253 0.2 OUTLIER -115.08 137.76 51.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 123.918 1.818 . . . . 0.0 113.646 -177.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 147.36 28.76 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 111.737 -2.483 . . . . 0.0 113.176 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -147.65 155.97 42.31 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.26 0.624 . . . . 0.0 109.591 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -156.19 170.7 21.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.512 0.673 . . . . 0.0 109.696 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER -105.5 119.65 39.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.274 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.81 -57.7 11.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.18 -18.88 64.54 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.879 2.064 . . . . 0.0 114.314 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -119.43 14.46 12.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.402 1.455 . . . . 0.0 113.923 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -48.91 -40.75 31.19 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.43 -10.43 59.33 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.819 1.676 . . . . 0.0 114.175 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.86 -7.23 52.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.88 2.072 . . . . 0.0 111.58 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.21 3.96 29.29 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 118.169 -1.351 . . . . 0.0 115.123 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.8 ttt -83.75 76.78 9.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 124.001 1.857 . . . . 0.0 108.413 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.09 146.4 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 129.101 2.96 . . . . 0.0 109.071 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -179.69 32.15 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 124.721 1.153 . . . . 0.0 114.692 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -138.92 120.17 14.74 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.473 1.509 . . . . 0.0 114.851 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.68 153.35 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.722 2.009 . . . . 0.0 108.591 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.77 122.24 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.66 126.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 123.347 0.659 . . . . 0.0 109.844 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.252 1.204 1 C-N-CA 135.391 5.477 . . . . 0.0 113.94 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 31.06 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 130.26 3.424 . . . . 0.0 111.944 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.34 172.78 7.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 m -151.42 147.37 26.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 130.757 3.623 . . . . 0.0 104.87 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.81 151.99 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 122.872 1.32 . . . . 0.0 109.647 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -111.86 123.84 51.1 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 mtp -87.46 125.17 34.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.97 92.77 1.2 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -58.58 147.0 33.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.257 0.621 . . . . 0.0 109.573 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.35 -15.94 30.41 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -76.73 -8.88 58.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.317 0.647 . . . . 0.0 111.107 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.92 58.1 2.29 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.627 2.06 . . . . 0.0 108.769 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.08 133.25 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 67.02 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.335 1.454 . . . . 0.0 113.062 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.08 147.72 16.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.8 140.58 31.16 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.504 1.921 . . . . 0.0 112.782 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -124.3 103.48 32.57 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.46 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.78 140.26 45.33 Favored 'Cis proline' 0 CA--C 1.551 1.357 0 N-CA-C 118.397 2.422 . . . . 0.0 118.397 -2.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -16.59 62.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.676 3.591 . . . . 0.0 114.495 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 20.8 m -157.16 141.09 16.13 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 128.513 2.725 . . . . 0.0 105.38 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.97 149.63 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.973 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -112.19 102.41 10.59 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 125.22 1.575 . . . . 0.0 109.113 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pt -126.32 -178.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 112.274 -2.239 . . . . 0.0 109.134 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.72 172.29 7.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.06 65.4 0.14 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.326 2.25 . . . . 0.0 111.932 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.05 40.35 0.09 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 129.653 3.501 . . . . 0.0 111.904 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -122.13 166.47 14.52 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 1.3 pt-20 -109.39 161.6 15.14 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.926 1.346 . . . . 0.0 114.39 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -145.69 103.47 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 129.442 3.097 . . . . 0.0 106.793 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -105.97 88.28 2.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -177.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.3 138.81 31.55 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.3 145.57 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 130.55 3.54 . . . . 0.0 115.363 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.417 ' OD1' ' CE1' ' A' ' 39' ' ' HIS . 11.1 t-20 -74.61 124.15 26.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.871 2.469 . . . . 0.0 107.285 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.24 -29.21 1.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.841 -1.552 . . . . 0.0 114.779 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.73 158.84 11.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.9 tp 48.51 57.21 6.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.685 . . . . 0.0 111.367 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.56 156.37 32.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.01 160.54 86.36 Favored 'Cis proline' 0 CA--C 1.544 0.982 0 CA-C-O 123.808 1.503 . . . . 0.0 113.857 -1.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 143.03 42.51 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 128.149 2.58 . . . . 0.0 113.599 177.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . 0.305 20.1 t-20 -141.56 150.64 42.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.13 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.86 94.74 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.62 114.61 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 123.908 0.883 . . . . 0.0 110.935 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.491 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 36.4 m-85 -74.4 167.96 20.63 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.725 0.81 . . . . 0.0 109.077 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.43 -6.05 23.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.961 2.949 . . . . 0.0 118.961 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 64.83 51.17 1.85 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.407 1.458 . . . . 0.0 110.328 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.15 -37.13 1.93 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.008 2.123 . . . . 0.0 112.641 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.26 -6.72 4.32 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.22 -7.66 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.15 0.975 . . . . 0.0 113.516 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.49 163.56 13.18 Favored 'General case' 0 CA--C 1.541 0.619 1 C-N-CA 134.04 4.936 . . . . 0.0 114.08 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.0 59.7 0.6 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.629 1.172 . . . . 0.0 111.69 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.59 -47.68 63.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -60.71 -7.27 2.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.093 1.757 . . . . 0.0 113.863 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.71 -0.01 11.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.36 1.864 . . . . 0.0 111.337 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.88 16.72 3.88 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -137.51 160.36 39.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.386 0.993 . . . . 0.0 111.8 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.36 1.464 . . . . 0.0 111.469 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -71.82 43.8 0.1 Allowed 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 128.935 2.894 . . . . 0.0 116.62 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.92 -56.17 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.098 1 C-N-CA 136.622 5.969 . . . . 0.0 112.115 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 -16.85 22.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.264 1.603 . . . . 0.0 108.23 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.59 139.51 23.9 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 103.193 -3.963 . . . . 0.0 103.193 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.1 176.74 12.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.94 95.35 8.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -88.45 -27.02 21.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.31 -130.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.176 0.99 . . . . 0.0 109.255 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.9 120.89 10.03 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.618 1.967 . . . . 0.0 109.895 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.27 -13.16 23.69 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 117.601 -1.666 . . . . 0.0 113.454 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.84 161.82 25.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.871 2.335 . . . . 0.0 109.329 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 p -161.37 162.76 30.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.242 -1.536 . . . . 0.0 112.655 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.75 139.73 28.06 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 101.608 -3.478 . . . . 0.0 101.608 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 118.968 -2.333 . . . . 0.0 109.519 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.0 p -121.68 126.02 47.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.543 1.137 . . . . 0.0 108.766 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.2 m -127.62 101.3 6.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.08 2.152 . . . . 0.0 107.796 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -116.62 138.84 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 118.754 2.872 . . . . 0.0 118.754 178.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -118.2 6.53 11.99 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.152 2.981 . . . . 0.0 118.114 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -106.31 94.83 10.31 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.345 1.058 . . . . 0.0 112.553 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -56.26 120.35 8.15 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.284 2.656 . . . . 0.0 108.453 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.34 -3.17 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t 53.79 94.85 0.02 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 130.619 3.568 . . . . 0.0 110.868 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -101.8 149.61 24.0 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 117.112 -1.835 . . . . 0.0 113.421 -177.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -92.21 154.42 18.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 110.851 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.78 171.62 19.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.55 1.54 . . . . 0.0 112.036 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.16 -171.41 2.19 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.746 2.019 . . . . 0.0 109.832 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -122.58 113.05 18.75 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.59 1.556 . . . . 0.0 111.185 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -41.38 -50.16 8.91 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -0.3 10.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.299 2.666 . . . . 0.0 116.799 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -137.54 10.13 2.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -43.71 -50.45 7.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.08 -8.88 85.96 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 126.152 1.834 . . . . 0.0 115.01 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.09 -8.94 35.12 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.43 1.892 . . . . 0.0 111.169 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 7.47 30.22 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.377 -1.235 . . . . 0.0 115.996 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.3 ttt -83.15 63.52 7.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.911 1.855 . . . . 0.0 110.623 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.57 145.78 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 129.312 3.045 . . . . 0.0 111.507 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.26 -176.74 31.65 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 125.406 1.479 . . . . 0.0 115.026 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.0 ttmm -136.11 171.45 14.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.36 1.464 . . . . 0.0 110.304 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -141.25 150.73 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 119.257 -2.152 . . . . 0.0 108.362 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.44 110.49 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 100.898 -3.741 . . . . 0.0 100.898 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.94 53.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 124.377 2.037 . . . . 0.0 110.98 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 131.379 3.871 . . . . 0.0 113.388 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.502 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 42.41 73.15 0.14 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.14 1.776 . . . . 0.0 110.453 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.02 157.32 35.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.856 1.789 . . . . 0.0 112.854 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 m -139.45 143.47 37.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 150.59 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 119.19 0.905 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -120.1 116.56 25.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtm -76.33 122.28 24.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.597 1.959 . . . . 0.0 106.917 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.04 1.19 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.041 -2.023 . . . . 0.0 108.041 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 t -58.2 148.18 27.84 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.148 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.23 -14.21 16.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.2 m -79.42 -10.83 59.89 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.75 0.704 . . . . 0.0 111.126 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.32 15.0 45.88 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.927 1.727 . . . . 0.0 113.461 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.76 128.31 35.32 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.821 1.311 . . . . 0.0 109.188 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.69 66.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.433 1.893 . . . . 0.0 111.667 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.03 151.01 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.52 130.4 46.59 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.757 1.223 . . . . 0.0 108.009 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -100.87 131.55 23.28 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.414 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . 0.301 7.4 Cg_exo -77.58 -13.23 30.16 Favored 'Cis proline' 0 C--N 1.355 0.882 1 N-CA-C 125.071 4.989 . . . . 0.0 125.071 2.757 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t 93.12 -15.98 0.13 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 131.242 3.817 . . . . 0.0 109.929 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 m -153.82 129.78 10.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.959 1.704 . . . . 0.0 108.083 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.86 168.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 113.307 -1.77 . . . . 0.0 113.726 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -132.63 115.08 14.96 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.518 -1.673 . . . . 0.0 110.936 -177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.8 -179.27 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.361 1.464 . . . . 0.0 110.267 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 176.65 5.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -60.44 115.18 3.38 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.181 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.77 67.61 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.878 1.704 . . . . 0.0 112.383 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 18.3 tt0 -82.92 161.58 21.8 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.162 0.985 . . . . 0.0 112.498 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.453 ' CD ' ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt-20 -108.09 166.7 10.54 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.977 1.37 . . . . 0.0 113.762 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.32 97.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.177 2.591 . . . . 0.0 105.456 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HE3' ' CD ' ' A' ' 28' ' ' GLU . 5.0 ptpp? -98.95 106.59 18.87 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.636 1.208 . . . . 0.0 112.756 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -106.57 122.22 45.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.08 153.02 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 109.092 -3.685 . . . . 0.0 113.435 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' CG ' ' CE1' ' A' ' 39' ' ' HIS 0.261 3.8 t-20 -86.81 107.84 18.47 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 131.612 3.965 . . . . 0.0 106.883 177.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.0 -32.54 4.18 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.96 34.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 tp 41.32 57.91 2.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.058 2.943 . . . . 0.0 112.952 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.41 151.53 59.34 Favored Pre-proline 0 CA--C 1.537 0.452 1 C-N-CA 132.256 4.222 . . . . 0.0 111.692 177.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.52 174.99 45.92 Favored 'Cis proline' 0 CA--C 1.543 0.96 0 CA-C-O 122.57 0.987 . . . . 0.0 112.314 -2.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.0 161.23 42.73 Favored 'General case' 0 C--O 1.224 -0.287 1 C-N-CA 132.99 4.516 . . . . 0.0 114.449 177.912 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.13 159.11 42.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.92 0.888 . . . . 0.0 112.602 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.87 109.14 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.262 0.625 . . . . 0.0 110.576 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.05 113.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.244 1.018 . . . . 0.0 113.722 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -80.85 134.6 35.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.177 1.391 . . . . 0.0 110.383 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.32 43.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.801 1.24 . . . . 0.0 113.616 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 87.92 -23.33 0.12 Allowed 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 129.742 3.217 . . . . 0.0 115.387 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.11 -6.3 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 129.076 2.95 . . . . 0.0 113.952 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 106.02 -14.46 44.63 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 126.994 2.235 . . . . 0.0 114.56 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.23 -26.2 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 148.63 41.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.406 0.548 . . . . 0.0 111.683 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.84 70.36 3.28 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -50.55 -42.19 54.96 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -71.78 0.1 9.77 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.46 -19.55 3.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.269 1.427 . . . . 0.0 112.532 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.21 0.15 39.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.753 1.221 . . . . 0.0 112.806 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -133.9 168.72 18.24 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 119.871 1.214 . . . . 0.0 113.86 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.45 163.32 28.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.999 1.319 . . . . 0.0 112.035 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -66.5 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 129.112 2.965 . . . . 0.0 118.487 -177.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 51.45 -47.9 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 1 C-N-CA 136.801 6.04 . . . . 0.0 111.518 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -88.18 -22.09 24.22 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 126.932 2.093 . . . . 0.0 106.958 177.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.37 150.98 41.11 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 177.13 11.22 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.449 2.124 . . . . 0.0 116.56 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.5 104.45 13.51 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -102.69 -24.06 13.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.17 131.69 55.77 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.35 116.06 1.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.357 1.463 . . . . 0.0 112.186 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.91 -9.96 34.35 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.712 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -68.36 163.39 23.22 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.286 2.043 . . . . 0.0 109.214 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -167.49 165.38 14.76 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 119.312 -2.117 . . . . 0.0 111.706 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.71 140.62 34.92 Favored 'General case' 0 CA--C 1.551 0.986 1 N-CA-C 99.626 -4.213 . . . . 0.0 99.626 176.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -110.6 143.85 40.38 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 109.504 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.9 p -124.53 135.03 52.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.858 1.263 . . . . 0.0 110.012 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.7 m -135.4 137.24 42.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.912 2.085 . . . . 0.0 107.651 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.324 0.2 OUTLIER -148.31 156.61 42.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 119.67 3.211 . . . . 0.0 119.67 -177.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -140.12 23.45 2.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.272 2.693 . . . . 0.0 118.272 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -101.04 92.51 2.48 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.82 1.648 . . . . 0.0 111.197 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.48 108.9 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.443 2.095 . . . . 0.0 112.037 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.13 -128.2 1.72 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.879 1.704 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 t -167.02 146.37 5.3 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.773 -1.427 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.06 140.55 46.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.669 1.223 . . . . 0.0 112.424 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.51 141.51 28.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.833 2.853 . . . . 0.0 112.233 -177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' CZ3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.52 169.63 18.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.082 0.944 . . . . 0.0 112.424 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -162.76 -178.31 6.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.26 2.224 . . . . 0.0 113.183 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.1 t -114.26 111.82 22.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.64 1.976 . . . . 0.0 109.059 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -38.04 -64.23 0.47 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -64.93 -10.3 24.8 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.931 2.421 . . . . 0.0 115.422 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -124.26 9.78 8.6 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -44.16 -62.33 1.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.87 1.668 . . . . 0.0 111.457 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.17 -13.85 60.63 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 126.025 1.774 . . . . 0.0 116.046 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.89 -7.2 40.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.383 2.273 . . . . 0.0 111.147 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.28 10.43 36.36 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.326 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.7 ttt -81.03 64.42 5.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.348 2.074 . . . . 0.0 109.635 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.07 154.86 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 131.494 3.918 . . . . 0.0 110.897 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.38 -169.61 32.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.687 1.613 . . . . 0.0 114.002 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -140.12 174.19 10.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.311 1.044 . . . . 0.0 110.208 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 t -150.72 133.83 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 128.18 2.592 . . . . 0.0 108.795 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.29 131.1 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.25 132.72 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 125.029 1.456 . . . . 0.0 112.911 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.482 1.167 1 C-N-CA 137.992 6.517 . . . . 0.0 114.526 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 13.51 96.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 130.969 3.708 . . . . 0.0 114.943 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 167.4 9.9 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 123.293 1.521 . . . . 0.0 112.161 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 m -146.37 155.75 42.83 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.051 2.941 . . . . 0.0 103.967 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.74 153.64 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.639 0.733 . . . . 0.0 109.588 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 17.8 mtpt -112.78 120.42 41.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.728 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.6 mtm -80.25 119.94 23.68 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.47 2.708 . . . . 0.0 106.109 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.34 97.74 1.06 Allowed Glycine 0 N--CA 1.47 0.929 0 N-CA-C 106.347 -2.701 . . . . 0.0 106.347 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -59.51 155.89 14.3 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 94.2 m-20 -57.52 -17.89 16.16 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -84.97 -3.74 58.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.591 1.556 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.18 14.6 68.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.241 0.924 . . . . 0.0 112.955 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.34 136.36 33.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.341 0.656 . . . . 0.0 109.798 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.23 65.28 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.8 2.04 . . . . 0.0 111.653 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -145.82 148.53 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.979 0.912 . . . . 0.0 108.563 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -92.93 135.98 33.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.779 1.232 . . . . 0.0 110.656 177.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 20.4 pt-20 -117.87 111.02 39.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.943 1.297 . . . . 0.0 112.216 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 79.2 Cg_endo -78.25 142.91 71.35 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 115.501 1.308 . . . . 0.0 115.501 -2.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -3.86 58.92 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 112.36 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m -151.96 129.28 11.27 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 129.732 3.213 . . . . 0.0 107.521 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.3 164.82 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.98 113.17 10.53 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.244 1.021 . . . . 0.0 111.703 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 141.35 52.03 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.174 1.806 . . . . 0.0 112.374 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -11.59 99.67 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 130.779 3.632 . . . . 0.0 115.747 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.31 -12.95 28.43 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.778 1.18 . . . . 0.0 112.679 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.43 173.06 12.38 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.549 1.166 . . . . 0.0 109.718 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 175.96 6.91 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.72 108.67 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 129.902 3.281 . . . . 0.0 106.64 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -104.77 52.51 0.74 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -49.54 142.83 7.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 120.739 3.607 . . . . 0.0 120.739 177.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.57 152.82 34.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 130.92 3.688 . . . . 0.0 112.65 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.713 HD22 ' HB1' ' A' ' 62' ' ' ALA . 10.4 t-20 -80.12 122.48 26.86 Favored 'General case' 0 CA--C 1.543 0.678 1 C-N-CA 132.479 4.312 . . . . 0.0 109.868 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -136.31 -29.88 0.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.974 -1.489 . . . . 0.0 114.112 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -154.65 157.44 38.16 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp 38.22 51.33 1.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 131.379 3.871 . . . . 0.0 112.534 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.86 151.39 2.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 130.16 3.384 . . . . 0.0 112.579 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.6 176.46 41.64 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-O 122.371 0.905 . . . . 0.0 113.135 -2.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.58 157.0 43.37 Favored 'General case' 0 N--CA 1.462 0.174 1 C-N-CA 132.541 4.336 . . . . 0.0 113.82 177.911 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -147.29 161.8 40.24 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.328 1.451 . . . . 0.0 109.974 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' A' ' 69' ' ' PHE . 28.1 mm -138.1 98.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.193 0.997 . . . . 0.0 111.996 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 2.5 m -120.53 122.15 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 120.796 -1.19 . . . . 0.0 112.624 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -82.04 162.01 22.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.355 0.598 . . . . 0.0 110.952 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.25 -14.07 34.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.67 39.75 0.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.91 1.686 . . . . 0.0 111.96 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 122.376 1.084 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -63.4 1.49 0.52 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.491 2.717 . . . . 0.0 114.279 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.5 4.21 5.1 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.889 2.876 . . . . 0.0 110.936 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.08 10.02 4.15 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.295 2.238 . . . . 0.0 113.054 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 31.7 pttt -132.73 162.9 30.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 129.396 3.078 . . . . 0.0 110.532 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -68.67 0.37 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.004 2.122 . . . . 0.0 110.904 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 59' ' ' LYS . 13.3 t 150.74 154.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.229 3.412 . . . . 0.0 107.764 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -69.77 15.05 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.811 1.645 . . . . 0.0 112.448 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 57' ' ' SER . 1.3 tpmp? -145.03 -18.04 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.69 3.196 . . . . 0.0 111.582 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.7 37.79 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 122.138 2.244 . . . . 0.0 110.555 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 tp -150.71 143.31 24.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -114.15 108.74 17.38 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -112.9 -26.18 8.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.28 49.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.586 1.154 . . . . 0.0 111.365 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.74 113.95 1.38 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.878 1.271 . . . . 0.0 111.64 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.37 -11.61 28.5 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.903 -1.499 . . . . 0.0 112.794 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -62.17 162.94 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.174 1.987 . . . . 0.0 109.606 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.4 t -161.25 162.55 31.13 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 119.755 -1.841 . . . . 0.0 114.998 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -142.3 146.25 34.86 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 100.35 -3.944 . . . . 0.0 100.35 176.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -118.85 149.7 41.1 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 119.43 -2.044 . . . . 0.0 111.64 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.9 p -134.08 141.99 47.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.503 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -139.79 124.51 18.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.547 2.339 . . . . 0.0 107.908 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.75 146.29 33.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 118.837 2.903 . . . . 0.0 118.837 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 6.9 t -131.69 15.28 4.88 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.28 108.95 39.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.818 2.553 . . . . 0.0 106.463 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -52.47 119.26 5.62 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.71 1.606 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.59 -178.95 24.86 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 128.956 3.169 . . . . 0.0 108.867 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -112.17 131.48 55.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.719 -1.24 . . . . 0.0 111.851 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.25 0.1 OUTLIER -121.94 137.25 54.86 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 124.328 2.013 . . . . 0.0 116.045 177.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -84.25 148.34 26.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 109.959 -3.291 . . . . 0.0 112.951 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 95' ' ' VAL . 27.2 p90 -155.53 168.58 26.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.373 1.869 . . . . 0.0 110.06 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -167.61 172.74 9.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.72 1.208 . . . . 0.0 111.628 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.92 114.71 29.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -41.36 -61.45 1.37 Allowed Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.37 -0.78 8.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.828 3.018 . . . . 0.0 114.973 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -129.53 -3.69 4.81 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -39.37 -59.51 1.06 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.83 2.452 . . . . 0.0 112.083 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.36 -13.13 59.92 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.621 1.581 . . . . 0.0 116.42 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.48 -6.07 28.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.839 2.456 . . . . 0.0 111.603 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.41 5.89 33.97 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 117.744 -1.587 . . . . 0.0 116.459 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.3 ttt -81.27 62.53 5.23 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.202 2.001 . . . . 0.0 110.497 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.57 149.26 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 130.292 3.437 . . . . 0.0 108.828 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.46 -178.39 34.41 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -144.72 124.29 13.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' A' ' 81' ' ' TYR . 18.6 t -95.77 153.7 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 129.558 3.143 . . . . 0.0 109.197 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.48 134.58 62.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 117.999 -1.001 . . . . 0.0 108.489 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.89 65.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 119.137 3.014 . . . . 0.0 119.137 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 129.578 3.151 . . . . 0.0 115.002 177.782 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 50.4 77.85 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.695 1.598 . . . . 0.0 111.255 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.94 165.0 23.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 123.81 1.767 . . . . 0.0 115.133 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -150.28 142.77 24.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.805 3.242 . . . . 0.0 105.491 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -149.75 153.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 122.802 1.287 . . . . 0.0 111.19 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -117.57 120.97 39.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.4 mmm -83.09 121.98 27.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.264 2.226 . . . . 0.0 106.04 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.51 98.07 0.89 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -61.72 155.25 23.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.671 -0.265 . . . . 0.0 111.474 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.35 -20.43 11.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.392 1.077 . . . . 0.0 113.639 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -84.92 -3.05 58.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.928 1.291 . . . . 0.0 113.216 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.41 12.31 76.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.131 0.872 . . . . 0.0 111.863 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.72 128.66 34.21 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.42 64.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.969 2.108 . . . . 0.0 110.898 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.48 155.23 22.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.751 1.221 . . . . 0.0 109.374 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' CE1' ' CE1' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -101.42 136.9 40.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.04 0.924 . . . . 0.0 110.964 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.5 pt-20 -121.92 109.05 34.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 125.787 1.635 . . . . 0.0 112.464 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 Cg_endo -78.2 141.32 65.1 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 N-CA-C 116.639 1.746 . . . . 0.0 116.639 -2.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -15.71 59.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.752 2.421 . . . . 0.0 113.917 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -153.12 133.35 13.48 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.431 2.692 . . . . 0.0 106.165 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.64 167.15 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.626 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -136.87 114.02 10.68 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.041 0.838 . . . . 0.0 111.164 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.84 -172.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.965 1.706 . . . . 0.0 109.754 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.53 171.51 9.94 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 177.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -61.66 84.2 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.295 2.238 . . . . 0.0 111.353 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 18.45 3.61 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.002 2.239 . . . . 0.0 113.571 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -106.64 177.39 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.342 1.457 . . . . 0.0 112.037 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -120.61 161.88 20.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -148.85 103.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.431 2.292 . . . . 0.0 107.184 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 104.13 13.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.363 1.065 . . . . 0.0 113.46 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -102.66 119.52 38.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.42 151.31 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 108.944 -3.753 . . . . 0.0 112.751 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.469 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 18.3 t-20 -79.7 113.88 18.19 Favored 'General case' 0 C--N 1.324 -0.511 1 C-N-CA 132.877 4.471 . . . . 0.0 108.553 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -127.61 -27.34 2.87 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 116.445 -1.74 . . . . 0.0 114.015 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.77 159.12 43.1 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.22 -66.32 0.31 Allowed 'General case' 0 CA--C 1.518 -0.258 1 C-N-CA 132.185 4.194 . . . . 0.0 111.75 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m 66.22 147.88 0.11 Allowed Pre-proline 0 C--N 1.292 -1.905 2 C-N-CA 132.966 4.506 . . . . 0.0 111.556 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.44 179.07 31.3 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-O 122.418 0.924 . . . . 0.0 112.318 -2.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.61 160.19 42.03 Favored 'General case' 0 CA--C 1.534 0.35 1 C-N-CA 135.149 5.38 . . . . 0.0 113.603 177.768 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.49 154.65 39.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.646 1.579 . . . . 0.0 111.668 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.2 mp -124.72 95.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 110.492 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 6.7 m -120.21 116.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 119.962 -1.711 . . . . 0.0 114.342 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -78.94 134.24 36.86 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.963 0.905 . . . . 0.0 109.906 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.44 58.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.67 70.82 0.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.801 1.64 . . . . 0.0 109.551 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 124.217 1.007 . . . . 0.0 109.998 177.706 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -63.79 -5.81 4.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.781 2.032 . . . . 0.0 114.245 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.55 -3.27 8.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.254 1.422 . . . . 0.0 110.482 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.12 3.01 9.87 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 25.3 pttt -136.59 161.31 36.26 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.272 1.397 . . . . 0.0 112.07 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.83 -24.22 64.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 112.813 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' LYS . 3.9 t 66.32 99.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 24.82 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 1 C-N-CA 140.867 7.667 . . . . 0.0 118.563 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.72 -12.4 0.12 Allowed 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 131.52 3.928 . . . . 0.0 110.291 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.96 148.7 50.04 Favored Glycine 0 N--CA 1.493 2.446 0 CA-C-N 123.867 3.03 . . . . 0.0 106.285 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tp -140.55 156.92 46.16 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.42 100.98 7.47 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 101.084 -3.673 . . . . 0.0 101.084 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.8 -19.44 12.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.48 134.23 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.467 1.03 . . . . 0.0 111.719 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.62 113.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.208 1.403 . . . . 0.0 112.295 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.84 26.8 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.818 -1.546 . . . . 0.0 112.484 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -68.03 164.77 19.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 120.541 2.17 . . . . 0.0 108.851 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -168.08 166.02 13.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 118.928 -2.357 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.41 136.22 32.86 Favored 'General case' 0 CA--C 1.55 0.959 1 N-CA-C 98.612 -4.588 . . . . 0.0 98.612 176.655 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -106.8 144.47 33.4 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 118.654 -2.529 . . . . 0.0 109.278 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -117.41 142.51 47.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.037 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.3 m -151.38 89.11 1.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 152.65 21.73 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 127.008 2.123 . . . . 0.0 114.539 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -129.16 2.47 5.2 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -90.82 102.8 5.78 Favored Pre-proline 0 N--CA 1.438 -1.063 0 C-N-CA 126.954 2.102 . . . . 0.0 108.787 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -56.54 123.78 14.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.003 3.135 . . . . 0.0 108.461 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.46 170.91 27.94 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.425 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.7 t -111.39 126.12 54.6 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 131.25 47.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.967 1.365 . . . . 0.0 113.989 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 148.49 25.87 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.718 2.007 . . . . 0.0 112.593 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -153.12 163.5 39.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.96 0.886 . . . . 0.0 109.489 177.274 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -159.01 178.21 10.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.525 1.53 . . . . 0.0 112.48 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.2 t -113.16 109.05 18.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.36 1.464 . . . . 0.0 107.212 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -38.12 -61.25 0.85 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.75 -10.64 27.41 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.154 1.903 . . . . 0.0 115.927 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -128.95 -2.78 5.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -44.92 34.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.079 1.752 . . . . 0.0 113.103 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.43 -14.78 67.3 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.226 1.393 . . . . 0.0 115.12 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.51 -3.34 26.99 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.094 2.958 . . . . 0.0 110.998 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.15 32.55 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 117.589 -1.673 . . . . 0.0 116.282 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.0 ttt -81.45 64.94 6.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.489 2.144 . . . . 0.0 109.258 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.96 158.41 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 131.178 3.791 . . . . 0.0 109.827 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.22 -168.61 35.31 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 114.056 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HG3' ' H ' ' A' ' 95' ' ' VAL . 30.6 tptt -131.92 173.21 11.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.285 1.034 . . . . 0.0 110.008 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 t -149.95 140.76 16.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 129.585 3.154 . . . . 0.0 107.026 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.7 t -127.31 129.23 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.75 141.71 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.428 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 14.4 pt-20 . . . . . 0 C--O 1.25 1.087 1 C-N-CA 136.377 5.871 . . . . 0.0 111.779 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.429 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.19 -1.386 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 4.16 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 129.444 3.098 . . . . 0.0 115.605 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.43 -178.38 6.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 118.267 2.691 . . . . 0.0 118.267 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 m -159.46 120.11 3.14 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 18' ' ' PRO . 2.4 t -122.9 159.76 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 123.625 1.679 . . . . 0.0 109.829 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -111.53 112.1 23.59 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.311 1.444 . . . . 0.0 109.084 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.2 mtt -74.39 115.52 14.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.7 95.33 1.75 Allowed Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.1 t -54.17 148.71 10.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.912 0.856 . . . . 0.0 111.991 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -22.7 21.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 p -75.05 -12.74 60.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.783 2.033 . . . . 0.0 111.343 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.02 66.44 1.62 Allowed Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.79 134.86 30.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' H ' HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.19 70.28 0.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.41 1.884 . . . . 0.0 111.912 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.49 133.52 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.11 145.53 31.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 23.3 pt-20 -137.07 103.18 8.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.279 1.032 . . . . 0.0 112.431 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 5' ' ' VAL 0.374 8.1 Cg_exo -70.44 126.58 10.25 Favored 'Cis proline' 0 CA--C 1.559 1.774 1 N-CA-C 128.411 6.273 . . . . 0.0 128.411 -2.102 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -80.51 -11.99 59.6 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.703 3.201 . . . . 0.0 112.667 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -150.33 120.42 7.22 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 130.356 3.462 . . . . 0.0 105.215 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -136.83 157.08 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.05 0.386 . . . . 0.0 111.769 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -131.68 107.38 8.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.125 0.964 . . . . 0.0 110.652 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.35 -175.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.707 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -134.0 172.2 13.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 177.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -44.09 111.97 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.418 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.39 -13.92 59.69 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.732 1.634 . . . . 0.0 114.506 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 98.3 mt-10 -79.67 162.64 25.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.715 1.245 . . . . 0.0 110.701 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 177.57 4.95 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.327 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.95 101.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 66.64 3.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.109 0.964 . . . . 0.0 112.437 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -74.45 138.38 43.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 39.2 t -118.28 151.58 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 1 C-N-CA 132.432 4.293 . . . . 0.0 116.485 -176.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.418 ' HB3' ' H ' ' A' ' 67' ' ' GLU . 39.0 t-20 -72.56 114.79 11.07 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -109.72 -41.55 4.51 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 114.108 -2.853 . . . . 0.0 113.336 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -169.65 152.64 4.7 Favored 'General case' 0 N--CA 1.483 1.191 1 N-CA-C 122.949 4.426 . . . . 0.0 122.949 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 tp 63.11 56.84 1.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.828 2.051 . . . . 0.0 108.521 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.42 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 3.2 m -60.75 154.11 59.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.083 2.153 . . . . 0.0 111.478 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.36 171.51 63.96 Favored 'Cis proline' 0 CA--C 1.545 1.045 0 N-CA-C 114.677 0.991 . . . . 0.0 114.677 -1.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 37' ' ' SER 0.292 0.8 OUTLIER -157.59 163.12 38.65 Favored 'General case' 0 C--O 1.21 -0.988 1 C-N-CA 136.504 5.921 . . . . 0.0 119.29 177.846 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.08 169.3 23.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.949 1.3 . . . . 0.0 113.425 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 38.2 mm -131.02 83.48 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 125.548 1.539 . . . . 0.0 111.459 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.43 110.71 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.148 0.975 . . . . 0.0 111.15 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 39.5 m-85 -69.09 166.93 17.12 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.65 -20.23 17.77 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 79.93 70.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.38 2.272 . . . . 0.0 106.477 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.55 0.973 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -177.358 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -60.1 -7.15 1.68 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.361 1.865 . . . . 0.0 113.248 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.48 1.39 14.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.65 1.58 . . . . 0.0 111.842 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.73 3.56 2.07 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -118.15 163.7 16.25 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.023 2.129 . . . . 0.0 113.877 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.52 165.49 25.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.361 1.464 . . . . 0.0 110.588 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -64.42 150.52 46.27 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.099 -1.626 . . . . 0.0 110.166 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -65.36 -20.42 66.38 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.607 -1.308 . . . . 0.0 110.847 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.92 -14.98 13.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.995 0.518 . . . . 0.0 111.306 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.66 153.4 33.08 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 104.822 -3.311 . . . . 0.0 104.822 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.07 177.34 10.81 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.78 96.35 6.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -103.57 -3.54 25.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . -146.43 129.77 16.72 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 120.411 1.459 . . . . 0.0 112.151 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.88 123.2 4.94 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.494 -1.379 . . . . 0.0 114.636 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.65 0.67 32.49 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 127.413 2.435 . . . . 0.0 114.697 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 33' ' ' ASN . 9.0 mt-10 -67.89 -67.04 0.49 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.688 2.744 . . . . 0.0 118.201 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 2.5 p 70.27 172.08 0.31 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -163.62 150.85 12.43 Favored 'General case' 0 CA--C 1.549 0.917 1 N-CA-C 99.906 -4.109 . . . . 0.0 99.906 176.074 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -108.84 138.54 45.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 118.392 -2.693 . . . . 0.0 109.087 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 62.5 p -117.19 160.09 21.61 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 m -157.75 138.75 13.3 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.277 0.2 OUTLIER -156.19 155.1 31.86 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 120.174 3.398 . . . . 0.0 120.174 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.2 t -139.82 23.5 2.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.458 2.303 . . . . 0.0 116.746 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -102.79 86.88 1.06 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.772 1.629 . . . . 0.0 112.121 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.26 114.07 0.9 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.726 2.284 . . . . 0.0 110.317 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.09 -132.78 3.06 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.186 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.72 128.55 2.46 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.439 -0.881 . . . . 0.0 110.488 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -124.61 141.56 52.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 124.297 1.999 . . . . 0.0 112.53 176.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 m -77.73 144.64 37.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 110.297 -3.138 . . . . 0.0 110.315 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.52 ' CD1' HG23 ' A' ' 95' ' ' VAL . 34.3 p90 -147.21 164.85 31.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.731 1.613 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -170.26 175.17 5.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.068 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' MET . 11.9 t -107.97 112.38 24.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.764 -2.016 . . . . 0.0 106.622 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.86 -65.52 0.29 Allowed Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.883 1.22 . . . . 0.0 113.869 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.98 -2.53 5.69 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.81 3.007 . . . . 0.0 116.499 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 91' ' ' MET . 6.5 m-70 -132.37 11.31 4.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -13.83 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.46 -7.51 32.12 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.602 2.049 . . . . 0.0 113.158 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.63 -8.33 23.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.083 2.553 . . . . 0.0 110.759 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.83 2.15 32.17 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 117.78 -1.567 . . . . 0.0 115.868 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 13.2 ttt -83.26 66.41 8.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.526 2.163 . . . . 0.0 110.65 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.26 148.47 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 129.205 3.002 . . . . 0.0 108.816 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.65 -178.29 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -140.79 113.0 7.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.87 1.668 . . . . 0.0 114.041 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' CD1' ' A' ' 81' ' ' TYR . 46.8 t -87.95 140.98 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 125.01 1.324 . . . . 0.0 107.638 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -118.38 129.36 74.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.67 131.75 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 O-C-N 124.227 0.954 . . . . 0.0 112.692 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.2 pt-20 . . . . . 0 C--O 1.255 1.363 1 C-N-CA 136.294 5.837 . . . . 0.0 116.204 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 34.47 78.24 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.334 2.653 . . . . 0.0 112.675 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.88 166.81 15.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.8 m -144.22 142.27 30.39 Favored 'General case' 0 C--N 1.329 -0.32 1 C-N-CA 132.489 4.316 . . . . 0.0 103.37 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.36 151.89 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 122.183 0.992 . . . . 0.0 109.436 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -112.99 126.82 55.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.459 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.9 mtm -90.71 125.88 35.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.866 2.066 . . . . 0.0 107.401 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.87 93.78 0.9 Allowed Glycine 0 N--CA 1.465 0.605 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -52.38 154.14 2.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.642 0.721 . . . . 0.0 112.526 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -16.19 34.44 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.993 -1.067 . . . . 0.0 113.112 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -82.94 -3.01 56.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.462 1.905 . . . . 0.0 111.451 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.47 6.13 84.01 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.894 1.712 . . . . 0.0 114.127 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.83 38.51 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.619 0.768 . . . . 0.0 110.048 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 HD23 ' A' ' 36' ' ' LEU . 3.0 mm? -72.06 71.56 0.83 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.857 1.663 . . . . 0.0 110.924 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.61 158.84 4.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.66 1.184 . . . . 0.0 108.268 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.16 137.41 42.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.627 1.571 . . . . 0.0 111.943 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.2 pt-20 -120.15 107.06 40.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.276 1.43 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -80.68 140.6 51.73 Favored 'Cis proline' 0 CA--C 1.549 1.235 0 N-CA-C 117.271 1.989 . . . . 0.0 117.271 -2.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.12 -9.7 59.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 129.147 2.979 . . . . 0.0 113.691 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -149.45 129.66 13.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 129.238 3.015 . . . . 0.0 106.956 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.66 167.56 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.577 1.08 . . . . 0.0 112.055 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -138.68 116.1 11.22 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.48 173.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.62 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -131.63 146.68 52.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -7.83 87.5 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 129.839 3.256 . . . . 0.0 116.826 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -8.24 29.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.693 1.616 . . . . 0.0 115.316 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.19 -172.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -136.44 161.05 36.92 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -143.04 100.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.237 2.615 . . . . 0.0 106.627 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HE3' ' OE2' ' A' ' 28' ' ' GLU . 6.6 ptpp? -101.49 84.8 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.6 142.27 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 118.602 2.816 . . . . 0.0 118.602 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.37 156.51 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 129.795 3.238 . . . . 0.0 112.88 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.442 HD21 ' C ' ' A' ' 62' ' ' ALA . 9.1 m-20 -75.64 140.31 42.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.036 2.534 . . . . 0.0 109.873 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.19 -30.95 0.33 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 116.178 -1.867 . . . . 0.0 114.234 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -158.16 157.76 33.33 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 14' ' ' LEU . 7.1 tp 37.79 52.79 1.46 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 130.497 3.519 . . . . 0.0 113.331 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.21 152.9 7.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 130.698 3.599 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.9 171.23 59.66 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-O 122.881 1.117 . . . . 0.0 112.527 -2.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 157.49 44.45 Favored 'General case' 0 CA--C 1.537 0.453 1 C-N-CA 131.795 4.038 . . . . 0.0 114.651 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 42' ' ' VAL . 7.4 t-20 -144.7 156.82 44.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 113.441 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.7 mp -123.79 87.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.997 1.719 . . . . 0.0 111.394 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 58' ' ' HIS . 19.5 m -117.11 118.99 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 121.143 1.792 . . . . 0.0 113.047 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' H ' ' HB2' ' A' ' 55' ' ' LYS . 28.2 m-85 -84.55 141.96 30.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.548 1.139 . . . . 0.0 111.209 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.35 156.7 35.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 71.36 4.16 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.363 -1.46 . . . . 0.0 108.422 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 125.437 1.495 . . . . 0.0 114.063 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.636 0.255 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -68.38 -1.86 7.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.52 1.928 . . . . 0.0 115.58 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -134.79 -14.66 2.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.1 1.76 . . . . 0.0 112.39 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.33 15.45 29.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.11 1.764 . . . . 0.0 110.971 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 16.7 pttt -148.26 166.14 28.85 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 113.2 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.8 80.6 8.89 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.36 2.264 . . . . 0.0 113.372 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' LYS . 1.5 m -1.11 49.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 1 N-CA-C 124.84 5.126 . . . . 0.0 124.84 -177.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.635 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.5 m-70 50.33 1.84 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.278 2.631 . . . . 0.0 115.199 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -152.78 -11.11 0.17 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 128.78 2.832 . . . . 0.0 110.648 177.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.97 144.58 46.76 Favored Glycine 0 C--N 1.364 2.122 0 C-N-CA 116.343 -2.837 . . . . 0.0 106.759 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 165.42 32.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.604 2.202 . . . . 0.0 115.555 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' C ' HD21 ' A' ' 33' ' ' ASN 0.274 . . -119.82 101.12 7.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -83.56 -23.03 32.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.89 140.99 43.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.47 1.032 . . . . 0.0 113.265 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 121.44 11.77 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.725 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.54 -13.14 39.32 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.98 -1.456 . . . . 0.0 112.563 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -67.08 166.64 13.44 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.206 2.003 . . . . 0.0 109.028 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 t -168.84 160.29 10.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 119.668 -1.895 . . . . 0.0 115.807 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.678 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -141.56 147.72 38.14 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 100.927 -3.731 . . . . 0.0 100.927 176.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -113.33 151.08 31.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 118.517 -2.614 . . . . 0.0 109.584 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.6 p -132.17 133.35 44.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.752 1.221 . . . . 0.0 110.075 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 136.06 36.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.81 2.844 . . . . 0.0 106.787 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.3 168.55 26.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -151.16 52.16 0.85 Allowed 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.02 101.84 38.31 Favored Pre-proline 0 CA--C 1.562 1.427 0 O-C-N 120.435 -1.415 . . . . 0.0 107.576 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . 0.278 19.2 Cg_endo -48.47 110.24 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.847 3.698 . . . . 0.0 118.996 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.44 -130.85 2.64 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.169 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.1 t -153.88 134.03 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.731 0.812 . . . . 0.0 112.723 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.85 131.71 51.14 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 124.101 1.905 . . . . 0.0 115.524 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.34 153.52 29.75 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 128.477 2.711 . . . . 0.0 112.581 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.416 ' CD1' HG23 ' A' ' 95' ' ' VAL . 35.2 p90 -157.84 163.81 37.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.135 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -164.23 165.9 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.355 1.062 . . . . 0.0 111.049 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -103.3 105.55 15.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 87' ' ' ARG . 6.7 mm-40 -38.72 -60.87 1.0 Allowed Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -60.76 -14.44 31.88 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.102 1.868 . . . . 0.0 114.114 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -121.39 12.26 10.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.059 1.3 . . . . 0.0 113.827 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 84' ' ' GLU . 6.8 ttp85 -50.61 -47.22 58.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.787 1.235 . . . . 0.0 112.867 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.94 -7.82 88.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.405 1.479 . . . . 0.0 115.811 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.7 30.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.161 2.185 . . . . 0.0 111.705 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.52 6.16 41.57 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.934 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.9 ttt -80.91 66.02 6.27 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.844 1.822 . . . . 0.0 109.261 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 149.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 129.996 3.318 . . . . 0.0 110.596 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.98 -177.09 31.74 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.72 1.153 . . . . 0.0 114.821 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -144.8 121.24 10.99 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.064 1.346 . . . . 0.0 114.128 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' A' ' 81' ' ' TYR . 16.6 t -91.26 148.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 127.395 2.278 . . . . 0.0 108.039 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.9 128.04 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.83 140.05 49.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 125.173 1.545 . . . . 0.0 112.113 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 1 C-N-CA 135.101 5.361 . . . . 0.0 107.864 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.49 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.027 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 26.66 86.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.149 2.98 . . . . 0.0 114.743 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 168.7 17.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.187 1.47 . . . . 0.0 113.877 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 m -152.16 124.22 8.09 Favored 'General case' 0 N--CA 1.464 0.228 1 C-N-CA 131.714 4.005 . . . . 0.0 102.783 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -134.08 153.61 36.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.216 1.406 . . . . 0.0 111.791 -177.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 19.7 mtpt -120.54 113.32 20.1 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.948 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 78.2 mtm -74.35 121.91 22.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.25 88.64 1.5 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.58 1.082 . . . . 0.0 110.485 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -57.35 145.47 32.31 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.862 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -21.42 28.28 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -74.91 -9.18 58.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.836 0.744 . . . . 0.0 110.388 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.45 66.89 1.33 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 126.532 2.015 . . . . 0.0 109.224 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.12 140.0 27.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.035 0.534 . . . . 0.0 109.611 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.54 69.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.808 1.243 . . . . 0.0 111.984 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -149.93 137.81 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.44 143.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 112.535 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 pt-20 -128.21 105.83 19.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.948 1.299 . . . . 0.0 112.793 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 43.9 Cg_endo -78.75 139.16 52.89 Favored 'Cis proline' 0 C--N 1.352 0.763 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 -2.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -76.34 -4.48 42.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.725 3.21 . . . . 0.0 116.007 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 m -135.04 -75.99 0.45 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.909 1.231 . . . . 0.0 109.7 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.29 160.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 130.264 3.425 . . . . 0.0 115.89 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -132.37 110.78 10.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 112.883 -1.962 . . . . 0.0 109.203 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.55 -178.26 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.89 0.876 . . . . 0.0 110.253 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.33 175.17 5.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.91 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.872 2.069 . . . . 0.0 110.256 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.33 -0.78 53.84 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.201 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 9.2 tt0 -79.91 -178.3 6.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 120.4 2.1 . . . . 0.0 114.038 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.84 154.69 37.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.636 -1.29 . . . . 0.0 112.595 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -146.22 105.08 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 127.389 2.275 . . . . 0.0 106.117 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -106.87 112.78 25.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.6 117.11 30.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 119.382 3.105 . . . . 0.0 119.382 178.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.42 149.55 9.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 109.859 -3.337 . . . . 0.0 115.725 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' CD2' ' A' ' 39' ' ' HIS . 2.5 t30 -77.56 106.06 9.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.563 2.345 . . . . 0.0 109.931 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -111.58 -37.91 5.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.681 -1.628 . . . . 0.0 114.801 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -164.2 122.06 1.77 Allowed 'General case' 0 N--CA 1.479 1.02 1 N-CA-C 123.482 4.623 . . . . 0.0 123.482 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp 85.48 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.978 3.711 . . . . 0.0 110.348 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -54.81 155.07 8.48 Favored Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 129.177 2.991 . . . . 0.0 112.636 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.82 168.17 67.77 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 N-CA-C 114.574 0.952 . . . . 0.0 114.574 0.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' CD2' ' OD1' ' A' ' 33' ' ' ASN 0.344 0.8 OUTLIER -160.39 125.91 3.97 Favored 'General case' 0 C--O 1.219 -0.518 1 C-N-CA 131.944 4.098 . . . . 0.0 121.079 177.495 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -114.06 164.51 13.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 129.03 2.932 . . . . 0.0 115.985 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.9 mm -124.44 109.02 21.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 126.271 1.828 . . . . 0.0 110.72 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 3.5 m -131.35 118.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.495 1.043 . . . . 0.0 113.621 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -82.03 131.28 35.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.333 1.453 . . . . 0.0 110.021 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -2.87 0.31 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.61 56.93 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.976 2.11 . . . . 0.0 108.607 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 127.527 2.331 . . . . 0.0 116.539 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 122.014 0.911 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -62.55 -4.1 1.79 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.42 -19.17 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.052 1.741 . . . . 0.0 112.182 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.22 -1.02 57.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.857 2.063 . . . . 0.0 111.793 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 11.7 pttt -137.3 155.09 49.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.117 0.967 . . . . 0.0 112.273 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.61 154.05 39.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.074 0.95 . . . . 0.0 109.171 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -58.11 42.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 133.632 4.773 . . . . 0.0 119.272 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 41.57 -37.01 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 138.426 6.69 . . . . 0.0 115.313 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.9 -13.28 14.15 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.962 1.705 . . . . 0.0 106.951 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.2 138.02 19.27 Favored Glycine 0 C--N 1.355 1.605 1 N-CA-C 103.01 -4.036 . . . . 0.0 103.01 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.48 170.47 16.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.98 105.98 16.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -95.38 -24.88 16.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.81 159.11 15.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.326 1.05 . . . . 0.0 109.415 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.59 120.79 22.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.589 -1.319 . . . . 0.0 108.516 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.36 35.86 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.691 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.37 146.03 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.558 1.679 . . . . 0.0 108.083 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 p -158.02 174.06 15.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 119.505 -1.997 . . . . 0.0 114.649 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -145.71 144.14 30.18 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 101.096 -3.668 . . . . 0.0 101.096 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 t -114.59 139.81 49.31 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.186 -2.196 . . . . 0.0 108.576 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 p -120.95 140.74 51.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.715 1.606 . . . . 0.0 111.734 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -143.71 125.93 15.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.07 172.21 13.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -152.31 44.38 0.71 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 120.767 3.617 . . . . 0.0 120.767 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -113.19 95.72 36.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 120.5 -1.375 . . . . 0.0 109.959 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.32 105.35 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.14 3.227 . . . . 0.0 115.147 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.81 -129.51 2.16 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.614 2.054 . . . . 0.0 110.674 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.1 t -149.46 135.07 18.55 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.553 -0.969 . . . . 0.0 112.848 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -133.28 100.69 4.92 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 124.598 2.142 . . . . 0.0 114.665 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.22 143.15 18.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 131.222 3.809 . . . . 0.0 110.621 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 3.1 p90 -155.24 167.64 29.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.196 0.998 . . . . 0.0 110.485 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -165.92 -178.16 4.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.87 1.268 . . . . 0.0 110.838 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.0 t -110.9 108.61 18.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -38.24 -50.62 3.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 119.186 3.032 . . . . 0.0 119.186 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 -12.86 25.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.904 1.736 . . . . 0.0 115.174 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -121.68 17.17 11.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.46 -28.92 67.42 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.08 -8.82 58.71 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 125.364 1.459 . . . . 0.0 114.732 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 -8.19 37.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.659 1.984 . . . . 0.0 111.459 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.84 3.22 34.39 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 118.021 -1.433 . . . . 0.0 115.809 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.8 ttt -82.25 62.73 6.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 120.056 1.928 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 147.38 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 129.036 2.934 . . . . 0.0 110.033 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.49 -169.43 15.35 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.714 1.626 . . . . 0.0 112.951 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.02 -62.98 1.38 Allowed 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t 75.56 127.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 131.607 3.963 . . . . 0.0 110.896 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -121.67 128.86 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.97 143.59 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.378 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.494 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.258 1.538 1 C-N-CA 137.496 6.318 . . . . 0.0 113.457 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.428 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 117.497 -1.24 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 20.65 99.03 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 129.73 3.212 . . . . 0.0 117.219 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.42 165.14 11.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.9 m -144.67 144.51 31.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.309 2.643 . . . . 0.0 106.006 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -150.3 152.18 11.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 122.583 1.182 . . . . 0.0 111.864 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -114.37 118.38 33.71 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.2 mtm -79.97 119.98 23.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.11 96.18 1.58 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 t -57.51 150.72 18.25 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 117.104 0.452 . . . . 0.0 111.363 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.6 -21.1 9.42 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -80.75 -6.37 58.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.193 1.397 . . . . 0.0 112.707 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.0 45.7 5.01 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.128 1.347 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.11 0.564 . . . . 0.0 110.214 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 62.9 0.06 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.495 1.918 . . . . 0.0 114.176 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.56 146.86 18.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 O-C-N 120.787 -1.195 . . . . 0.0 107.992 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.86 137.36 32.42 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.415 1.486 . . . . 0.0 112.035 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -119.97 106.77 40.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.141 1.376 . . . . 0.0 111.711 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.88 151.9 94.63 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 -2.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.28 -7.83 46.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.781 2.832 . . . . 0.0 113.518 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.2 m -149.58 124.65 10.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.267 3.027 . . . . 0.0 105.231 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.8 155.49 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.675 0.671 . . . . 0.0 112.494 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -130.97 100.47 5.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.57 1.176 . . . . 0.0 112.069 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.04 -177.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.69 135.33 52.95 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.636 1.107 . . . . 0.0 111.643 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 98' ' ' GLU . . . -31.16 103.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.933 2.093 . . . . 0.0 112.966 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 -4.64 14.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.688 1.613 . . . . 0.0 112.968 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 64.7 mt-10 -91.94 169.61 10.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.34 1.57 . . . . 0.0 114.747 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.64 163.9 12.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.4 t -148.0 104.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 127.844 2.458 . . . . 0.0 106.715 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.68 111.28 23.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.682 0.793 . . . . 0.0 110.926 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.602 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.14 114.06 26.26 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 14.2 t -96.9 136.98 25.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 131.094 3.757 . . . . 0.0 114.161 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 65' ' ' ALA 0.263 0.0 OUTLIER -69.9 120.16 15.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 129.955 3.302 . . . . 0.0 107.3 177.394 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -132.8 -30.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 116.968 -1.492 . . . . 0.0 113.482 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -158.99 163.96 35.98 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 tp 43.15 48.45 5.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.433 3.093 . . . . 0.0 111.478 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -56.41 144.88 61.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.493 2.317 . . . . 0.0 111.747 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.09 175.22 49.07 Favored 'Cis proline' 0 CA--C 1.548 1.214 0 CA-C-O 123.108 1.212 . . . . 0.0 114.166 0.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -146.46 152.11 38.49 Favored 'General case' 0 CA--C 1.528 0.123 1 C-N-CA 132.815 4.446 . . . . 0.0 113.956 177.886 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -142.46 162.03 36.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.279 1.832 . . . . 0.0 110.006 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.624 HG21 ' CE1' ' A' ' 69' ' ' PHE . 20.7 mm -135.62 94.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.312 1.445 . . . . 0.0 110.867 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 58' ' ' HIS . 4.2 m -115.5 118.45 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 O-C-N 120.839 -1.163 . . . . 0.0 112.056 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 132.83 39.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -0.71 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 73.24 33.03 1.19 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.101 2.56 . . . . 0.0 111.602 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 CA--C 1.548 0.877 0 CA-C-O 115.644 -2.122 . . . . 0.0 116.061 -177.976 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.53 -10.38 11.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.395 1.878 . . . . 0.0 115.531 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.48 -10.19 7.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.411 2.284 . . . . 0.0 110.316 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 8.56 25.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.885 1.674 . . . . 0.0 112.563 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -142.61 156.96 45.15 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.272 0.942 . . . . 0.0 109.393 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HB2' ' H ' ' A' ' 41' ' ' ILE . 19.1 mt -76.37 60.71 1.59 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.044 2.538 . . . . 0.0 105.338 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 59' ' ' LYS . 44.7 m -21.0 86.11 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 121.106 3.743 . . . . 0.0 121.106 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.434 ' HA ' HG11 ' A' ' 42' ' ' VAL . 96.8 m-70 34.38 12.21 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 1 C-N-CA 135.087 5.355 . . . . 0.0 115.803 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -156.38 -13.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.375 3.07 . . . . 0.0 110.01 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.53 148.85 50.51 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 116.296 -2.859 . . . . 0.0 106.531 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.06 147.43 32.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 33' ' ' ASN . . . -117.29 110.43 18.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 102.505 -3.146 . . . . 0.0 102.505 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -116.9 -31.08 5.54 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.1 136.2 41.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.394 1.477 . . . . 0.0 110.752 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.516 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . . . -55.62 118.54 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.683 1.193 . . . . 0.0 112.423 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.79 4.04 52.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.297 1.904 . . . . 0.0 113.793 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.29 -60.8 3.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 1.2 p 64.03 171.38 0.18 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -154.82 135.99 13.95 Favored 'General case' 0 CA--C 1.559 1.318 1 N-CA-C 98.35 -4.685 . . . . 0.0 98.35 176.22 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.26 146.9 30.89 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 118.88 -2.387 . . . . 0.0 108.357 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 p -126.52 151.98 47.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.8 m -153.0 118.68 5.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.95 158.47 44.02 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -136.81 23.71 3.09 Favored 'General case' 0 CA--C 1.546 0.807 1 N-CA-C 123.439 4.607 . . . . 0.0 123.439 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 2.8 pt-20 -89.6 108.83 27.68 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.45 103.0 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.497 1.464 . . . . 0.0 110.446 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.11 -162.98 36.77 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 127.899 2.666 . . . . 0.0 110.969 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -124.01 128.67 49.72 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.107 0.956 . . . . 0.0 113.054 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -120.27 127.11 52.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 124.203 1.954 . . . . 0.0 114.25 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -80.53 144.5 32.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.617 -2.538 . . . . 0.0 108.406 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.421 ' CE1' HG23 ' A' ' 95' ' ' VAL . 35.9 p90 -152.5 166.06 33.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.848 0.832 . . . . 0.0 109.709 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -163.77 175.23 10.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.701 0.8 . . . . 0.0 111.502 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.6 t -109.32 116.17 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -42.35 -63.47 0.9 Allowed Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.89 -4.24 8.41 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.427 2.751 . . . . 0.0 116.02 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -130.77 12.18 5.26 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.908 1.231 . . . . 0.0 113.128 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.79 -28.42 22.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.851 2.06 . . . . 0.0 115.161 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.59 -5.77 41.85 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 126.68 2.086 . . . . 0.0 114.813 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.2 -5.74 32.74 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.019 2.528 . . . . 0.0 110.932 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.25 34.22 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.789 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 ttt -82.99 63.47 7.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.285 2.042 . . . . 0.0 110.656 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.11 144.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 129.879 3.272 . . . . 0.0 109.345 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.4 -175.94 27.0 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.567 1.079 . . . . 0.0 113.927 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -143.35 115.71 8.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.368 1.467 . . . . 0.0 114.074 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 81' ' ' TYR . 11.9 t -89.6 147.38 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 127.569 2.348 . . . . 0.0 107.594 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.78 120.5 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.58 113.68 37.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 123.83 0.852 . . . . 0.0 110.481 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.474 ' N ' ' HA ' ' A' ' 24' ' ' LYS . 17.2 pt-20 . . . . . 0 C--O 1.256 1.43 1 C-N-CA 133.961 4.904 . . . . 0.0 114.89 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 26.2 t-20 48.41 72.86 0.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 109.699 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.12 163.62 27.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 123.941 1.829 . . . . 0.0 112.638 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -143.8 148.55 35.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 129.579 3.152 . . . . 0.0 103.377 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -154.36 156.0 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.283 1.04 . . . . 0.0 109.532 177.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -120.58 105.66 11.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.5 mtm -65.26 119.34 10.72 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.78 99.61 1.09 Allowed Glycine 0 N--CA 1.47 0.961 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.3 t -59.41 152.01 22.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.65 -18.36 53.14 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.907 -1.121 . . . . 0.0 111.16 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -81.49 -7.84 59.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.619 1.968 . . . . 0.0 112.412 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.87 9.19 64.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.84 2.162 . . . . 0.0 115.292 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.56 138.65 34.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.356 0.663 . . . . 0.0 110.154 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.05 73.94 0.91 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.066 1.746 . . . . 0.0 108.646 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.43 134.66 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.02 132.41 37.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.6 pt-20 -117.45 113.34 38.75 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.466 -0.772 . . . . 0.0 112.568 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 92.8 Cg_endo -78.67 138.82 51.56 Favored 'Cis proline' 0 C--N 1.354 0.865 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 -2.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -78.1 -10.94 59.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.62 1.968 . . . . 0.0 112.588 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -142.82 128.47 19.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 129.676 3.191 . . . . 0.0 108.561 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 p -148.14 165.51 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.19 0.904 . . . . 0.0 113.426 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -131.13 106.32 8.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.943 1.297 . . . . 0.0 110.855 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 2.6 pp -123.24 175.21 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 0.0 109.291 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.535 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -130.79 174.09 10.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.91 100.77 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.889 1.275 . . . . 0.0 113.519 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.88 -2.59 25.82 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.01 1.767 . . . . 0.0 114.245 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.47 173.31 9.71 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.729 1.252 . . . . 0.0 114.356 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -130.71 171.77 12.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 123.426 1.584 . . . . 0.0 111.361 -178.032 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.84 94.85 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.443 2.297 . . . . 0.0 106.332 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -84.44 51.92 2.23 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -57.94 133.67 55.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 177.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t -118.86 149.9 21.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 1 C-N-CA 133.564 4.746 . . . . 0.0 114.277 -176.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.651 HD22 ' HB1' ' A' ' 62' ' ' ALA . 2.9 t-20 -78.71 117.72 20.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.57 3.148 . . . . 0.0 107.047 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -129.53 -20.12 3.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 115.748 -2.072 . . . . 0.0 113.939 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.06 153.73 16.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.6 tp 45.98 50.46 11.43 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 131.466 3.907 . . . . 0.0 112.08 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 151.18 4.08 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 129.616 3.166 . . . . 0.0 112.33 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.95 174.25 45.48 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 O-C-N 122.13 0.542 . . . . 0.0 112.507 -2.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.95 163.33 37.17 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 130.097 3.359 . . . . 0.0 113.624 177.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -149.28 163.09 38.67 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.82 1.248 . . . . 0.0 113.089 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.14 79.68 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.781 2.032 . . . . 0.0 110.109 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 4.0 m -105.86 118.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 119.89 -1.756 . . . . 0.0 111.663 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 10.6 m-85 -79.54 141.38 36.7 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 121.699 -0.626 . . . . 0.0 110.371 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.64 -16.17 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 69.4 68.51 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.584 1.954 . . . . 0.0 108.181 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.513 0.725 . . . . 0.0 112.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -60.6 -5.83 1.4 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.679 2.392 . . . . 0.0 115.466 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.34 -3.32 6.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 111.114 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.77 -5.72 14.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.913 2.085 . . . . 0.0 114.642 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 28.4 pttt -130.32 167.61 18.24 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.05 1.74 . . . . 0.0 114.904 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.97 -69.16 0.35 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.93 2.092 . . . . 0.0 110.534 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t 153.06 150.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.737 2.815 . . . . 0.0 110.014 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -70.8 5.16 2.07 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.212 2.205 . . . . 0.0 111.481 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 -25.92 0.82 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.887 2.475 . . . . 0.0 111.266 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.85 136.97 18.0 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 120.342 1.428 . . . . 0.0 110.352 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.45 165.56 29.04 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.651 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -103.64 105.55 15.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -99.07 -24.92 14.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.22 56.26 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.73 112.35 0.45 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.102 1.761 . . . . 0.0 112.288 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.93 -12.61 29.42 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.407 1.48 . . . . 0.0 112.712 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -68.92 87.04 0.36 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.207 1.503 . . . . 0.0 113.811 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 80.6 p -83.71 157.26 22.23 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.799 -1.188 . . . . 0.0 109.863 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -26.02 6.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.387 -2.125 . . . . 0.0 108.526 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t 47.49 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 131.529 3.932 . . . . 0.0 116.868 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -135.27 152.79 51.85 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.679 -1.263 . . . . 0.0 111.777 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -143.93 112.05 6.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.753 2.021 . . . . 0.0 109.503 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 154.6 51.24 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.792 2.037 . . . . 0.0 115.44 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -136.52 16.87 3.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 pm0 -92.85 96.05 1.26 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' GLU . 8.5 Cg_endo -41.84 118.22 0.86 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 124.433 3.422 . . . . 0.0 112.893 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.51 -152.05 22.7 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 123.243 1.468 . . . . 0.0 112.983 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -145.63 117.57 8.25 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.692 1.197 . . . . 0.0 108.968 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.82 133.43 54.44 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 124.076 1.893 . . . . 0.0 112.346 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 151.15 24.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.927 3.291 . . . . 0.0 115.021 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CE2' HG23 ' A' ' 95' ' ' VAL . 19.4 p90 -154.78 162.32 41.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.987 1.315 . . . . 0.0 110.108 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -159.64 164.15 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 110.164 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.9 t -99.69 104.59 16.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -35.8 -60.62 0.63 Allowed Pre-proline 0 N--CA 1.48 1.055 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.75 -8.11 20.28 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.504 2.136 . . . . 0.0 114.048 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.8 1.84 7.42 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.859 1.209 . . . . 0.0 112.64 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -43.15 -59.69 1.96 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.29 2.636 . . . . 0.0 111.353 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.13 71.04 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.127 1.346 . . . . 0.0 116.056 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -11.25 33.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.274 1.429 . . . . 0.0 111.803 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.03 -0.2 17.1 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-O 118.3 -1.278 . . . . 0.0 115.733 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttt -81.67 73.84 8.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.092 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.53 147.65 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 129.351 3.061 . . . . 0.0 108.251 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.63 179.73 34.09 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.039 0.828 . . . . 0.0 114.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -147.48 131.71 17.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.71 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.5 t -97.31 155.99 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 127.367 2.267 . . . . 0.0 108.161 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.71 125.47 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -123.96 142.17 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 124.489 1.118 . . . . 0.0 112.997 177.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 6.0 pt-20 . . . . . 0 C--O 1.253 1.261 1 C-N-CA 134.396 5.078 . . . . 0.0 116.254 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 18.93 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 128.976 2.91 . . . . 0.0 115.189 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.73 156.8 24.82 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.951 -1.093 . . . . 0.0 113.855 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.0 m -136.88 125.08 23.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 103.433 -2.803 . . . . 0.0 103.433 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.06 149.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 122.79 1.281 . . . . 0.0 112.486 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -117.02 116.83 28.12 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.946 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp -76.97 120.81 22.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.68 94.43 1.54 Allowed Glycine 0 N--CA 1.47 0.962 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -58.01 152.41 16.52 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.726 0.411 . . . . 0.0 111.836 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -57.46 -17.63 14.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -80.54 -7.53 59.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.255 1.022 . . . . 0.0 112.183 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.97 25.86 30.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.529 1.538 . . . . 0.0 113.984 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.73 140.61 32.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.529 0.732 . . . . 0.0 109.863 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.14 63.41 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.132 1.773 . . . . 0.0 112.093 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.85 145.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.609 -1.307 . . . . 0.0 107.637 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.46 144.54 28.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.666 1.186 . . . . 0.0 111.367 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 24.3 pt-20 -123.86 108.07 30.72 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.544 1.538 . . . . 0.0 110.928 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -78.41 147.26 81.8 Favored 'Cis proline' 0 CA--C 1.542 0.911 0 N-CA-C 116.042 1.516 . . . . 0.0 116.042 -2.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -0.77 57.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.819 2.048 . . . . 0.0 113.351 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -151.48 127.11 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 128.671 2.788 . . . . 0.0 104.929 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.6 158.21 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -138.49 107.17 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.272 1.034 . . . . 0.0 111.078 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.76 173.34 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.239 1.416 . . . . 0.0 108.088 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -128.81 152.01 48.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.68 1.582 . . . . 0.0 110.87 177.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -24.34 115.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.506 2.722 . . . . 0.0 114.713 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.13 -19.92 39.31 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.827 1.679 . . . . 0.0 113.364 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 mt-10 -79.54 167.63 20.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 122.455 1.121 . . . . 0.0 111.097 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.02 -178.89 3.97 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 122.667 1.222 . . . . 0.0 109.937 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.54 101.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -88.5 123.11 32.7 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -127.88 122.22 31.99 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 177.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.32 148.9 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 128.872 2.869 . . . . 0.0 115.315 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.845 HD22 ' HB1' ' A' ' 62' ' ' ALA . 14.0 t-20 -76.88 116.19 17.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 131.182 3.793 . . . . 0.0 109.879 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -131.33 -27.44 1.99 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 116.995 -1.479 . . . . 0.0 114.09 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.35 159.96 37.98 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tp 47.8 49.57 16.52 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 127.92 2.488 . . . . 0.0 111.503 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 140.48 64.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.919 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 165.53 84.79 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 CA-C-O 125.068 2.028 . . . . 0.0 115.79 2.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.508 ' HA ' ' SG ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -144.04 169.63 17.47 Favored 'General case' 0 CA--C 1.515 -0.395 1 C-N-CA 131.915 4.086 . . . . 0.0 111.833 177.723 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -167.63 175.04 7.28 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.372 1.869 . . . . 0.0 109.282 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.5 mm -146.67 93.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.402 1.481 . . . . 0.0 109.404 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.03 111.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.209 1.404 . . . . 0.0 112.362 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.431 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 14.9 m-85 -72.49 131.8 43.01 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 120.813 -1.179 . . . . 0.0 108.259 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.55 -3.41 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.642 1.977 . . . . 0.0 115.856 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.44 52.62 8.36 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.282 1.033 . . . . 0.0 109.783 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 126.898 2.079 . . . . 0.0 110.865 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -56.95 -9.0 0.71 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 129.713 3.205 . . . . 0.0 115.677 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.39 -4.28 6.08 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.792 2.037 . . . . 0.0 111.003 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.23 -10.52 14.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.68 2.392 . . . . 0.0 113.935 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CB ' ' H ' ' A' ' 43' ' ' PHE . 27.2 pttt -130.5 166.9 19.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.045 1.738 . . . . 0.0 114.368 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.17 -72.51 0.21 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.721 1.608 . . . . 0.0 111.99 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t 158.15 149.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.619 2.367 . . . . 0.0 108.664 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -69.43 -10.26 57.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.123 0.969 . . . . 0.0 111.482 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -19.47 8.6 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.244 1.418 . . . . 0.0 110.444 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.46 111.32 4.21 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 120.228 1.377 . . . . 0.0 110.938 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.52 173.08 7.63 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -107.5 101.47 10.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 126.911 2.084 . . . . 0.0 105.95 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.82 -14.09 16.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.842 1.657 . . . . 0.0 114.24 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.47 51.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.552 1.524 . . . . 0.0 113.312 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.11 116.25 1.92 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.127 1.371 . . . . 0.0 112.312 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.35 -13.29 33.45 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.262 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -65.54 157.47 29.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.294 2.047 . . . . 0.0 109.35 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 p -163.29 174.04 12.55 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 118.893 -2.379 . . . . 0.0 113.361 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -152.03 151.03 30.62 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -113.22 139.27 48.93 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 120.168 -1.583 . . . . 0.0 108.718 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 54.0 p -119.53 152.21 37.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -153.74 125.6 7.76 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.263 0.3 OUTLIER -143.15 150.91 40.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.6 t -137.21 14.71 3.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 111.573 -2.558 . . . . 0.0 114.93 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -103.97 99.58 17.14 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.364 1.865 . . . . 0.0 109.409 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.55 125.92 15.03 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.778 2.986 . . . . 0.0 111.395 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.43 -174.72 43.18 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 123.7 1.722 . . . . 0.0 113.157 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -134.11 106.31 7.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.253 0.2 OUTLIER -115.08 137.76 51.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 123.918 1.818 . . . . 0.0 113.646 -177.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 147.36 28.76 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 111.737 -2.483 . . . . 0.0 113.176 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 95' ' ' VAL . 38.6 p90 -147.65 155.97 42.31 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.26 0.624 . . . . 0.0 109.591 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -156.19 170.7 21.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.512 0.673 . . . . 0.0 109.696 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER -105.5 119.65 39.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.274 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.81 -57.7 11.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.18 -18.88 64.54 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.879 2.064 . . . . 0.0 114.314 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -119.43 14.46 12.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.402 1.455 . . . . 0.0 113.923 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -48.91 -40.75 31.19 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.43 -10.43 59.33 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.819 1.676 . . . . 0.0 114.175 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.86 -7.23 52.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.88 2.072 . . . . 0.0 111.58 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.21 3.96 29.29 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 118.169 -1.351 . . . . 0.0 115.123 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.8 ttt -83.75 76.78 9.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 124.001 1.857 . . . . 0.0 108.413 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.09 146.4 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 129.101 2.96 . . . . 0.0 109.071 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -179.69 32.15 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 124.721 1.153 . . . . 0.0 114.692 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -138.92 120.17 14.74 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.473 1.509 . . . . 0.0 114.851 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.691 HG23 ' CE1' ' A' ' 81' ' ' TYR . 48.1 t -91.68 153.35 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.722 2.009 . . . . 0.0 108.591 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.77 122.24 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.66 126.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 123.347 0.659 . . . . 0.0 109.844 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.507 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 8.4 pt-20 . . . . . 0 C--O 1.252 1.204 1 C-N-CA 135.391 5.477 . . . . 0.0 113.94 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 31.06 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 130.26 3.424 . . . . 0.0 111.944 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.34 172.78 7.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 m -151.42 147.37 26.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 130.757 3.623 . . . . 0.0 104.87 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.81 151.99 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 122.872 1.32 . . . . 0.0 109.647 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -111.86 123.84 51.1 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 mtp -87.46 125.17 34.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 35' ' ' LYS . . . 89.97 92.77 1.2 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -58.58 147.0 33.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.257 0.621 . . . . 0.0 109.573 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.35 -15.94 30.41 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -76.73 -8.88 58.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.317 0.647 . . . . 0.0 111.107 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.92 58.1 2.29 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.627 2.06 . . . . 0.0 108.769 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.08 133.25 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 67.02 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.335 1.454 . . . . 0.0 113.062 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.08 147.72 16.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.8 140.58 31.16 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.504 1.921 . . . . 0.0 112.782 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.4 pt-20 -124.3 103.48 32.57 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.46 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 60.1 Cg_endo -81.78 140.26 45.33 Favored 'Cis proline' 0 CA--C 1.551 1.357 0 N-CA-C 118.397 2.422 . . . . 0.0 118.397 -2.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -16.59 62.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.676 3.591 . . . . 0.0 114.495 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 20.8 m -157.16 141.09 16.13 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 128.513 2.725 . . . . 0.0 105.38 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.97 149.63 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.973 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -112.19 102.41 10.59 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 125.22 1.575 . . . . 0.0 109.113 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pt -126.32 -178.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 112.274 -2.239 . . . . 0.0 109.134 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.72 172.29 7.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.06 65.4 0.14 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.326 2.25 . . . . 0.0 111.932 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.05 40.35 0.09 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 129.653 3.501 . . . . 0.0 111.904 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -122.13 166.47 14.52 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -109.39 161.6 15.14 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.926 1.346 . . . . 0.0 114.39 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -145.69 103.47 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 129.442 3.097 . . . . 0.0 106.793 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.97 88.28 2.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.3 138.81 31.55 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.3 145.57 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 130.55 3.54 . . . . 0.0 115.363 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.673 HD22 ' HB1' ' A' ' 62' ' ' ALA . 11.1 t-20 -74.61 124.15 26.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.871 2.469 . . . . 0.0 107.285 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.24 -29.21 1.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.841 -1.552 . . . . 0.0 114.779 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HA3' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -167.73 158.84 11.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 177.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.9 tp 48.51 57.21 6.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.685 . . . . 0.0 111.367 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.56 156.37 32.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.01 160.54 86.36 Favored 'Cis proline' 0 CA--C 1.544 0.982 0 CA-C-O 123.808 1.503 . . . . 0.0 113.857 -1.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 143.03 42.51 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 128.149 2.58 . . . . 0.0 113.599 177.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' HD12 ' A' ' 56' ' ' LEU 0.305 20.1 t-20 -141.56 150.64 42.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.13 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 56' ' ' LEU . 30.4 mm -117.86 94.74 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 58' ' ' HIS . 15.4 m -124.62 114.61 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 123.908 0.883 . . . . 0.0 110.935 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.491 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 36.4 m-85 -74.4 167.96 20.63 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.725 0.81 . . . . 0.0 109.077 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.43 -6.05 23.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.961 2.949 . . . . 0.0 118.961 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 64.83 51.17 1.85 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.407 1.458 . . . . 0.0 110.328 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 127.008 2.123 . . . . 0.0 112.641 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -60.71 -7.27 2.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.093 1.757 . . . . 0.0 113.863 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.71 -0.01 11.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.36 1.864 . . . . 0.0 111.337 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.88 16.72 3.88 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 40.9 pttt -137.51 160.36 39.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.386 0.993 . . . . 0.0 111.8 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 41' ' ' ILE . 30.8 mt -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.36 1.464 . . . . 0.0 111.469 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -71.82 43.8 0.1 Allowed 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 128.935 2.894 . . . . 0.0 116.62 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER 44.92 -56.17 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.098 1 C-N-CA 136.622 5.969 . . . . 0.0 112.115 -177.785 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 -16.85 22.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.264 1.603 . . . . 0.0 108.23 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.59 139.51 23.9 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 103.193 -3.963 . . . . 0.0 103.193 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.1 176.74 12.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -94.94 95.35 8.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -88.45 -27.02 21.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.31 -130.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.176 0.99 . . . . 0.0 109.255 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.9 120.89 10.03 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.618 1.967 . . . . 0.0 109.895 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.27 -13.16 23.69 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 117.601 -1.666 . . . . 0.0 113.454 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.84 161.82 25.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.871 2.335 . . . . 0.0 109.329 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 p -161.37 162.76 30.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.242 -1.536 . . . . 0.0 112.655 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.75 139.73 28.06 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 101.608 -3.478 . . . . 0.0 101.608 177.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 118.968 -2.333 . . . . 0.0 109.519 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.0 p -121.68 126.02 47.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.543 1.137 . . . . 0.0 108.766 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.2 m -127.62 101.3 6.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.08 2.152 . . . . 0.0 107.796 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -116.62 138.84 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 118.754 2.872 . . . . 0.0 118.754 178.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -118.2 6.53 11.99 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.152 2.981 . . . . 0.0 118.114 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -106.31 94.83 10.31 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.345 1.058 . . . . 0.0 112.553 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 98' ' ' GLU . 36.4 Cg_endo -56.26 120.35 8.15 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.284 2.656 . . . . 0.0 108.453 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.34 -3.17 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t 53.79 94.85 0.02 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 130.619 3.568 . . . . 0.0 110.868 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -101.8 149.61 24.0 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 117.112 -1.835 . . . . 0.0 113.421 -177.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -92.21 154.42 18.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 110.851 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.78 171.62 19.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.55 1.54 . . . . 0.0 112.036 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.16 -171.41 2.19 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.746 2.019 . . . . 0.0 109.832 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -122.58 113.05 18.75 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.59 1.556 . . . . 0.0 111.185 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -41.38 -50.16 8.91 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -0.3 10.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.299 2.666 . . . . 0.0 116.799 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -137.54 10.13 2.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -43.71 -50.45 7.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.08 -8.88 85.96 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 126.152 1.834 . . . . 0.0 115.01 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.09 -8.94 35.12 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.43 1.892 . . . . 0.0 111.169 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 7.47 30.22 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.377 -1.235 . . . . 0.0 115.996 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.3 ttt -83.15 63.52 7.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.911 1.855 . . . . 0.0 110.623 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.57 145.78 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 129.312 3.045 . . . . 0.0 111.507 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.26 -176.74 31.65 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 125.406 1.479 . . . . 0.0 115.026 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.0 ttmm -136.11 171.45 14.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.36 1.464 . . . . 0.0 110.304 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -141.25 150.73 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 119.257 -2.152 . . . . 0.0 108.362 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.44 110.49 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 100.898 -3.741 . . . . 0.0 100.898 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.94 53.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 124.377 2.037 . . . . 0.0 110.98 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 131.379 3.871 . . . . 0.0 113.388 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 42.41 73.15 0.14 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.14 1.776 . . . . 0.0 110.453 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.02 157.32 35.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.856 1.789 . . . . 0.0 112.854 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 m -139.45 143.47 37.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 150.59 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 119.19 0.905 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 10.0 mtpt -120.1 116.56 25.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtm -76.33 122.28 24.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.597 1.959 . . . . 0.0 106.917 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.04 1.19 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.041 -2.023 . . . . 0.0 108.041 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 t -58.2 148.18 27.84 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.148 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.23 -14.21 16.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.2 m -79.42 -10.83 59.89 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.75 0.704 . . . . 0.0 111.126 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.32 15.0 45.88 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.927 1.727 . . . . 0.0 113.461 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.76 128.31 35.32 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.821 1.311 . . . . 0.0 109.188 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.69 66.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.433 1.893 . . . . 0.0 111.667 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.03 151.01 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -100.52 130.4 46.59 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.757 1.223 . . . . 0.0 108.009 177.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 3.7 pt-20 -100.87 131.55 23.28 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.414 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' GLU 0.301 7.4 Cg_exo -77.58 -13.23 30.16 Favored 'Cis proline' 0 C--N 1.355 0.882 1 N-CA-C 125.071 4.989 . . . . 0.0 125.071 2.757 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t 93.12 -15.98 0.13 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 131.242 3.817 . . . . 0.0 109.929 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 m -153.82 129.78 10.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.959 1.704 . . . . 0.0 108.083 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 22' ' ' THR . 1.8 p -144.86 168.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 113.307 -1.77 . . . . 0.0 113.726 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 21' ' ' VAL . 9.9 t -132.63 115.08 14.96 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.518 -1.673 . . . . 0.0 110.936 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.8 -179.27 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.361 1.464 . . . . 0.0 110.267 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.98 176.65 5.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 177.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -60.44 115.18 3.38 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.181 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.77 67.61 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.878 1.704 . . . . 0.0 112.383 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 18.3 tt0 -82.92 161.58 21.8 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.162 0.985 . . . . 0.0 112.498 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' CD ' ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt-20 -108.09 166.7 10.54 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.977 1.37 . . . . 0.0 113.762 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.32 97.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.177 2.591 . . . . 0.0 105.456 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HE3' ' CD ' ' A' ' 28' ' ' GLU . 5.0 ptpp? -98.95 106.59 18.87 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.636 1.208 . . . . 0.0 112.756 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -106.57 122.22 45.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.08 153.02 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 109.092 -3.685 . . . . 0.0 113.435 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.581 HD22 ' HB1' ' A' ' 62' ' ' ALA 0.261 3.8 t-20 -86.81 107.84 18.47 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 131.612 3.965 . . . . 0.0 106.883 177.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.0 -32.54 4.18 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.96 34.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 tp 41.32 57.91 2.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.058 2.943 . . . . 0.0 112.952 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.41 151.53 59.34 Favored Pre-proline 0 CA--C 1.537 0.452 1 C-N-CA 132.256 4.222 . . . . 0.0 111.692 177.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.52 174.99 45.92 Favored 'Cis proline' 0 CA--C 1.543 0.96 0 CA-C-O 122.57 0.987 . . . . 0.0 112.314 -2.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.0 161.23 42.73 Favored 'General case' 0 C--O 1.224 -0.287 1 C-N-CA 132.99 4.516 . . . . 0.0 114.449 177.912 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.13 159.11 42.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.92 0.888 . . . . 0.0 112.602 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.727 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.8 mp -120.87 109.14 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.262 0.625 . . . . 0.0 110.576 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.05 113.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.244 1.018 . . . . 0.0 113.722 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 79' ' ' TYR . 27.3 m-85 -80.85 134.6 35.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.177 1.391 . . . . 0.0 110.383 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.32 43.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.801 1.24 . . . . 0.0 113.616 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 87.92 -23.33 0.12 Allowed 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 129.742 3.217 . . . . 0.0 115.387 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.557 1.239 0 C-N-CA 129.076 2.95 . . . . 0.0 113.952 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -71.78 0.1 9.77 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.46 -19.55 3.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.269 1.427 . . . . 0.0 112.532 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.21 0.15 39.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.753 1.221 . . . . 0.0 112.806 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -133.9 168.72 18.24 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 119.871 1.214 . . . . 0.0 113.86 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' ILE . 39.6 mt -72.45 163.32 28.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.999 1.319 . . . . 0.0 112.035 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.5 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 129.112 2.965 . . . . 0.0 118.487 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 51.45 -47.9 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 1 C-N-CA 136.801 6.04 . . . . 0.0 111.518 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.18 -22.09 24.22 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 126.932 2.093 . . . . 0.0 106.958 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.37 150.98 41.11 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 177.13 11.22 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.449 2.124 . . . . 0.0 116.56 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -109.5 104.45 13.51 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -102.69 -24.06 13.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.17 131.69 55.77 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.35 116.06 1.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.357 1.463 . . . . 0.0 112.186 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.91 -9.96 34.35 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.712 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -68.36 163.39 23.22 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.286 2.043 . . . . 0.0 109.214 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -167.49 165.38 14.76 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 119.312 -2.117 . . . . 0.0 111.706 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.727 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.71 140.62 34.92 Favored 'General case' 0 CA--C 1.551 0.986 1 N-CA-C 99.626 -4.213 . . . . 0.0 99.626 176.702 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -110.6 143.85 40.38 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 109.504 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.9 p -124.53 135.03 52.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.858 1.263 . . . . 0.0 110.012 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.7 m -135.4 137.24 42.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.912 2.085 . . . . 0.0 107.651 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' HG11 ' A' ' 97' ' ' VAL 0.324 0.2 OUTLIER -148.31 156.61 42.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 119.67 3.211 . . . . 0.0 119.67 -177.758 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -140.12 23.45 2.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.272 2.693 . . . . 0.0 118.272 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -101.04 92.51 2.48 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.82 1.648 . . . . 0.0 111.197 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.48 108.9 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.443 2.095 . . . . 0.0 112.037 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.13 -128.2 1.72 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.879 1.704 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 t -167.02 146.37 5.3 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.773 -1.427 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' HD2' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -134.06 140.55 46.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.669 1.223 . . . . 0.0 112.424 176.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -91.51 141.51 28.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.833 2.853 . . . . 0.0 112.233 -177.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' CZ3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.52 169.63 18.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.082 0.944 . . . . 0.0 112.424 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -162.76 -178.31 6.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.26 2.224 . . . . 0.0 113.183 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.1 t -114.26 111.82 22.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.64 1.976 . . . . 0.0 109.059 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -38.04 -64.23 0.47 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -64.93 -10.3 24.8 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.931 2.421 . . . . 0.0 115.422 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -124.26 9.78 8.6 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -44.16 -62.33 1.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.87 1.668 . . . . 0.0 111.457 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.17 -13.85 60.63 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 126.025 1.774 . . . . 0.0 116.046 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.89 -7.2 40.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.383 2.273 . . . . 0.0 111.147 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.28 10.43 36.36 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.326 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.7 ttt -81.03 64.42 5.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.348 2.074 . . . . 0.0 109.635 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.07 154.86 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 131.494 3.918 . . . . 0.0 110.897 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.38 -169.61 32.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.687 1.613 . . . . 0.0 114.002 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' HG2' ' H ' ' A' ' 95' ' ' VAL . 18.6 tttm -140.12 174.19 10.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.311 1.044 . . . . 0.0 110.208 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 12.2 t -150.72 133.83 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 128.18 2.592 . . . . 0.0 108.795 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.29 131.1 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 ' CD1' ' A' ' 73' ' ' PHE . 1.4 m -127.25 132.72 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 125.029 1.456 . . . . 0.0 112.911 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.482 1.167 1 C-N-CA 137.992 6.517 . . . . 0.0 114.526 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 13.51 96.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 130.969 3.708 . . . . 0.0 114.943 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 167.4 9.9 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 123.293 1.521 . . . . 0.0 112.161 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 m -146.37 155.75 42.83 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.051 2.941 . . . . 0.0 103.967 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.74 153.64 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.639 0.733 . . . . 0.0 109.588 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 17.8 mtpt -112.78 120.42 41.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.728 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.6 mtm -80.25 119.94 23.68 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.47 2.708 . . . . 0.0 106.109 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.34 97.74 1.06 Allowed Glycine 0 N--CA 1.47 0.929 0 N-CA-C 106.347 -2.701 . . . . 0.0 106.347 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -59.51 155.89 14.3 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 94.2 m-20 -57.52 -17.89 16.16 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -84.97 -3.74 58.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.591 1.556 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.18 14.6 68.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.241 0.924 . . . . 0.0 112.955 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.34 136.36 33.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.341 0.656 . . . . 0.0 109.798 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.23 65.28 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.8 2.04 . . . . 0.0 111.653 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -145.82 148.53 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.979 0.912 . . . . 0.0 108.563 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -92.93 135.98 33.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.779 1.232 . . . . 0.0 110.656 177.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 20.4 pt-20 -117.87 111.02 39.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.943 1.297 . . . . 0.0 112.216 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 79.2 Cg_endo -78.25 142.91 71.35 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 115.501 1.308 . . . . 0.0 115.501 -2.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -3.86 58.92 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 112.36 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m -151.96 129.28 11.27 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 129.732 3.213 . . . . 0.0 107.521 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.3 164.82 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.98 113.17 10.53 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.244 1.021 . . . . 0.0 111.703 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 141.35 52.03 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.174 1.806 . . . . 0.0 112.374 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -11.59 99.67 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 130.779 3.632 . . . . 0.0 115.747 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.31 -12.95 28.43 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.778 1.18 . . . . 0.0 112.679 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.43 173.06 12.38 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.549 1.166 . . . . 0.0 109.718 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 175.96 6.91 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.72 108.67 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 129.902 3.281 . . . . 0.0 106.64 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -104.77 52.51 0.74 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -49.54 142.83 7.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 120.739 3.607 . . . . 0.0 120.739 177.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.57 152.82 34.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 130.92 3.688 . . . . 0.0 112.65 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.713 HD22 ' HB1' ' A' ' 62' ' ' ALA . 10.4 t-20 -80.12 122.48 26.86 Favored 'General case' 0 CA--C 1.543 0.678 1 C-N-CA 132.479 4.312 . . . . 0.0 109.868 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -136.31 -29.88 0.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.974 -1.489 . . . . 0.0 114.112 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -154.65 157.44 38.16 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp 38.22 51.33 1.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 131.379 3.871 . . . . 0.0 112.534 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.86 151.39 2.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 130.16 3.384 . . . . 0.0 112.579 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.6 176.46 41.64 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-O 122.371 0.905 . . . . 0.0 113.135 -2.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.58 157.0 43.37 Favored 'General case' 0 N--CA 1.462 0.174 1 C-N-CA 132.541 4.336 . . . . 0.0 113.82 177.911 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -147.29 161.8 40.24 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.328 1.451 . . . . 0.0 109.974 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' A' ' 69' ' ' PHE . 28.1 mm -138.1 98.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.193 0.997 . . . . 0.0 111.996 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 2.5 m -120.53 122.15 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 120.796 -1.19 . . . . 0.0 112.624 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -82.04 162.01 22.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.355 0.598 . . . . 0.0 110.952 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.25 -14.07 34.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.67 39.75 0.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.91 1.686 . . . . 0.0 111.96 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.28 -24.33 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.98 -100.43 0.32 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 121.552 1.978 . . . . 0.0 116.206 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.74 -9.78 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.194 0.598 . . . . 0.0 112.426 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.29 152.13 44.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 123.24 1.495 . . . . 0.0 110.149 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.47 76.39 4.98 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.52 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.99 -29.26 28.06 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.376 1.084 . . . . 0.0 109.937 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -63.4 1.49 0.52 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.491 2.717 . . . . 0.0 114.279 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.5 4.21 5.1 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.889 2.876 . . . . 0.0 110.936 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.08 10.02 4.15 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.295 2.238 . . . . 0.0 113.054 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 31.7 pttt -132.73 162.9 30.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 129.396 3.078 . . . . 0.0 110.532 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -68.67 0.37 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.004 2.122 . . . . 0.0 110.904 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 59' ' ' LYS . 13.3 t 150.74 154.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.229 3.412 . . . . 0.0 107.764 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -69.77 15.05 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.811 1.645 . . . . 0.0 112.448 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 57' ' ' SER . 1.3 tpmp? -145.03 -18.04 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.69 3.196 . . . . 0.0 111.582 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.7 37.79 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 122.138 2.244 . . . . 0.0 110.555 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 tp -150.71 143.31 24.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -114.15 108.74 17.38 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -112.9 -26.18 8.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.28 49.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.586 1.154 . . . . 0.0 111.365 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.74 113.95 1.38 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.878 1.271 . . . . 0.0 111.64 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.37 -11.61 28.5 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.903 -1.499 . . . . 0.0 112.794 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -62.17 162.94 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.174 1.987 . . . . 0.0 109.606 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.4 t -161.25 162.55 31.13 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 119.755 -1.841 . . . . 0.0 114.998 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -142.3 146.25 34.86 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 100.35 -3.944 . . . . 0.0 100.35 176.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -118.85 149.7 41.1 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 119.43 -2.044 . . . . 0.0 111.64 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.9 p -134.08 141.99 47.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.503 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -139.79 124.51 18.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.547 2.339 . . . . 0.0 107.908 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.75 146.29 33.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 118.837 2.903 . . . . 0.0 118.837 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 6.9 t -131.69 15.28 4.88 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.28 108.95 39.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.818 2.553 . . . . 0.0 106.463 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -52.47 119.26 5.62 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.71 1.606 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.59 -178.95 24.86 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 128.956 3.169 . . . . 0.0 108.867 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -112.17 131.48 55.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.719 -1.24 . . . . 0.0 111.851 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.25 0.1 OUTLIER -121.94 137.25 54.86 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 124.328 2.013 . . . . 0.0 116.045 177.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -84.25 148.34 26.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 109.959 -3.291 . . . . 0.0 112.951 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 95' ' ' VAL . 27.2 p90 -155.53 168.58 26.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.373 1.869 . . . . 0.0 110.06 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -167.61 172.74 9.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.72 1.208 . . . . 0.0 111.628 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.92 114.71 29.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -41.36 -61.45 1.37 Allowed Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.37 -0.78 8.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.828 3.018 . . . . 0.0 114.973 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -129.53 -3.69 4.81 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -39.37 -59.51 1.06 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.83 2.452 . . . . 0.0 112.083 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.36 -13.13 59.92 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.621 1.581 . . . . 0.0 116.42 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.48 -6.07 28.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.839 2.456 . . . . 0.0 111.603 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.41 5.89 33.97 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 117.744 -1.587 . . . . 0.0 116.459 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.3 ttt -81.27 62.53 5.23 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.202 2.001 . . . . 0.0 110.497 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.57 149.26 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 130.292 3.437 . . . . 0.0 108.828 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.46 -178.39 34.41 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -144.72 124.29 13.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' A' ' 81' ' ' TYR . 18.6 t -95.77 153.7 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 129.558 3.143 . . . . 0.0 109.197 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.48 134.58 62.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 117.999 -1.001 . . . . 0.0 108.489 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.89 65.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 119.137 3.014 . . . . 0.0 119.137 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 129.578 3.151 . . . . 0.0 115.002 177.782 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 50.4 77.85 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.695 1.598 . . . . 0.0 111.255 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.94 165.0 23.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 123.81 1.767 . . . . 0.0 115.133 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -150.28 142.77 24.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.805 3.242 . . . . 0.0 105.491 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -149.75 153.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 122.802 1.287 . . . . 0.0 111.19 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -117.57 120.97 39.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.4 mmm -83.09 121.98 27.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.264 2.226 . . . . 0.0 106.04 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.51 98.07 0.89 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -61.72 155.25 23.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.671 -0.265 . . . . 0.0 111.474 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.35 -20.43 11.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.392 1.077 . . . . 0.0 113.639 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -84.92 -3.05 58.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.928 1.291 . . . . 0.0 113.216 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.41 12.31 76.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.131 0.872 . . . . 0.0 111.863 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.72 128.66 34.21 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.42 64.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.969 2.108 . . . . 0.0 110.898 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.48 155.23 22.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.751 1.221 . . . . 0.0 109.374 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' CE1' ' CE1' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -101.42 136.9 40.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.04 0.924 . . . . 0.0 110.964 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.5 pt-20 -121.92 109.05 34.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 125.787 1.635 . . . . 0.0 112.464 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 Cg_endo -78.2 141.32 65.1 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 N-CA-C 116.639 1.746 . . . . 0.0 116.639 -2.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -15.71 59.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.752 2.421 . . . . 0.0 113.917 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -153.12 133.35 13.48 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.431 2.692 . . . . 0.0 106.165 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.64 167.15 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.626 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -136.87 114.02 10.68 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.041 0.838 . . . . 0.0 111.164 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.84 -172.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.965 1.706 . . . . 0.0 109.754 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.53 171.51 9.94 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 177.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -61.66 84.2 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.295 2.238 . . . . 0.0 111.353 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 18.45 3.61 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.002 2.239 . . . . 0.0 113.571 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -106.64 177.39 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.342 1.457 . . . . 0.0 112.037 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -120.61 161.88 20.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -148.85 103.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.431 2.292 . . . . 0.0 107.184 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 104.13 13.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.363 1.065 . . . . 0.0 113.46 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -102.66 119.52 38.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.42 151.31 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 108.944 -3.753 . . . . 0.0 112.751 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.469 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 18.3 t-20 -79.7 113.88 18.19 Favored 'General case' 0 C--N 1.324 -0.511 1 C-N-CA 132.877 4.471 . . . . 0.0 108.553 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -127.61 -27.34 2.87 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 116.445 -1.74 . . . . 0.0 114.015 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.77 159.12 43.1 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.22 -66.32 0.31 Allowed 'General case' 0 CA--C 1.518 -0.258 1 C-N-CA 132.185 4.194 . . . . 0.0 111.75 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m 66.22 147.88 0.11 Allowed Pre-proline 0 C--N 1.292 -1.905 2 C-N-CA 132.966 4.506 . . . . 0.0 111.556 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.44 179.07 31.3 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-O 122.418 0.924 . . . . 0.0 112.318 -2.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.61 160.19 42.03 Favored 'General case' 0 CA--C 1.534 0.35 1 C-N-CA 135.149 5.38 . . . . 0.0 113.603 177.768 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.49 154.65 39.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.646 1.579 . . . . 0.0 111.668 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.2 mp -124.72 95.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 110.492 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 6.7 m -120.21 116.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 119.962 -1.711 . . . . 0.0 114.342 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -78.94 134.24 36.86 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.963 0.905 . . . . 0.0 109.906 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.44 58.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.67 70.82 0.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.801 1.64 . . . . 0.0 109.551 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.8 -8.36 21.13 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.217 1.007 . . . . 0.0 109.998 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.2 -9.17 69.9 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 127.587 2.517 . . . . 0.0 114.413 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 m -97.42 -12.86 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.346 1.458 . . . . 0.0 112.556 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.498 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.3 p-10 -115.14 145.13 42.67 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 130.144 3.378 . . . . 0.0 116.332 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.59 68.15 9.48 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.236 1.414 . . . . 0.0 107.528 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -44.67 -54.37 6.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.315 1.446 . . . . 0.0 113.907 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -63.79 -5.81 4.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.781 2.032 . . . . 0.0 114.245 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.55 -3.27 8.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.254 1.422 . . . . 0.0 110.482 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.12 3.01 9.87 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 25.3 pttt -136.59 161.31 36.26 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.272 1.397 . . . . 0.0 112.07 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.83 -24.22 64.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 112.813 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' LYS . 3.9 t 66.32 99.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 24.82 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 1 C-N-CA 140.867 7.667 . . . . 0.0 118.563 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.72 -12.4 0.12 Allowed 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 131.52 3.928 . . . . 0.0 110.291 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.96 148.7 50.04 Favored Glycine 0 N--CA 1.493 2.446 0 CA-C-N 123.867 3.03 . . . . 0.0 106.285 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tp -140.55 156.92 46.16 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.42 100.98 7.47 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 101.084 -3.673 . . . . 0.0 101.084 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.8 -19.44 12.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.48 134.23 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.467 1.03 . . . . 0.0 111.719 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.62 113.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.208 1.403 . . . . 0.0 112.295 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.84 26.8 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.818 -1.546 . . . . 0.0 112.484 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -68.03 164.77 19.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 120.541 2.17 . . . . 0.0 108.851 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -168.08 166.02 13.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 118.928 -2.357 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.41 136.22 32.86 Favored 'General case' 0 CA--C 1.55 0.959 1 N-CA-C 98.612 -4.588 . . . . 0.0 98.612 176.655 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -106.8 144.47 33.4 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 118.654 -2.529 . . . . 0.0 109.278 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -117.41 142.51 47.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.037 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.3 m -151.38 89.11 1.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 152.65 21.73 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 127.008 2.123 . . . . 0.0 114.539 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -129.16 2.47 5.2 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 49' ' ' ASP . 19.6 pm0 -90.82 102.8 5.78 Favored Pre-proline 0 N--CA 1.438 -1.063 0 C-N-CA 126.954 2.102 . . . . 0.0 108.787 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -56.54 123.78 14.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.003 3.135 . . . . 0.0 108.461 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.46 170.91 27.94 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.425 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.7 t -111.39 126.12 54.6 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.495 ' CG ' ' HB3' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -128.86 131.25 47.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.967 1.365 . . . . 0.0 113.989 -177.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 148.49 25.87 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.718 2.007 . . . . 0.0 112.593 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -153.12 163.5 39.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.96 0.886 . . . . 0.0 109.489 177.274 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -159.01 178.21 10.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.525 1.53 . . . . 0.0 112.48 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.2 t -113.16 109.05 18.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.36 1.464 . . . . 0.0 107.212 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -38.12 -61.25 0.85 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.75 -10.64 27.41 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.154 1.903 . . . . 0.0 115.927 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -128.95 -2.78 5.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -44.92 34.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.079 1.752 . . . . 0.0 113.103 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.43 -14.78 67.3 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.226 1.393 . . . . 0.0 115.12 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.51 -3.34 26.99 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.094 2.958 . . . . 0.0 110.998 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.15 32.55 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 117.589 -1.673 . . . . 0.0 116.282 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.0 ttt -81.45 64.94 6.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.489 2.144 . . . . 0.0 109.258 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.96 158.41 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 131.178 3.791 . . . . 0.0 109.827 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.22 -168.61 35.31 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 114.056 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HG3' ' H ' ' A' ' 95' ' ' VAL . 30.6 tptt -131.92 173.21 11.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.285 1.034 . . . . 0.0 110.008 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 t -149.95 140.76 16.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 129.585 3.154 . . . . 0.0 107.026 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.7 t -127.31 129.23 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.75 141.71 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.428 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 14.4 pt-20 . . . . . 0 C--O 1.25 1.087 1 C-N-CA 136.377 5.871 . . . . 0.0 111.779 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.19 -1.386 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 4.16 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 129.444 3.098 . . . . 0.0 115.605 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.43 -178.38 6.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 118.267 2.691 . . . . 0.0 118.267 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 m -159.46 120.11 3.14 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 18' ' ' PRO . 2.4 t -122.9 159.76 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 123.625 1.679 . . . . 0.0 109.829 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -111.53 112.1 23.59 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.311 1.444 . . . . 0.0 109.084 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.2 mtt -74.39 115.52 14.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.7 95.33 1.75 Allowed Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.1 t -54.17 148.71 10.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.912 0.856 . . . . 0.0 111.991 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -22.7 21.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 p -75.05 -12.74 60.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.783 2.033 . . . . 0.0 111.343 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.02 66.44 1.62 Allowed Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.79 134.86 30.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' H ' HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.19 70.28 0.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.41 1.884 . . . . 0.0 111.912 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.49 133.52 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.11 145.53 31.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 23.3 pt-20 -137.07 103.18 8.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.279 1.032 . . . . 0.0 112.431 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 5' ' ' VAL 0.374 8.1 Cg_exo -70.44 126.58 10.25 Favored 'Cis proline' 0 CA--C 1.559 1.774 1 N-CA-C 128.411 6.273 . . . . 0.0 128.411 -2.102 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -80.51 -11.99 59.6 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.703 3.201 . . . . 0.0 112.667 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -150.33 120.42 7.22 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 130.356 3.462 . . . . 0.0 105.215 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -136.83 157.08 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.05 0.386 . . . . 0.0 111.769 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -131.68 107.38 8.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.125 0.964 . . . . 0.0 110.652 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.35 -175.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.707 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -134.0 172.2 13.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 177.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -44.09 111.97 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.418 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.39 -13.92 59.69 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.732 1.634 . . . . 0.0 114.506 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 98.3 mt-10 -79.67 162.64 25.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.715 1.245 . . . . 0.0 110.701 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 177.57 4.95 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.327 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.95 101.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 66.64 3.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.109 0.964 . . . . 0.0 112.437 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -74.45 138.38 43.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 39.2 t -118.28 151.58 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 1 C-N-CA 132.432 4.293 . . . . 0.0 116.485 -176.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.418 ' HB3' ' H ' ' A' ' 67' ' ' GLU . 39.0 t-20 -72.56 114.79 11.07 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -109.72 -41.55 4.51 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 114.108 -2.853 . . . . 0.0 113.336 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -169.65 152.64 4.7 Favored 'General case' 0 N--CA 1.483 1.191 1 N-CA-C 122.949 4.426 . . . . 0.0 122.949 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 tp 63.11 56.84 1.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.828 2.051 . . . . 0.0 108.521 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.42 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 3.2 m -60.75 154.11 59.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.083 2.153 . . . . 0.0 111.478 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.36 171.51 63.96 Favored 'Cis proline' 0 CA--C 1.545 1.045 0 N-CA-C 114.677 0.991 . . . . 0.0 114.677 -1.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 37' ' ' SER 0.292 0.8 OUTLIER -157.59 163.12 38.65 Favored 'General case' 0 C--O 1.21 -0.988 1 C-N-CA 136.504 5.921 . . . . 0.0 119.29 177.846 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.08 169.3 23.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.949 1.3 . . . . 0.0 113.425 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 38.2 mm -131.02 83.48 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 125.548 1.539 . . . . 0.0 111.459 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.43 110.71 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.148 0.975 . . . . 0.0 111.15 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 39.5 m-85 -69.09 166.93 17.12 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.65 -20.23 17.77 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 79.93 70.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.38 2.272 . . . . 0.0 106.477 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.6 -16.48 56.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.13 -5.35 27.03 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 119.229 2.451 . . . . 0.0 119.229 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.45 -12.78 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.992 1.377 . . . . 0.0 113.502 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -92.43 -179.47 5.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.801 3.24 . . . . 0.0 113.987 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.21 66.97 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.51 1.524 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -51.68 -54.35 29.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.875 1.27 . . . . 0.0 113.214 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -60.1 -7.15 1.68 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.361 1.865 . . . . 0.0 113.248 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.48 1.39 14.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.65 1.58 . . . . 0.0 111.842 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.73 3.56 2.07 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -118.15 163.7 16.25 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.023 2.129 . . . . 0.0 113.877 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.52 165.49 25.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.361 1.464 . . . . 0.0 110.588 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -64.42 150.52 46.27 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.099 -1.626 . . . . 0.0 110.166 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -65.36 -20.42 66.38 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.607 -1.308 . . . . 0.0 110.847 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.92 -14.98 13.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.995 0.518 . . . . 0.0 111.306 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.66 153.4 33.08 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 104.822 -3.311 . . . . 0.0 104.822 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.07 177.34 10.81 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.78 96.35 6.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -103.57 -3.54 25.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . -146.43 129.77 16.72 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 120.411 1.459 . . . . 0.0 112.151 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.88 123.2 4.94 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.494 -1.379 . . . . 0.0 114.636 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.65 0.67 32.49 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 127.413 2.435 . . . . 0.0 114.697 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 33' ' ' ASN . 9.0 mt-10 -67.89 -67.04 0.49 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.688 2.744 . . . . 0.0 118.201 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 2.5 p 70.27 172.08 0.31 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -163.62 150.85 12.43 Favored 'General case' 0 CA--C 1.549 0.917 1 N-CA-C 99.906 -4.109 . . . . 0.0 99.906 176.074 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -108.84 138.54 45.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 118.392 -2.693 . . . . 0.0 109.087 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 62.5 p -117.19 160.09 21.61 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 m -157.75 138.75 13.3 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.277 0.2 OUTLIER -156.19 155.1 31.86 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 120.174 3.398 . . . . 0.0 120.174 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.2 t -139.82 23.5 2.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.458 2.303 . . . . 0.0 116.746 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -102.79 86.88 1.06 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.772 1.629 . . . . 0.0 112.121 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.26 114.07 0.9 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.726 2.284 . . . . 0.0 110.317 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.09 -132.78 3.06 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.186 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.72 128.55 2.46 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.439 -0.881 . . . . 0.0 110.488 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -124.61 141.56 52.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 124.297 1.999 . . . . 0.0 112.53 176.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 m -77.73 144.64 37.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 110.297 -3.138 . . . . 0.0 110.315 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.52 ' CD1' HG23 ' A' ' 95' ' ' VAL . 34.3 p90 -147.21 164.85 31.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.731 1.613 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -170.26 175.17 5.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.068 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' MET . 11.9 t -107.97 112.38 24.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.764 -2.016 . . . . 0.0 106.622 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.86 -65.52 0.29 Allowed Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.883 1.22 . . . . 0.0 113.869 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.98 -2.53 5.69 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.81 3.007 . . . . 0.0 116.499 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 91' ' ' MET . 6.5 m-70 -132.37 11.31 4.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -13.83 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.46 -7.51 32.12 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.602 2.049 . . . . 0.0 113.158 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.63 -8.33 23.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.083 2.553 . . . . 0.0 110.759 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.83 2.15 32.17 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 117.78 -1.567 . . . . 0.0 115.868 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 13.2 ttt -83.26 66.41 8.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.526 2.163 . . . . 0.0 110.65 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.26 148.47 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 129.205 3.002 . . . . 0.0 108.816 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.65 -178.29 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -140.79 113.0 7.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.87 1.668 . . . . 0.0 114.041 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' CD1' ' A' ' 81' ' ' TYR . 46.8 t -87.95 140.98 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 125.01 1.324 . . . . 0.0 107.638 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -118.38 129.36 74.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.67 131.75 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 O-C-N 124.227 0.954 . . . . 0.0 112.692 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.2 pt-20 . . . . . 0 C--O 1.255 1.363 1 C-N-CA 136.294 5.837 . . . . 0.0 116.204 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 34.47 78.24 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.334 2.653 . . . . 0.0 112.675 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.88 166.81 15.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.8 m -144.22 142.27 30.39 Favored 'General case' 0 C--N 1.329 -0.32 1 C-N-CA 132.489 4.316 . . . . 0.0 103.37 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.36 151.89 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 122.183 0.992 . . . . 0.0 109.436 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -112.99 126.82 55.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.459 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.9 mtm -90.71 125.88 35.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.866 2.066 . . . . 0.0 107.401 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.87 93.78 0.9 Allowed Glycine 0 N--CA 1.465 0.605 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -52.38 154.14 2.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.642 0.721 . . . . 0.0 112.526 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -16.19 34.44 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.993 -1.067 . . . . 0.0 113.112 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -82.94 -3.01 56.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.462 1.905 . . . . 0.0 111.451 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.47 6.13 84.01 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.894 1.712 . . . . 0.0 114.127 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.83 38.51 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.619 0.768 . . . . 0.0 110.048 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 HD23 ' A' ' 36' ' ' LEU . 3.0 mm? -72.06 71.56 0.83 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.857 1.663 . . . . 0.0 110.924 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.61 158.84 4.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.66 1.184 . . . . 0.0 108.268 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.16 137.41 42.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.627 1.571 . . . . 0.0 111.943 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.2 pt-20 -120.15 107.06 40.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.276 1.43 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -80.68 140.6 51.73 Favored 'Cis proline' 0 CA--C 1.549 1.235 0 N-CA-C 117.271 1.989 . . . . 0.0 117.271 -2.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.12 -9.7 59.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 129.147 2.979 . . . . 0.0 113.691 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -149.45 129.66 13.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 129.238 3.015 . . . . 0.0 106.956 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.66 167.56 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.577 1.08 . . . . 0.0 112.055 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -138.68 116.1 11.22 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.48 173.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.62 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -131.63 146.68 52.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -7.83 87.5 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 129.839 3.256 . . . . 0.0 116.826 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -8.24 29.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.693 1.616 . . . . 0.0 115.316 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.19 -172.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -136.44 161.05 36.92 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -143.04 100.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.237 2.615 . . . . 0.0 106.627 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HE3' ' OE2' ' A' ' 28' ' ' GLU . 6.6 ptpp? -101.49 84.8 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.6 142.27 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 118.602 2.816 . . . . 0.0 118.602 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.37 156.51 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 129.795 3.238 . . . . 0.0 112.88 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.442 HD21 ' C ' ' A' ' 62' ' ' ALA . 9.1 m-20 -75.64 140.31 42.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.036 2.534 . . . . 0.0 109.873 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.19 -30.95 0.33 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 116.178 -1.867 . . . . 0.0 114.234 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -158.16 157.76 33.33 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 14' ' ' LEU . 7.1 tp 37.79 52.79 1.46 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 130.497 3.519 . . . . 0.0 113.331 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.21 152.9 7.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 130.698 3.599 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.9 171.23 59.66 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-O 122.881 1.117 . . . . 0.0 112.527 -2.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 157.49 44.45 Favored 'General case' 0 CA--C 1.537 0.453 1 C-N-CA 131.795 4.038 . . . . 0.0 114.651 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 42' ' ' VAL . 7.4 t-20 -144.7 156.82 44.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 113.441 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.7 mp -123.79 87.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.997 1.719 . . . . 0.0 111.394 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 58' ' ' HIS . 19.5 m -117.11 118.99 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 121.143 1.792 . . . . 0.0 113.047 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' H ' ' HB2' ' A' ' 55' ' ' LYS . 28.2 m-85 -84.55 141.96 30.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.548 1.139 . . . . 0.0 111.209 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.35 156.7 35.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 71.36 4.16 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.363 -1.46 . . . . 0.0 108.422 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.44 -15.51 61.82 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.437 1.495 . . . . 0.0 114.063 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.63 -141.17 3.12 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 120.686 1.584 . . . . 0.0 114.782 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.01 -0.22 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.276 -0.868 . . . . 0.0 112.381 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -68.61 159.53 31.81 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.61 73.18 6.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.8 -36.48 62.49 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.599 -0.688 . . . . 0.0 111.278 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -68.38 -1.86 7.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.52 1.928 . . . . 0.0 115.58 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -134.79 -14.66 2.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.1 1.76 . . . . 0.0 112.39 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.33 15.45 29.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.11 1.764 . . . . 0.0 110.971 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 16.7 pttt -148.26 166.14 28.85 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 113.2 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.8 80.6 8.89 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.36 2.264 . . . . 0.0 113.372 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' LYS . 1.5 m -1.11 49.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 1 N-CA-C 124.84 5.126 . . . . 0.0 124.84 -177.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.635 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.5 m-70 50.33 1.84 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.278 2.631 . . . . 0.0 115.199 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -152.78 -11.11 0.17 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 128.78 2.832 . . . . 0.0 110.648 177.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.97 144.58 46.76 Favored Glycine 0 C--N 1.364 2.122 0 C-N-CA 116.343 -2.837 . . . . 0.0 106.759 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 165.42 32.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.604 2.202 . . . . 0.0 115.555 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' C ' HD21 ' A' ' 33' ' ' ASN 0.274 . . -119.82 101.12 7.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -83.56 -23.03 32.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.89 140.99 43.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.47 1.032 . . . . 0.0 113.265 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 121.44 11.77 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.725 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.54 -13.14 39.32 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.98 -1.456 . . . . 0.0 112.563 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -67.08 166.64 13.44 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.206 2.003 . . . . 0.0 109.028 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 t -168.84 160.29 10.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 119.668 -1.895 . . . . 0.0 115.807 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.678 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -141.56 147.72 38.14 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 100.927 -3.731 . . . . 0.0 100.927 176.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -113.33 151.08 31.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 118.517 -2.614 . . . . 0.0 109.584 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.6 p -132.17 133.35 44.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.752 1.221 . . . . 0.0 110.075 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 136.06 36.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.81 2.844 . . . . 0.0 106.787 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.3 168.55 26.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -151.16 52.16 0.85 Allowed 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.02 101.84 38.31 Favored Pre-proline 0 CA--C 1.562 1.427 0 O-C-N 120.435 -1.415 . . . . 0.0 107.576 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . 0.278 19.2 Cg_endo -48.47 110.24 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.847 3.698 . . . . 0.0 118.996 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.44 -130.85 2.64 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.169 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.1 t -153.88 134.03 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.731 0.812 . . . . 0.0 112.723 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.85 131.71 51.14 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 124.101 1.905 . . . . 0.0 115.524 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.34 153.52 29.75 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 128.477 2.711 . . . . 0.0 112.581 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.416 ' CD1' HG23 ' A' ' 95' ' ' VAL . 35.2 p90 -157.84 163.81 37.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.135 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -164.23 165.9 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.355 1.062 . . . . 0.0 111.049 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -103.3 105.55 15.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 87' ' ' ARG . 6.7 mm-40 -38.72 -60.87 1.0 Allowed Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -60.76 -14.44 31.88 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.102 1.868 . . . . 0.0 114.114 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -121.39 12.26 10.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.059 1.3 . . . . 0.0 113.827 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 84' ' ' GLU . 6.8 ttp85 -50.61 -47.22 58.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.787 1.235 . . . . 0.0 112.867 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.94 -7.82 88.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.405 1.479 . . . . 0.0 115.811 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.7 30.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.161 2.185 . . . . 0.0 111.705 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.52 6.16 41.57 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.934 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.9 ttt -80.91 66.02 6.27 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.844 1.822 . . . . 0.0 109.261 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 149.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 129.996 3.318 . . . . 0.0 110.596 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.98 -177.09 31.74 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.72 1.153 . . . . 0.0 114.821 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -144.8 121.24 10.99 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.064 1.346 . . . . 0.0 114.128 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' A' ' 81' ' ' TYR . 16.6 t -91.26 148.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 127.395 2.278 . . . . 0.0 108.039 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.9 128.04 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.83 140.05 49.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 125.173 1.545 . . . . 0.0 112.113 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 1 C-N-CA 135.101 5.361 . . . . 0.0 107.864 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.49 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.027 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 26.66 86.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.149 2.98 . . . . 0.0 114.743 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 168.7 17.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.187 1.47 . . . . 0.0 113.877 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 m -152.16 124.22 8.09 Favored 'General case' 0 N--CA 1.464 0.228 1 C-N-CA 131.714 4.005 . . . . 0.0 102.783 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -134.08 153.61 36.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.216 1.406 . . . . 0.0 111.791 -177.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 19.7 mtpt -120.54 113.32 20.1 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.948 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 78.2 mtm -74.35 121.91 22.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.25 88.64 1.5 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.58 1.082 . . . . 0.0 110.485 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -57.35 145.47 32.31 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.862 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -21.42 28.28 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -74.91 -9.18 58.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.836 0.744 . . . . 0.0 110.388 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.45 66.89 1.33 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 126.532 2.015 . . . . 0.0 109.224 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.12 140.0 27.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.035 0.534 . . . . 0.0 109.611 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.54 69.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.808 1.243 . . . . 0.0 111.984 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -149.93 137.81 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.44 143.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 112.535 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 pt-20 -128.21 105.83 19.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.948 1.299 . . . . 0.0 112.793 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 43.9 Cg_endo -78.75 139.16 52.89 Favored 'Cis proline' 0 C--N 1.352 0.763 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 -2.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -76.34 -4.48 42.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.725 3.21 . . . . 0.0 116.007 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 m -135.04 -75.99 0.45 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.909 1.231 . . . . 0.0 109.7 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.29 160.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 130.264 3.425 . . . . 0.0 115.89 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -132.37 110.78 10.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 112.883 -1.962 . . . . 0.0 109.203 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.55 -178.26 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.89 0.876 . . . . 0.0 110.253 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.33 175.17 5.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.91 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.872 2.069 . . . . 0.0 110.256 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.33 -0.78 53.84 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.201 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 9.2 tt0 -79.91 -178.3 6.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 120.4 2.1 . . . . 0.0 114.038 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.84 154.69 37.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.636 -1.29 . . . . 0.0 112.595 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -146.22 105.08 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 127.389 2.275 . . . . 0.0 106.117 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -106.87 112.78 25.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.6 117.11 30.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 119.382 3.105 . . . . 0.0 119.382 178.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.42 149.55 9.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 109.859 -3.337 . . . . 0.0 115.725 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' CD2' ' A' ' 39' ' ' HIS . 2.5 t30 -77.56 106.06 9.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.563 2.345 . . . . 0.0 109.931 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -111.58 -37.91 5.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.681 -1.628 . . . . 0.0 114.801 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -164.2 122.06 1.77 Allowed 'General case' 0 N--CA 1.479 1.02 1 N-CA-C 123.482 4.623 . . . . 0.0 123.482 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp 85.48 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.978 3.711 . . . . 0.0 110.348 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -54.81 155.07 8.48 Favored Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 129.177 2.991 . . . . 0.0 112.636 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.82 168.17 67.77 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 N-CA-C 114.574 0.952 . . . . 0.0 114.574 0.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' CD2' ' OD1' ' A' ' 33' ' ' ASN 0.344 0.8 OUTLIER -160.39 125.91 3.97 Favored 'General case' 0 C--O 1.219 -0.518 1 C-N-CA 131.944 4.098 . . . . 0.0 121.079 177.495 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -114.06 164.51 13.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 129.03 2.932 . . . . 0.0 115.985 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.9 mm -124.44 109.02 21.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 126.271 1.828 . . . . 0.0 110.72 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 3.5 m -131.35 118.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.495 1.043 . . . . 0.0 113.621 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -82.03 131.28 35.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.333 1.453 . . . . 0.0 110.021 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -2.87 0.31 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.61 56.93 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.976 2.11 . . . . 0.0 108.607 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -20.34 62.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.527 2.331 . . . . 0.0 116.539 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.45 -103.92 0.18 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 121.507 1.958 . . . . 0.0 117.928 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.94 -8.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -70.55 164.69 24.3 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.97 78.81 5.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -50.29 -42.43 52.4 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.549 1.068 . . . . 0.0 110.854 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -62.55 -4.1 1.79 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.42 -19.17 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.052 1.741 . . . . 0.0 112.182 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.22 -1.02 57.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.857 2.063 . . . . 0.0 111.793 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 11.7 pttt -137.3 155.09 49.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.117 0.967 . . . . 0.0 112.273 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.61 154.05 39.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.074 0.95 . . . . 0.0 109.171 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -58.11 42.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 133.632 4.773 . . . . 0.0 119.272 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 41.57 -37.01 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 138.426 6.69 . . . . 0.0 115.313 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.9 -13.28 14.15 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.962 1.705 . . . . 0.0 106.951 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.2 138.02 19.27 Favored Glycine 0 C--N 1.355 1.605 1 N-CA-C 103.01 -4.036 . . . . 0.0 103.01 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.48 170.47 16.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.98 105.98 16.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -95.38 -24.88 16.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.81 159.11 15.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.326 1.05 . . . . 0.0 109.415 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.59 120.79 22.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.589 -1.319 . . . . 0.0 108.516 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.36 35.86 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.691 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.37 146.03 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.558 1.679 . . . . 0.0 108.083 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 p -158.02 174.06 15.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 119.505 -1.997 . . . . 0.0 114.649 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -145.71 144.14 30.18 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 101.096 -3.668 . . . . 0.0 101.096 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 t -114.59 139.81 49.31 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.186 -2.196 . . . . 0.0 108.576 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 p -120.95 140.74 51.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.715 1.606 . . . . 0.0 111.734 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -143.71 125.93 15.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.07 172.21 13.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -152.31 44.38 0.71 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 120.767 3.617 . . . . 0.0 120.767 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -113.19 95.72 36.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 120.5 -1.375 . . . . 0.0 109.959 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.32 105.35 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.14 3.227 . . . . 0.0 115.147 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.81 -129.51 2.16 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.614 2.054 . . . . 0.0 110.674 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.1 t -149.46 135.07 18.55 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.553 -0.969 . . . . 0.0 112.848 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -133.28 100.69 4.92 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 124.598 2.142 . . . . 0.0 114.665 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.22 143.15 18.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 131.222 3.809 . . . . 0.0 110.621 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 3.1 p90 -155.24 167.64 29.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.196 0.998 . . . . 0.0 110.485 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -165.92 -178.16 4.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.87 1.268 . . . . 0.0 110.838 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.0 t -110.9 108.61 18.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -38.24 -50.62 3.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 119.186 3.032 . . . . 0.0 119.186 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 -12.86 25.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.904 1.736 . . . . 0.0 115.174 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -121.68 17.17 11.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.46 -28.92 67.42 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.08 -8.82 58.71 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 125.364 1.459 . . . . 0.0 114.732 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 -8.19 37.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.659 1.984 . . . . 0.0 111.459 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.84 3.22 34.39 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 118.021 -1.433 . . . . 0.0 115.809 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.8 ttt -82.25 62.73 6.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 120.056 1.928 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 147.38 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 129.036 2.934 . . . . 0.0 110.033 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.49 -169.43 15.35 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.714 1.626 . . . . 0.0 112.951 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.02 -62.98 1.38 Allowed 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t 75.56 127.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 131.607 3.963 . . . . 0.0 110.896 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -121.67 128.86 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.97 143.59 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.378 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.494 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.258 1.538 1 C-N-CA 137.496 6.318 . . . . 0.0 113.457 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 117.497 -1.24 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 20.65 99.03 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 129.73 3.212 . . . . 0.0 117.219 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.42 165.14 11.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.9 m -144.67 144.51 31.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.309 2.643 . . . . 0.0 106.006 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -150.3 152.18 11.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 122.583 1.182 . . . . 0.0 111.864 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -114.37 118.38 33.71 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.2 mtm -79.97 119.98 23.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.11 96.18 1.58 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 t -57.51 150.72 18.25 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 117.104 0.452 . . . . 0.0 111.363 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.6 -21.1 9.42 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -80.75 -6.37 58.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.193 1.397 . . . . 0.0 112.707 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.0 45.7 5.01 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.128 1.347 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.11 0.564 . . . . 0.0 110.214 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 62.9 0.06 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.495 1.918 . . . . 0.0 114.176 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.56 146.86 18.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 O-C-N 120.787 -1.195 . . . . 0.0 107.992 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.86 137.36 32.42 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.415 1.486 . . . . 0.0 112.035 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -119.97 106.77 40.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.141 1.376 . . . . 0.0 111.711 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.88 151.9 94.63 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 -2.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.28 -7.83 46.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.781 2.832 . . . . 0.0 113.518 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.2 m -149.58 124.65 10.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.267 3.027 . . . . 0.0 105.231 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.8 155.49 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.675 0.671 . . . . 0.0 112.494 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -130.97 100.47 5.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.57 1.176 . . . . 0.0 112.069 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.04 -177.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.69 135.33 52.95 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.636 1.107 . . . . 0.0 111.643 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 98' ' ' GLU . . . -31.16 103.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.933 2.093 . . . . 0.0 112.966 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 -4.64 14.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.688 1.613 . . . . 0.0 112.968 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 64.7 mt-10 -91.94 169.61 10.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.34 1.57 . . . . 0.0 114.747 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.64 163.9 12.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.4 t -148.0 104.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 127.844 2.458 . . . . 0.0 106.715 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.68 111.28 23.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.682 0.793 . . . . 0.0 110.926 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.602 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.14 114.06 26.26 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 14.2 t -96.9 136.98 25.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 131.094 3.757 . . . . 0.0 114.161 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 65' ' ' ALA 0.263 0.0 OUTLIER -69.9 120.16 15.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 129.955 3.302 . . . . 0.0 107.3 177.394 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -132.8 -30.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 116.968 -1.492 . . . . 0.0 113.482 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -158.99 163.96 35.98 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 tp 43.15 48.45 5.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.433 3.093 . . . . 0.0 111.478 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -56.41 144.88 61.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.493 2.317 . . . . 0.0 111.747 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.09 175.22 49.07 Favored 'Cis proline' 0 CA--C 1.548 1.214 0 CA-C-O 123.108 1.212 . . . . 0.0 114.166 0.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -146.46 152.11 38.49 Favored 'General case' 0 CA--C 1.528 0.123 1 C-N-CA 132.815 4.446 . . . . 0.0 113.956 177.886 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -142.46 162.03 36.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.279 1.832 . . . . 0.0 110.006 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.624 HG21 ' CE1' ' A' ' 69' ' ' PHE . 20.7 mm -135.62 94.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.312 1.445 . . . . 0.0 110.867 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 58' ' ' HIS . 4.2 m -115.5 118.45 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 O-C-N 120.839 -1.163 . . . . 0.0 112.056 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 132.83 39.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -0.71 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 73.24 33.03 1.19 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.101 2.56 . . . . 0.0 111.602 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.88 -16.63 0.44 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 115.644 -2.122 . . . . 0.0 116.061 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.41 -140.94 3.03 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 123.334 2.788 . . . . 0.0 118.748 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.54 -7.11 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.147 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -64.75 153.35 40.08 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.132 1.373 . . . . 0.0 109.447 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.21 66.05 9.11 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.293 -0.879 . . . . 0.0 112.442 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.59 -38.39 20.61 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.53 -10.38 11.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.395 1.878 . . . . 0.0 115.531 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.48 -10.19 7.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.411 2.284 . . . . 0.0 110.316 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 8.56 25.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.885 1.674 . . . . 0.0 112.563 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -142.61 156.96 45.15 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.272 0.942 . . . . 0.0 109.393 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HB2' ' H ' ' A' ' 41' ' ' ILE . 19.1 mt -76.37 60.71 1.59 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.044 2.538 . . . . 0.0 105.338 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 59' ' ' LYS . 44.7 m -21.0 86.11 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 121.106 3.743 . . . . 0.0 121.106 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.434 ' HA ' HG11 ' A' ' 42' ' ' VAL . 96.8 m-70 34.38 12.21 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 1 C-N-CA 135.087 5.355 . . . . 0.0 115.803 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -156.38 -13.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.375 3.07 . . . . 0.0 110.01 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.53 148.85 50.51 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 116.296 -2.859 . . . . 0.0 106.531 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.06 147.43 32.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 33' ' ' ASN . . . -117.29 110.43 18.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 102.505 -3.146 . . . . 0.0 102.505 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -116.9 -31.08 5.54 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.1 136.2 41.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.394 1.477 . . . . 0.0 110.752 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.516 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . . . -55.62 118.54 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.683 1.193 . . . . 0.0 112.423 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.79 4.04 52.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.297 1.904 . . . . 0.0 113.793 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.29 -60.8 3.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 1.2 p 64.03 171.38 0.18 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -154.82 135.99 13.95 Favored 'General case' 0 CA--C 1.559 1.318 1 N-CA-C 98.35 -4.685 . . . . 0.0 98.35 176.22 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.26 146.9 30.89 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 118.88 -2.387 . . . . 0.0 108.357 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 p -126.52 151.98 47.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.8 m -153.0 118.68 5.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.95 158.47 44.02 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -136.81 23.71 3.09 Favored 'General case' 0 CA--C 1.546 0.807 1 N-CA-C 123.439 4.607 . . . . 0.0 123.439 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 2.8 pt-20 -89.6 108.83 27.68 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.45 103.0 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.497 1.464 . . . . 0.0 110.446 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.11 -162.98 36.77 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 127.899 2.666 . . . . 0.0 110.969 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -124.01 128.67 49.72 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.107 0.956 . . . . 0.0 113.054 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -120.27 127.11 52.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 124.203 1.954 . . . . 0.0 114.25 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -80.53 144.5 32.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.617 -2.538 . . . . 0.0 108.406 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.421 ' CE1' HG23 ' A' ' 95' ' ' VAL . 35.9 p90 -152.5 166.06 33.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.848 0.832 . . . . 0.0 109.709 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -163.77 175.23 10.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.701 0.8 . . . . 0.0 111.502 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.6 t -109.32 116.17 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -42.35 -63.47 0.9 Allowed Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.89 -4.24 8.41 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.427 2.751 . . . . 0.0 116.02 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -130.77 12.18 5.26 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.908 1.231 . . . . 0.0 113.128 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.79 -28.42 22.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.851 2.06 . . . . 0.0 115.161 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.59 -5.77 41.85 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 126.68 2.086 . . . . 0.0 114.813 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.2 -5.74 32.74 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.019 2.528 . . . . 0.0 110.932 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.25 34.22 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.789 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 ttt -82.99 63.47 7.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.285 2.042 . . . . 0.0 110.656 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.11 144.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 129.879 3.272 . . . . 0.0 109.345 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.4 -175.94 27.0 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.567 1.079 . . . . 0.0 113.927 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -143.35 115.71 8.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.368 1.467 . . . . 0.0 114.074 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 81' ' ' TYR . 11.9 t -89.6 147.38 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 127.569 2.348 . . . . 0.0 107.594 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.78 120.5 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.58 113.68 37.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 123.83 0.852 . . . . 0.0 110.481 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.474 ' N ' ' HA ' ' A' ' 24' ' ' LYS . 17.2 pt-20 . . . . . 0 C--O 1.256 1.43 1 C-N-CA 133.961 4.904 . . . . 0.0 114.89 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 26.2 t-20 48.41 72.86 0.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 109.699 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.12 163.62 27.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 123.941 1.829 . . . . 0.0 112.638 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -143.8 148.55 35.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 129.579 3.152 . . . . 0.0 103.377 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -154.36 156.0 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.283 1.04 . . . . 0.0 109.532 177.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -120.58 105.66 11.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.5 mtm -65.26 119.34 10.72 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.78 99.61 1.09 Allowed Glycine 0 N--CA 1.47 0.961 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.3 t -59.41 152.01 22.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.65 -18.36 53.14 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.907 -1.121 . . . . 0.0 111.16 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -81.49 -7.84 59.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.619 1.968 . . . . 0.0 112.412 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.87 9.19 64.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.84 2.162 . . . . 0.0 115.292 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.56 138.65 34.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.356 0.663 . . . . 0.0 110.154 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.05 73.94 0.91 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.066 1.746 . . . . 0.0 108.646 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.43 134.66 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.02 132.41 37.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.6 pt-20 -117.45 113.34 38.75 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.466 -0.772 . . . . 0.0 112.568 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 92.8 Cg_endo -78.67 138.82 51.56 Favored 'Cis proline' 0 C--N 1.354 0.865 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 -2.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -78.1 -10.94 59.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.62 1.968 . . . . 0.0 112.588 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -142.82 128.47 19.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 129.676 3.191 . . . . 0.0 108.561 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 p -148.14 165.51 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.19 0.904 . . . . 0.0 113.426 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -131.13 106.32 8.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.943 1.297 . . . . 0.0 110.855 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 2.6 pp -123.24 175.21 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 0.0 109.291 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.535 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -130.79 174.09 10.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.91 100.77 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.889 1.275 . . . . 0.0 113.519 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.88 -2.59 25.82 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.01 1.767 . . . . 0.0 114.245 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.47 173.31 9.71 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.729 1.252 . . . . 0.0 114.356 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -130.71 171.77 12.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 123.426 1.584 . . . . 0.0 111.361 -178.032 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.84 94.85 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.443 2.297 . . . . 0.0 106.332 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -84.44 51.92 2.23 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.487 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -57.94 133.67 55.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 177.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t -118.86 149.9 21.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 1 C-N-CA 133.564 4.746 . . . . 0.0 114.277 -176.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.651 HD22 ' HB1' ' A' ' 62' ' ' ALA . 2.9 t-20 -78.71 117.72 20.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.57 3.148 . . . . 0.0 107.047 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -129.53 -20.12 3.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 115.748 -2.072 . . . . 0.0 113.939 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.06 153.73 16.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.6 tp 45.98 50.46 11.43 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 131.466 3.907 . . . . 0.0 112.08 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 151.18 4.08 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 129.616 3.166 . . . . 0.0 112.33 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.95 174.25 45.48 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 O-C-N 122.13 0.542 . . . . 0.0 112.507 -2.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.95 163.33 37.17 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 130.097 3.359 . . . . 0.0 113.624 177.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -149.28 163.09 38.67 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.82 1.248 . . . . 0.0 113.089 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.14 79.68 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.781 2.032 . . . . 0.0 110.109 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 4.0 m -105.86 118.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 119.89 -1.756 . . . . 0.0 111.663 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 10.6 m-85 -79.54 141.38 36.7 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 121.699 -0.626 . . . . 0.0 110.371 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.64 -16.17 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 69.4 68.51 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.584 1.954 . . . . 0.0 108.181 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -17.44 12.81 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.513 0.725 . . . . 0.0 112.616 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.07 -25.72 6.99 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 117.781 1.872 . . . . 0.0 117.781 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 -9.33 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.906 0.86 . . . . 0.0 111.598 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -93.07 137.78 32.12 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.852 2.461 . . . . 0.0 114.675 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.04 65.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.241 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -43.56 -50.1 7.31 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.175 1.39 . . . . 0.0 112.635 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -60.6 -5.83 1.4 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.679 2.392 . . . . 0.0 115.466 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.34 -3.32 6.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 111.114 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.77 -5.72 14.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.913 2.085 . . . . 0.0 114.642 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 28.4 pttt -130.32 167.61 18.24 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.05 1.74 . . . . 0.0 114.904 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.97 -69.16 0.35 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.93 2.092 . . . . 0.0 110.534 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t 153.06 150.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.737 2.815 . . . . 0.0 110.014 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -70.8 5.16 2.07 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.212 2.205 . . . . 0.0 111.481 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 -25.92 0.82 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.887 2.475 . . . . 0.0 111.266 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.85 136.97 18.0 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 120.342 1.428 . . . . 0.0 110.352 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.45 165.56 29.04 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.651 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -103.64 105.55 15.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -99.07 -24.92 14.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.22 56.26 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.73 112.35 0.45 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.102 1.761 . . . . 0.0 112.288 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.93 -12.61 29.42 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.407 1.48 . . . . 0.0 112.712 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -68.92 87.04 0.36 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.207 1.503 . . . . 0.0 113.811 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 80.6 p -83.71 157.26 22.23 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.799 -1.188 . . . . 0.0 109.863 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -26.02 6.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.387 -2.125 . . . . 0.0 108.526 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t 47.49 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 131.529 3.932 . . . . 0.0 116.868 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -135.27 152.79 51.85 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.679 -1.263 . . . . 0.0 111.777 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -143.93 112.05 6.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.753 2.021 . . . . 0.0 109.503 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 154.6 51.24 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.792 2.037 . . . . 0.0 115.44 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -136.52 16.87 3.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 pm0 -92.85 96.05 1.26 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' GLU . 8.5 Cg_endo -41.84 118.22 0.86 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 124.433 3.422 . . . . 0.0 112.893 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.51 -152.05 22.7 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 123.243 1.468 . . . . 0.0 112.983 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -145.63 117.57 8.25 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.692 1.197 . . . . 0.0 108.968 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.82 133.43 54.44 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 124.076 1.893 . . . . 0.0 112.346 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 151.15 24.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.927 3.291 . . . . 0.0 115.021 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CE2' HG23 ' A' ' 95' ' ' VAL . 19.4 p90 -154.78 162.32 41.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.987 1.315 . . . . 0.0 110.108 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -159.64 164.15 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 110.164 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.9 t -99.69 104.59 16.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -35.8 -60.62 0.63 Allowed Pre-proline 0 N--CA 1.48 1.055 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.75 -8.11 20.28 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.504 2.136 . . . . 0.0 114.048 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.8 1.84 7.42 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.859 1.209 . . . . 0.0 112.64 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -43.15 -59.69 1.96 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.29 2.636 . . . . 0.0 111.353 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.13 71.04 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.127 1.346 . . . . 0.0 116.056 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -11.25 33.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.274 1.429 . . . . 0.0 111.803 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.03 -0.2 17.1 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-O 118.3 -1.278 . . . . 0.0 115.733 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttt -81.67 73.84 8.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.092 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.53 147.65 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 129.351 3.061 . . . . 0.0 108.251 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.63 179.73 34.09 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.039 0.828 . . . . 0.0 114.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -147.48 131.71 17.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.71 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.5 t -97.31 155.99 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 127.367 2.267 . . . . 0.0 108.161 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.71 125.47 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -123.96 142.17 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 124.489 1.118 . . . . 0.0 112.997 177.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 6.0 pt-20 . . . . . 0 C--O 1.253 1.261 1 C-N-CA 134.396 5.078 . . . . 0.0 116.254 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 18.93 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 128.976 2.91 . . . . 0.0 115.189 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.73 156.8 24.82 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.951 -1.093 . . . . 0.0 113.855 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.0 m -136.88 125.08 23.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 103.433 -2.803 . . . . 0.0 103.433 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.06 149.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 122.79 1.281 . . . . 0.0 112.486 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -117.02 116.83 28.12 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.946 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp -76.97 120.81 22.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.68 94.43 1.54 Allowed Glycine 0 N--CA 1.47 0.962 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -58.01 152.41 16.52 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.726 0.411 . . . . 0.0 111.836 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -57.46 -17.63 14.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -80.54 -7.53 59.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.255 1.022 . . . . 0.0 112.183 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.97 25.86 30.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.529 1.538 . . . . 0.0 113.984 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.73 140.61 32.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.529 0.732 . . . . 0.0 109.863 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.14 63.41 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.132 1.773 . . . . 0.0 112.093 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.85 145.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.609 -1.307 . . . . 0.0 107.637 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.46 144.54 28.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.666 1.186 . . . . 0.0 111.367 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 24.3 pt-20 -123.86 108.07 30.72 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.544 1.538 . . . . 0.0 110.928 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -78.41 147.26 81.8 Favored 'Cis proline' 0 CA--C 1.542 0.911 0 N-CA-C 116.042 1.516 . . . . 0.0 116.042 -2.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -0.77 57.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.819 2.048 . . . . 0.0 113.351 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -151.48 127.11 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 128.671 2.788 . . . . 0.0 104.929 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.6 158.21 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -138.49 107.17 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.272 1.034 . . . . 0.0 111.078 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.76 173.34 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.239 1.416 . . . . 0.0 108.088 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -128.81 152.01 48.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.68 1.582 . . . . 0.0 110.87 177.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -24.34 115.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.506 2.722 . . . . 0.0 114.713 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.13 -19.92 39.31 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.827 1.679 . . . . 0.0 113.364 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 mt-10 -79.54 167.63 20.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 122.455 1.121 . . . . 0.0 111.097 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.02 -178.89 3.97 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 122.667 1.222 . . . . 0.0 109.937 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.54 101.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -88.5 123.11 32.7 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -127.88 122.22 31.99 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 177.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.32 148.9 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 128.872 2.869 . . . . 0.0 115.315 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.845 HD22 ' HB1' ' A' ' 62' ' ' ALA . 14.0 t-20 -76.88 116.19 17.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 131.182 3.793 . . . . 0.0 109.879 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -131.33 -27.44 1.99 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 116.995 -1.479 . . . . 0.0 114.09 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.35 159.96 37.98 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tp 47.8 49.57 16.52 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 127.92 2.488 . . . . 0.0 111.503 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 140.48 64.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.919 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 165.53 84.79 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 CA-C-O 125.068 2.028 . . . . 0.0 115.79 2.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.508 ' HA ' ' SG ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -144.04 169.63 17.47 Favored 'General case' 0 CA--C 1.515 -0.395 1 C-N-CA 131.915 4.086 . . . . 0.0 111.833 177.723 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -167.63 175.04 7.28 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.372 1.869 . . . . 0.0 109.282 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.5 mm -146.67 93.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.402 1.481 . . . . 0.0 109.404 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.03 111.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.209 1.404 . . . . 0.0 112.362 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.431 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 14.9 m-85 -72.49 131.8 43.01 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 120.813 -1.179 . . . . 0.0 108.259 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.55 -3.41 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.642 1.977 . . . . 0.0 115.856 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.44 52.62 8.36 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.282 1.033 . . . . 0.0 109.783 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.64 -36.02 2.0 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.898 2.079 . . . . 0.0 110.865 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.68 -21.53 3.77 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 118.033 1.973 . . . . 0.0 118.033 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.94 -23.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 117.334 0.567 . . . . 0.0 111.584 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.03 134.45 41.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.257 3.023 . . . . 0.0 113.752 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 64.44 8.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -38.6 -50.85 1.62 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.206 2.203 . . . . 0.0 112.733 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -56.95 -9.0 0.71 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 129.713 3.205 . . . . 0.0 115.677 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.39 -4.28 6.08 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.792 2.037 . . . . 0.0 111.003 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.23 -10.52 14.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.68 2.392 . . . . 0.0 113.935 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CB ' ' H ' ' A' ' 43' ' ' PHE . 27.2 pttt -130.5 166.9 19.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.045 1.738 . . . . 0.0 114.368 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.17 -72.51 0.21 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.721 1.608 . . . . 0.0 111.99 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t 158.15 149.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.619 2.367 . . . . 0.0 108.664 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -69.43 -10.26 57.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.123 0.969 . . . . 0.0 111.482 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -19.47 8.6 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.244 1.418 . . . . 0.0 110.444 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.46 111.32 4.21 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 120.228 1.377 . . . . 0.0 110.938 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.52 173.08 7.63 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -107.5 101.47 10.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 126.911 2.084 . . . . 0.0 105.95 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.82 -14.09 16.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.842 1.657 . . . . 0.0 114.24 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.47 51.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.552 1.524 . . . . 0.0 113.312 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.11 116.25 1.92 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.127 1.371 . . . . 0.0 112.312 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.35 -13.29 33.45 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.262 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -65.54 157.47 29.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.294 2.047 . . . . 0.0 109.35 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 p -163.29 174.04 12.55 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 118.893 -2.379 . . . . 0.0 113.361 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -152.03 151.03 30.62 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -113.22 139.27 48.93 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 120.168 -1.583 . . . . 0.0 108.718 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 54.0 p -119.53 152.21 37.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -153.74 125.6 7.76 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.263 0.3 OUTLIER -143.15 150.91 40.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.6 t -137.21 14.71 3.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 111.573 -2.558 . . . . 0.0 114.93 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -103.97 99.58 17.14 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.364 1.865 . . . . 0.0 109.409 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.55 125.92 15.03 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.778 2.986 . . . . 0.0 111.395 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.43 -174.72 43.18 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 123.7 1.722 . . . . 0.0 113.157 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -134.11 106.31 7.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.253 0.2 OUTLIER -115.08 137.76 51.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 123.918 1.818 . . . . 0.0 113.646 -177.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 147.36 28.76 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 111.737 -2.483 . . . . 0.0 113.176 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 95' ' ' VAL . 38.6 p90 -147.65 155.97 42.31 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.26 0.624 . . . . 0.0 109.591 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -156.19 170.7 21.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.512 0.673 . . . . 0.0 109.696 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER -105.5 119.65 39.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.274 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.81 -57.7 11.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.18 -18.88 64.54 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.879 2.064 . . . . 0.0 114.314 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -119.43 14.46 12.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.402 1.455 . . . . 0.0 113.923 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -48.91 -40.75 31.19 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.43 -10.43 59.33 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.819 1.676 . . . . 0.0 114.175 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.86 -7.23 52.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.88 2.072 . . . . 0.0 111.58 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.21 3.96 29.29 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 118.169 -1.351 . . . . 0.0 115.123 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.8 ttt -83.75 76.78 9.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 124.001 1.857 . . . . 0.0 108.413 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.09 146.4 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 129.101 2.96 . . . . 0.0 109.071 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -179.69 32.15 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 124.721 1.153 . . . . 0.0 114.692 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -138.92 120.17 14.74 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.473 1.509 . . . . 0.0 114.851 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.691 HG23 ' CE1' ' A' ' 81' ' ' TYR . 48.1 t -91.68 153.35 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.722 2.009 . . . . 0.0 108.591 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.77 122.24 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.66 126.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 123.347 0.659 . . . . 0.0 109.844 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.507 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 8.4 pt-20 . . . . . 0 C--O 1.252 1.204 1 C-N-CA 135.391 5.477 . . . . 0.0 113.94 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 31.06 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 130.26 3.424 . . . . 0.0 111.944 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.34 172.78 7.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 m -151.42 147.37 26.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 130.757 3.623 . . . . 0.0 104.87 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.81 151.99 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 122.872 1.32 . . . . 0.0 109.647 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -111.86 123.84 51.1 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 mtp -87.46 125.17 34.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 35' ' ' LYS . . . 89.97 92.77 1.2 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -58.58 147.0 33.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.257 0.621 . . . . 0.0 109.573 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.35 -15.94 30.41 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -76.73 -8.88 58.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.317 0.647 . . . . 0.0 111.107 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.92 58.1 2.29 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.627 2.06 . . . . 0.0 108.769 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.08 133.25 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 67.02 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.335 1.454 . . . . 0.0 113.062 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.08 147.72 16.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.8 140.58 31.16 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.504 1.921 . . . . 0.0 112.782 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.4 pt-20 -124.3 103.48 32.57 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.46 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 60.1 Cg_endo -81.78 140.26 45.33 Favored 'Cis proline' 0 CA--C 1.551 1.357 0 N-CA-C 118.397 2.422 . . . . 0.0 118.397 -2.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -16.59 62.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.676 3.591 . . . . 0.0 114.495 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 20.8 m -157.16 141.09 16.13 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 128.513 2.725 . . . . 0.0 105.38 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.97 149.63 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.973 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -112.19 102.41 10.59 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 125.22 1.575 . . . . 0.0 109.113 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pt -126.32 -178.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 112.274 -2.239 . . . . 0.0 109.134 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.72 172.29 7.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.06 65.4 0.14 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.326 2.25 . . . . 0.0 111.932 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.05 40.35 0.09 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 129.653 3.501 . . . . 0.0 111.904 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -122.13 166.47 14.52 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -109.39 161.6 15.14 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.926 1.346 . . . . 0.0 114.39 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -145.69 103.47 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 129.442 3.097 . . . . 0.0 106.793 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.97 88.28 2.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.3 138.81 31.55 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.3 145.57 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 130.55 3.54 . . . . 0.0 115.363 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.673 HD22 ' HB1' ' A' ' 62' ' ' ALA . 11.1 t-20 -74.61 124.15 26.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.871 2.469 . . . . 0.0 107.285 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.24 -29.21 1.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.841 -1.552 . . . . 0.0 114.779 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HA3' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -167.73 158.84 11.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 177.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.9 tp 48.51 57.21 6.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.685 . . . . 0.0 111.367 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.56 156.37 32.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.01 160.54 86.36 Favored 'Cis proline' 0 CA--C 1.544 0.982 0 CA-C-O 123.808 1.503 . . . . 0.0 113.857 -1.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 143.03 42.51 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 128.149 2.58 . . . . 0.0 113.599 177.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' HD12 ' A' ' 56' ' ' LEU 0.305 20.1 t-20 -141.56 150.64 42.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.13 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 56' ' ' LEU . 30.4 mm -117.86 94.74 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 58' ' ' HIS . 15.4 m -124.62 114.61 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 123.908 0.883 . . . . 0.0 110.935 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.491 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 36.4 m-85 -74.4 167.96 20.63 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.725 0.81 . . . . 0.0 109.077 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.43 -6.05 23.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.961 2.949 . . . . 0.0 118.961 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 64.83 51.17 1.85 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.407 1.458 . . . . 0.0 110.328 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.15 -37.13 1.93 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.008 2.123 . . . . 0.0 112.641 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.26 -6.72 4.32 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.22 -7.66 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.15 0.975 . . . . 0.0 113.516 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.49 163.56 13.18 Favored 'General case' 0 CA--C 1.541 0.619 1 C-N-CA 134.04 4.936 . . . . 0.0 114.08 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.0 59.7 0.6 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.629 1.172 . . . . 0.0 111.69 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.59 -47.68 63.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -60.71 -7.27 2.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.093 1.757 . . . . 0.0 113.863 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.71 -0.01 11.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.36 1.864 . . . . 0.0 111.337 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.88 16.72 3.88 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 40.9 pttt -137.51 160.36 39.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.386 0.993 . . . . 0.0 111.8 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 41' ' ' ILE . 30.8 mt -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.36 1.464 . . . . 0.0 111.469 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -71.82 43.8 0.1 Allowed 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 128.935 2.894 . . . . 0.0 116.62 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER 44.92 -56.17 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.098 1 C-N-CA 136.622 5.969 . . . . 0.0 112.115 -177.785 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 -16.85 22.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.264 1.603 . . . . 0.0 108.23 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.59 139.51 23.9 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 103.193 -3.963 . . . . 0.0 103.193 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.1 176.74 12.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -94.94 95.35 8.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -88.45 -27.02 21.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.31 -130.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.176 0.99 . . . . 0.0 109.255 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.9 120.89 10.03 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.618 1.967 . . . . 0.0 109.895 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.27 -13.16 23.69 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 117.601 -1.666 . . . . 0.0 113.454 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.84 161.82 25.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.871 2.335 . . . . 0.0 109.329 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 p -161.37 162.76 30.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.242 -1.536 . . . . 0.0 112.655 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.75 139.73 28.06 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 101.608 -3.478 . . . . 0.0 101.608 177.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 118.968 -2.333 . . . . 0.0 109.519 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.0 p -121.68 126.02 47.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.543 1.137 . . . . 0.0 108.766 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.2 m -127.62 101.3 6.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.08 2.152 . . . . 0.0 107.796 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -116.62 138.84 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 118.754 2.872 . . . . 0.0 118.754 178.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -118.2 6.53 11.99 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.152 2.981 . . . . 0.0 118.114 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -106.31 94.83 10.31 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.345 1.058 . . . . 0.0 112.553 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 98' ' ' GLU . 36.4 Cg_endo -56.26 120.35 8.15 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.284 2.656 . . . . 0.0 108.453 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.34 -3.17 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t 53.79 94.85 0.02 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 130.619 3.568 . . . . 0.0 110.868 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -101.8 149.61 24.0 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 117.112 -1.835 . . . . 0.0 113.421 -177.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -92.21 154.42 18.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 110.851 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.78 171.62 19.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.55 1.54 . . . . 0.0 112.036 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.16 -171.41 2.19 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.746 2.019 . . . . 0.0 109.832 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -122.58 113.05 18.75 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.59 1.556 . . . . 0.0 111.185 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -41.38 -50.16 8.91 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -0.3 10.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.299 2.666 . . . . 0.0 116.799 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -137.54 10.13 2.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -43.71 -50.45 7.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.08 -8.88 85.96 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 126.152 1.834 . . . . 0.0 115.01 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.09 -8.94 35.12 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.43 1.892 . . . . 0.0 111.169 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 7.47 30.22 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.377 -1.235 . . . . 0.0 115.996 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.3 ttt -83.15 63.52 7.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.911 1.855 . . . . 0.0 110.623 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.57 145.78 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 129.312 3.045 . . . . 0.0 111.507 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.26 -176.74 31.65 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 125.406 1.479 . . . . 0.0 115.026 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.0 ttmm -136.11 171.45 14.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.36 1.464 . . . . 0.0 110.304 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -141.25 150.73 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 119.257 -2.152 . . . . 0.0 108.362 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.44 110.49 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 100.898 -3.741 . . . . 0.0 100.898 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.94 53.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 124.377 2.037 . . . . 0.0 110.98 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 131.379 3.871 . . . . 0.0 113.388 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 42.41 73.15 0.14 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.14 1.776 . . . . 0.0 110.453 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.02 157.32 35.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.856 1.789 . . . . 0.0 112.854 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 m -139.45 143.47 37.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 150.59 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 119.19 0.905 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 10.0 mtpt -120.1 116.56 25.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtm -76.33 122.28 24.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.597 1.959 . . . . 0.0 106.917 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.04 1.19 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.041 -2.023 . . . . 0.0 108.041 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 t -58.2 148.18 27.84 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.148 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.23 -14.21 16.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.2 m -79.42 -10.83 59.89 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.75 0.704 . . . . 0.0 111.126 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.32 15.0 45.88 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.927 1.727 . . . . 0.0 113.461 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.76 128.31 35.32 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.821 1.311 . . . . 0.0 109.188 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.69 66.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.433 1.893 . . . . 0.0 111.667 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.03 151.01 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -100.52 130.4 46.59 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.757 1.223 . . . . 0.0 108.009 177.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 3.7 pt-20 -100.87 131.55 23.28 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.414 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' GLU 0.301 7.4 Cg_exo -77.58 -13.23 30.16 Favored 'Cis proline' 0 C--N 1.355 0.882 1 N-CA-C 125.071 4.989 . . . . 0.0 125.071 2.757 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t 93.12 -15.98 0.13 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 131.242 3.817 . . . . 0.0 109.929 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 m -153.82 129.78 10.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.959 1.704 . . . . 0.0 108.083 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 22' ' ' THR . 1.8 p -144.86 168.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 113.307 -1.77 . . . . 0.0 113.726 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 21' ' ' VAL . 9.9 t -132.63 115.08 14.96 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.518 -1.673 . . . . 0.0 110.936 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.8 -179.27 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.361 1.464 . . . . 0.0 110.267 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.98 176.65 5.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 177.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -60.44 115.18 3.38 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.181 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.77 67.61 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.878 1.704 . . . . 0.0 112.383 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 18.3 tt0 -82.92 161.58 21.8 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.162 0.985 . . . . 0.0 112.498 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' CD ' ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt-20 -108.09 166.7 10.54 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.977 1.37 . . . . 0.0 113.762 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.32 97.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.177 2.591 . . . . 0.0 105.456 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HE3' ' CD ' ' A' ' 28' ' ' GLU . 5.0 ptpp? -98.95 106.59 18.87 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.636 1.208 . . . . 0.0 112.756 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -106.57 122.22 45.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.08 153.02 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 109.092 -3.685 . . . . 0.0 113.435 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.581 HD22 ' HB1' ' A' ' 62' ' ' ALA 0.261 3.8 t-20 -86.81 107.84 18.47 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 131.612 3.965 . . . . 0.0 106.883 177.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.0 -32.54 4.18 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.96 34.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 tp 41.32 57.91 2.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.058 2.943 . . . . 0.0 112.952 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.41 151.53 59.34 Favored Pre-proline 0 CA--C 1.537 0.452 1 C-N-CA 132.256 4.222 . . . . 0.0 111.692 177.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.52 174.99 45.92 Favored 'Cis proline' 0 CA--C 1.543 0.96 0 CA-C-O 122.57 0.987 . . . . 0.0 112.314 -2.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.0 161.23 42.73 Favored 'General case' 0 C--O 1.224 -0.287 1 C-N-CA 132.99 4.516 . . . . 0.0 114.449 177.912 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.13 159.11 42.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.92 0.888 . . . . 0.0 112.602 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.727 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.8 mp -120.87 109.14 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.262 0.625 . . . . 0.0 110.576 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.05 113.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.244 1.018 . . . . 0.0 113.722 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 79' ' ' TYR . 27.3 m-85 -80.85 134.6 35.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.177 1.391 . . . . 0.0 110.383 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.32 43.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.801 1.24 . . . . 0.0 113.616 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 87.92 -23.33 0.12 Allowed 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 129.742 3.217 . . . . 0.0 115.387 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.11 -6.3 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 129.076 2.95 . . . . 0.0 113.952 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 106.02 -14.46 44.63 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 126.994 2.235 . . . . 0.0 114.56 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.23 -26.2 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 148.63 41.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.406 0.548 . . . . 0.0 111.683 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.84 70.36 3.28 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -50.55 -42.19 54.96 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -71.78 0.1 9.77 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.46 -19.55 3.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.269 1.427 . . . . 0.0 112.532 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.21 0.15 39.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.753 1.221 . . . . 0.0 112.806 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -133.9 168.72 18.24 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 119.871 1.214 . . . . 0.0 113.86 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' ILE . 39.6 mt -72.45 163.32 28.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.999 1.319 . . . . 0.0 112.035 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.5 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 129.112 2.965 . . . . 0.0 118.487 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 51.45 -47.9 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 1 C-N-CA 136.801 6.04 . . . . 0.0 111.518 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.18 -22.09 24.22 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 126.932 2.093 . . . . 0.0 106.958 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.37 150.98 41.11 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 177.13 11.22 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.449 2.124 . . . . 0.0 116.56 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -109.5 104.45 13.51 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -102.69 -24.06 13.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.17 131.69 55.77 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.35 116.06 1.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.357 1.463 . . . . 0.0 112.186 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.91 -9.96 34.35 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.712 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -68.36 163.39 23.22 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.286 2.043 . . . . 0.0 109.214 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -167.49 165.38 14.76 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 119.312 -2.117 . . . . 0.0 111.706 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.727 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.71 140.62 34.92 Favored 'General case' 0 CA--C 1.551 0.986 1 N-CA-C 99.626 -4.213 . . . . 0.0 99.626 176.702 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -110.6 143.85 40.38 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 109.504 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.9 p -124.53 135.03 52.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.858 1.263 . . . . 0.0 110.012 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.7 m -135.4 137.24 42.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.912 2.085 . . . . 0.0 107.651 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' HG11 ' A' ' 97' ' ' VAL 0.324 0.2 OUTLIER -148.31 156.61 42.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 119.67 3.211 . . . . 0.0 119.67 -177.758 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -140.12 23.45 2.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.272 2.693 . . . . 0.0 118.272 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -101.04 92.51 2.48 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.82 1.648 . . . . 0.0 111.197 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.48 108.9 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.443 2.095 . . . . 0.0 112.037 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.13 -128.2 1.72 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.879 1.704 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 t -167.02 146.37 5.3 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.773 -1.427 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' HD2' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -134.06 140.55 46.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.669 1.223 . . . . 0.0 112.424 176.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -91.51 141.51 28.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.833 2.853 . . . . 0.0 112.233 -177.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' CZ3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.52 169.63 18.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.082 0.944 . . . . 0.0 112.424 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -162.76 -178.31 6.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.26 2.224 . . . . 0.0 113.183 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.1 t -114.26 111.82 22.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.64 1.976 . . . . 0.0 109.059 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -38.04 -64.23 0.47 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -64.93 -10.3 24.8 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.931 2.421 . . . . 0.0 115.422 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -124.26 9.78 8.6 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -44.16 -62.33 1.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.87 1.668 . . . . 0.0 111.457 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.17 -13.85 60.63 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 126.025 1.774 . . . . 0.0 116.046 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.89 -7.2 40.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.383 2.273 . . . . 0.0 111.147 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.28 10.43 36.36 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.326 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.7 ttt -81.03 64.42 5.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.348 2.074 . . . . 0.0 109.635 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.07 154.86 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 131.494 3.918 . . . . 0.0 110.897 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.38 -169.61 32.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.687 1.613 . . . . 0.0 114.002 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' HG2' ' H ' ' A' ' 95' ' ' VAL . 18.6 tttm -140.12 174.19 10.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.311 1.044 . . . . 0.0 110.208 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 12.2 t -150.72 133.83 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 128.18 2.592 . . . . 0.0 108.795 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.29 131.1 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 ' CD1' ' A' ' 73' ' ' PHE . 1.4 m -127.25 132.72 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 125.029 1.456 . . . . 0.0 112.911 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.482 1.167 1 C-N-CA 137.992 6.517 . . . . 0.0 114.526 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 13.51 96.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 130.969 3.708 . . . . 0.0 114.943 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 167.4 9.9 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 123.293 1.521 . . . . 0.0 112.161 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 m -146.37 155.75 42.83 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.051 2.941 . . . . 0.0 103.967 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.74 153.64 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.639 0.733 . . . . 0.0 109.588 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 17.8 mtpt -112.78 120.42 41.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.728 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.6 mtm -80.25 119.94 23.68 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.47 2.708 . . . . 0.0 106.109 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.34 97.74 1.06 Allowed Glycine 0 N--CA 1.47 0.929 0 N-CA-C 106.347 -2.701 . . . . 0.0 106.347 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -59.51 155.89 14.3 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 94.2 m-20 -57.52 -17.89 16.16 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -84.97 -3.74 58.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.591 1.556 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.18 14.6 68.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.241 0.924 . . . . 0.0 112.955 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.34 136.36 33.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.341 0.656 . . . . 0.0 109.798 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.23 65.28 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.8 2.04 . . . . 0.0 111.653 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -145.82 148.53 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.979 0.912 . . . . 0.0 108.563 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -92.93 135.98 33.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.779 1.232 . . . . 0.0 110.656 177.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 20.4 pt-20 -117.87 111.02 39.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.943 1.297 . . . . 0.0 112.216 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 79.2 Cg_endo -78.25 142.91 71.35 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 115.501 1.308 . . . . 0.0 115.501 -2.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -3.86 58.92 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 112.36 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m -151.96 129.28 11.27 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 129.732 3.213 . . . . 0.0 107.521 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.3 164.82 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.98 113.17 10.53 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.244 1.021 . . . . 0.0 111.703 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 141.35 52.03 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.174 1.806 . . . . 0.0 112.374 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -11.59 99.67 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 130.779 3.632 . . . . 0.0 115.747 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.31 -12.95 28.43 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.778 1.18 . . . . 0.0 112.679 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.43 173.06 12.38 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.549 1.166 . . . . 0.0 109.718 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 175.96 6.91 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.72 108.67 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 129.902 3.281 . . . . 0.0 106.64 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -104.77 52.51 0.74 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -49.54 142.83 7.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 120.739 3.607 . . . . 0.0 120.739 177.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.57 152.82 34.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 130.92 3.688 . . . . 0.0 112.65 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.713 HD22 ' HB1' ' A' ' 62' ' ' ALA . 10.4 t-20 -80.12 122.48 26.86 Favored 'General case' 0 CA--C 1.543 0.678 1 C-N-CA 132.479 4.312 . . . . 0.0 109.868 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -136.31 -29.88 0.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.974 -1.489 . . . . 0.0 114.112 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -154.65 157.44 38.16 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp 38.22 51.33 1.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 131.379 3.871 . . . . 0.0 112.534 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.86 151.39 2.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 130.16 3.384 . . . . 0.0 112.579 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.6 176.46 41.64 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-O 122.371 0.905 . . . . 0.0 113.135 -2.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.58 157.0 43.37 Favored 'General case' 0 N--CA 1.462 0.174 1 C-N-CA 132.541 4.336 . . . . 0.0 113.82 177.911 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -147.29 161.8 40.24 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.328 1.451 . . . . 0.0 109.974 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' A' ' 69' ' ' PHE . 28.1 mm -138.1 98.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.193 0.997 . . . . 0.0 111.996 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 2.5 m -120.53 122.15 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 120.796 -1.19 . . . . 0.0 112.624 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -82.04 162.01 22.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.355 0.598 . . . . 0.0 110.952 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.25 -14.07 34.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.67 39.75 0.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.91 1.686 . . . . 0.0 111.96 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 122.376 1.084 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -63.4 1.49 0.52 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.491 2.717 . . . . 0.0 114.279 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.5 4.21 5.1 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.889 2.876 . . . . 0.0 110.936 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.08 10.02 4.15 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.295 2.238 . . . . 0.0 113.054 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 31.7 pttt -132.73 162.9 30.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 129.396 3.078 . . . . 0.0 110.532 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -68.67 0.37 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.004 2.122 . . . . 0.0 110.904 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 59' ' ' LYS . 13.3 t 150.74 154.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.229 3.412 . . . . 0.0 107.764 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -69.77 15.05 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.811 1.645 . . . . 0.0 112.448 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 57' ' ' SER . 1.3 tpmp? -145.03 -18.04 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.69 3.196 . . . . 0.0 111.582 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.7 37.79 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 122.138 2.244 . . . . 0.0 110.555 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 tp -150.71 143.31 24.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -114.15 108.74 17.38 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -112.9 -26.18 8.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.28 49.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.586 1.154 . . . . 0.0 111.365 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.74 113.95 1.38 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.878 1.271 . . . . 0.0 111.64 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.37 -11.61 28.5 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.903 -1.499 . . . . 0.0 112.794 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -62.17 162.94 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.174 1.987 . . . . 0.0 109.606 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.4 t -161.25 162.55 31.13 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 119.755 -1.841 . . . . 0.0 114.998 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -142.3 146.25 34.86 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 100.35 -3.944 . . . . 0.0 100.35 176.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -118.85 149.7 41.1 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 119.43 -2.044 . . . . 0.0 111.64 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.9 p -134.08 141.99 47.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.503 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -139.79 124.51 18.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.547 2.339 . . . . 0.0 107.908 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.75 146.29 33.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 118.837 2.903 . . . . 0.0 118.837 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 6.9 t -131.69 15.28 4.88 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.28 108.95 39.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.818 2.553 . . . . 0.0 106.463 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -52.47 119.26 5.62 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.71 1.606 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.59 -178.95 24.86 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 128.956 3.169 . . . . 0.0 108.867 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -112.17 131.48 55.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.719 -1.24 . . . . 0.0 111.851 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.25 0.1 OUTLIER -121.94 137.25 54.86 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 124.328 2.013 . . . . 0.0 116.045 177.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -84.25 148.34 26.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 109.959 -3.291 . . . . 0.0 112.951 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 95' ' ' VAL . 27.2 p90 -155.53 168.58 26.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.373 1.869 . . . . 0.0 110.06 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -167.61 172.74 9.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.72 1.208 . . . . 0.0 111.628 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.92 114.71 29.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -41.36 -61.45 1.37 Allowed Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.37 -0.78 8.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.828 3.018 . . . . 0.0 114.973 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -129.53 -3.69 4.81 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -39.37 -59.51 1.06 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.83 2.452 . . . . 0.0 112.083 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.36 -13.13 59.92 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.621 1.581 . . . . 0.0 116.42 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.48 -6.07 28.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.839 2.456 . . . . 0.0 111.603 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.41 5.89 33.97 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 117.744 -1.587 . . . . 0.0 116.459 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.3 ttt -81.27 62.53 5.23 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.202 2.001 . . . . 0.0 110.497 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.57 149.26 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 130.292 3.437 . . . . 0.0 108.828 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.46 -178.39 34.41 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -144.72 124.29 13.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' A' ' 81' ' ' TYR . 18.6 t -95.77 153.7 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 129.558 3.143 . . . . 0.0 109.197 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.48 134.58 62.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 117.999 -1.001 . . . . 0.0 108.489 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.89 65.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 119.137 3.014 . . . . 0.0 119.137 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 129.578 3.151 . . . . 0.0 115.002 177.782 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 50.4 77.85 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.695 1.598 . . . . 0.0 111.255 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.94 165.0 23.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 123.81 1.767 . . . . 0.0 115.133 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -150.28 142.77 24.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.805 3.242 . . . . 0.0 105.491 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -149.75 153.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 122.802 1.287 . . . . 0.0 111.19 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -117.57 120.97 39.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.4 mmm -83.09 121.98 27.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.264 2.226 . . . . 0.0 106.04 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.51 98.07 0.89 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -61.72 155.25 23.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.671 -0.265 . . . . 0.0 111.474 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.35 -20.43 11.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.392 1.077 . . . . 0.0 113.639 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -84.92 -3.05 58.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.928 1.291 . . . . 0.0 113.216 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.41 12.31 76.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.131 0.872 . . . . 0.0 111.863 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.72 128.66 34.21 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.42 64.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.969 2.108 . . . . 0.0 110.898 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.48 155.23 22.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.751 1.221 . . . . 0.0 109.374 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' CE1' ' CE1' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -101.42 136.9 40.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.04 0.924 . . . . 0.0 110.964 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.5 pt-20 -121.92 109.05 34.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 125.787 1.635 . . . . 0.0 112.464 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 Cg_endo -78.2 141.32 65.1 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 N-CA-C 116.639 1.746 . . . . 0.0 116.639 -2.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -15.71 59.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.752 2.421 . . . . 0.0 113.917 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -153.12 133.35 13.48 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.431 2.692 . . . . 0.0 106.165 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.64 167.15 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.626 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -136.87 114.02 10.68 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.041 0.838 . . . . 0.0 111.164 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.84 -172.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.965 1.706 . . . . 0.0 109.754 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.53 171.51 9.94 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 177.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -61.66 84.2 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.295 2.238 . . . . 0.0 111.353 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 18.45 3.61 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.002 2.239 . . . . 0.0 113.571 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -106.64 177.39 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.342 1.457 . . . . 0.0 112.037 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -120.61 161.88 20.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -148.85 103.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.431 2.292 . . . . 0.0 107.184 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 104.13 13.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.363 1.065 . . . . 0.0 113.46 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -102.66 119.52 38.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.42 151.31 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 108.944 -3.753 . . . . 0.0 112.751 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.469 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 18.3 t-20 -79.7 113.88 18.19 Favored 'General case' 0 C--N 1.324 -0.511 1 C-N-CA 132.877 4.471 . . . . 0.0 108.553 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -127.61 -27.34 2.87 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 116.445 -1.74 . . . . 0.0 114.015 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.77 159.12 43.1 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.22 -66.32 0.31 Allowed 'General case' 0 CA--C 1.518 -0.258 1 C-N-CA 132.185 4.194 . . . . 0.0 111.75 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m 66.22 147.88 0.11 Allowed Pre-proline 0 C--N 1.292 -1.905 2 C-N-CA 132.966 4.506 . . . . 0.0 111.556 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.44 179.07 31.3 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-O 122.418 0.924 . . . . 0.0 112.318 -2.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.61 160.19 42.03 Favored 'General case' 0 CA--C 1.534 0.35 1 C-N-CA 135.149 5.38 . . . . 0.0 113.603 177.768 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.49 154.65 39.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.646 1.579 . . . . 0.0 111.668 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.2 mp -124.72 95.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 110.492 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 6.7 m -120.21 116.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 119.962 -1.711 . . . . 0.0 114.342 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -78.94 134.24 36.86 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.963 0.905 . . . . 0.0 109.906 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.44 58.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.67 70.82 0.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.801 1.64 . . . . 0.0 109.551 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 124.217 1.007 . . . . 0.0 109.998 177.706 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -63.79 -5.81 4.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.781 2.032 . . . . 0.0 114.245 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.55 -3.27 8.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.254 1.422 . . . . 0.0 110.482 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.12 3.01 9.87 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 25.3 pttt -136.59 161.31 36.26 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.272 1.397 . . . . 0.0 112.07 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.83 -24.22 64.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 112.813 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' LYS . 3.9 t 66.32 99.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 24.82 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 1 C-N-CA 140.867 7.667 . . . . 0.0 118.563 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.72 -12.4 0.12 Allowed 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 131.52 3.928 . . . . 0.0 110.291 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.96 148.7 50.04 Favored Glycine 0 N--CA 1.493 2.446 0 CA-C-N 123.867 3.03 . . . . 0.0 106.285 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tp -140.55 156.92 46.16 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.42 100.98 7.47 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 101.084 -3.673 . . . . 0.0 101.084 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.8 -19.44 12.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.48 134.23 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.467 1.03 . . . . 0.0 111.719 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.62 113.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.208 1.403 . . . . 0.0 112.295 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.84 26.8 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.818 -1.546 . . . . 0.0 112.484 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -68.03 164.77 19.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 120.541 2.17 . . . . 0.0 108.851 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -168.08 166.02 13.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 118.928 -2.357 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.41 136.22 32.86 Favored 'General case' 0 CA--C 1.55 0.959 1 N-CA-C 98.612 -4.588 . . . . 0.0 98.612 176.655 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -106.8 144.47 33.4 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 118.654 -2.529 . . . . 0.0 109.278 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -117.41 142.51 47.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.037 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.3 m -151.38 89.11 1.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 152.65 21.73 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 127.008 2.123 . . . . 0.0 114.539 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -129.16 2.47 5.2 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -90.82 102.8 5.78 Favored Pre-proline 0 N--CA 1.438 -1.063 0 C-N-CA 126.954 2.102 . . . . 0.0 108.787 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -56.54 123.78 14.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.003 3.135 . . . . 0.0 108.461 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.46 170.91 27.94 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.425 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.7 t -111.39 126.12 54.6 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 131.25 47.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.967 1.365 . . . . 0.0 113.989 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 148.49 25.87 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.718 2.007 . . . . 0.0 112.593 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -153.12 163.5 39.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.96 0.886 . . . . 0.0 109.489 177.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -159.01 178.21 10.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.525 1.53 . . . . 0.0 112.48 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.2 t -113.16 109.05 18.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.36 1.464 . . . . 0.0 107.212 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -38.12 -61.25 0.85 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.75 -10.64 27.41 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.154 1.903 . . . . 0.0 115.927 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -128.95 -2.78 5.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -44.92 34.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.079 1.752 . . . . 0.0 113.103 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.43 -14.78 67.3 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.226 1.393 . . . . 0.0 115.12 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.51 -3.34 26.99 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.094 2.958 . . . . 0.0 110.998 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.15 32.55 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 117.589 -1.673 . . . . 0.0 116.282 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.0 ttt -81.45 64.94 6.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.489 2.144 . . . . 0.0 109.258 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.96 158.41 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 131.178 3.791 . . . . 0.0 109.827 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.22 -168.61 35.31 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 114.056 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HG3' ' H ' ' A' ' 95' ' ' VAL . 30.6 tptt -131.92 173.21 11.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.285 1.034 . . . . 0.0 110.008 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 t -149.95 140.76 16.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 129.585 3.154 . . . . 0.0 107.026 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.7 t -127.31 129.23 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.75 141.71 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.428 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 14.4 pt-20 . . . . . 0 C--O 1.25 1.087 1 C-N-CA 136.377 5.871 . . . . 0.0 111.779 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.429 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.19 -1.386 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.9 m120 4.16 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 129.444 3.098 . . . . 0.0 115.605 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.43 -178.38 6.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 118.267 2.691 . . . . 0.0 118.267 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 m -159.46 120.11 3.14 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 18' ' ' PRO . 2.4 t -122.9 159.76 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 123.625 1.679 . . . . 0.0 109.829 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -111.53 112.1 23.59 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.311 1.444 . . . . 0.0 109.084 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.2 mtt -74.39 115.52 14.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.7 95.33 1.75 Allowed Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.1 t -54.17 148.71 10.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.912 0.856 . . . . 0.0 111.991 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -22.7 21.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 p -75.05 -12.74 60.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.783 2.033 . . . . 0.0 111.343 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.02 66.44 1.62 Allowed Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.79 134.86 30.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.418 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.19 70.28 0.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.41 1.884 . . . . 0.0 111.912 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.49 133.52 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.11 145.53 31.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 23.3 pt-20 -137.07 103.18 8.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.279 1.032 . . . . 0.0 112.431 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 5' ' ' VAL 0.374 8.1 Cg_exo -70.44 126.58 10.25 Favored 'Cis proline' 0 CA--C 1.559 1.774 1 N-CA-C 128.411 6.273 . . . . 0.0 128.411 -2.102 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -80.51 -11.99 59.6 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.703 3.201 . . . . 0.0 112.667 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -150.33 120.42 7.22 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 130.356 3.462 . . . . 0.0 105.215 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -136.83 157.08 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.05 0.386 . . . . 0.0 111.769 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -131.68 107.38 8.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.125 0.964 . . . . 0.0 110.652 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.35 -175.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.707 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -134.0 172.2 13.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 177.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -44.09 111.97 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.418 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.39 -13.92 59.69 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.732 1.634 . . . . 0.0 114.506 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 98.3 mt-10 -79.67 162.64 25.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.715 1.245 . . . . 0.0 110.701 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 177.57 4.95 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.327 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.95 101.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 66.64 3.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.109 0.964 . . . . 0.0 112.437 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -74.45 138.38 43.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 39.2 t -118.28 151.58 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 1 C-N-CA 132.432 4.293 . . . . 0.0 116.485 -176.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.418 ' HB3' ' H ' ' A' ' 67' ' ' GLU . 39.0 t-20 -72.56 114.79 11.07 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -109.72 -41.55 4.51 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 114.108 -2.853 . . . . 0.0 113.336 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -169.65 152.64 4.7 Favored 'General case' 0 N--CA 1.483 1.191 1 N-CA-C 122.949 4.426 . . . . 0.0 122.949 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 tp 63.11 56.84 1.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.828 2.051 . . . . 0.0 108.521 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.42 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 3.2 m -60.75 154.11 59.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.083 2.153 . . . . 0.0 111.478 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.36 171.51 63.96 Favored 'Cis proline' 0 CA--C 1.545 1.045 0 N-CA-C 114.677 0.991 . . . . 0.0 114.677 -1.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 37' ' ' SER 0.292 0.8 OUTLIER -157.59 163.12 38.65 Favored 'General case' 0 C--O 1.21 -0.988 1 C-N-CA 136.504 5.921 . . . . 0.0 119.29 177.846 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.08 169.3 23.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.949 1.3 . . . . 0.0 113.425 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 38.2 mm -131.02 83.48 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 125.548 1.539 . . . . 0.0 111.459 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.43 110.71 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.148 0.975 . . . . 0.0 111.15 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 39.5 m-85 -69.09 166.93 17.12 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.65 -20.23 17.77 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 79.93 70.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.38 2.272 . . . . 0.0 106.477 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.55 0.973 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -177.358 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -60.1 -7.15 1.68 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.361 1.865 . . . . 0.0 113.248 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.48 1.39 14.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.65 1.58 . . . . 0.0 111.842 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.73 3.56 2.07 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -118.15 163.7 16.25 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.023 2.129 . . . . 0.0 113.877 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.52 165.49 25.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.361 1.464 . . . . 0.0 110.588 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -64.42 150.52 46.27 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.099 -1.626 . . . . 0.0 110.166 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -65.36 -20.42 66.38 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.607 -1.308 . . . . 0.0 110.847 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.92 -14.98 13.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.995 0.518 . . . . 0.0 111.306 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.66 153.4 33.08 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 104.822 -3.311 . . . . 0.0 104.822 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.07 177.34 10.81 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.78 96.35 6.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -103.57 -3.54 25.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . -146.43 129.77 16.72 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 120.411 1.459 . . . . 0.0 112.151 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.88 123.2 4.94 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.494 -1.379 . . . . 0.0 114.636 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.65 0.67 32.49 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 127.413 2.435 . . . . 0.0 114.697 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 33' ' ' ASN . 9.0 mt-10 -67.89 -67.04 0.49 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.688 2.744 . . . . 0.0 118.201 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 2.5 p 70.27 172.08 0.31 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -163.62 150.85 12.43 Favored 'General case' 0 CA--C 1.549 0.917 1 N-CA-C 99.906 -4.109 . . . . 0.0 99.906 176.074 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -108.84 138.54 45.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 118.392 -2.693 . . . . 0.0 109.087 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 62.5 p -117.19 160.09 21.61 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 m -157.75 138.75 13.3 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.277 0.2 OUTLIER -156.19 155.1 31.86 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 120.174 3.398 . . . . 0.0 120.174 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.2 t -139.82 23.5 2.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.458 2.303 . . . . 0.0 116.746 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -102.79 86.88 1.06 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.772 1.629 . . . . 0.0 112.121 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.26 114.07 0.9 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.726 2.284 . . . . 0.0 110.317 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.09 -132.78 3.06 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.186 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.72 128.55 2.46 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.439 -0.881 . . . . 0.0 110.488 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -124.61 141.56 52.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 124.297 1.999 . . . . 0.0 112.53 176.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 m -77.73 144.64 37.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 110.297 -3.138 . . . . 0.0 110.315 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.52 ' CD1' HG23 ' A' ' 95' ' ' VAL . 34.3 p90 -147.21 164.85 31.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.731 1.613 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -170.26 175.17 5.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.068 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' MET . 11.9 t -107.97 112.38 24.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.764 -2.016 . . . . 0.0 106.622 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.86 -65.52 0.29 Allowed Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.883 1.22 . . . . 0.0 113.869 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.98 -2.53 5.69 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.81 3.007 . . . . 0.0 116.499 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 91' ' ' MET . 6.5 m-70 -132.37 11.31 4.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -13.83 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.46 -7.51 32.12 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.602 2.049 . . . . 0.0 113.158 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.63 -8.33 23.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.083 2.553 . . . . 0.0 110.759 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.83 2.15 32.17 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 117.78 -1.567 . . . . 0.0 115.868 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 13.2 ttt -83.26 66.41 8.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.526 2.163 . . . . 0.0 110.65 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.26 148.47 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 129.205 3.002 . . . . 0.0 108.816 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.65 -178.29 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -140.79 113.0 7.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.87 1.668 . . . . 0.0 114.041 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' CD1' ' A' ' 81' ' ' TYR . 46.8 t -87.95 140.98 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 125.01 1.324 . . . . 0.0 107.638 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -118.38 129.36 74.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.67 131.75 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 O-C-N 124.227 0.954 . . . . 0.0 112.692 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.2 pt-20 . . . . . 0 C--O 1.255 1.363 1 C-N-CA 136.294 5.837 . . . . 0.0 116.204 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 34.47 78.24 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.334 2.653 . . . . 0.0 112.675 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.88 166.81 15.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.8 m -144.22 142.27 30.39 Favored 'General case' 0 C--N 1.329 -0.32 1 C-N-CA 132.489 4.316 . . . . 0.0 103.37 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.36 151.89 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 122.183 0.992 . . . . 0.0 109.436 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -112.99 126.82 55.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.459 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.9 mtm -90.71 125.88 35.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.866 2.066 . . . . 0.0 107.401 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.87 93.78 0.9 Allowed Glycine 0 N--CA 1.465 0.605 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -52.38 154.14 2.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.642 0.721 . . . . 0.0 112.526 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -16.19 34.44 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.993 -1.067 . . . . 0.0 113.112 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -82.94 -3.01 56.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.462 1.905 . . . . 0.0 111.451 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.47 6.13 84.01 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.894 1.712 . . . . 0.0 114.127 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.83 38.51 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.619 0.768 . . . . 0.0 110.048 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 HD23 ' A' ' 36' ' ' LEU . 3.0 mm? -72.06 71.56 0.83 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.857 1.663 . . . . 0.0 110.924 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.61 158.84 4.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.66 1.184 . . . . 0.0 108.268 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.16 137.41 42.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.627 1.571 . . . . 0.0 111.943 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.2 pt-20 -120.15 107.06 40.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.276 1.43 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -80.68 140.6 51.73 Favored 'Cis proline' 0 CA--C 1.549 1.235 0 N-CA-C 117.271 1.989 . . . . 0.0 117.271 -2.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.12 -9.7 59.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 129.147 2.979 . . . . 0.0 113.691 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -149.45 129.66 13.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 129.238 3.015 . . . . 0.0 106.956 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.66 167.56 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.577 1.08 . . . . 0.0 112.055 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -138.68 116.1 11.22 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.48 173.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.62 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -131.63 146.68 52.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -7.83 87.5 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 129.839 3.256 . . . . 0.0 116.826 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -8.24 29.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.693 1.616 . . . . 0.0 115.316 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.19 -172.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -136.44 161.05 36.92 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -143.04 100.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.237 2.615 . . . . 0.0 106.627 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HE3' ' OE2' ' A' ' 28' ' ' GLU . 6.6 ptpp? -101.49 84.8 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.6 142.27 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 118.602 2.816 . . . . 0.0 118.602 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.37 156.51 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 129.795 3.238 . . . . 0.0 112.88 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.442 HD21 ' C ' ' A' ' 62' ' ' ALA . 9.1 m-20 -75.64 140.31 42.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.036 2.534 . . . . 0.0 109.873 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.19 -30.95 0.33 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 116.178 -1.867 . . . . 0.0 114.234 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -158.16 157.76 33.33 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 14' ' ' LEU . 7.1 tp 37.79 52.79 1.46 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 130.497 3.519 . . . . 0.0 113.331 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.21 152.9 7.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 130.698 3.599 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.9 171.23 59.66 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-O 122.881 1.117 . . . . 0.0 112.527 -2.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 157.49 44.45 Favored 'General case' 0 CA--C 1.537 0.453 1 C-N-CA 131.795 4.038 . . . . 0.0 114.651 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 42' ' ' VAL . 7.4 t-20 -144.7 156.82 44.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 113.441 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.7 mp -123.79 87.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.997 1.719 . . . . 0.0 111.394 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 58' ' ' HIS . 19.5 m -117.11 118.99 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 121.143 1.792 . . . . 0.0 113.047 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' H ' ' HB2' ' A' ' 55' ' ' LYS . 28.2 m-85 -84.55 141.96 30.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.548 1.139 . . . . 0.0 111.209 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.35 156.7 35.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 71.36 4.16 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.363 -1.46 . . . . 0.0 108.422 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 125.437 1.495 . . . . 0.0 114.063 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.636 0.255 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -68.38 -1.86 7.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.52 1.928 . . . . 0.0 115.58 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -134.79 -14.66 2.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.1 1.76 . . . . 0.0 112.39 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.33 15.45 29.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.11 1.764 . . . . 0.0 110.971 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 16.7 pttt -148.26 166.14 28.85 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 113.2 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.8 80.6 8.89 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.36 2.264 . . . . 0.0 113.372 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' LYS . 1.5 m -1.11 49.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 1 N-CA-C 124.84 5.126 . . . . 0.0 124.84 -177.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.635 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.5 m-70 50.33 1.84 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.278 2.631 . . . . 0.0 115.199 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -152.78 -11.11 0.17 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 128.78 2.832 . . . . 0.0 110.648 177.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.97 144.58 46.76 Favored Glycine 0 C--N 1.364 2.122 0 C-N-CA 116.343 -2.837 . . . . 0.0 106.759 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 165.42 32.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.604 2.202 . . . . 0.0 115.555 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' C ' HD21 ' A' ' 33' ' ' ASN 0.274 . . -119.82 101.12 7.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -83.56 -23.03 32.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.89 140.99 43.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.47 1.032 . . . . 0.0 113.265 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 121.44 11.77 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.725 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.54 -13.14 39.32 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.98 -1.456 . . . . 0.0 112.563 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -67.08 166.64 13.44 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.206 2.003 . . . . 0.0 109.028 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 t -168.84 160.29 10.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 119.668 -1.895 . . . . 0.0 115.807 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.678 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -141.56 147.72 38.14 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 100.927 -3.731 . . . . 0.0 100.927 176.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -113.33 151.08 31.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 118.517 -2.614 . . . . 0.0 109.584 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.6 p -132.17 133.35 44.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.752 1.221 . . . . 0.0 110.075 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 136.06 36.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.81 2.844 . . . . 0.0 106.787 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.3 168.55 26.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -151.16 52.16 0.85 Allowed 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.02 101.84 38.31 Favored Pre-proline 0 CA--C 1.562 1.427 0 O-C-N 120.435 -1.415 . . . . 0.0 107.576 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . 0.278 19.2 Cg_endo -48.47 110.24 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.847 3.698 . . . . 0.0 118.996 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.44 -130.85 2.64 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.169 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.1 t -153.88 134.03 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.731 0.812 . . . . 0.0 112.723 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.85 131.71 51.14 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 124.101 1.905 . . . . 0.0 115.524 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.34 153.52 29.75 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 128.477 2.711 . . . . 0.0 112.581 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.416 ' CD1' HG23 ' A' ' 95' ' ' VAL . 35.2 p90 -157.84 163.81 37.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.135 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -164.23 165.9 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.355 1.062 . . . . 0.0 111.049 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -103.3 105.55 15.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 87' ' ' ARG . 6.7 mm-40 -38.72 -60.87 1.0 Allowed Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -60.76 -14.44 31.88 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.102 1.868 . . . . 0.0 114.114 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -121.39 12.26 10.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.059 1.3 . . . . 0.0 113.827 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 84' ' ' GLU . 6.8 ttp85 -50.61 -47.22 58.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.787 1.235 . . . . 0.0 112.867 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.94 -7.82 88.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.405 1.479 . . . . 0.0 115.811 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.7 30.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.161 2.185 . . . . 0.0 111.705 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.52 6.16 41.57 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.934 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.9 ttt -80.91 66.02 6.27 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.844 1.822 . . . . 0.0 109.261 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 149.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 129.996 3.318 . . . . 0.0 110.596 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.98 -177.09 31.74 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.72 1.153 . . . . 0.0 114.821 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -144.8 121.24 10.99 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.064 1.346 . . . . 0.0 114.128 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' A' ' 81' ' ' TYR . 16.6 t -91.26 148.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 127.395 2.278 . . . . 0.0 108.039 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.9 128.04 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.83 140.05 49.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 125.173 1.545 . . . . 0.0 112.113 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 1 C-N-CA 135.101 5.361 . . . . 0.0 107.864 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.49 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.027 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 26.66 86.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.149 2.98 . . . . 0.0 114.743 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 168.7 17.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.187 1.47 . . . . 0.0 113.877 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 m -152.16 124.22 8.09 Favored 'General case' 0 N--CA 1.464 0.228 1 C-N-CA 131.714 4.005 . . . . 0.0 102.783 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -134.08 153.61 36.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.216 1.406 . . . . 0.0 111.791 -177.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 19.7 mtpt -120.54 113.32 20.1 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.948 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 78.2 mtm -74.35 121.91 22.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.25 88.64 1.5 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.58 1.082 . . . . 0.0 110.485 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -57.35 145.47 32.31 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.862 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -21.42 28.28 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -74.91 -9.18 58.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.836 0.744 . . . . 0.0 110.388 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.45 66.89 1.33 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 126.532 2.015 . . . . 0.0 109.224 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.12 140.0 27.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.035 0.534 . . . . 0.0 109.611 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.54 69.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.808 1.243 . . . . 0.0 111.984 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -149.93 137.81 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.44 143.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 112.535 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 pt-20 -128.21 105.83 19.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.948 1.299 . . . . 0.0 112.793 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 43.9 Cg_endo -78.75 139.16 52.89 Favored 'Cis proline' 0 C--N 1.352 0.763 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 -2.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -76.34 -4.48 42.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.725 3.21 . . . . 0.0 116.007 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 m -135.04 -75.99 0.45 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.909 1.231 . . . . 0.0 109.7 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.29 160.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 130.264 3.425 . . . . 0.0 115.89 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -132.37 110.78 10.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 112.883 -1.962 . . . . 0.0 109.203 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.55 -178.26 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.89 0.876 . . . . 0.0 110.253 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.33 175.17 5.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.91 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.872 2.069 . . . . 0.0 110.256 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.33 -0.78 53.84 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.201 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 9.2 tt0 -79.91 -178.3 6.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 120.4 2.1 . . . . 0.0 114.038 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.84 154.69 37.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.636 -1.29 . . . . 0.0 112.595 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -146.22 105.08 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 127.389 2.275 . . . . 0.0 106.117 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -106.87 112.78 25.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.6 117.11 30.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 119.382 3.105 . . . . 0.0 119.382 178.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.42 149.55 9.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 109.859 -3.337 . . . . 0.0 115.725 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' CD2' ' A' ' 39' ' ' HIS . 2.5 t30 -77.56 106.06 9.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.563 2.345 . . . . 0.0 109.931 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -111.58 -37.91 5.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.681 -1.628 . . . . 0.0 114.801 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -164.2 122.06 1.77 Allowed 'General case' 0 N--CA 1.479 1.02 1 N-CA-C 123.482 4.623 . . . . 0.0 123.482 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp 85.48 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.978 3.711 . . . . 0.0 110.348 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -54.81 155.07 8.48 Favored Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 129.177 2.991 . . . . 0.0 112.636 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.82 168.17 67.77 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 N-CA-C 114.574 0.952 . . . . 0.0 114.574 0.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' CD2' ' OD1' ' A' ' 33' ' ' ASN 0.344 0.8 OUTLIER -160.39 125.91 3.97 Favored 'General case' 0 C--O 1.219 -0.518 1 C-N-CA 131.944 4.098 . . . . 0.0 121.079 177.495 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -114.06 164.51 13.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 129.03 2.932 . . . . 0.0 115.985 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.9 mm -124.44 109.02 21.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 126.271 1.828 . . . . 0.0 110.72 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 3.5 m -131.35 118.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.495 1.043 . . . . 0.0 113.621 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -82.03 131.28 35.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.333 1.453 . . . . 0.0 110.021 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -2.87 0.31 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.61 56.93 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.976 2.11 . . . . 0.0 108.607 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 127.527 2.331 . . . . 0.0 116.539 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 122.014 0.911 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -62.55 -4.1 1.79 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.42 -19.17 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.052 1.741 . . . . 0.0 112.182 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.22 -1.02 57.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.857 2.063 . . . . 0.0 111.793 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 11.7 pttt -137.3 155.09 49.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.117 0.967 . . . . 0.0 112.273 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.61 154.05 39.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.074 0.95 . . . . 0.0 109.171 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -58.11 42.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 133.632 4.773 . . . . 0.0 119.272 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 41.57 -37.01 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 138.426 6.69 . . . . 0.0 115.313 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.9 -13.28 14.15 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.962 1.705 . . . . 0.0 106.951 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.2 138.02 19.27 Favored Glycine 0 C--N 1.355 1.605 1 N-CA-C 103.01 -4.036 . . . . 0.0 103.01 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.48 170.47 16.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.98 105.98 16.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -95.38 -24.88 16.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.81 159.11 15.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.326 1.05 . . . . 0.0 109.415 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.59 120.79 22.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.589 -1.319 . . . . 0.0 108.516 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.36 35.86 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.691 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.37 146.03 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.558 1.679 . . . . 0.0 108.083 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 p -158.02 174.06 15.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 119.505 -1.997 . . . . 0.0 114.649 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -145.71 144.14 30.18 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 101.096 -3.668 . . . . 0.0 101.096 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 t -114.59 139.81 49.31 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.186 -2.196 . . . . 0.0 108.576 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 p -120.95 140.74 51.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.715 1.606 . . . . 0.0 111.734 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -143.71 125.93 15.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.07 172.21 13.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -152.31 44.38 0.71 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 120.767 3.617 . . . . 0.0 120.767 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -113.19 95.72 36.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 120.5 -1.375 . . . . 0.0 109.959 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.32 105.35 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.14 3.227 . . . . 0.0 115.147 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.81 -129.51 2.16 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.614 2.054 . . . . 0.0 110.674 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.1 t -149.46 135.07 18.55 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.553 -0.969 . . . . 0.0 112.848 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -133.28 100.69 4.92 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 124.598 2.142 . . . . 0.0 114.665 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.22 143.15 18.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 131.222 3.809 . . . . 0.0 110.621 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 3.1 p90 -155.24 167.64 29.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.196 0.998 . . . . 0.0 110.485 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -165.92 -178.16 4.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.87 1.268 . . . . 0.0 110.838 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.0 t -110.9 108.61 18.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -38.24 -50.62 3.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 119.186 3.032 . . . . 0.0 119.186 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 -12.86 25.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.904 1.736 . . . . 0.0 115.174 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -121.68 17.17 11.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.46 -28.92 67.42 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.08 -8.82 58.71 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 125.364 1.459 . . . . 0.0 114.732 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 -8.19 37.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.659 1.984 . . . . 0.0 111.459 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.84 3.22 34.39 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 118.021 -1.433 . . . . 0.0 115.809 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.8 ttt -82.25 62.73 6.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 120.056 1.928 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 147.38 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 129.036 2.934 . . . . 0.0 110.033 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.49 -169.43 15.35 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.714 1.626 . . . . 0.0 112.951 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.02 -62.98 1.38 Allowed 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t 75.56 127.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 131.607 3.963 . . . . 0.0 110.896 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -121.67 128.86 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.97 143.59 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.378 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.494 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.258 1.538 1 C-N-CA 137.496 6.318 . . . . 0.0 113.457 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.428 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 117.497 -1.24 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 20.65 99.03 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 129.73 3.212 . . . . 0.0 117.219 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.42 165.14 11.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.9 m -144.67 144.51 31.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.309 2.643 . . . . 0.0 106.006 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -150.3 152.18 11.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 122.583 1.182 . . . . 0.0 111.864 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -114.37 118.38 33.71 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.2 mtm -79.97 119.98 23.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.11 96.18 1.58 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 t -57.51 150.72 18.25 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 117.104 0.452 . . . . 0.0 111.363 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.6 -21.1 9.42 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -80.75 -6.37 58.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.193 1.397 . . . . 0.0 112.707 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.0 45.7 5.01 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.128 1.347 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.11 0.564 . . . . 0.0 110.214 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 62.9 0.06 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.495 1.918 . . . . 0.0 114.176 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.56 146.86 18.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 O-C-N 120.787 -1.195 . . . . 0.0 107.992 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.86 137.36 32.42 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.415 1.486 . . . . 0.0 112.035 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -119.97 106.77 40.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.141 1.376 . . . . 0.0 111.711 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.88 151.9 94.63 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 -2.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.28 -7.83 46.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.781 2.832 . . . . 0.0 113.518 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.2 m -149.58 124.65 10.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.267 3.027 . . . . 0.0 105.231 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.8 155.49 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.675 0.671 . . . . 0.0 112.494 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -130.97 100.47 5.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.57 1.176 . . . . 0.0 112.069 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.04 -177.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.69 135.33 52.95 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.636 1.107 . . . . 0.0 111.643 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 98' ' ' GLU . . . -31.16 103.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.933 2.093 . . . . 0.0 112.966 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 -4.64 14.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.688 1.613 . . . . 0.0 112.968 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 64.7 mt-10 -91.94 169.61 10.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.34 1.57 . . . . 0.0 114.747 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.64 163.9 12.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.4 t -148.0 104.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 127.844 2.458 . . . . 0.0 106.715 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.68 111.28 23.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.682 0.793 . . . . 0.0 110.926 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.602 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.14 114.06 26.26 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 14.2 t -96.9 136.98 25.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 131.094 3.757 . . . . 0.0 114.161 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.762 HD22 ' HB1' ' A' ' 62' ' ' ALA 0.263 3.7 t-20 -69.9 120.16 15.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 129.955 3.302 . . . . 0.0 107.3 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -132.8 -30.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 116.968 -1.492 . . . . 0.0 113.482 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -158.99 163.96 35.98 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 tp 43.15 48.45 5.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.433 3.093 . . . . 0.0 111.478 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -56.41 144.88 61.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.493 2.317 . . . . 0.0 111.747 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.09 175.22 49.07 Favored 'Cis proline' 0 CA--C 1.548 1.214 0 CA-C-O 123.108 1.212 . . . . 0.0 114.166 0.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -146.46 152.11 38.49 Favored 'General case' 0 CA--C 1.528 0.123 1 C-N-CA 132.815 4.446 . . . . 0.0 113.956 177.886 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -142.46 162.03 36.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.279 1.832 . . . . 0.0 110.006 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.624 HG21 ' CE1' ' A' ' 69' ' ' PHE . 20.7 mm -135.62 94.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.312 1.445 . . . . 0.0 110.867 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 58' ' ' HIS . 4.2 m -115.5 118.45 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 O-C-N 120.839 -1.163 . . . . 0.0 112.056 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 132.83 39.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -0.71 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 73.24 33.03 1.19 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.101 2.56 . . . . 0.0 111.602 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 CA--C 1.548 0.877 0 CA-C-O 115.644 -2.122 . . . . 0.0 116.061 -177.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.53 -10.38 11.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.395 1.878 . . . . 0.0 115.531 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.48 -10.19 7.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.411 2.284 . . . . 0.0 110.316 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 8.56 25.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.885 1.674 . . . . 0.0 112.563 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -142.61 156.96 45.15 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.272 0.942 . . . . 0.0 109.393 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HB2' ' H ' ' A' ' 41' ' ' ILE . 19.1 mt -76.37 60.71 1.59 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.044 2.538 . . . . 0.0 105.338 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 59' ' ' LYS . 44.7 m -21.0 86.11 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 121.106 3.743 . . . . 0.0 121.106 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.434 ' HA ' HG11 ' A' ' 42' ' ' VAL . 96.8 m-70 34.38 12.21 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 1 C-N-CA 135.087 5.355 . . . . 0.0 115.803 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -156.38 -13.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.375 3.07 . . . . 0.0 110.01 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.53 148.85 50.51 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 116.296 -2.859 . . . . 0.0 106.531 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.06 147.43 32.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.762 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -117.29 110.43 18.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 102.505 -3.146 . . . . 0.0 102.505 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -116.9 -31.08 5.54 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.1 136.2 41.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.394 1.477 . . . . 0.0 110.752 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.62 118.54 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.683 1.193 . . . . 0.0 112.423 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.79 4.04 52.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.297 1.904 . . . . 0.0 113.793 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.29 -60.8 3.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 1.2 p 64.03 171.38 0.18 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -154.82 135.99 13.95 Favored 'General case' 0 CA--C 1.559 1.318 1 N-CA-C 98.35 -4.685 . . . . 0.0 98.35 176.22 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.26 146.9 30.89 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 118.88 -2.387 . . . . 0.0 108.357 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 p -126.52 151.98 47.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.8 m -153.0 118.68 5.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.95 158.47 44.02 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -136.81 23.71 3.09 Favored 'General case' 0 CA--C 1.546 0.807 1 N-CA-C 123.439 4.607 . . . . 0.0 123.439 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 2.8 pt-20 -89.6 108.83 27.68 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.45 103.0 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.497 1.464 . . . . 0.0 110.446 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.11 -162.98 36.77 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 127.899 2.666 . . . . 0.0 110.969 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -124.01 128.67 49.72 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.107 0.956 . . . . 0.0 113.054 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -120.27 127.11 52.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 124.203 1.954 . . . . 0.0 114.25 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -80.53 144.5 32.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.617 -2.538 . . . . 0.0 108.406 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.421 ' CE1' HG23 ' A' ' 95' ' ' VAL . 35.9 p90 -152.5 166.06 33.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.848 0.832 . . . . 0.0 109.709 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -163.77 175.23 10.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.701 0.8 . . . . 0.0 111.502 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.6 t -109.32 116.17 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -42.35 -63.47 0.9 Allowed Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.89 -4.24 8.41 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.427 2.751 . . . . 0.0 116.02 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -130.77 12.18 5.26 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.908 1.231 . . . . 0.0 113.128 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.79 -28.42 22.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.851 2.06 . . . . 0.0 115.161 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.59 -5.77 41.85 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 126.68 2.086 . . . . 0.0 114.813 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.2 -5.74 32.74 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.019 2.528 . . . . 0.0 110.932 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.25 34.22 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.789 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 ttt -82.99 63.47 7.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.285 2.042 . . . . 0.0 110.656 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.11 144.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 129.879 3.272 . . . . 0.0 109.345 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.4 -175.94 27.0 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.567 1.079 . . . . 0.0 113.927 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -143.35 115.71 8.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.368 1.467 . . . . 0.0 114.074 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 81' ' ' TYR . 11.9 t -89.6 147.38 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 127.569 2.348 . . . . 0.0 107.594 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.78 120.5 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.58 113.68 37.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 123.83 0.852 . . . . 0.0 110.481 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.474 ' N ' ' HA ' ' A' ' 24' ' ' LYS . 17.2 pt-20 . . . . . 0 C--O 1.256 1.43 1 C-N-CA 133.961 4.904 . . . . 0.0 114.89 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 26.2 t-20 48.41 72.86 0.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 109.699 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.12 163.62 27.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 123.941 1.829 . . . . 0.0 112.638 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -143.8 148.55 35.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 129.579 3.152 . . . . 0.0 103.377 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -154.36 156.0 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.283 1.04 . . . . 0.0 109.532 177.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -120.58 105.66 11.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.5 mtm -65.26 119.34 10.72 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.78 99.61 1.09 Allowed Glycine 0 N--CA 1.47 0.961 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.3 t -59.41 152.01 22.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.65 -18.36 53.14 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.907 -1.121 . . . . 0.0 111.16 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -81.49 -7.84 59.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.619 1.968 . . . . 0.0 112.412 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.87 9.19 64.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.84 2.162 . . . . 0.0 115.292 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.56 138.65 34.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.356 0.663 . . . . 0.0 110.154 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.05 73.94 0.91 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.066 1.746 . . . . 0.0 108.646 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.43 134.66 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.02 132.41 37.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.6 pt-20 -117.45 113.34 38.75 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.466 -0.772 . . . . 0.0 112.568 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 92.8 Cg_endo -78.67 138.82 51.56 Favored 'Cis proline' 0 C--N 1.354 0.865 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 -2.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -78.1 -10.94 59.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.62 1.968 . . . . 0.0 112.588 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -142.82 128.47 19.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 129.676 3.191 . . . . 0.0 108.561 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 p -148.14 165.51 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.19 0.904 . . . . 0.0 113.426 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -131.13 106.32 8.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.943 1.297 . . . . 0.0 110.855 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 2.6 pp -123.24 175.21 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 0.0 109.291 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.535 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -130.79 174.09 10.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.91 100.77 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.889 1.275 . . . . 0.0 113.519 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.88 -2.59 25.82 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.01 1.767 . . . . 0.0 114.245 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.47 173.31 9.71 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.729 1.252 . . . . 0.0 114.356 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -130.71 171.77 12.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 123.426 1.584 . . . . 0.0 111.361 -178.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.84 94.85 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.443 2.297 . . . . 0.0 106.332 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -84.44 51.92 2.23 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -57.94 133.67 55.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 177.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t -118.86 149.9 21.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 1 C-N-CA 133.564 4.746 . . . . 0.0 114.277 -176.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.651 HD22 ' HB1' ' A' ' 62' ' ' ALA . 2.9 t-20 -78.71 117.72 20.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.57 3.148 . . . . 0.0 107.047 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -129.53 -20.12 3.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 115.748 -2.072 . . . . 0.0 113.939 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.06 153.73 16.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.6 tp 45.98 50.46 11.43 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 131.466 3.907 . . . . 0.0 112.08 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 151.18 4.08 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 129.616 3.166 . . . . 0.0 112.33 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.95 174.25 45.48 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 O-C-N 122.13 0.542 . . . . 0.0 112.507 -2.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.95 163.33 37.17 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 130.097 3.359 . . . . 0.0 113.624 177.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -149.28 163.09 38.67 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.82 1.248 . . . . 0.0 113.089 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.14 79.68 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.781 2.032 . . . . 0.0 110.109 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 4.0 m -105.86 118.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 119.89 -1.756 . . . . 0.0 111.663 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 10.6 m-85 -79.54 141.38 36.7 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 121.699 -0.626 . . . . 0.0 110.371 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.64 -16.17 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 69.4 68.51 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.584 1.954 . . . . 0.0 108.181 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.513 0.725 . . . . 0.0 112.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -60.6 -5.83 1.4 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.679 2.392 . . . . 0.0 115.466 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.34 -3.32 6.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 111.114 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.77 -5.72 14.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.913 2.085 . . . . 0.0 114.642 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 28.4 pttt -130.32 167.61 18.24 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.05 1.74 . . . . 0.0 114.904 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.97 -69.16 0.35 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.93 2.092 . . . . 0.0 110.534 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t 153.06 150.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.737 2.815 . . . . 0.0 110.014 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -70.8 5.16 2.07 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.212 2.205 . . . . 0.0 111.481 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 -25.92 0.82 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.887 2.475 . . . . 0.0 111.266 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.85 136.97 18.0 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 120.342 1.428 . . . . 0.0 110.352 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.45 165.56 29.04 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.651 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -103.64 105.55 15.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -99.07 -24.92 14.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.22 56.26 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.73 112.35 0.45 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.102 1.761 . . . . 0.0 112.288 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.93 -12.61 29.42 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.407 1.48 . . . . 0.0 112.712 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -68.92 87.04 0.36 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.207 1.503 . . . . 0.0 113.811 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 80.6 p -83.71 157.26 22.23 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.799 -1.188 . . . . 0.0 109.863 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -26.02 6.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.387 -2.125 . . . . 0.0 108.526 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t 47.49 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 131.529 3.932 . . . . 0.0 116.868 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -135.27 152.79 51.85 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.679 -1.263 . . . . 0.0 111.777 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -143.93 112.05 6.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.753 2.021 . . . . 0.0 109.503 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 154.6 51.24 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.792 2.037 . . . . 0.0 115.44 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -136.52 16.87 3.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 pm0 -92.85 96.05 1.26 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' GLU . 8.5 Cg_endo -41.84 118.22 0.86 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 124.433 3.422 . . . . 0.0 112.893 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.51 -152.05 22.7 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 123.243 1.468 . . . . 0.0 112.983 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -145.63 117.57 8.25 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.692 1.197 . . . . 0.0 108.968 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.82 133.43 54.44 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 124.076 1.893 . . . . 0.0 112.346 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 151.15 24.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.927 3.291 . . . . 0.0 115.021 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CE2' HG23 ' A' ' 95' ' ' VAL . 19.4 p90 -154.78 162.32 41.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.987 1.315 . . . . 0.0 110.108 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -159.64 164.15 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 110.164 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.9 t -99.69 104.59 16.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -35.8 -60.62 0.63 Allowed Pre-proline 0 N--CA 1.48 1.055 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.75 -8.11 20.28 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.504 2.136 . . . . 0.0 114.048 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.8 1.84 7.42 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.859 1.209 . . . . 0.0 112.64 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -43.15 -59.69 1.96 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.29 2.636 . . . . 0.0 111.353 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.13 71.04 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.127 1.346 . . . . 0.0 116.056 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -11.25 33.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.274 1.429 . . . . 0.0 111.803 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.03 -0.2 17.1 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-O 118.3 -1.278 . . . . 0.0 115.733 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttt -81.67 73.84 8.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.092 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.53 147.65 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 129.351 3.061 . . . . 0.0 108.251 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.63 179.73 34.09 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.039 0.828 . . . . 0.0 114.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -147.48 131.71 17.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.71 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.5 t -97.31 155.99 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 127.367 2.267 . . . . 0.0 108.161 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.71 125.47 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -123.96 142.17 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 124.489 1.118 . . . . 0.0 112.997 177.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 6.0 pt-20 . . . . . 0 C--O 1.253 1.261 1 C-N-CA 134.396 5.078 . . . . 0.0 116.254 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 18.93 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 128.976 2.91 . . . . 0.0 115.189 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.73 156.8 24.82 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.951 -1.093 . . . . 0.0 113.855 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.0 m -136.88 125.08 23.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 103.433 -2.803 . . . . 0.0 103.433 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.06 149.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 122.79 1.281 . . . . 0.0 112.486 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -117.02 116.83 28.12 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.946 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp -76.97 120.81 22.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.68 94.43 1.54 Allowed Glycine 0 N--CA 1.47 0.962 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -58.01 152.41 16.52 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.726 0.411 . . . . 0.0 111.836 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -57.46 -17.63 14.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -80.54 -7.53 59.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.255 1.022 . . . . 0.0 112.183 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.97 25.86 30.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.529 1.538 . . . . 0.0 113.984 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.73 140.61 32.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.529 0.732 . . . . 0.0 109.863 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.14 63.41 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.132 1.773 . . . . 0.0 112.093 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.85 145.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.609 -1.307 . . . . 0.0 107.637 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.46 144.54 28.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.666 1.186 . . . . 0.0 111.367 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 24.3 pt-20 -123.86 108.07 30.72 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.544 1.538 . . . . 0.0 110.928 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -78.41 147.26 81.8 Favored 'Cis proline' 0 CA--C 1.542 0.911 0 N-CA-C 116.042 1.516 . . . . 0.0 116.042 -2.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -0.77 57.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.819 2.048 . . . . 0.0 113.351 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -151.48 127.11 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 128.671 2.788 . . . . 0.0 104.929 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.6 158.21 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -138.49 107.17 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.272 1.034 . . . . 0.0 111.078 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.76 173.34 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.239 1.416 . . . . 0.0 108.088 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -128.81 152.01 48.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.68 1.582 . . . . 0.0 110.87 177.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -24.34 115.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.506 2.722 . . . . 0.0 114.713 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.13 -19.92 39.31 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.827 1.679 . . . . 0.0 113.364 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 mt-10 -79.54 167.63 20.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 122.455 1.121 . . . . 0.0 111.097 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.02 -178.89 3.97 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 122.667 1.222 . . . . 0.0 109.937 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.54 101.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -88.5 123.11 32.7 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -127.88 122.22 31.99 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 177.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.32 148.9 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 128.872 2.869 . . . . 0.0 115.315 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.845 HD22 ' HB1' ' A' ' 62' ' ' ALA . 14.0 t-20 -76.88 116.19 17.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 131.182 3.793 . . . . 0.0 109.879 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -131.33 -27.44 1.99 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 116.995 -1.479 . . . . 0.0 114.09 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.35 159.96 37.98 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tp 47.8 49.57 16.52 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 127.92 2.488 . . . . 0.0 111.503 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 140.48 64.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.919 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 165.53 84.79 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 CA-C-O 125.068 2.028 . . . . 0.0 115.79 2.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.508 ' HA ' ' SG ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -144.04 169.63 17.47 Favored 'General case' 0 CA--C 1.515 -0.395 1 C-N-CA 131.915 4.086 . . . . 0.0 111.833 177.723 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -167.63 175.04 7.28 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.372 1.869 . . . . 0.0 109.282 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.5 mm -146.67 93.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.402 1.481 . . . . 0.0 109.404 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.03 111.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.209 1.404 . . . . 0.0 112.362 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.431 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 14.9 m-85 -72.49 131.8 43.01 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 120.813 -1.179 . . . . 0.0 108.259 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.55 -3.41 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.642 1.977 . . . . 0.0 115.856 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.44 52.62 8.36 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.282 1.033 . . . . 0.0 109.783 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 126.898 2.079 . . . . 0.0 110.865 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -56.95 -9.0 0.71 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 129.713 3.205 . . . . 0.0 115.677 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.39 -4.28 6.08 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.792 2.037 . . . . 0.0 111.003 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.23 -10.52 14.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.68 2.392 . . . . 0.0 113.935 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CB ' ' H ' ' A' ' 43' ' ' PHE . 27.2 pttt -130.5 166.9 19.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.045 1.738 . . . . 0.0 114.368 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.17 -72.51 0.21 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.721 1.608 . . . . 0.0 111.99 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t 158.15 149.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.619 2.367 . . . . 0.0 108.664 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -69.43 -10.26 57.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.123 0.969 . . . . 0.0 111.482 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -19.47 8.6 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.244 1.418 . . . . 0.0 110.444 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.46 111.32 4.21 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 120.228 1.377 . . . . 0.0 110.938 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.52 173.08 7.63 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -107.5 101.47 10.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 126.911 2.084 . . . . 0.0 105.95 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.82 -14.09 16.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.842 1.657 . . . . 0.0 114.24 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.47 51.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.552 1.524 . . . . 0.0 113.312 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.11 116.25 1.92 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.127 1.371 . . . . 0.0 112.312 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.35 -13.29 33.45 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.262 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -65.54 157.47 29.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.294 2.047 . . . . 0.0 109.35 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 p -163.29 174.04 12.55 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 118.893 -2.379 . . . . 0.0 113.361 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -152.03 151.03 30.62 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -113.22 139.27 48.93 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 120.168 -1.583 . . . . 0.0 108.718 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 54.0 p -119.53 152.21 37.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -153.74 125.6 7.76 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.263 0.3 OUTLIER -143.15 150.91 40.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.6 t -137.21 14.71 3.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 111.573 -2.558 . . . . 0.0 114.93 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -103.97 99.58 17.14 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.364 1.865 . . . . 0.0 109.409 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.55 125.92 15.03 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.778 2.986 . . . . 0.0 111.395 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.43 -174.72 43.18 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 123.7 1.722 . . . . 0.0 113.157 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -134.11 106.31 7.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.253 0.2 OUTLIER -115.08 137.76 51.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 123.918 1.818 . . . . 0.0 113.646 -177.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 147.36 28.76 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 111.737 -2.483 . . . . 0.0 113.176 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 95' ' ' VAL . 38.6 p90 -147.65 155.97 42.31 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.26 0.624 . . . . 0.0 109.591 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -156.19 170.7 21.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.512 0.673 . . . . 0.0 109.696 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER -105.5 119.65 39.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.274 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.81 -57.7 11.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.18 -18.88 64.54 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.879 2.064 . . . . 0.0 114.314 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -119.43 14.46 12.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.402 1.455 . . . . 0.0 113.923 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -48.91 -40.75 31.19 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.43 -10.43 59.33 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.819 1.676 . . . . 0.0 114.175 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.86 -7.23 52.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.88 2.072 . . . . 0.0 111.58 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.21 3.96 29.29 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 118.169 -1.351 . . . . 0.0 115.123 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.8 ttt -83.75 76.78 9.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 124.001 1.857 . . . . 0.0 108.413 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.09 146.4 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 129.101 2.96 . . . . 0.0 109.071 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -179.69 32.15 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 124.721 1.153 . . . . 0.0 114.692 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -138.92 120.17 14.74 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.473 1.509 . . . . 0.0 114.851 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.691 HG23 ' CE1' ' A' ' 81' ' ' TYR . 48.1 t -91.68 153.35 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.722 2.009 . . . . 0.0 108.591 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.77 122.24 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.66 126.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 123.347 0.659 . . . . 0.0 109.844 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.507 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 8.4 pt-20 . . . . . 0 C--O 1.252 1.204 1 C-N-CA 135.391 5.477 . . . . 0.0 113.94 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 31.06 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 130.26 3.424 . . . . 0.0 111.944 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.34 172.78 7.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 m -151.42 147.37 26.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 130.757 3.623 . . . . 0.0 104.87 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.81 151.99 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 122.872 1.32 . . . . 0.0 109.647 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -111.86 123.84 51.1 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 mtp -87.46 125.17 34.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 35' ' ' LYS . . . 89.97 92.77 1.2 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -58.58 147.0 33.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.257 0.621 . . . . 0.0 109.573 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.35 -15.94 30.41 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -76.73 -8.88 58.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.317 0.647 . . . . 0.0 111.107 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.92 58.1 2.29 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.627 2.06 . . . . 0.0 108.769 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.08 133.25 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 67.02 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.335 1.454 . . . . 0.0 113.062 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.08 147.72 16.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.8 140.58 31.16 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.504 1.921 . . . . 0.0 112.782 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.4 pt-20 -124.3 103.48 32.57 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.46 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 60.1 Cg_endo -81.78 140.26 45.33 Favored 'Cis proline' 0 CA--C 1.551 1.357 0 N-CA-C 118.397 2.422 . . . . 0.0 118.397 -2.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -16.59 62.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.676 3.591 . . . . 0.0 114.495 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 20.8 m -157.16 141.09 16.13 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 128.513 2.725 . . . . 0.0 105.38 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.97 149.63 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.973 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -112.19 102.41 10.59 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 125.22 1.575 . . . . 0.0 109.113 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pt -126.32 -178.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 112.274 -2.239 . . . . 0.0 109.134 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.72 172.29 7.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.06 65.4 0.14 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.326 2.25 . . . . 0.0 111.932 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.05 40.35 0.09 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 129.653 3.501 . . . . 0.0 111.904 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -122.13 166.47 14.52 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -109.39 161.6 15.14 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.926 1.346 . . . . 0.0 114.39 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -145.69 103.47 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 129.442 3.097 . . . . 0.0 106.793 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.97 88.28 2.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.3 138.81 31.55 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.3 145.57 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 130.55 3.54 . . . . 0.0 115.363 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.673 HD22 ' HB1' ' A' ' 62' ' ' ALA . 11.1 t-20 -74.61 124.15 26.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.871 2.469 . . . . 0.0 107.285 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.24 -29.21 1.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.841 -1.552 . . . . 0.0 114.779 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HA3' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -167.73 158.84 11.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 177.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.9 tp 48.51 57.21 6.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.685 . . . . 0.0 111.367 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.56 156.37 32.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.01 160.54 86.36 Favored 'Cis proline' 0 CA--C 1.544 0.982 0 CA-C-O 123.808 1.503 . . . . 0.0 113.857 -1.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 143.03 42.51 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 128.149 2.58 . . . . 0.0 113.599 177.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' HD12 ' A' ' 56' ' ' LEU 0.305 20.1 t-20 -141.56 150.64 42.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.13 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 56' ' ' LEU . 30.4 mm -117.86 94.74 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 58' ' ' HIS . 15.4 m -124.62 114.61 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 123.908 0.883 . . . . 0.0 110.935 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.491 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 36.4 m-85 -74.4 167.96 20.63 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.725 0.81 . . . . 0.0 109.077 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.43 -6.05 23.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.961 2.949 . . . . 0.0 118.961 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 64.83 51.17 1.85 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.407 1.458 . . . . 0.0 110.328 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 127.008 2.123 . . . . 0.0 112.641 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -60.71 -7.27 2.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.093 1.757 . . . . 0.0 113.863 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.71 -0.01 11.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.36 1.864 . . . . 0.0 111.337 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.88 16.72 3.88 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 40.9 pttt -137.51 160.36 39.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.386 0.993 . . . . 0.0 111.8 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 41' ' ' ILE . 30.8 mt -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.36 1.464 . . . . 0.0 111.469 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -71.82 43.8 0.1 Allowed 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 128.935 2.894 . . . . 0.0 116.62 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER 44.92 -56.17 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.098 1 C-N-CA 136.622 5.969 . . . . 0.0 112.115 -177.785 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 -16.85 22.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.264 1.603 . . . . 0.0 108.23 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.59 139.51 23.9 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 103.193 -3.963 . . . . 0.0 103.193 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.1 176.74 12.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -94.94 95.35 8.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -88.45 -27.02 21.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.31 -130.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.176 0.99 . . . . 0.0 109.255 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.9 120.89 10.03 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.618 1.967 . . . . 0.0 109.895 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.27 -13.16 23.69 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 117.601 -1.666 . . . . 0.0 113.454 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.84 161.82 25.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.871 2.335 . . . . 0.0 109.329 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 p -161.37 162.76 30.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.242 -1.536 . . . . 0.0 112.655 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.75 139.73 28.06 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 101.608 -3.478 . . . . 0.0 101.608 177.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 118.968 -2.333 . . . . 0.0 109.519 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.0 p -121.68 126.02 47.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.543 1.137 . . . . 0.0 108.766 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.2 m -127.62 101.3 6.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.08 2.152 . . . . 0.0 107.796 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -116.62 138.84 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 118.754 2.872 . . . . 0.0 118.754 178.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -118.2 6.53 11.99 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.152 2.981 . . . . 0.0 118.114 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -106.31 94.83 10.31 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.345 1.058 . . . . 0.0 112.553 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 98' ' ' GLU . 36.4 Cg_endo -56.26 120.35 8.15 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.284 2.656 . . . . 0.0 108.453 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.34 -3.17 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t 53.79 94.85 0.02 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 130.619 3.568 . . . . 0.0 110.868 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -101.8 149.61 24.0 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 117.112 -1.835 . . . . 0.0 113.421 -177.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -92.21 154.42 18.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 110.851 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.78 171.62 19.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.55 1.54 . . . . 0.0 112.036 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.16 -171.41 2.19 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.746 2.019 . . . . 0.0 109.832 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -122.58 113.05 18.75 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.59 1.556 . . . . 0.0 111.185 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -41.38 -50.16 8.91 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -0.3 10.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.299 2.666 . . . . 0.0 116.799 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -137.54 10.13 2.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -43.71 -50.45 7.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.08 -8.88 85.96 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 126.152 1.834 . . . . 0.0 115.01 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.09 -8.94 35.12 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.43 1.892 . . . . 0.0 111.169 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 7.47 30.22 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.377 -1.235 . . . . 0.0 115.996 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.3 ttt -83.15 63.52 7.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.911 1.855 . . . . 0.0 110.623 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.57 145.78 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 129.312 3.045 . . . . 0.0 111.507 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.26 -176.74 31.65 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 125.406 1.479 . . . . 0.0 115.026 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.0 ttmm -136.11 171.45 14.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.36 1.464 . . . . 0.0 110.304 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -141.25 150.73 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 119.257 -2.152 . . . . 0.0 108.362 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.44 110.49 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 100.898 -3.741 . . . . 0.0 100.898 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.94 53.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 124.377 2.037 . . . . 0.0 110.98 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 131.379 3.871 . . . . 0.0 113.388 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 42.41 73.15 0.14 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.14 1.776 . . . . 0.0 110.453 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.02 157.32 35.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.856 1.789 . . . . 0.0 112.854 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 m -139.45 143.47 37.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 150.59 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 119.19 0.905 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 10.0 mtpt -120.1 116.56 25.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtm -76.33 122.28 24.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.597 1.959 . . . . 0.0 106.917 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.04 1.19 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.041 -2.023 . . . . 0.0 108.041 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 t -58.2 148.18 27.84 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.148 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.23 -14.21 16.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.2 m -79.42 -10.83 59.89 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.75 0.704 . . . . 0.0 111.126 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.32 15.0 45.88 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.927 1.727 . . . . 0.0 113.461 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.76 128.31 35.32 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.821 1.311 . . . . 0.0 109.188 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.69 66.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.433 1.893 . . . . 0.0 111.667 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.03 151.01 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -100.52 130.4 46.59 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.757 1.223 . . . . 0.0 108.009 177.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 3.7 pt-20 -100.87 131.55 23.28 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.414 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' GLU 0.301 7.4 Cg_exo -77.58 -13.23 30.16 Favored 'Cis proline' 0 C--N 1.355 0.882 1 N-CA-C 125.071 4.989 . . . . 0.0 125.071 2.757 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t 93.12 -15.98 0.13 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 131.242 3.817 . . . . 0.0 109.929 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 m -153.82 129.78 10.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.959 1.704 . . . . 0.0 108.083 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 22' ' ' THR . 1.8 p -144.86 168.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 113.307 -1.77 . . . . 0.0 113.726 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 21' ' ' VAL . 9.9 t -132.63 115.08 14.96 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.518 -1.673 . . . . 0.0 110.936 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.8 -179.27 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.361 1.464 . . . . 0.0 110.267 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.98 176.65 5.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 177.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -60.44 115.18 3.38 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.181 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.77 67.61 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.878 1.704 . . . . 0.0 112.383 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 18.3 tt0 -82.92 161.58 21.8 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.162 0.985 . . . . 0.0 112.498 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' CD ' ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt-20 -108.09 166.7 10.54 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.977 1.37 . . . . 0.0 113.762 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.32 97.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.177 2.591 . . . . 0.0 105.456 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HE3' ' CD ' ' A' ' 28' ' ' GLU . 5.0 ptpp? -98.95 106.59 18.87 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.636 1.208 . . . . 0.0 112.756 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -106.57 122.22 45.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.08 153.02 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 109.092 -3.685 . . . . 0.0 113.435 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.581 HD22 ' HB1' ' A' ' 62' ' ' ALA 0.261 3.8 t-20 -86.81 107.84 18.47 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 131.612 3.965 . . . . 0.0 106.883 177.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.0 -32.54 4.18 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.96 34.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 tp 41.32 57.91 2.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.058 2.943 . . . . 0.0 112.952 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.41 151.53 59.34 Favored Pre-proline 0 CA--C 1.537 0.452 1 C-N-CA 132.256 4.222 . . . . 0.0 111.692 177.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.52 174.99 45.92 Favored 'Cis proline' 0 CA--C 1.543 0.96 0 CA-C-O 122.57 0.987 . . . . 0.0 112.314 -2.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.0 161.23 42.73 Favored 'General case' 0 C--O 1.224 -0.287 1 C-N-CA 132.99 4.516 . . . . 0.0 114.449 177.912 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.13 159.11 42.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.92 0.888 . . . . 0.0 112.602 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.727 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.8 mp -120.87 109.14 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.262 0.625 . . . . 0.0 110.576 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.05 113.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.244 1.018 . . . . 0.0 113.722 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 79' ' ' TYR . 27.3 m-85 -80.85 134.6 35.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.177 1.391 . . . . 0.0 110.383 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.32 43.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.801 1.24 . . . . 0.0 113.616 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 87.92 -23.33 0.12 Allowed 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 129.742 3.217 . . . . 0.0 115.387 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.557 1.239 0 C-N-CA 129.076 2.95 . . . . 0.0 113.952 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -71.78 0.1 9.77 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.46 -19.55 3.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.269 1.427 . . . . 0.0 112.532 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.21 0.15 39.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.753 1.221 . . . . 0.0 112.806 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -133.9 168.72 18.24 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 119.871 1.214 . . . . 0.0 113.86 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' ILE . 39.6 mt -72.45 163.32 28.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.999 1.319 . . . . 0.0 112.035 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.5 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 129.112 2.965 . . . . 0.0 118.487 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 51.45 -47.9 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 1 C-N-CA 136.801 6.04 . . . . 0.0 111.518 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.18 -22.09 24.22 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 126.932 2.093 . . . . 0.0 106.958 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.37 150.98 41.11 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 177.13 11.22 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.449 2.124 . . . . 0.0 116.56 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -109.5 104.45 13.51 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -102.69 -24.06 13.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.17 131.69 55.77 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.35 116.06 1.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.357 1.463 . . . . 0.0 112.186 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.91 -9.96 34.35 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.712 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -68.36 163.39 23.22 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.286 2.043 . . . . 0.0 109.214 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -167.49 165.38 14.76 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 119.312 -2.117 . . . . 0.0 111.706 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.727 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.71 140.62 34.92 Favored 'General case' 0 CA--C 1.551 0.986 1 N-CA-C 99.626 -4.213 . . . . 0.0 99.626 176.702 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -110.6 143.85 40.38 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 109.504 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.9 p -124.53 135.03 52.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.858 1.263 . . . . 0.0 110.012 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.7 m -135.4 137.24 42.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.912 2.085 . . . . 0.0 107.651 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' HG11 ' A' ' 97' ' ' VAL 0.324 0.2 OUTLIER -148.31 156.61 42.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 119.67 3.211 . . . . 0.0 119.67 -177.758 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -140.12 23.45 2.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.272 2.693 . . . . 0.0 118.272 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -101.04 92.51 2.48 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.82 1.648 . . . . 0.0 111.197 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.48 108.9 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.443 2.095 . . . . 0.0 112.037 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.13 -128.2 1.72 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.879 1.704 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 t -167.02 146.37 5.3 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.773 -1.427 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' HD2' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -134.06 140.55 46.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.669 1.223 . . . . 0.0 112.424 176.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -91.51 141.51 28.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.833 2.853 . . . . 0.0 112.233 -177.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' CZ3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.52 169.63 18.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.082 0.944 . . . . 0.0 112.424 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -162.76 -178.31 6.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.26 2.224 . . . . 0.0 113.183 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.1 t -114.26 111.82 22.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.64 1.976 . . . . 0.0 109.059 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -38.04 -64.23 0.47 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -64.93 -10.3 24.8 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.931 2.421 . . . . 0.0 115.422 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -124.26 9.78 8.6 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -44.16 -62.33 1.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.87 1.668 . . . . 0.0 111.457 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.17 -13.85 60.63 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 126.025 1.774 . . . . 0.0 116.046 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.89 -7.2 40.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.383 2.273 . . . . 0.0 111.147 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.28 10.43 36.36 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.326 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.7 ttt -81.03 64.42 5.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.348 2.074 . . . . 0.0 109.635 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.07 154.86 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 131.494 3.918 . . . . 0.0 110.897 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.38 -169.61 32.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.687 1.613 . . . . 0.0 114.002 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' HG2' ' H ' ' A' ' 95' ' ' VAL . 18.6 tttm -140.12 174.19 10.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.311 1.044 . . . . 0.0 110.208 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 12.2 t -150.72 133.83 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 128.18 2.592 . . . . 0.0 108.795 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.29 131.1 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 ' CD1' ' A' ' 73' ' ' PHE . 1.4 m -127.25 132.72 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 125.029 1.456 . . . . 0.0 112.911 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.482 1.167 1 C-N-CA 137.992 6.517 . . . . 0.0 114.526 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 13.51 96.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 130.969 3.708 . . . . 0.0 114.943 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 167.4 9.9 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 123.293 1.521 . . . . 0.0 112.161 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.2 m -146.37 155.75 42.83 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.051 2.941 . . . . 0.0 103.967 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.74 153.64 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.639 0.733 . . . . 0.0 109.588 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 17.8 mtpt -112.78 120.42 41.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.728 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.6 mtm -80.25 119.94 23.68 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.47 2.708 . . . . 0.0 106.109 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.34 97.74 1.06 Allowed Glycine 0 N--CA 1.47 0.929 0 N-CA-C 106.347 -2.701 . . . . 0.0 106.347 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -59.51 155.89 14.3 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 94.2 m-20 -57.52 -17.89 16.16 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -84.97 -3.74 58.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.591 1.556 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.18 14.6 68.69 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.241 0.924 . . . . 0.0 112.955 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.34 136.36 33.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.341 0.656 . . . . 0.0 109.798 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.23 65.28 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.8 2.04 . . . . 0.0 111.653 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -145.82 148.53 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.979 0.912 . . . . 0.0 108.563 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -92.93 135.98 33.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.779 1.232 . . . . 0.0 110.656 177.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 20.4 pt-20 -117.87 111.02 39.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.943 1.297 . . . . 0.0 112.216 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 79.2 Cg_endo -78.25 142.91 71.35 Favored 'Cis proline' 0 CA--C 1.542 0.897 0 N-CA-C 115.501 1.308 . . . . 0.0 115.501 -2.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.79 -3.86 58.92 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 112.36 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m -151.96 129.28 11.27 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 129.732 3.213 . . . . 0.0 107.521 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.3 164.82 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.98 113.17 10.53 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.244 1.021 . . . . 0.0 111.703 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 141.35 52.03 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.174 1.806 . . . . 0.0 112.374 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -11.59 99.67 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 130.779 3.632 . . . . 0.0 115.747 -177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.31 -12.95 28.43 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.778 1.18 . . . . 0.0 112.679 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.43 173.06 12.38 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.549 1.166 . . . . 0.0 109.718 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 175.96 6.91 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.72 108.67 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 129.902 3.281 . . . . 0.0 106.64 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -104.77 52.51 0.74 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -49.54 142.83 7.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 120.739 3.607 . . . . 0.0 120.739 177.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.57 152.82 34.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 130.92 3.688 . . . . 0.0 112.65 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.713 HD22 ' HB1' ' A' ' 62' ' ' ALA . 10.4 t-20 -80.12 122.48 26.86 Favored 'General case' 0 CA--C 1.543 0.678 1 C-N-CA 132.479 4.312 . . . . 0.0 109.868 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -136.31 -29.88 0.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.974 -1.489 . . . . 0.0 114.112 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -154.65 157.44 38.16 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp 38.22 51.33 1.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 131.379 3.871 . . . . 0.0 112.534 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.86 151.39 2.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 130.16 3.384 . . . . 0.0 112.579 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.6 176.46 41.64 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-O 122.371 0.905 . . . . 0.0 113.135 -2.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.58 157.0 43.37 Favored 'General case' 0 N--CA 1.462 0.174 1 C-N-CA 132.541 4.336 . . . . 0.0 113.82 177.911 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -147.29 161.8 40.24 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.328 1.451 . . . . 0.0 109.974 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' A' ' 69' ' ' PHE . 28.1 mm -138.1 98.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.193 0.997 . . . . 0.0 111.996 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 2.5 m -120.53 122.15 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 120.796 -1.19 . . . . 0.0 112.624 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -82.04 162.01 22.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.355 0.598 . . . . 0.0 110.952 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.25 -14.07 34.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.67 39.75 0.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.91 1.686 . . . . 0.0 111.96 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.28 -24.33 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.98 -100.43 0.32 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 121.552 1.978 . . . . 0.0 116.206 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.74 -9.78 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.194 0.598 . . . . 0.0 112.426 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.29 152.13 44.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 123.24 1.495 . . . . 0.0 110.149 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.47 76.39 4.98 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.52 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.99 -29.26 28.06 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.376 1.084 . . . . 0.0 109.937 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -63.4 1.49 0.52 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.491 2.717 . . . . 0.0 114.279 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.5 4.21 5.1 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.889 2.876 . . . . 0.0 110.936 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.08 10.02 4.15 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.295 2.238 . . . . 0.0 113.054 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 31.7 pttt -132.73 162.9 30.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 129.396 3.078 . . . . 0.0 110.532 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -68.67 0.37 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.004 2.122 . . . . 0.0 110.904 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 59' ' ' LYS . 13.3 t 150.74 154.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.229 3.412 . . . . 0.0 107.764 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -69.77 15.05 0.09 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.811 1.645 . . . . 0.0 112.448 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 57' ' ' SER . 1.3 tpmp? -145.03 -18.04 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.69 3.196 . . . . 0.0 111.582 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.7 37.79 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 122.138 2.244 . . . . 0.0 110.555 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 tp -150.71 143.31 24.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -114.15 108.74 17.38 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -112.9 -26.18 8.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.28 49.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.586 1.154 . . . . 0.0 111.365 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.74 113.95 1.38 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.878 1.271 . . . . 0.0 111.64 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.37 -11.61 28.5 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 117.903 -1.499 . . . . 0.0 112.794 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -62.17 162.94 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.174 1.987 . . . . 0.0 109.606 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.4 t -161.25 162.55 31.13 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 119.755 -1.841 . . . . 0.0 114.998 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -142.3 146.25 34.86 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 100.35 -3.944 . . . . 0.0 100.35 176.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -118.85 149.7 41.1 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 119.43 -2.044 . . . . 0.0 111.64 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.9 p -134.08 141.99 47.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.503 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -139.79 124.51 18.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.547 2.339 . . . . 0.0 107.908 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.75 146.29 33.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 118.837 2.903 . . . . 0.0 118.837 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 6.9 t -131.69 15.28 4.88 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.28 108.95 39.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 122.818 2.553 . . . . 0.0 106.463 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -52.47 119.26 5.62 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.71 1.606 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.59 -178.95 24.86 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 128.956 3.169 . . . . 0.0 108.867 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -112.17 131.48 55.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.719 -1.24 . . . . 0.0 111.851 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.25 0.1 OUTLIER -121.94 137.25 54.86 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 124.328 2.013 . . . . 0.0 116.045 177.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -84.25 148.34 26.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 109.959 -3.291 . . . . 0.0 112.951 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 95' ' ' VAL . 27.2 p90 -155.53 168.58 26.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.373 1.869 . . . . 0.0 110.06 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -167.61 172.74 9.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.72 1.208 . . . . 0.0 111.628 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.92 114.71 29.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -41.36 -61.45 1.37 Allowed Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.37 -0.78 8.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.828 3.018 . . . . 0.0 114.973 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -129.53 -3.69 4.81 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -39.37 -59.51 1.06 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.83 2.452 . . . . 0.0 112.083 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.36 -13.13 59.92 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.621 1.581 . . . . 0.0 116.42 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.48 -6.07 28.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.839 2.456 . . . . 0.0 111.603 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.41 5.89 33.97 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 117.744 -1.587 . . . . 0.0 116.459 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.3 ttt -81.27 62.53 5.23 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.202 2.001 . . . . 0.0 110.497 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.57 149.26 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 130.292 3.437 . . . . 0.0 108.828 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.46 -178.39 34.41 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -144.72 124.29 13.23 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' A' ' 81' ' ' TYR . 18.6 t -95.77 153.7 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 129.558 3.143 . . . . 0.0 109.197 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.48 134.58 62.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 117.999 -1.001 . . . . 0.0 108.489 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.89 65.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 119.137 3.014 . . . . 0.0 119.137 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 129.578 3.151 . . . . 0.0 115.002 177.782 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 50.4 77.85 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.695 1.598 . . . . 0.0 111.255 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.94 165.0 23.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 123.81 1.767 . . . . 0.0 115.133 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -150.28 142.77 24.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.805 3.242 . . . . 0.0 105.491 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -149.75 153.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 122.802 1.287 . . . . 0.0 111.19 178.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -117.57 120.97 39.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.4 mmm -83.09 121.98 27.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.264 2.226 . . . . 0.0 106.04 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.51 98.07 0.89 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -61.72 155.25 23.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.671 -0.265 . . . . 0.0 111.474 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.35 -20.43 11.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.392 1.077 . . . . 0.0 113.639 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -84.92 -3.05 58.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.928 1.291 . . . . 0.0 113.216 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.41 12.31 76.01 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.131 0.872 . . . . 0.0 111.863 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.72 128.66 34.21 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.42 64.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.969 2.108 . . . . 0.0 110.898 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -140.48 155.23 22.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.751 1.221 . . . . 0.0 109.374 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' CE1' ' CE1' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -101.42 136.9 40.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.04 0.924 . . . . 0.0 110.964 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.5 pt-20 -121.92 109.05 34.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 125.787 1.635 . . . . 0.0 112.464 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 Cg_endo -78.2 141.32 65.1 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 N-CA-C 116.639 1.746 . . . . 0.0 116.639 -2.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -15.71 59.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.752 2.421 . . . . 0.0 113.917 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -153.12 133.35 13.48 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.431 2.692 . . . . 0.0 106.165 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.64 167.15 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.626 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -136.87 114.02 10.68 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.041 0.838 . . . . 0.0 111.164 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.84 -172.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.965 1.706 . . . . 0.0 109.754 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.53 171.51 9.94 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 177.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -61.66 84.2 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.295 2.238 . . . . 0.0 111.353 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 18.45 3.61 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.002 2.239 . . . . 0.0 113.571 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -106.64 177.39 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.342 1.457 . . . . 0.0 112.037 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -120.61 161.88 20.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -148.85 103.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.431 2.292 . . . . 0.0 107.184 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 104.13 13.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.363 1.065 . . . . 0.0 113.46 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -102.66 119.52 38.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.42 151.31 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 108.944 -3.753 . . . . 0.0 112.751 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.469 ' CG ' ' CE1' ' A' ' 39' ' ' HIS . 18.3 t-20 -79.7 113.88 18.19 Favored 'General case' 0 C--N 1.324 -0.511 1 C-N-CA 132.877 4.471 . . . . 0.0 108.553 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -127.61 -27.34 2.87 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 116.445 -1.74 . . . . 0.0 114.015 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.77 159.12 43.1 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.22 -66.32 0.31 Allowed 'General case' 0 CA--C 1.518 -0.258 1 C-N-CA 132.185 4.194 . . . . 0.0 111.75 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m 66.22 147.88 0.11 Allowed Pre-proline 0 C--N 1.292 -1.905 2 C-N-CA 132.966 4.506 . . . . 0.0 111.556 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.44 179.07 31.3 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-O 122.418 0.924 . . . . 0.0 112.318 -2.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.61 160.19 42.03 Favored 'General case' 0 CA--C 1.534 0.35 1 C-N-CA 135.149 5.38 . . . . 0.0 113.603 177.768 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.49 154.65 39.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.646 1.579 . . . . 0.0 111.668 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.754 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.2 mp -124.72 95.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.353 1.061 . . . . 0.0 110.492 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 6.7 m -120.21 116.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 119.962 -1.711 . . . . 0.0 114.342 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -78.94 134.24 36.86 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.963 0.905 . . . . 0.0 109.906 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.44 58.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.67 70.82 0.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.801 1.64 . . . . 0.0 109.551 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.8 -8.36 21.13 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.217 1.007 . . . . 0.0 109.998 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.2 -9.17 69.9 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 127.587 2.517 . . . . 0.0 114.413 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 m -97.42 -12.86 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.346 1.458 . . . . 0.0 112.556 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.498 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.3 p-10 -115.14 145.13 42.67 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 130.144 3.378 . . . . 0.0 116.332 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.59 68.15 9.48 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.236 1.414 . . . . 0.0 107.528 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -44.67 -54.37 6.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.315 1.446 . . . . 0.0 113.907 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -63.79 -5.81 4.81 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.781 2.032 . . . . 0.0 114.245 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.55 -3.27 8.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.254 1.422 . . . . 0.0 110.482 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.12 3.01 9.87 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 25.3 pttt -136.59 161.31 36.26 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.272 1.397 . . . . 0.0 112.07 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.83 -24.22 64.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 112.813 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' LYS . 3.9 t 66.32 99.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 24.82 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 1 C-N-CA 140.867 7.667 . . . . 0.0 118.563 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.72 -12.4 0.12 Allowed 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 131.52 3.928 . . . . 0.0 110.291 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.96 148.7 50.04 Favored Glycine 0 N--CA 1.493 2.446 0 CA-C-N 123.867 3.03 . . . . 0.0 106.285 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tp -140.55 156.92 46.16 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.42 100.98 7.47 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 101.084 -3.673 . . . . 0.0 101.084 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -111.8 -19.44 12.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.48 134.23 55.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.467 1.03 . . . . 0.0 111.719 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.62 113.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.208 1.403 . . . . 0.0 112.295 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.84 26.8 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.818 -1.546 . . . . 0.0 112.484 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -68.03 164.77 19.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 120.541 2.17 . . . . 0.0 108.851 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -168.08 166.02 13.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 118.928 -2.357 . . . . 0.0 111.962 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.41 136.22 32.86 Favored 'General case' 0 CA--C 1.55 0.959 1 N-CA-C 98.612 -4.588 . . . . 0.0 98.612 176.655 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -106.8 144.47 33.4 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 118.654 -2.529 . . . . 0.0 109.278 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 60.9 p -117.41 142.51 47.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.037 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.3 m -151.38 89.11 1.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 152.65 21.73 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 127.008 2.123 . . . . 0.0 114.539 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -129.16 2.47 5.2 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 49' ' ' ASP . 19.6 pm0 -90.82 102.8 5.78 Favored Pre-proline 0 N--CA 1.438 -1.063 0 C-N-CA 126.954 2.102 . . . . 0.0 108.787 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -56.54 123.78 14.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.003 3.135 . . . . 0.0 108.461 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.46 170.91 27.94 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.425 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.7 t -111.39 126.12 54.6 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.495 ' CG ' ' HB3' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -128.86 131.25 47.64 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.967 1.365 . . . . 0.0 113.989 -177.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 148.49 25.87 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.718 2.007 . . . . 0.0 112.593 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -153.12 163.5 39.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.96 0.886 . . . . 0.0 109.489 177.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -159.01 178.21 10.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.525 1.53 . . . . 0.0 112.48 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.2 t -113.16 109.05 18.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.36 1.464 . . . . 0.0 107.212 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -38.12 -61.25 0.85 Allowed Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.75 -10.64 27.41 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.154 1.903 . . . . 0.0 115.927 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -128.95 -2.78 5.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -44.92 34.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.079 1.752 . . . . 0.0 113.103 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.43 -14.78 67.3 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 125.226 1.393 . . . . 0.0 115.12 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.51 -3.34 26.99 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.094 2.958 . . . . 0.0 110.998 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.15 32.55 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 117.589 -1.673 . . . . 0.0 116.282 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.0 ttt -81.45 64.94 6.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.489 2.144 . . . . 0.0 109.258 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.96 158.41 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 131.178 3.791 . . . . 0.0 109.827 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.22 -168.61 35.31 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 114.056 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HG3' ' H ' ' A' ' 95' ' ' VAL . 30.6 tptt -131.92 173.21 11.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.285 1.034 . . . . 0.0 110.008 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 t -149.95 140.76 16.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 129.585 3.154 . . . . 0.0 107.026 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.7 t -127.31 129.23 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.75 141.71 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.428 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 14.4 pt-20 . . . . . 0 C--O 1.25 1.087 1 C-N-CA 136.377 5.871 . . . . 0.0 111.779 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 117.19 -1.386 . . . . 0.0 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.9 m120 4.16 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 129.444 3.098 . . . . 0.0 115.605 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.43 -178.38 6.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 118.267 2.691 . . . . 0.0 118.267 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 m -159.46 120.11 3.14 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 18' ' ' PRO . 2.4 t -122.9 159.76 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 123.625 1.679 . . . . 0.0 109.829 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -111.53 112.1 23.59 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.311 1.444 . . . . 0.0 109.084 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.2 mtt -74.39 115.52 14.02 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.7 95.33 1.75 Allowed Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.1 t -54.17 148.71 10.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.912 0.856 . . . . 0.0 111.991 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -22.7 21.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 p -75.05 -12.74 60.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.783 2.033 . . . . 0.0 111.343 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.02 66.44 1.62 Allowed Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.79 134.86 30.82 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.418 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.19 70.28 0.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.41 1.884 . . . . 0.0 111.912 177.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.49 133.52 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.11 145.53 31.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 23.3 pt-20 -137.07 103.18 8.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.279 1.032 . . . . 0.0 112.431 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 5' ' ' VAL 0.374 8.1 Cg_exo -70.44 126.58 10.25 Favored 'Cis proline' 0 CA--C 1.559 1.774 1 N-CA-C 128.411 6.273 . . . . 0.0 128.411 -2.102 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -80.51 -11.99 59.6 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.703 3.201 . . . . 0.0 112.667 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -150.33 120.42 7.22 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 130.356 3.462 . . . . 0.0 105.215 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -136.83 157.08 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.05 0.386 . . . . 0.0 111.769 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -131.68 107.38 8.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.125 0.964 . . . . 0.0 110.652 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.35 -175.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.707 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -134.0 172.2 13.15 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 177.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -44.09 111.97 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.418 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.39 -13.92 59.69 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.732 1.634 . . . . 0.0 114.506 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 98.3 mt-10 -79.67 162.64 25.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.715 1.245 . . . . 0.0 110.701 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 177.57 4.95 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.327 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.95 101.75 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 66.64 3.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.109 0.964 . . . . 0.0 112.437 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -74.45 138.38 43.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 39.2 t -118.28 151.58 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 1 C-N-CA 132.432 4.293 . . . . 0.0 116.485 -176.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.418 ' HB3' ' H ' ' A' ' 67' ' ' GLU . 39.0 t-20 -72.56 114.79 11.07 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -109.72 -41.55 4.51 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 114.108 -2.853 . . . . 0.0 113.336 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -169.65 152.64 4.7 Favored 'General case' 0 N--CA 1.483 1.191 1 N-CA-C 122.949 4.426 . . . . 0.0 122.949 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 tp 63.11 56.84 1.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.828 2.051 . . . . 0.0 108.521 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.42 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 3.2 m -60.75 154.11 59.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 127.083 2.153 . . . . 0.0 111.478 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.36 171.51 63.96 Favored 'Cis proline' 0 CA--C 1.545 1.045 0 N-CA-C 114.677 0.991 . . . . 0.0 114.677 -1.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 37' ' ' SER 0.292 0.8 OUTLIER -157.59 163.12 38.65 Favored 'General case' 0 C--O 1.21 -0.988 1 C-N-CA 136.504 5.921 . . . . 0.0 119.29 177.846 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.08 169.3 23.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.949 1.3 . . . . 0.0 113.425 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 38.2 mm -131.02 83.48 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 125.548 1.539 . . . . 0.0 111.459 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.43 110.71 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.148 0.975 . . . . 0.0 111.15 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 39.5 m-85 -69.09 166.93 17.12 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.65 -20.23 17.77 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 79.93 70.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.38 2.272 . . . . 0.0 106.477 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.6 -16.48 56.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.13 -5.35 27.03 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 119.229 2.451 . . . . 0.0 119.229 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.45 -12.78 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.992 1.377 . . . . 0.0 113.502 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -92.43 -179.47 5.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.801 3.24 . . . . 0.0 113.987 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.21 66.97 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.51 1.524 . . . . 0.0 111.479 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -51.68 -54.35 29.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.875 1.27 . . . . 0.0 113.214 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -60.1 -7.15 1.68 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.361 1.865 . . . . 0.0 113.248 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.48 1.39 14.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.65 1.58 . . . . 0.0 111.842 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.73 3.56 2.07 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -118.15 163.7 16.25 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.023 2.129 . . . . 0.0 113.877 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -75.52 165.49 25.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.361 1.464 . . . . 0.0 110.588 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -64.42 150.52 46.27 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.099 -1.626 . . . . 0.0 110.166 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -65.36 -20.42 66.38 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.607 -1.308 . . . . 0.0 110.847 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.92 -14.98 13.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.995 0.518 . . . . 0.0 111.306 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.66 153.4 33.08 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 104.822 -3.311 . . . . 0.0 104.822 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.07 177.34 10.81 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.78 96.35 6.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -103.57 -3.54 25.1 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' ' 67' ' ' GLU . . . -146.43 129.77 16.72 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 120.411 1.459 . . . . 0.0 112.151 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.88 123.2 4.94 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.494 -1.379 . . . . 0.0 114.636 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.65 0.67 32.49 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 127.413 2.435 . . . . 0.0 114.697 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 33' ' ' ASN . 9.0 mt-10 -67.89 -67.04 0.49 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.688 2.744 . . . . 0.0 118.201 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 2.5 p 70.27 172.08 0.31 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -163.62 150.85 12.43 Favored 'General case' 0 CA--C 1.549 0.917 1 N-CA-C 99.906 -4.109 . . . . 0.0 99.906 176.074 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -108.84 138.54 45.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 118.392 -2.693 . . . . 0.0 109.087 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 62.5 p -117.19 160.09 21.61 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 m -157.75 138.75 13.3 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.277 0.2 OUTLIER -156.19 155.1 31.86 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 120.174 3.398 . . . . 0.0 120.174 -177.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.2 t -139.82 23.5 2.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.458 2.303 . . . . 0.0 116.746 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -102.79 86.88 1.06 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 125.772 1.629 . . . . 0.0 112.121 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.26 114.07 0.9 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.726 2.284 . . . . 0.0 110.317 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.09 -132.78 3.06 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.186 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.72 128.55 2.46 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.439 -0.881 . . . . 0.0 110.488 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -124.61 141.56 52.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 124.297 1.999 . . . . 0.0 112.53 176.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 m -77.73 144.64 37.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 110.297 -3.138 . . . . 0.0 110.315 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.52 ' CD1' HG23 ' A' ' 95' ' ' VAL . 34.3 p90 -147.21 164.85 31.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.731 1.613 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -170.26 175.17 5.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.068 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 91' ' ' MET . 11.9 t -107.97 112.38 24.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.764 -2.016 . . . . 0.0 106.622 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.86 -65.52 0.29 Allowed Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.883 1.22 . . . . 0.0 113.869 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.98 -2.53 5.69 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.81 3.007 . . . . 0.0 116.499 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 91' ' ' MET . 6.5 m-70 -132.37 11.31 4.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -13.83 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.46 -7.51 32.12 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.602 2.049 . . . . 0.0 113.158 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.63 -8.33 23.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.083 2.553 . . . . 0.0 110.759 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.83 2.15 32.17 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 117.78 -1.567 . . . . 0.0 115.868 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 13.2 ttt -83.26 66.41 8.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.526 2.163 . . . . 0.0 110.65 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.26 148.47 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 129.205 3.002 . . . . 0.0 108.816 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.65 -178.29 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 115.3 0.88 . . . . 0.0 115.3 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -140.79 113.0 7.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.87 1.668 . . . . 0.0 114.041 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' CD1' ' A' ' 81' ' ' TYR . 46.8 t -87.95 140.98 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 125.01 1.324 . . . . 0.0 107.638 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -118.38 129.36 74.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.67 131.75 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 O-C-N 124.227 0.954 . . . . 0.0 112.692 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.2 pt-20 . . . . . 0 C--O 1.255 1.363 1 C-N-CA 136.294 5.837 . . . . 0.0 116.204 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 34.47 78.24 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.334 2.653 . . . . 0.0 112.675 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.88 166.81 15.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.8 m -144.22 142.27 30.39 Favored 'General case' 0 C--N 1.329 -0.32 1 C-N-CA 132.489 4.316 . . . . 0.0 103.37 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.36 151.89 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 122.183 0.992 . . . . 0.0 109.436 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -112.99 126.82 55.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.459 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.9 mtm -90.71 125.88 35.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.866 2.066 . . . . 0.0 107.401 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.87 93.78 0.9 Allowed Glycine 0 N--CA 1.465 0.605 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -52.38 154.14 2.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.642 0.721 . . . . 0.0 112.526 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -16.19 34.44 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.993 -1.067 . . . . 0.0 113.112 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -82.94 -3.01 56.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.462 1.905 . . . . 0.0 111.451 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.47 6.13 84.01 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.894 1.712 . . . . 0.0 114.127 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.83 38.51 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.619 0.768 . . . . 0.0 110.048 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 HD23 ' A' ' 36' ' ' LEU . 3.0 mm? -72.06 71.56 0.83 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.857 1.663 . . . . 0.0 110.924 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.61 158.84 4.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.66 1.184 . . . . 0.0 108.268 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.16 137.41 42.13 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.627 1.571 . . . . 0.0 111.943 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.2 pt-20 -120.15 107.06 40.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.276 1.43 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -80.68 140.6 51.73 Favored 'Cis proline' 0 CA--C 1.549 1.235 0 N-CA-C 117.271 1.989 . . . . 0.0 117.271 -2.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.12 -9.7 59.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 129.147 2.979 . . . . 0.0 113.691 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -149.45 129.66 13.67 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 129.238 3.015 . . . . 0.0 106.956 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.66 167.56 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.577 1.08 . . . . 0.0 112.055 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -138.68 116.1 11.22 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.48 173.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.62 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -131.63 146.68 52.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -7.83 87.5 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 129.839 3.256 . . . . 0.0 116.826 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -8.24 29.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.693 1.616 . . . . 0.0 115.316 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.19 -172.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -136.44 161.05 36.92 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -143.04 100.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.237 2.615 . . . . 0.0 106.627 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HE3' ' OE2' ' A' ' 28' ' ' GLU . 6.6 ptpp? -101.49 84.8 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.6 142.27 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 118.602 2.816 . . . . 0.0 118.602 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.37 156.51 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 129.795 3.238 . . . . 0.0 112.88 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.442 HD21 ' C ' ' A' ' 62' ' ' ALA . 9.1 m-20 -75.64 140.31 42.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.036 2.534 . . . . 0.0 109.873 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.19 -30.95 0.33 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 116.178 -1.867 . . . . 0.0 114.234 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -158.16 157.76 33.33 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 14' ' ' LEU . 7.1 tp 37.79 52.79 1.46 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 130.497 3.519 . . . . 0.0 113.331 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.21 152.9 7.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 130.698 3.599 . . . . 0.0 111.778 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.9 171.23 59.66 Favored 'Cis proline' 0 CA--C 1.542 0.903 0 CA-C-O 122.881 1.117 . . . . 0.0 112.527 -2.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 157.49 44.45 Favored 'General case' 0 CA--C 1.537 0.453 1 C-N-CA 131.795 4.038 . . . . 0.0 114.651 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 42' ' ' VAL . 7.4 t-20 -144.7 156.82 44.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 113.441 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.7 mp -123.79 87.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.997 1.719 . . . . 0.0 111.394 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 58' ' ' HIS . 19.5 m -117.11 118.99 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 121.143 1.792 . . . . 0.0 113.047 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' H ' ' HB2' ' A' ' 55' ' ' LYS . 28.2 m-85 -84.55 141.96 30.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.548 1.139 . . . . 0.0 111.209 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.35 156.7 35.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.69 71.36 4.16 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.363 -1.46 . . . . 0.0 108.422 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.44 -15.51 61.82 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.437 1.495 . . . . 0.0 114.063 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.63 -141.17 3.12 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 120.686 1.584 . . . . 0.0 114.782 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.01 -0.22 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.276 -0.868 . . . . 0.0 112.381 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -68.61 159.53 31.81 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.61 73.18 6.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.8 -36.48 62.49 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.599 -0.688 . . . . 0.0 111.278 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -68.38 -1.86 7.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.52 1.928 . . . . 0.0 115.58 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -134.79 -14.66 2.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.1 1.76 . . . . 0.0 112.39 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.33 15.45 29.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.11 1.764 . . . . 0.0 110.971 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 16.7 pttt -148.26 166.14 28.85 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 113.2 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.8 80.6 8.89 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.36 2.264 . . . . 0.0 113.372 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' LYS . 1.5 m -1.11 49.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 1 N-CA-C 124.84 5.126 . . . . 0.0 124.84 -177.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.635 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.5 m-70 50.33 1.84 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.278 2.631 . . . . 0.0 115.199 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -152.78 -11.11 0.17 Allowed 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 128.78 2.832 . . . . 0.0 110.648 177.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.97 144.58 46.76 Favored Glycine 0 C--N 1.364 2.122 0 C-N-CA 116.343 -2.837 . . . . 0.0 106.759 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 165.42 32.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.604 2.202 . . . . 0.0 115.555 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' C ' HD21 ' A' ' 33' ' ' ASN 0.274 . . -119.82 101.12 7.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -83.56 -23.03 32.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.89 140.99 43.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.47 1.032 . . . . 0.0 113.265 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 121.44 11.77 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.725 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.54 -13.14 39.32 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-O 117.98 -1.456 . . . . 0.0 112.563 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -67.08 166.64 13.44 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.206 2.003 . . . . 0.0 109.028 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 t -168.84 160.29 10.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 119.668 -1.895 . . . . 0.0 115.807 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.678 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -141.56 147.72 38.14 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 100.927 -3.731 . . . . 0.0 100.927 176.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -113.33 151.08 31.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 118.517 -2.614 . . . . 0.0 109.584 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.6 p -132.17 133.35 44.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.752 1.221 . . . . 0.0 110.075 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 136.06 36.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.81 2.844 . . . . 0.0 106.787 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.3 168.55 26.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -151.16 52.16 0.85 Allowed 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.02 101.84 38.31 Favored Pre-proline 0 CA--C 1.562 1.427 0 O-C-N 120.435 -1.415 . . . . 0.0 107.576 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . 0.278 19.2 Cg_endo -48.47 110.24 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.847 3.698 . . . . 0.0 118.996 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.44 -130.85 2.64 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.169 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.1 t -153.88 134.03 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.731 0.812 . . . . 0.0 112.723 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.85 131.71 51.14 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 124.101 1.905 . . . . 0.0 115.524 -177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.34 153.52 29.75 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 128.477 2.711 . . . . 0.0 112.581 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.416 ' CD1' HG23 ' A' ' 95' ' ' VAL . 35.2 p90 -157.84 163.81 37.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.135 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -164.23 165.9 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.355 1.062 . . . . 0.0 111.049 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -103.3 105.55 15.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 87' ' ' ARG . 6.7 mm-40 -38.72 -60.87 1.0 Allowed Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -60.76 -14.44 31.88 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.102 1.868 . . . . 0.0 114.114 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -121.39 12.26 10.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.059 1.3 . . . . 0.0 113.827 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 84' ' ' GLU . 6.8 ttp85 -50.61 -47.22 58.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.787 1.235 . . . . 0.0 112.867 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.94 -7.82 88.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.405 1.479 . . . . 0.0 115.811 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.7 30.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.161 2.185 . . . . 0.0 111.705 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.52 6.16 41.57 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 118.134 -1.37 . . . . 0.0 115.934 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.9 ttt -80.91 66.02 6.27 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.844 1.822 . . . . 0.0 109.261 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 149.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 129.996 3.318 . . . . 0.0 110.596 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.98 -177.09 31.74 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.72 1.153 . . . . 0.0 114.821 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -144.8 121.24 10.99 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.064 1.346 . . . . 0.0 114.128 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' A' ' 81' ' ' TYR . 16.6 t -91.26 148.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 127.395 2.278 . . . . 0.0 108.039 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.9 128.04 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.83 140.05 49.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 125.173 1.545 . . . . 0.0 112.113 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 1 C-N-CA 135.101 5.361 . . . . 0.0 107.864 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.49 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.027 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 26.66 86.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.149 2.98 . . . . 0.0 114.743 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 168.7 17.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 123.187 1.47 . . . . 0.0 113.877 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 m -152.16 124.22 8.09 Favored 'General case' 0 N--CA 1.464 0.228 1 C-N-CA 131.714 4.005 . . . . 0.0 102.783 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -134.08 153.61 36.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.216 1.406 . . . . 0.0 111.791 -177.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 19.7 mtpt -120.54 113.32 20.1 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.948 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 78.2 mtm -74.35 121.91 22.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.25 88.64 1.5 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.58 1.082 . . . . 0.0 110.485 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -57.35 145.47 32.31 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.862 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -21.42 28.28 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -74.91 -9.18 58.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.836 0.744 . . . . 0.0 110.388 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.45 66.89 1.33 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 126.532 2.015 . . . . 0.0 109.224 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.12 140.0 27.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.035 0.534 . . . . 0.0 109.611 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.54 69.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.808 1.243 . . . . 0.0 111.984 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -149.93 137.81 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.44 143.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 112.535 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 pt-20 -128.21 105.83 19.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.948 1.299 . . . . 0.0 112.793 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 43.9 Cg_endo -78.75 139.16 52.89 Favored 'Cis proline' 0 C--N 1.352 0.763 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 -2.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -76.34 -4.48 42.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.725 3.21 . . . . 0.0 116.007 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 m -135.04 -75.99 0.45 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.909 1.231 . . . . 0.0 109.7 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.29 160.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 130.264 3.425 . . . . 0.0 115.89 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -132.37 110.78 10.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 112.883 -1.962 . . . . 0.0 109.203 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.55 -178.26 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.89 0.876 . . . . 0.0 110.253 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.33 175.17 5.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.91 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.872 2.069 . . . . 0.0 110.256 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.33 -0.78 53.84 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.549 1.547 . . . . 0.0 115.201 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 9.2 tt0 -79.91 -178.3 6.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 120.4 2.1 . . . . 0.0 114.038 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.84 154.69 37.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.636 -1.29 . . . . 0.0 112.595 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -146.22 105.08 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 127.389 2.275 . . . . 0.0 106.117 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -106.87 112.78 25.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.717 0.807 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.6 117.11 30.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 119.382 3.105 . . . . 0.0 119.382 178.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.42 149.55 9.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 109.859 -3.337 . . . . 0.0 115.725 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' CD2' ' A' ' 39' ' ' HIS . 2.5 t30 -77.56 106.06 9.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.563 2.345 . . . . 0.0 109.931 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -111.58 -37.91 5.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.681 -1.628 . . . . 0.0 114.801 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -164.2 122.06 1.77 Allowed 'General case' 0 N--CA 1.479 1.02 1 N-CA-C 123.482 4.623 . . . . 0.0 123.482 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp 85.48 53.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.978 3.711 . . . . 0.0 110.348 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -54.81 155.07 8.48 Favored Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 129.177 2.991 . . . . 0.0 112.636 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.82 168.17 67.77 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 N-CA-C 114.574 0.952 . . . . 0.0 114.574 0.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' CD2' ' OD1' ' A' ' 33' ' ' ASN 0.344 0.8 OUTLIER -160.39 125.91 3.97 Favored 'General case' 0 C--O 1.219 -0.518 1 C-N-CA 131.944 4.098 . . . . 0.0 121.079 177.495 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -114.06 164.51 13.73 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 129.03 2.932 . . . . 0.0 115.985 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.9 mm -124.44 109.02 21.55 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 126.271 1.828 . . . . 0.0 110.72 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 3.5 m -131.35 118.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.495 1.043 . . . . 0.0 113.621 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -82.03 131.28 35.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.333 1.453 . . . . 0.0 110.021 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -2.87 0.31 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 63.61 56.93 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.976 2.11 . . . . 0.0 108.607 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -20.34 62.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.527 2.331 . . . . 0.0 116.539 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.45 -103.92 0.18 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 121.507 1.958 . . . . 0.0 117.928 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.94 -8.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -70.55 164.69 24.3 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.97 78.81 5.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -50.29 -42.43 52.4 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.549 1.068 . . . . 0.0 110.854 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -62.55 -4.1 1.79 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.42 -19.17 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.052 1.741 . . . . 0.0 112.182 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.22 -1.02 57.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.857 2.063 . . . . 0.0 111.793 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 11.7 pttt -137.3 155.09 49.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.117 0.967 . . . . 0.0 112.273 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.61 154.05 39.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.074 0.95 . . . . 0.0 109.171 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -58.11 42.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 133.632 4.773 . . . . 0.0 119.272 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 41.57 -37.01 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 138.426 6.69 . . . . 0.0 115.313 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.9 -13.28 14.15 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.962 1.705 . . . . 0.0 106.951 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.2 138.02 19.27 Favored Glycine 0 C--N 1.355 1.605 1 N-CA-C 103.01 -4.036 . . . . 0.0 103.01 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.48 170.47 16.8 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.98 105.98 16.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -95.38 -24.88 16.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.81 159.11 15.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.326 1.05 . . . . 0.0 109.415 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.59 120.79 22.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.589 -1.319 . . . . 0.0 108.516 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.36 35.86 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.691 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.37 146.03 53.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.558 1.679 . . . . 0.0 108.083 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 p -158.02 174.06 15.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 119.505 -1.997 . . . . 0.0 114.649 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -145.71 144.14 30.18 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 101.096 -3.668 . . . . 0.0 101.096 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 t -114.59 139.81 49.31 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.186 -2.196 . . . . 0.0 108.576 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 p -120.95 140.74 51.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.715 1.606 . . . . 0.0 111.734 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -143.71 125.93 15.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.07 172.21 13.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -152.31 44.38 0.71 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 120.767 3.617 . . . . 0.0 120.767 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -113.19 95.72 36.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 120.5 -1.375 . . . . 0.0 109.959 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.32 105.35 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.14 3.227 . . . . 0.0 115.147 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.81 -129.51 2.16 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.614 2.054 . . . . 0.0 110.674 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.1 t -149.46 135.07 18.55 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.553 -0.969 . . . . 0.0 112.848 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -133.28 100.69 4.92 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 124.598 2.142 . . . . 0.0 114.665 -177.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.22 143.15 18.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 131.222 3.809 . . . . 0.0 110.621 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 3.1 p90 -155.24 167.64 29.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.196 0.998 . . . . 0.0 110.485 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -165.92 -178.16 4.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.87 1.268 . . . . 0.0 110.838 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.0 t -110.9 108.61 18.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -38.24 -50.62 3.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 119.186 3.032 . . . . 0.0 119.186 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 -12.86 25.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.904 1.736 . . . . 0.0 115.174 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -121.68 17.17 11.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -59.46 -28.92 67.42 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.08 -8.82 58.71 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 125.364 1.459 . . . . 0.0 114.732 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 -8.19 37.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.659 1.984 . . . . 0.0 111.459 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.84 3.22 34.39 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 118.021 -1.433 . . . . 0.0 115.809 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.8 ttt -82.25 62.73 6.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 120.056 1.928 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 147.38 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 129.036 2.934 . . . . 0.0 110.033 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.49 -169.43 15.35 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.714 1.626 . . . . 0.0 112.951 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.02 -62.98 1.38 Allowed 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t 75.56 127.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 131.607 3.963 . . . . 0.0 110.896 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -121.67 128.86 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.97 143.59 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.378 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.494 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.258 1.538 1 C-N-CA 137.496 6.318 . . . . 0.0 113.457 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 117.497 -1.24 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 20.65 99.03 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 129.73 3.212 . . . . 0.0 117.219 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.42 165.14 11.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.9 m -144.67 144.51 31.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.309 2.643 . . . . 0.0 106.006 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -150.3 152.18 11.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 122.583 1.182 . . . . 0.0 111.864 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -114.37 118.38 33.71 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.2 mtm -79.97 119.98 23.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.11 96.18 1.58 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 t -57.51 150.72 18.25 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 117.104 0.452 . . . . 0.0 111.363 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.6 -21.1 9.42 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -80.75 -6.37 58.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.193 1.397 . . . . 0.0 112.707 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.0 45.7 5.01 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.128 1.347 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.11 0.564 . . . . 0.0 110.214 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 62.9 0.06 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.495 1.918 . . . . 0.0 114.176 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.56 146.86 18.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 O-C-N 120.787 -1.195 . . . . 0.0 107.992 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.86 137.36 32.42 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.415 1.486 . . . . 0.0 112.035 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -119.97 106.77 40.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.141 1.376 . . . . 0.0 111.711 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.88 151.9 94.63 Favored 'Cis proline' 0 CA--C 1.542 0.901 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 -2.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.28 -7.83 46.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.781 2.832 . . . . 0.0 113.518 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.2 m -149.58 124.65 10.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.267 3.027 . . . . 0.0 105.231 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.8 155.49 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.675 0.671 . . . . 0.0 112.494 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -130.97 100.47 5.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.57 1.176 . . . . 0.0 112.069 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.04 -177.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -124.69 135.33 52.95 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.636 1.107 . . . . 0.0 111.643 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 98' ' ' GLU . . . -31.16 103.2 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.933 2.093 . . . . 0.0 112.966 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 -4.64 14.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.688 1.613 . . . . 0.0 112.968 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 64.7 mt-10 -91.94 169.61 10.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.34 1.57 . . . . 0.0 114.747 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.64 163.9 12.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.4 t -148.0 104.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 127.844 2.458 . . . . 0.0 106.715 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.68 111.28 23.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.682 0.793 . . . . 0.0 110.926 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.602 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.14 114.06 26.26 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 14.2 t -96.9 136.98 25.87 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 131.094 3.757 . . . . 0.0 114.161 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.762 HD22 ' HB1' ' A' ' 62' ' ' ALA 0.263 3.7 t-20 -69.9 120.16 15.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 129.955 3.302 . . . . 0.0 107.3 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -132.8 -30.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 116.968 -1.492 . . . . 0.0 113.482 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -158.99 163.96 35.98 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 tp 43.15 48.45 5.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.433 3.093 . . . . 0.0 111.478 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -56.41 144.88 61.15 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.493 2.317 . . . . 0.0 111.747 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.09 175.22 49.07 Favored 'Cis proline' 0 CA--C 1.548 1.214 0 CA-C-O 123.108 1.212 . . . . 0.0 114.166 0.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -146.46 152.11 38.49 Favored 'General case' 0 CA--C 1.528 0.123 1 C-N-CA 132.815 4.446 . . . . 0.0 113.956 177.886 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -142.46 162.03 36.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.279 1.832 . . . . 0.0 110.006 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.624 HG21 ' CE1' ' A' ' 69' ' ' PHE . 20.7 mm -135.62 94.36 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.312 1.445 . . . . 0.0 110.867 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 58' ' ' HIS . 4.2 m -115.5 118.45 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 O-C-N 120.839 -1.163 . . . . 0.0 112.056 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 132.83 39.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -0.71 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 73.24 33.03 1.19 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.101 2.56 . . . . 0.0 111.602 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.88 -16.63 0.44 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 115.644 -2.122 . . . . 0.0 116.061 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.41 -140.94 3.03 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 123.334 2.788 . . . . 0.0 118.748 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.54 -7.11 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.147 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -64.75 153.35 40.08 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.132 1.373 . . . . 0.0 109.447 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.21 66.05 9.11 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.293 -0.879 . . . . 0.0 112.442 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.59 -38.39 20.61 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.53 -10.38 11.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.395 1.878 . . . . 0.0 115.531 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.48 -10.19 7.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.411 2.284 . . . . 0.0 110.316 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 8.56 25.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.885 1.674 . . . . 0.0 112.563 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -142.61 156.96 45.15 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.272 0.942 . . . . 0.0 109.393 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HB2' ' H ' ' A' ' 41' ' ' ILE . 19.1 mt -76.37 60.71 1.59 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.044 2.538 . . . . 0.0 105.338 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 59' ' ' LYS . 44.7 m -21.0 86.11 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 121.106 3.743 . . . . 0.0 121.106 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.434 ' HA ' HG11 ' A' ' 42' ' ' VAL . 96.8 m-70 34.38 12.21 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 1 C-N-CA 135.087 5.355 . . . . 0.0 115.803 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -156.38 -13.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.375 3.07 . . . . 0.0 110.01 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.53 148.85 50.51 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 116.296 -2.859 . . . . 0.0 106.531 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.06 147.43 32.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.762 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -117.29 110.43 18.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 102.505 -3.146 . . . . 0.0 102.505 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -116.9 -31.08 5.54 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.1 136.2 41.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.394 1.477 . . . . 0.0 110.752 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.62 118.54 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.683 1.193 . . . . 0.0 112.423 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.79 4.04 52.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.297 1.904 . . . . 0.0 113.793 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.29 -60.8 3.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 32' ' ' VAL . 1.2 p 64.03 171.38 0.18 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -154.82 135.99 13.95 Favored 'General case' 0 CA--C 1.559 1.318 1 N-CA-C 98.35 -4.685 . . . . 0.0 98.35 176.22 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.26 146.9 30.89 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 118.88 -2.387 . . . . 0.0 108.357 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 p -126.52 151.98 47.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.8 m -153.0 118.68 5.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.95 158.47 44.02 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -136.81 23.71 3.09 Favored 'General case' 0 CA--C 1.546 0.807 1 N-CA-C 123.439 4.607 . . . . 0.0 123.439 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 2.8 pt-20 -89.6 108.83 27.68 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.45 103.0 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.497 1.464 . . . . 0.0 110.446 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.11 -162.98 36.77 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 127.899 2.666 . . . . 0.0 110.969 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -124.01 128.67 49.72 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 122.107 0.956 . . . . 0.0 113.054 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -120.27 127.11 52.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 124.203 1.954 . . . . 0.0 114.25 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -80.53 144.5 32.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.617 -2.538 . . . . 0.0 108.406 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.421 ' CE1' HG23 ' A' ' 95' ' ' VAL . 35.9 p90 -152.5 166.06 33.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.848 0.832 . . . . 0.0 109.709 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -163.77 175.23 10.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.701 0.8 . . . . 0.0 111.502 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.6 t -109.32 116.17 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -42.35 -63.47 0.9 Allowed Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.89 -4.24 8.41 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.427 2.751 . . . . 0.0 116.02 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -130.77 12.18 5.26 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.908 1.231 . . . . 0.0 113.128 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.79 -28.42 22.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.851 2.06 . . . . 0.0 115.161 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -104.59 -5.77 41.85 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 126.68 2.086 . . . . 0.0 114.813 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.2 -5.74 32.74 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.019 2.528 . . . . 0.0 110.932 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.25 34.22 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.789 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 ttt -82.99 63.47 7.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.285 2.042 . . . . 0.0 110.656 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.11 144.5 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 129.879 3.272 . . . . 0.0 109.345 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.4 -175.94 27.0 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.567 1.079 . . . . 0.0 113.927 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -143.35 115.71 8.52 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.368 1.467 . . . . 0.0 114.074 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 81' ' ' TYR . 11.9 t -89.6 147.38 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 127.569 2.348 . . . . 0.0 107.594 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.78 120.5 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.58 113.68 37.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 123.83 0.852 . . . . 0.0 110.481 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.474 ' N ' ' HA ' ' A' ' 24' ' ' LYS . 17.2 pt-20 . . . . . 0 C--O 1.256 1.43 1 C-N-CA 133.961 4.904 . . . . 0.0 114.89 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 26.2 t-20 48.41 72.86 0.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 109.699 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.12 163.62 27.37 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 123.941 1.829 . . . . 0.0 112.638 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -143.8 148.55 35.73 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 129.579 3.152 . . . . 0.0 103.377 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -154.36 156.0 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.283 1.04 . . . . 0.0 109.532 177.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -120.58 105.66 11.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.5 mtm -65.26 119.34 10.72 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.78 99.61 1.09 Allowed Glycine 0 N--CA 1.47 0.961 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.3 t -59.41 152.01 22.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.65 -18.36 53.14 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.907 -1.121 . . . . 0.0 111.16 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -81.49 -7.84 59.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.619 1.968 . . . . 0.0 112.412 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.87 9.19 64.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.84 2.162 . . . . 0.0 115.292 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.56 138.65 34.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.356 0.663 . . . . 0.0 110.154 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.05 73.94 0.91 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.066 1.746 . . . . 0.0 108.646 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.43 134.66 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.02 132.41 37.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.6 pt-20 -117.45 113.34 38.75 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.466 -0.772 . . . . 0.0 112.568 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 92.8 Cg_endo -78.67 138.82 51.56 Favored 'Cis proline' 0 C--N 1.354 0.865 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 -2.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -78.1 -10.94 59.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.62 1.968 . . . . 0.0 112.588 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -142.82 128.47 19.2 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 129.676 3.191 . . . . 0.0 108.561 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 p -148.14 165.51 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.19 0.904 . . . . 0.0 113.426 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 t -131.13 106.32 8.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.943 1.297 . . . . 0.0 110.855 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 2.6 pp -123.24 175.21 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 0.0 109.291 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.535 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -130.79 174.09 10.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.91 100.77 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.889 1.275 . . . . 0.0 113.519 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.88 -2.59 25.82 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.01 1.767 . . . . 0.0 114.245 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.47 173.31 9.71 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.729 1.252 . . . . 0.0 114.356 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -130.71 171.77 12.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 123.426 1.584 . . . . 0.0 111.361 -178.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.84 94.85 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.443 2.297 . . . . 0.0 106.332 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -84.44 51.92 2.23 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.487 ' HB3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -57.94 133.67 55.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.387 2.736 . . . . 0.0 118.387 177.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t -118.86 149.9 21.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 1 C-N-CA 133.564 4.746 . . . . 0.0 114.277 -176.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.651 HD22 ' HB1' ' A' ' 62' ' ' ALA . 2.9 t-20 -78.71 117.72 20.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.57 3.148 . . . . 0.0 107.047 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -129.53 -20.12 3.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 115.748 -2.072 . . . . 0.0 113.939 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.06 153.73 16.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.6 tp 45.98 50.46 11.43 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 131.466 3.907 . . . . 0.0 112.08 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 151.18 4.08 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 129.616 3.166 . . . . 0.0 112.33 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.95 174.25 45.48 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 O-C-N 122.13 0.542 . . . . 0.0 112.507 -2.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -147.95 163.33 37.17 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 130.097 3.359 . . . . 0.0 113.624 177.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -149.28 163.09 38.67 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.82 1.248 . . . . 0.0 113.089 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.14 79.68 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.781 2.032 . . . . 0.0 110.109 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 4.0 m -105.86 118.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 119.89 -1.756 . . . . 0.0 111.663 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 10.6 m-85 -79.54 141.38 36.7 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 121.699 -0.626 . . . . 0.0 110.371 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.64 -16.17 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 69.4 68.51 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.584 1.954 . . . . 0.0 108.181 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -17.44 12.81 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.513 0.725 . . . . 0.0 112.616 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.07 -25.72 6.99 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 117.781 1.872 . . . . 0.0 117.781 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 -9.33 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.906 0.86 . . . . 0.0 111.598 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -93.07 137.78 32.12 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.852 2.461 . . . . 0.0 114.675 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.04 65.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.241 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -43.56 -50.1 7.31 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.175 1.39 . . . . 0.0 112.635 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -60.6 -5.83 1.4 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.679 2.392 . . . . 0.0 115.466 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.34 -3.32 6.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 111.114 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.77 -5.72 14.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.913 2.085 . . . . 0.0 114.642 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 28.4 pttt -130.32 167.61 18.24 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.05 1.74 . . . . 0.0 114.904 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.97 -69.16 0.35 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.93 2.092 . . . . 0.0 110.534 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t 153.06 150.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.737 2.815 . . . . 0.0 110.014 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -70.8 5.16 2.07 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.212 2.205 . . . . 0.0 111.481 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 -25.92 0.82 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.887 2.475 . . . . 0.0 111.266 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.85 136.97 18.0 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 120.342 1.428 . . . . 0.0 110.352 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.45 165.56 29.04 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.651 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -103.64 105.55 15.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -99.07 -24.92 14.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.22 56.26 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.73 112.35 0.45 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.102 1.761 . . . . 0.0 112.288 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.93 -12.61 29.42 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.407 1.48 . . . . 0.0 112.712 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -68.92 87.04 0.36 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.207 1.503 . . . . 0.0 113.811 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 80.6 p -83.71 157.26 22.23 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.799 -1.188 . . . . 0.0 109.863 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -26.02 6.92 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.387 -2.125 . . . . 0.0 108.526 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t 47.49 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 131.529 3.932 . . . . 0.0 116.868 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -135.27 152.79 51.85 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.679 -1.263 . . . . 0.0 111.777 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -143.93 112.05 6.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.753 2.021 . . . . 0.0 109.503 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 154.6 51.24 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.792 2.037 . . . . 0.0 115.44 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -136.52 16.87 3.14 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 pm0 -92.85 96.05 1.26 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' GLU . 8.5 Cg_endo -41.84 118.22 0.86 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 124.433 3.422 . . . . 0.0 112.893 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.51 -152.05 22.7 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 123.243 1.468 . . . . 0.0 112.983 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -145.63 117.57 8.25 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.692 1.197 . . . . 0.0 108.968 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.82 133.43 54.44 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 124.076 1.893 . . . . 0.0 112.346 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.57 151.15 24.73 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.927 3.291 . . . . 0.0 115.021 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CE2' HG23 ' A' ' 95' ' ' VAL . 19.4 p90 -154.78 162.32 41.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.987 1.315 . . . . 0.0 110.108 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -159.64 164.15 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 110.164 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.9 t -99.69 104.59 16.34 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -35.8 -60.62 0.63 Allowed Pre-proline 0 N--CA 1.48 1.055 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.75 -8.11 20.28 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.504 2.136 . . . . 0.0 114.048 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.8 1.84 7.42 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.859 1.209 . . . . 0.0 112.64 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -43.15 -59.69 1.96 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.29 2.636 . . . . 0.0 111.353 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.13 71.04 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.127 1.346 . . . . 0.0 116.056 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -11.25 33.49 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.274 1.429 . . . . 0.0 111.803 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.03 -0.2 17.1 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-O 118.3 -1.278 . . . . 0.0 115.733 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttt -81.67 73.84 8.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.092 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.53 147.65 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 129.351 3.061 . . . . 0.0 108.251 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.63 179.73 34.09 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.039 0.828 . . . . 0.0 114.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -147.48 131.71 17.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.71 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.5 t -97.31 155.99 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 127.367 2.267 . . . . 0.0 108.161 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.71 125.47 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -123.96 142.17 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 124.489 1.118 . . . . 0.0 112.997 177.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 6.0 pt-20 . . . . . 0 C--O 1.253 1.261 1 C-N-CA 134.396 5.078 . . . . 0.0 116.254 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 18.93 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 128.976 2.91 . . . . 0.0 115.189 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.73 156.8 24.82 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.951 -1.093 . . . . 0.0 113.855 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.0 m -136.88 125.08 23.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 103.433 -2.803 . . . . 0.0 103.433 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.06 149.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 122.79 1.281 . . . . 0.0 112.486 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -117.02 116.83 28.12 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.946 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp -76.97 120.81 22.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.68 94.43 1.54 Allowed Glycine 0 N--CA 1.47 0.962 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -58.01 152.41 16.52 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.726 0.411 . . . . 0.0 111.836 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -57.46 -17.63 14.31 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -80.54 -7.53 59.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.255 1.022 . . . . 0.0 112.183 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.97 25.86 30.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.529 1.538 . . . . 0.0 113.984 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.73 140.61 32.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.529 0.732 . . . . 0.0 109.863 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.14 63.41 0.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.132 1.773 . . . . 0.0 112.093 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.85 145.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.609 -1.307 . . . . 0.0 107.637 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.46 144.54 28.67 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.666 1.186 . . . . 0.0 111.367 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 24.3 pt-20 -123.86 108.07 30.72 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.544 1.538 . . . . 0.0 110.928 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 72.1 Cg_endo -78.41 147.26 81.8 Favored 'Cis proline' 0 CA--C 1.542 0.911 0 N-CA-C 116.042 1.516 . . . . 0.0 116.042 -2.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -0.77 57.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.819 2.048 . . . . 0.0 113.351 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -151.48 127.11 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 128.671 2.788 . . . . 0.0 104.929 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.6 158.21 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -138.49 107.17 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.272 1.034 . . . . 0.0 111.078 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.76 173.34 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.239 1.416 . . . . 0.0 108.088 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -128.81 152.01 48.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.68 1.582 . . . . 0.0 110.87 177.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -24.34 115.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.506 2.722 . . . . 0.0 114.713 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.13 -19.92 39.31 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.827 1.679 . . . . 0.0 113.364 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CD ' ' HA ' ' A' ' 1' ' ' ALA . 16.5 mt-10 -79.54 167.63 20.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 122.455 1.121 . . . . 0.0 111.097 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.02 -178.89 3.97 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 122.667 1.222 . . . . 0.0 109.937 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.54 101.41 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -88.5 123.11 32.7 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -127.88 122.22 31.99 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 177.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.32 148.9 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 128.872 2.869 . . . . 0.0 115.315 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.845 HD22 ' HB1' ' A' ' 62' ' ' ALA . 14.0 t-20 -76.88 116.19 17.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 131.182 3.793 . . . . 0.0 109.879 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -131.33 -27.44 1.99 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 116.995 -1.479 . . . . 0.0 114.09 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.35 159.96 37.98 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tp 47.8 49.57 16.52 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 127.92 2.488 . . . . 0.0 111.503 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 140.48 64.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.919 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 165.53 84.79 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 CA-C-O 125.068 2.028 . . . . 0.0 115.79 2.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.508 ' HA ' ' SG ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -144.04 169.63 17.47 Favored 'General case' 0 CA--C 1.515 -0.395 1 C-N-CA 131.915 4.086 . . . . 0.0 111.833 177.723 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -167.63 175.04 7.28 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.372 1.869 . . . . 0.0 109.282 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.539 HG21 ' CE1' ' A' ' 69' ' ' PHE . 33.5 mm -146.67 93.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.402 1.481 . . . . 0.0 109.404 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.03 111.47 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.209 1.404 . . . . 0.0 112.362 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.431 ' H ' ' CB ' ' A' ' 55' ' ' LYS . 14.9 m-85 -72.49 131.8 43.01 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 120.813 -1.179 . . . . 0.0 108.259 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.55 -3.41 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.642 1.977 . . . . 0.0 115.856 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 57.44 52.62 8.36 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.282 1.033 . . . . 0.0 109.783 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.64 -36.02 2.0 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.898 2.079 . . . . 0.0 110.865 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.68 -21.53 3.77 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 118.033 1.973 . . . . 0.0 118.033 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.94 -23.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 117.334 0.567 . . . . 0.0 111.584 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.03 134.45 41.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 129.257 3.023 . . . . 0.0 113.752 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 64.44 8.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -38.6 -50.85 1.62 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.206 2.203 . . . . 0.0 112.733 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -56.95 -9.0 0.71 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 129.713 3.205 . . . . 0.0 115.677 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.39 -4.28 6.08 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.792 2.037 . . . . 0.0 111.003 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.23 -10.52 14.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.68 2.392 . . . . 0.0 113.935 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CB ' ' H ' ' A' ' 43' ' ' PHE . 27.2 pttt -130.5 166.9 19.58 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.045 1.738 . . . . 0.0 114.368 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.17 -72.51 0.21 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.721 1.608 . . . . 0.0 111.99 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t 158.15 149.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.619 2.367 . . . . 0.0 108.664 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -69.43 -10.26 57.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.123 0.969 . . . . 0.0 111.482 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -19.47 8.6 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.244 1.418 . . . . 0.0 110.444 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.46 111.32 4.21 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 120.228 1.377 . . . . 0.0 110.938 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.52 173.08 7.63 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -107.5 101.47 10.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 126.911 2.084 . . . . 0.0 105.95 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.82 -14.09 16.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.842 1.657 . . . . 0.0 114.24 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.47 51.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.552 1.524 . . . . 0.0 113.312 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.11 116.25 1.92 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.127 1.371 . . . . 0.0 112.312 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.35 -13.29 33.45 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.262 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -65.54 157.47 29.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.294 2.047 . . . . 0.0 109.35 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 p -163.29 174.04 12.55 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 118.893 -2.379 . . . . 0.0 113.361 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -152.03 151.03 30.62 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 176.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -113.22 139.27 48.93 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 120.168 -1.583 . . . . 0.0 108.718 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 54.0 p -119.53 152.21 37.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -153.74 125.6 7.76 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.263 0.3 OUTLIER -143.15 150.91 40.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 13.6 t -137.21 14.71 3.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 111.573 -2.558 . . . . 0.0 114.93 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -103.97 99.58 17.14 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.364 1.865 . . . . 0.0 109.409 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.55 125.92 15.03 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.778 2.986 . . . . 0.0 111.395 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.43 -174.72 43.18 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 123.7 1.722 . . . . 0.0 113.157 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -134.11 106.31 7.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.253 0.2 OUTLIER -115.08 137.76 51.65 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 123.918 1.818 . . . . 0.0 113.646 -177.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 147.36 28.76 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 111.737 -2.483 . . . . 0.0 113.176 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 95' ' ' VAL . 38.6 p90 -147.65 155.97 42.31 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.26 0.624 . . . . 0.0 109.591 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -156.19 170.7 21.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.512 0.673 . . . . 0.0 109.696 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER -105.5 119.65 39.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.274 177.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.81 -57.7 11.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.18 -18.88 64.54 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.879 2.064 . . . . 0.0 114.314 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -119.43 14.46 12.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.402 1.455 . . . . 0.0 113.923 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -48.91 -40.75 31.19 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.43 -10.43 59.33 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.819 1.676 . . . . 0.0 114.175 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.86 -7.23 52.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.88 2.072 . . . . 0.0 111.58 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.21 3.96 29.29 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 118.169 -1.351 . . . . 0.0 115.123 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.8 ttt -83.75 76.78 9.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 124.001 1.857 . . . . 0.0 108.413 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.09 146.4 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 129.101 2.96 . . . . 0.0 109.071 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -179.69 32.15 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 124.721 1.153 . . . . 0.0 114.692 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -138.92 120.17 14.74 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.473 1.509 . . . . 0.0 114.851 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.691 HG23 ' CE1' ' A' ' 81' ' ' TYR . 48.1 t -91.68 153.35 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.722 2.009 . . . . 0.0 108.591 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.77 122.24 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.66 126.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 123.347 0.659 . . . . 0.0 109.844 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.507 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 8.4 pt-20 . . . . . 0 C--O 1.252 1.204 1 C-N-CA 135.391 5.477 . . . . 0.0 113.94 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 31.06 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 130.26 3.424 . . . . 0.0 111.944 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.34 172.78 7.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 m -151.42 147.37 26.8 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 130.757 3.623 . . . . 0.0 104.87 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.81 151.99 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 122.872 1.32 . . . . 0.0 109.647 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -111.86 123.84 51.1 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 mtp -87.46 125.17 34.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 35' ' ' LYS . . . 89.97 92.77 1.2 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -58.58 147.0 33.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.257 0.621 . . . . 0.0 109.573 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.35 -15.94 30.41 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -76.73 -8.88 58.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.317 0.647 . . . . 0.0 111.107 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.92 58.1 2.29 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.627 2.06 . . . . 0.0 108.769 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.08 133.25 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 67.02 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.335 1.454 . . . . 0.0 113.062 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.08 147.72 16.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.8 140.58 31.16 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.504 1.921 . . . . 0.0 112.782 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 10.4 pt-20 -124.3 103.48 32.57 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.46 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 60.1 Cg_endo -81.78 140.26 45.33 Favored 'Cis proline' 0 CA--C 1.551 1.357 0 N-CA-C 118.397 2.422 . . . . 0.0 118.397 -2.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -16.59 62.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.676 3.591 . . . . 0.0 114.495 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 20.8 m -157.16 141.09 16.13 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 128.513 2.725 . . . . 0.0 105.38 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.97 149.63 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.973 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -112.19 102.41 10.59 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 125.22 1.575 . . . . 0.0 109.113 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pt -126.32 -178.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 112.274 -2.239 . . . . 0.0 109.134 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.72 172.29 7.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.06 65.4 0.14 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.326 2.25 . . . . 0.0 111.932 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.05 40.35 0.09 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 129.653 3.501 . . . . 0.0 111.904 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -122.13 166.47 14.52 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -109.39 161.6 15.14 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.926 1.346 . . . . 0.0 114.39 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.2 t -145.69 103.47 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 129.442 3.097 . . . . 0.0 106.793 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.97 88.28 2.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.3 138.81 31.55 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.3 145.57 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 130.55 3.54 . . . . 0.0 115.363 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.673 HD22 ' HB1' ' A' ' 62' ' ' ALA . 11.1 t-20 -74.61 124.15 26.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.871 2.469 . . . . 0.0 107.285 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.24 -29.21 1.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.841 -1.552 . . . . 0.0 114.779 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' O ' ' HA3' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -167.73 158.84 11.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 177.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.9 tp 48.51 57.21 6.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.685 . . . . 0.0 111.367 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.56 156.37 32.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.01 160.54 86.36 Favored 'Cis proline' 0 CA--C 1.544 0.982 0 CA-C-O 123.808 1.503 . . . . 0.0 113.857 -1.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 143.03 42.51 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 128.149 2.58 . . . . 0.0 113.599 177.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' HD12 ' A' ' 56' ' ' LEU 0.305 20.1 t-20 -141.56 150.64 42.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.13 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 56' ' ' LEU . 30.4 mm -117.86 94.74 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 58' ' ' HIS . 15.4 m -124.62 114.61 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 123.908 0.883 . . . . 0.0 110.935 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.491 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 36.4 m-85 -74.4 167.96 20.63 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.725 0.81 . . . . 0.0 109.077 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.43 -6.05 23.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.961 2.949 . . . . 0.0 118.961 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 64.83 51.17 1.85 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.407 1.458 . . . . 0.0 110.328 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.15 -37.13 1.93 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.008 2.123 . . . . 0.0 112.641 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.26 -6.72 4.32 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.22 -7.66 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.15 0.975 . . . . 0.0 113.516 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.49 163.56 13.18 Favored 'General case' 0 CA--C 1.541 0.619 1 C-N-CA 134.04 4.936 . . . . 0.0 114.08 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.0 59.7 0.6 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.629 1.172 . . . . 0.0 111.69 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.59 -47.68 63.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -60.71 -7.27 2.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.093 1.757 . . . . 0.0 113.863 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.71 -0.01 11.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.36 1.864 . . . . 0.0 111.337 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.88 16.72 3.88 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 40.9 pttt -137.51 160.36 39.35 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.386 0.993 . . . . 0.0 111.8 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 41' ' ' ILE . 30.8 mt -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.36 1.464 . . . . 0.0 111.469 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 m -71.82 43.8 0.1 Allowed 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 128.935 2.894 . . . . 0.0 116.62 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER 44.92 -56.17 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.098 1 C-N-CA 136.622 5.969 . . . . 0.0 112.115 -177.785 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 -16.85 22.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.264 1.603 . . . . 0.0 108.23 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.59 139.51 23.9 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 103.193 -3.963 . . . . 0.0 103.193 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.1 176.74 12.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -94.94 95.35 8.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -88.45 -27.02 21.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.31 -130.07 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.176 0.99 . . . . 0.0 109.255 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.9 120.89 10.03 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.618 1.967 . . . . 0.0 109.895 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.27 -13.16 23.69 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 117.601 -1.666 . . . . 0.0 113.454 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.84 161.82 25.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.871 2.335 . . . . 0.0 109.329 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 p -161.37 162.76 30.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 120.242 -1.536 . . . . 0.0 112.655 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.75 139.73 28.06 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 101.608 -3.478 . . . . 0.0 101.608 177.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 118.968 -2.333 . . . . 0.0 109.519 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.0 p -121.68 126.02 47.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.543 1.137 . . . . 0.0 108.766 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.2 m -127.62 101.3 6.34 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.08 2.152 . . . . 0.0 107.796 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -116.62 138.84 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 118.754 2.872 . . . . 0.0 118.754 178.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -118.2 6.53 11.99 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.152 2.981 . . . . 0.0 118.114 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -106.31 94.83 10.31 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.345 1.058 . . . . 0.0 112.553 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 98' ' ' GLU . 36.4 Cg_endo -56.26 120.35 8.15 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.284 2.656 . . . . 0.0 108.453 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.34 -3.17 0.03 OUTLIER Glycine 0 CA--C 1.528 0.85 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t 53.79 94.85 0.02 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 130.619 3.568 . . . . 0.0 110.868 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -101.8 149.61 24.0 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 117.112 -1.835 . . . . 0.0 113.421 -177.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -92.21 154.42 18.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 110.851 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.78 171.62 19.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.55 1.54 . . . . 0.0 112.036 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.16 -171.41 2.19 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.746 2.019 . . . . 0.0 109.832 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.1 t -122.58 113.05 18.75 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.59 1.556 . . . . 0.0 111.185 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -41.38 -50.16 8.91 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -0.3 10.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.299 2.666 . . . . 0.0 116.799 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -137.54 10.13 2.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -43.71 -50.45 7.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.08 -8.88 85.96 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 126.152 1.834 . . . . 0.0 115.01 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.09 -8.94 35.12 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.43 1.892 . . . . 0.0 111.169 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 7.47 30.22 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.377 -1.235 . . . . 0.0 115.996 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.3 ttt -83.15 63.52 7.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.911 1.855 . . . . 0.0 110.623 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.57 145.78 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 129.312 3.045 . . . . 0.0 111.507 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.26 -176.74 31.65 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 125.406 1.479 . . . . 0.0 115.026 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.0 ttmm -136.11 171.45 14.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.36 1.464 . . . . 0.0 110.304 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -141.25 150.73 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 119.257 -2.152 . . . . 0.0 108.362 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.44 110.49 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 100.898 -3.741 . . . . 0.0 100.898 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.94 53.65 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 124.377 2.037 . . . . 0.0 110.98 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 131.379 3.871 . . . . 0.0 113.388 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 42.41 73.15 0.14 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.14 1.776 . . . . 0.0 110.453 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.02 157.32 35.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.856 1.789 . . . . 0.0 112.854 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 m -139.45 143.47 37.59 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 150.59 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 119.19 0.905 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 16' ' ' PHE . 10.0 mtpt -120.1 116.56 25.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtm -76.33 122.28 24.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.597 1.959 . . . . 0.0 106.917 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.04 1.19 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.041 -2.023 . . . . 0.0 108.041 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 t -58.2 148.18 27.84 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.148 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.23 -14.21 16.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.2 m -79.42 -10.83 59.89 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.75 0.704 . . . . 0.0 111.126 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.32 15.0 45.88 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.927 1.727 . . . . 0.0 113.461 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.76 128.31 35.32 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.821 1.311 . . . . 0.0 109.188 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.69 66.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.433 1.893 . . . . 0.0 111.667 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.03 151.01 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -100.52 130.4 46.59 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.757 1.223 . . . . 0.0 108.009 177.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 3.7 pt-20 -100.87 131.55 23.28 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.414 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' GLU 0.301 7.4 Cg_exo -77.58 -13.23 30.16 Favored 'Cis proline' 0 C--N 1.355 0.882 1 N-CA-C 125.071 4.989 . . . . 0.0 125.071 2.757 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t 93.12 -15.98 0.13 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 131.242 3.817 . . . . 0.0 109.929 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 m -153.82 129.78 10.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 125.959 1.704 . . . . 0.0 108.083 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 22' ' ' THR . 1.8 p -144.86 168.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 113.307 -1.77 . . . . 0.0 113.726 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 21' ' ' VAL . 9.9 t -132.63 115.08 14.96 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 113.518 -1.673 . . . . 0.0 110.936 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pt -133.8 -179.27 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.361 1.464 . . . . 0.0 110.267 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HA ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -119.98 176.65 5.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 177.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 74' ' ' THR . . . -60.44 115.18 3.38 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.181 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.77 67.61 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.878 1.704 . . . . 0.0 112.383 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 1' ' ' ALA . 18.3 tt0 -82.92 161.58 21.8 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.162 0.985 . . . . 0.0 112.498 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' CD ' ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt-20 -108.09 166.7 10.54 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.977 1.37 . . . . 0.0 113.762 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.32 97.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.177 2.591 . . . . 0.0 105.456 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HE3' ' CD ' ' A' ' 28' ' ' GLU . 5.0 ptpp? -98.95 106.59 18.87 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.636 1.208 . . . . 0.0 112.756 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE1' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -106.57 122.22 45.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.08 153.02 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 109.092 -3.685 . . . . 0.0 113.435 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.581 HD22 ' HB1' ' A' ' 62' ' ' ALA 0.261 3.8 t-20 -86.81 107.84 18.47 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 131.612 3.965 . . . . 0.0 106.883 177.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -120.0 -32.54 4.18 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.96 34.61 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 tp 41.32 57.91 2.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.058 2.943 . . . . 0.0 112.952 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.41 151.53 59.34 Favored Pre-proline 0 CA--C 1.537 0.452 1 C-N-CA 132.256 4.222 . . . . 0.0 111.692 177.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.52 174.99 45.92 Favored 'Cis proline' 0 CA--C 1.543 0.96 0 CA-C-O 122.57 0.987 . . . . 0.0 112.314 -2.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CE1' ' CG ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.0 161.23 42.73 Favored 'General case' 0 C--O 1.224 -0.287 1 C-N-CA 132.99 4.516 . . . . 0.0 114.449 177.912 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.13 159.11 42.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.92 0.888 . . . . 0.0 112.602 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.727 HG21 ' CE1' ' A' ' 69' ' ' PHE . 4.8 mp -120.87 109.14 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.262 0.625 . . . . 0.0 110.576 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.05 113.8 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.244 1.018 . . . . 0.0 113.722 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 79' ' ' TYR . 27.3 m-85 -80.85 134.6 35.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.177 1.391 . . . . 0.0 110.383 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.32 43.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.801 1.24 . . . . 0.0 113.616 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 87.92 -23.33 0.12 Allowed 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 129.742 3.217 . . . . 0.0 115.387 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.11 -6.3 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 129.076 2.95 . . . . 0.0 113.952 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 106.02 -14.46 44.63 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 126.994 2.235 . . . . 0.0 114.56 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.23 -26.2 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.33 148.63 41.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.406 0.548 . . . . 0.0 111.683 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.84 70.36 3.28 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -50.55 -42.19 54.96 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -71.78 0.1 9.77 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.46 -19.55 3.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.269 1.427 . . . . 0.0 112.532 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.21 0.15 39.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.753 1.221 . . . . 0.0 112.806 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -133.9 168.72 18.24 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 119.871 1.214 . . . . 0.0 113.86 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' ILE . 39.6 mt -72.45 163.32 28.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.999 1.319 . . . . 0.0 112.035 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.5 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 129.112 2.965 . . . . 0.0 118.487 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 51.45 -47.9 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 1 C-N-CA 136.801 6.04 . . . . 0.0 111.518 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.18 -22.09 24.22 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 126.932 2.093 . . . . 0.0 106.958 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.37 150.98 41.11 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 177.13 11.22 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.449 2.124 . . . . 0.0 116.56 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 33' ' ' ASN . . . -109.5 104.45 13.51 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.063 -2.94 . . . . 0.0 103.063 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -102.69 -24.06 13.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.17 131.69 55.77 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.35 116.06 1.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.357 1.463 . . . . 0.0 112.186 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.91 -9.96 34.35 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.712 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -68.36 163.39 23.22 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.286 2.043 . . . . 0.0 109.214 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -167.49 165.38 14.76 Favored 'General case' 0 CA--C 1.501 -0.937 0 O-C-N 119.312 -2.117 . . . . 0.0 111.706 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.727 ' CE1' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.71 140.62 34.92 Favored 'General case' 0 CA--C 1.551 0.986 1 N-CA-C 99.626 -4.213 . . . . 0.0 99.626 176.702 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -110.6 143.85 40.38 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 109.504 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.9 p -124.53 135.03 52.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.858 1.263 . . . . 0.0 110.012 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.7 m -135.4 137.24 42.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.912 2.085 . . . . 0.0 107.651 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CD1' HG11 ' A' ' 97' ' ' VAL 0.324 0.2 OUTLIER -148.31 156.61 42.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 119.67 3.211 . . . . 0.0 119.67 -177.758 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 14.7 t -140.12 23.45 2.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.272 2.693 . . . . 0.0 118.272 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -101.04 92.51 2.48 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.82 1.648 . . . . 0.0 111.197 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.48 108.9 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.443 2.095 . . . . 0.0 112.037 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.13 -128.2 1.72 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.879 1.704 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 t -167.02 146.37 5.3 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.773 -1.427 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' HD2' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -134.06 140.55 46.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.669 1.223 . . . . 0.0 112.424 176.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -91.51 141.51 28.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.833 2.853 . . . . 0.0 112.233 -177.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' CZ3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.52 169.63 18.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.082 0.944 . . . . 0.0 112.424 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -162.76 -178.31 6.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.26 2.224 . . . . 0.0 113.183 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.1 t -114.26 111.82 22.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.64 1.976 . . . . 0.0 109.059 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -38.04 -64.23 0.47 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -64.93 -10.3 24.8 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.931 2.421 . . . . 0.0 115.422 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -124.26 9.78 8.6 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -44.16 -62.33 1.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.87 1.668 . . . . 0.0 111.457 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.17 -13.85 60.63 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 126.025 1.774 . . . . 0.0 116.046 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.89 -7.2 40.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.383 2.273 . . . . 0.0 111.147 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.28 10.43 36.36 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.326 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.7 ttt -81.03 64.42 5.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.348 2.074 . . . . 0.0 109.635 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.07 154.86 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 131.494 3.918 . . . . 0.0 110.897 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.38 -169.61 32.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.687 1.613 . . . . 0.0 114.002 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' HG2' ' H ' ' A' ' 95' ' ' VAL . 18.6 tttm -140.12 174.19 10.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.311 1.044 . . . . 0.0 110.208 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 12.2 t -150.72 133.83 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 128.18 2.592 . . . . 0.0 108.795 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.29 131.1 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 ' CD1' ' A' ' 73' ' ' PHE . 1.4 m -127.25 132.72 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 125.029 1.456 . . . . 0.0 112.911 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' A' ' 24' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.482 1.167 1 C-N-CA 137.992 6.517 . . . . 0.0 114.526 -179.365 . . . . . . . . 2 2 . 1 stop_ save_